Scientific Program for 31 st World Congress of Endourology & SWL Program Book

Tuesday, October 22, 2013   Moderated Poster Session MP1A   1:00 pm–3:00 pm

BASIC RESEARCH: UPPER TRACT PHYSIOLOGY

Room Nottoway @ Sheraton New Orleans

Chair: John D. Denstedt

Faculty: Yoshinari Ono and Gunter Janetschek

*Presenting author

MP1A-01 EVALUATION OF POTENTIAL PHARMACEUTICAL AGENTS FOR A DRUG ELUTING URETERIC STENT USING EX-VIVO INVESTIGATION INTO THE UROTHELIAL PERMEABILITY

Nicholas Williams, Chris Allender, Jenna Bowen, Marc Gumbleton, Cardiff, United Kingdom, Tim Harrah, Jamie Li, Boston, MA, Hrishi Joshi*, Cardiff, United Kingdom

MP1A-02 UNDERSTANDING STENT-INDUCED URETERAL APERISTALSIS

Claudia Janssen*, Wolfgang Jaeger, Dennis Solomon, Ladan Fazli, Ralph Buttyan, Ben H. Chew, Chun Y. Seow, Dirk Lange, Vancouver, Canada

MP1A-03 ACOUSTIC BUBBLE REMOVAL TO ENHANCE THE EFFICACY OF SHOCK WAVE LITHOTRIPSY: AN IN-VITRO STUDY

Alexander P. Duryea*, William W. Roberts, Charles A. Cain, Hedieh A. Tamaddoni, Timothy L. Hall, Ann Arbor, MI

MP1A-04 COMPARATIVE IN-VITRO STUDY OF THE EFFECTIVENESS OF NANOSECOND ELECTRICAL PULSE AND LASER LITHOTRIPTERS

Alexey Martov, Dimitry Ergakov*, Moscow, Russian Federation, Valery Diamant, Katsrin, Israel, Artem Borisik, Andrey Andronov, Moscow, Russian Federation, Vladimir Chernenko, Tomsk, Russian Federation

MP1A-05 DETECTING MICRO-STONES IN URINE WITH QUANTITATIVE RAMAN SPECTROSCOPY AFTER ESWL

Yichun Chiu*, Po-An Chen, Huihua Chiang, Thomas Hsueh, Shing-Hwa Lu, Allen Chiu, Taipei, Taiwan

MP1A-06 URINE AQUAPORIN-1 AND PERILIPIN-2: CAN THESE MARKERS ASSIST IN THE EVALUATION OF SMALL RENAL MASSES?

Jonathan Mobley*, Jeremiah Morrissey, Sam Bhayani, Joseph Song, Joel Vetter, Evan Kharasch, Robert Figenshau, St. Louis, MO

MP1A-07 INTRA AND EXTRA-RENAL AUTONOMIC NERVOUS SYSTEM REDEFINED

Achim Lusch*, Emon Heidari, Ryan Leary, Zhamshid Okhunov, Jamie Wikenheiser, Jaime Landman, Orange, CA

MP1A-08 SECRETED FACTORS FROM PERITUMOR ADIPOSE TISSUES OF CLEAR CELL RENAL CELL CARCINOMA INCREASED THE MOTILITY OF HUMAN CCRCC CELL LINE CAKI-2 VIA ENHANCEMENT OF WNT SIGNALING

Achim Lusch*, Christopher Blair, Molly Baker, Zhamshid Okhunov, Victor Huynh, Xiaolin Zi, Jaime Landman, Orange, CA

MP1A-09 CAN REMOTE ISCHEMIC PRECONDITIONING CONFER PROTECTION AGAINST REPERFUSION INJURY FOLLOWING WARM ISCHEMIA IN A PORCINE SOLITARY-KIDNEY MODEL?

Jeffrey Gahan*, Jodi Antonelli, Bedir Selahattin, Yunbo Ma, Steve Faddegon, Payal Kapur, Jeffrey Cadeddu, Dallas, TX

MP1A-10 URINARY CYSTATIN C AND NGAL AS EARLY BIOMARKERS FOR ASSESSMENT OF RENAL ISCHEMIA- REPERFUSION INJURY: A SERUM MARKER TO REPLACE CREATININE?

Ben Woodson*, Liang Wang, Sree Mandava, Benjamin Lee, New Orleans, LA

MP1A-11 MULTIPHOTON MICROSCOPIC CHARACTERIZATION OF RENAL CELL CARCINOMA

Sara Best*, E. Jason Abel, Matthew Houlihan, Kevin Eliceiri, Madison, WI

MP1A-12 ADDITION OF SODIUM BICARBONATE TO IRRIGATION SOLUTION MAY ASSIST IN DISSOLUTION OF URIC ACID FRAGMENTS DURING URETEROSCOPY

Jessica E Paonessa*, Naeem Bhojani, James C Williams, Jr., James E Lingeman, Indianapolis, IN

MP1A-13 DIETARY HYDROXYPROLINE INDUCED CALCIUM OXALATE LITHIASIS AND ASSOCIATED RENAL INJURY IN THE PORCINE MODEL

Sri Sivalingam*, Stephen Nakada, Priyanka Sehgal, Tom Crenshaw, Kristina Penniston, Madison, WI

MP1A-14 THE RECOVERY OF URETERAL PERISTALSIS AFTER TRANSIENT OBSTRUCTION IN A NOVEL MURINE MODEL

Claudia Janssen*, Wolfgang Jaeger, Igor Moskalev, Ben H. Chew, Dirk Lange, Vancouver, Canada

MP1A-15 RAMAN SPECTROSCOPIC COMPOSITION ANALYSIS OF URINARY CALCULI

Matthias Eder*, Elena Foditsch, Reinhold Zimmermann, Maurizio Musso, Guenther Redhammer, Paolo Sereni, Salzburg, Austria

MP1A-16 KIDNEY STONE PREVENTION: CAN OBESE PATIENTS FOLLOW A DIET?

Fabio Torricelli*, Shubha De, Ina Tien, Manoj Monga, Cleveland, OH

MP1A-17 HYDROXYPROLINE METABOLISM TO URINARY OXALATE AND GLYCOLATE EXCRETION IN NORMAL SUBJECTS

Dean Assimos*, Ross Holmes, John Knight, Birmingham, AL

MP1A-18 STONE DEPICTION WITH THE URO DYNA-CT: STONES OF DIFFERENT COMPOSITIONS

Benjamin Meister*, Marie-Claire Rassweiler, Maurice-Stephan Michel, Manuel Ritter, Mannheim, Germany

MP1A-19 IN VITRO STONE DISINTEGRATION OF STANDARDIZED BON(N) STONES TO COMPARE THE DIODE LASER 1.318NM WITH THE HOLMIUM LASER 2.100 NM AND ESTABLISHING AN EX VIVO ANIMAL MODEL FOR IN SITU DIODE LASER EVALUATION

Reinhold Zimmermann*, Markus Wallner, Salzburg, Austria, Roswitha Siener, Bonn, Germany, Gunter Janetschek, Esra Foditsch, Salzburg, Austria

MP1A-20 THE TENSION TEST AND IN VITRO DEGRADATION OF POLY(LACTIC ACID - GLYCOLIC ACID)/POLYCAPROLACTONE BIODEGRADABLE NANO-STRUCTURE URETERAL STENT FABRICATED BY ELECTROSPINNING

Xiao Qing Wang, Hong Li Shan, Zhi Hua Lu, Yu Chuan Hou, Chun Xi Wang*, Changchun, China, People's Republic of

MP1A-21 HOW TO DETECT ACUTE POST-OPERATIVE KIDNEY INJURY AFTER CLAMPLESS LAPAROSCOPIC PARTIAL NEPHRECTOMY? A PILOT STUDY

Francesco Porpiglia*, Daniele Amparore, Riccardo Bertolo, Fabrizio Mele, Diletta Garrou, Giovanni Cattaneo, Matteo Manfredi, Cristian Fiori, Orbassano (Torino), Italy

MP1A-22 BIOMECHANICAL PROPERTIES OF THE URETER: PRELIMINARY RESULTS

Yaniv Shilo*, Joseph E. Pichamuthu, Timothy D. Averch, Stephen V. Jackman, David A. Vorp, Pittsburgh, PA

MP1A-23 SPECTROSCOPIC TISSUE ANALYSIS OF RENAL ISCHEMIA AND RECOVERY DURING SEGMENTAL RENAL ARTERY VS MAIN RENAL ARTERY CLAMPING

Philip Dorsey*, Quincy Brown, New Orleans, LA, Janet Colli, Memphis, TN, Kate Elfer, Theodore Saitz, Ross McCaslin, Benjamin Lee, New Orleans, LA

MP1A-24 NOVEL BIOMARKERS TO MEASURE CHANGES IN KIDNEY FUNCTION IN THE ADULT HUMAN

Sree Harsha Mandava*, Benjamin Woodson, Liang Wang, Benjamin Lee, New Orleans, LA

MP1A-25 INCIDENCE OF HYBRID TUMORS FOUND IN EXCISED RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS

David Fumo*, Toledo, OH, Pengbo Jiang, Hackensack, NJ, Khaled Shahrour, Toledo, OH, Ravi Munver, Hackensack, NJ, Samay Jain, Toledo, OH

Tuesday, October 22, 2013   Moderated Poster Session MP1B   1:00 pm–3:00 pm

BASIC RESEARCH: UROLITHIASIS

Room Bayside A-C @ Sheraton New Orleans

Chair: Dean Assimos

Faculty: Mahesh Desai and Mantu Gupta

*Presenting author

MP1B-01 A URETEROSCOPIC LITHOTRITE: IN VITRO ASSESSMENT OF A NOVEL FLEXIBLE PROBE ULTRASONIC INTRACORPOREAL DEVICE

Jessica E Paonessa*, Naeem Bhojani, James A McAteer, James C Williams, Jr., James E Lingeman, Indianapolis, IN

MP1B-02 ACTIVITY LEVELS AND STONE DISEASE: A POPULATION BASED ANALYSIS USING THE NATIONAL HEALTH AND NUTRITION EXAMINATION DATABASE

Shubha De*, Jiangbo Li, Fabio Torricelli, Manoj Monga, Cleveland, OH

MP1B-03 THE VALUE OF REPEATING A TEST: METABOLIC PROFILES

Ranan Dasgupta*, Saskia Verhagen, Jeremy Cox, London, United Kingdom

MP1B-04 CHANGING TRENDS IN AMERICAN DIET AND THE RISING PREVALENCE OF KIDNEY STONES

Fabio Torricelli*, Shubha De, XIaobo Liu, Manoj Monga, Cleveland, OH

MP1B-05 HOW MUCH FORCE TO DISLODGE A STONE FROM RANDALL'S PLAQUE? INTRAOPERATIVE DISTRACTION FORCES

Shubha De, Robert Brown*, Carl Sarkissian, Manoj Monga, Cleveland, OH

MP1B-06 UPPER CALYCEAL PERCUTANEOUS NEPHROLITHOTOMY (PCNL) UNDER SPINAL ANESTHESIA: A PROSPECTIVE STUDY

Haresh Thummar*, R Ganatra, Rajkot, India

MP1B-07 DEVELOPMENT OF A NOVEL ACCESS SHEATH THAT ALLOWS SIMULTANEOUS SHEATH PLACEMENT AND SAFETY WIRE ACCESS

Yung Tan*, Doh Cha, Edan Shapiro, Ciara Marley, Mantu Gupta, New York, NY

MP1B-08 DISSOLUTION KINETICS OF URIC ACID STONES IN RELATION TO URIC ACID SOLUTION CONCENTRATION. AN IN VITRO STUDY

Itay Sagy*, Bezalel Sivan, Petach Tikva, Israel, Ruth Frid, Ytzhak Mastai, Ramat-Gan, Israel, Pinchas M. Livne, David Lifshitz, Petach Tikva, Israel

MP1B-09 EFFECT OF HYDROPHILIC EXTRACT OF ALHAGI MAURORUM ON ETHYLENE GLYCOL-INDUCED RENAL STONE IN MALE WISTAR RATS

Sadrollah Mehrabi*, Yasuj, Iran, Farhad Mehrabi, Shiraz, Iran

MP1B-10 COMPARISON OF THE IMPACT OF NANOSECOND ELECTROPULSE AND ELECTROHYDRAULIC LITHOTRIPTERS ON URINARY TRACT TISSUE

Alexander Gudkov, Dimitry Ergakov*, Tomsk, Russian Federation, Valery Diamant, Katsrin, Israel, Maxim Lozovsky, Tomsk, Russian Federation, Gennady Chepovetsky, Katsrin, Israel, Marat Lerner, Tomsk, Russian Federation

MP1B-11 STUDY OF THE DIFFERENCES BETWEEN NANOSECOND ELECTROPULSE AND ELECTROHYDRAULIC METHODS OF LITHOTRIPSY

Alexey Martov, Moscow, Russian Federation, Alexander Gudkov, Dimitry Ergakov*, Tomsk, Russian Federation, Valery Diamant, Gennady Chepovetsky, Katsrin, Israel, Marat Lerner, Tomsk, Russian Federation

MP1B-12 COMBINATION OF RIGID URETEROSCOPY WITH FLEXIBLE URETEROSCOPY DOES NOT HAVE ANY NEGATIVE IMPACT ON THE OUTCOMES

Erdal Alkan, Mirac Turan, Oguz Ozkanli, Egemen Avcý, Mehmet Murad Basar, Yusuf Oguz Acar, Derya Balbay*, Istanbul, Turkey

MP1B-13 SIZE-MEASUREMENT OF RENAL STONES WITH THE URO DYNA-CT

Benjamin Meister*, Marie-Claire Rassweiler, Christel Weiß, Maurice-Stephan Michel, Axel Haecker, Manuel Ritter, Mannheim, Germany

MP1B-14 IS LYMPHOCYTOPENIA A NEW MARKER FOR PYONEPHROTIC OBSTRUCTED KIDNEYS (POK) SECONDARY TO URINARY STONE DISEASE?

Ahmed Ali*, Liam Farrell, Bhaskar Somani, Southampton, United Kingdom

MP1B-15 AN IN VITRO COMPARISON OF THE USE OF ABDOMINAL AND BONE WINDOWS ON COMPUTED TOMOGRAPHY MEASUREMENTS OF HOUNSFIELD UNITS AND SIZE OF STONES

Paul Erotocritou*, Miles Walkden, Daron Smith, London, United Kingdom

MP1B-16 EFFECTIVENESS OF FLEXIBLE URETERORENOSCOPY FOR MULTIPLE UNILATERAL INTRARENAL STONES SMALLER THAN 2 CM

Erdal Alkan, Oguz Ozkanli, Egemen Avcý, Mirac Turan, Mehmet Murad Basar, Yusuf Oguz Acar, Derya Balbay*, Istanbul, Turkey

MP1B-17 EXTERNAL VALIDATION OF AN INDIVIDUALIZED WEIGHT-BASED GOAL URINE VOLUME (WGUV) MODEL INTENDED TO IMPROVE EXPECTED CALIUM URINE CONCENTRATIONS

Jack Lambert*, Norfolk, VA, Nicole Miller, Nashville, TN, Justin Watson, Michael Fabrizio, Mark Sawyer, Norfolk, VA

MP1B-18 THE ANIMAL MODEL IN STONE DISEASE: A TRIBUTE

Michael Moran*, Tucson, AZ

MP1B-19 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) FOR RENAL AND URETERAL STONES IN SOETOMO HOSPITAL FROM 2011 TO 2012

Muhammad Ridha, M Ayodhia Soebadi*, Doddy M Soebadi, Surabaya, Indonesia

MP1B-20 FACILITY SITUATION OF STONE TREATMENT 2013 IN GERMANY: RESULTS FROM A NATION-WIDE HOSPITAL SURVEY

Wolfgang Brummeisl*, Christian Chaussy, Regensburg, Germany, Jens Rassweiler, Heilbronn, Germany, Thomas Knoll, Sindelfingen, Germany, Andreas Gross, Hamburg, Germany, Kai Koehrmann, Mannheim, Germany, Wolf Wieland, Hans-Martin Fritsche, Regensburg, Germany

MP1B-21 STONE RADIODENSITY ON NON-CONTRAST COMPUTED TOMOGRAPHY IS A PARAMETER FOR PREDICTING OUTCOME OF EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY FOR RENAL STONE

Heshmatollah Sofi Majidpour*, Hooshmand Sofi Majidpour, Sanandaj, Iran

MP1B-22 PROSPECTIVE COMPARISON BETWEEN TAMSULOSIN AND RENALIT COMBI COLIC AS A TREATMENT OF RENO-URETERAL CALCULI EXPULSION AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL)

Alessio Zordani, Marco Rosa*, Alessandro Mofferdin, Maria Chiara Sighinolfi, Eugenio Martorana, Salvatore MIcali, Giampaolo Bianchi, Modena, Italy

MP1B-23 RADIATION EXPOSURE IS 2.6 FOLD HIGHER AT ENDOSCOPIC LITHOTRIPSY VERSUS SWL

Yoram I. Siegel, Shmuel Roizman*, Sigalit Haruz-Waschitz, Zerifin, Israel, Avi Ben-Shlomo, yAvne, Israel, David Yudelevich, Amir Cooper, Yaniv Shilo, Amnon Zisman, Zerifin, Israel

MP1B-24 AGE PREDICTS SUCCESS OF ELECTROMAGNETIC SHOCK WAVE LITHOTRIPSY FOR URETERAL STONES

Sameer Deshmukh*, Brian Eisner, Boston, MA

MP1B-25 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR RENAL CALCULI: A REVIEW OF 4041 CONSECUTIVE CASES DONE OVER 20 YEARS

Jitendra Jagtap*, Raguram Ganesamoni, Jigish Vyas, Shashikant Mishra, Arvind Ganpule, Ravindra Sabnis, Mahesh Desai, Nadiad, India

Tuesday, October 22, 2013   Moderated Poster Session MP2A   3:00 pm–5:00 pm

BASIC RESEARCH: LOWER TRACT PHYSIOLOGY

Room Nottoway @ Sheraton New Orleans

Chair: Glenn Preminger

Faculty: Jean de la Rosette and Isaac Y. Kim

*Presenting author

MP2A-01 ALDH1 EXPRESSION AS TUMOR STEM CELLS MARKER AND ITS RELATIONSHIP TO CLINICOPATHOLOGIC PARAMETERS AND PROGNOSIS IN INVASIVE BLADDER CANCER

Hai Ming Wang, Hai Tao Zhang, Ning Xu*, Changchun, China, People's Republic of

MP2A-02 THE CLINICAL SIGNIFICANCE OF SERUM AMYLOID PROTEIN A IN PROSTATE CANCER PATIENTS

Zhong Shuai Cao, Hong Li Shan*, Changchun, China, People's Republic of

MP2A-03 ALDH1 EXPRESSION AS TUMOR STEM CELLS MARKER AND CLINICAL SIGNIFICANCE IN NONINVASIVE BLADDER CANCER

Hai Ming Wang, Ming Ming Shao, Ning Xu*, Changchun, China, People's Republic of

MP2A-04 EFFECTIVENESS OF TAMSULOSIN IN PREVENTION OF POST-OPERATIVE URINARY RETENTION: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

Ali Hamidi Madani*, Hamidreza Baghani Aval, Gholamreza Mokhtari, Hamidreza Nasseh, Samaneh Esmaeili, Rasht, Iran, Maryam Shakiba, Tehran, Iran, Reza Shahrokhi Damavand, Seyed Mohamad Seyed Saadat, Rasht, Iran

MP2A-05 NON OBSTRUCTIVE URINARY TRACT DILATATION: LONG TERM FOLLOW UP OF A SINGLE CASE

Aditi Kumar*, Aniruddha Chakravarti, Anthony D'Sa, Birmingham, United Kingdom

MP2A-06 URINE CONCENTRATIONS OF AQUAPORIN-1 AND PERILIPIN-2 NORMALIZE IN PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING EXCISION OF TUMORS

Jonathan Mobley*, Jeremiah Morrissey, Sam Bhayani, Joseph Song, Joel Vetter, Evan Kharasch, Robert Figenshau, St. Louis, MO

MP2A-07 THE BIOCOMPATIBILITY OF POLY(LACTIC ACID - GLYCOLIC ACID)/POLYCAPROLACTONE BIODEGRADABLE NANO-STRUCTURE URETERAL STENT FABRICATED BY ELECTROSPINNING

Xiao Qing Wang, Hong Li Shan, Yu Chuan Hou, Jing Hai Hu, Yuan Yuan Hao, Chun Xi Wang*, Changchun, China, People's Republic of

MP2A-08 ASSOCIATION OF HYPERTENSION WITH SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA

Xin Jiang, Shi Ying Li*, Jilin, China, People's Republic of

MP2A-09 IMPACT OF RHO-KINASE INHIBITOR HYDROXYFUSIDIL IN PROTAMINE SULPHATE INDUCED CYSTITIS IN RATS

Yigit Akin*, Aliseydi Bozkurt, Erzincan, Turkey, Huseyin Serkan Erol, Mesut Halici, Fikret Celebi, Kubra Asena Kapakin Terim, Erzurum, Turkey, Hakan Gulmez, Ankara, Turkey, Mutlu Ates, Afyonkarahisar, Turkey, Taha Abdulkadir Coban, Baris Nuhoglu, Erzincan, Turkey

MP2A-10 THE RECLASSIFICATION OF PREOPERATIVE HIGH RISK PROSTATE CANCER PATIENTS AFTER ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY

Vladimir Mouraviev*, Matt Kardjian, Po Lam, Angelo Rosalio, Elan Salzhauer, Harvey Sauer, Syracuse, NY, Matvey Tsivian, Durham, NC, Christopher Pieczonka, Jeffrey Sekula, Ilija Aleksic, David Albala, Syracuse, NY

MP2A-11 ANASTOMOTIC STRICTURES IN A LARGE COHORT OF 2800 PATIENTS AFTER LAPAROSCOPIC AND ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY

Marcel Hruza*, Ali Goezen, Heilbronn, Germany, Justo Lorenzo Bermejo, Heidelberg, Germany, Michael Schulze, Jan Klein, Jens Rassweiler, Heilbronn, Germany

MP2A-12 ROBOT ASSISTED RADICAL PROSTATECTOMY (RALP): “TRIFECTA” RESULTS IN MORE THAN FIVE YEARS OF ACTIVITY

Giampaolo Bianchi, Modena, Italy, Ahmed Ghaith*, Tanta, Egypt, Cosimo De Carne, Francesco Fidanza, Stefano Puliatti, Eugenio Martorana, Salvatore MIcali, Modena, Italy

MP2A-13 PERIOPERATIVE OUTCOMES OF OPEN RADICAL PROSTATECTOMY VERSUS ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY IN FILIPINO MEN: EXPERIENCE IN A SINGLE INSTITUTION

Joel Estanislao*, Jose Benito Abraham, Josefino Castillo, Michael Chua, Quezon, Philippines

MP2A-14 UROLOGIC LAPAROSCOPE SURGERIES IN ELDERLY: ANALYSIS OF PRE-OPERATIVE RISK FACTORS AND POSTOPERATIVE COMPLICATIONS

Sompol Permpongkosol*, Bangkok, Thailand

MP2A-15 POSITIVE SURGICAL MARGINS LOCATION IN ROBOTIC PROSTATECTOMY: ARE TRENDS CHANGING IN THE PT3 POPULATION?

Yu-Kai Su*, Shailen Sehgal, Ziho Lee, Philadelphia, PA, Yu-Chen Su, Los Angeles, CA, David Lee, Philadelphia, PA

MP2A-16 REMOVAL OF PELVIC SCHWANNOMA USING A HAND-ASSISTED TRANSPERITONEOSCOPIC APPROACH: DESCRIPTION OF AN EFFECTIVE NOVEL TECHNIQUE

Thomas Y. Hsueh*, Allen W. Chiu, Taipei, Taiwan

MP2A-17 PREDICTING MIDDLE-TERM SURVIVAL IN INTERMEDIATE RISK PROSTATE CANCER IN PATIENTS SUBMITTED TO ROBOTIC ASSISTED RADICAL PROSTATECTOMY (RARP) AND LAPAROSCOPIC RADICAL PROSTATECTOMY (LRP) WITH AND WITHOUT

Guilherme de Almeida Prado Costa*, Ana Maria Autran-Gomez, Francois Audenet, Rafael Sanchez-Salas, Dominique Prapotnich, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP2A-18 STAGE MIGRATION OF PROSTATE CANCER FOLLOWING A NATIONAL DISASTER – ANALYSIS OF THE SURVEILLANCE EPIDEMIOLOGY END RESULTS DATABASE

Sree Harsha Mandava*, Greg Mitchell, Larry Webber, Oliver Sartor, Raju Thomas, Benjmin Lee, New Orleans, LA

MP2A-19 LONG TERM EVALUATION OF ONCOLOGIC AND FUNCTIONAL OUTCOMES AFTER LAPAROSCOPIC OPEN-ASSISTED RADICAL CYSTECTOMY: A MATCHED PAIR ANALYSIS

Simone Albisinni*, Ksenija Limeni Limeni, Lisa Ingels, Felix Kwizera, Renaud Bollens, Thierry Quackels, Marc Vanden Bossche, Alexandre Peltier, Eric Hawaux, Thierry Roumeguere, Roland Van Velthoven, Bruxelles, Belgium

MP2A-20 PERIOPERATIVE, PATHOLOGIC AND LONG TERM ONCOLOGIC RESULTS OF LAPAROSCOPIC RADICAL CYSTECTOMY IN EIGHT EXCELLENCE CENTERS ACROSS EUROPE: A MULTICENTER PROSPECTIVE EUROPEAN COHORT

Simone Albisinni*, Renaud Bollens, Bruxelles, Belgium, Jens Rassweiler, Dogu Teber, Heilbronn, Germany, Jens-Uwe Stolzenburg, Leipzig, Germany, Piotr Chlosta, Krakow, Poland, Franco Gaboardi, Milan, Belgium, Claude Abbou, Alexandre De la taille, Creteil, France, Peter Rimington, Eastbourne, United Kingdom, Roland Van Velthoven, Bruxelles, Belgium

MP2A-21 ROBOTIC-ASSISTED LAPAROSCOPIC REPAIR OF COMPLEX VESICOVAGINAL FISTULAS AT A SINGLE ACADEMIC INSTITUTION

Thomas Tieu*, Sohail Siddique, Alex Gorbonos, Springfield, IL

MP2A-22 PURE-LAPAROSCOPIC ORTHOTOPIC ILEAL NEOBLADDER AND ILEAL CONDUIT DURING RADICAL CYSTECTOMY

Changjun Yin*, Pengfei Shao, Chao Qin, Nanjing, China, People's Republic of

MP2A-23 LAPAROSCOPIC EXTENDED PELVIC LYMPH NODE DISSECTION DURING RADICAL CYSTECTOMY

Pengfei Shao*, Changjun Yin, Chao Qin, Nanjing, China, People's Republic of

MP2A-24 COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOTIC-ASSISTED RADICAL CYSTECTOMY: A SINGLE-TEAM EXPERIENCE

Yang Cheng-Kuang*, Ou Yen-Chuan, Taichung, Taiwan

MP2A-25 SINGLE SURGEON EXPERIENCE OF ROBOTIC VERSUS OPEN RADICAL CYSTECTOMY: COMPARISON OF QUALITY OF LYMPH NODE DISSECTION AND PERIOPERATIVE COMPLICATIONS

Hoon Ah Jang*, Sung Gu Kang, Seok Ho Kang, Jun Choen, Jae Hyun Bae, Seoul, Korea, Republic of

Tuesday, October 22, 2013   Moderated Poster Session MP2B   3:00 pm–5:00 pm

BASIC RESEARCH: LAPAROSCOPY/ROBOTICS/LESS

Room Bayside A-C @ Sheraton New Orleans

Chair: William Roberts

Faculty: Misop Han and Olivier Traxer

*Presenting author

MP2B-01 EVALUATION OF THE IMPACT OF THREE-DIMENSIONAL VISION ON LAPAROSCOPIC PERFORMANCE

Philip Bucur*, Achim Lusch, Ashleigh Menhadji, Michael A Liss, Zhamshid Okhunov, Jaime Landman, Orange, CA

MP2B-02 LAPAROSCOPIC WIRELESS PALPATION DEVICE: PRELIMINARY ASSESSMENT OF TISSUE STIFFNESS MEASUREMENTS ON ELASTIC MODULI

Aaron Benson*, Marco Beccani, Christian Di Natali, Ryan Pickens, Pietro Valdastri, S. Duke Herrell, Nashville, TN

MP2B-03 LAPAROSCOPIC WIRELESS PALPATION DEVICE: PRELIMINARY ASSESSMENT OF SIMULATED TUMOR DETECTION IN AN ELASTIC MODULUS

Aaron Benson*, Christian Di Natali, Marco Beccani, Ryan Pickens, Pietro Valdastri, S. Duke Herrell, Nashville, TN

MP2B-04 OFF-CLAMP LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HILAR TUMORS: ONCOLOGIC AND RENAL FUNCTIONAL OUTCOMES

Simpa Salami*, Arvin George, Nikhil Waingankar, Louis Kavoussi, New Hyde Park, NY

MP2B-05 COMPARISON OF RENAL PARENCHYMAL CLOSING PRESSURE DURING OPEN, LAPAROSCOPIC AND ROBOTIC-ASSISTED RENAL RECONSTRUCTION

Ramtin Khanipour*, Michael del Junco, Achim Lusch, Renai Yoon, Philip Bucur, Zhamshid Okhunov, Jaime Landman, Orange, CA

MP2B-06 MINIMALLY-INVASIVE ESTABLISHMENT OF UROLOGIC CANCER XENOGRAFTS: A HIGH-PRECISION APPROACH BY ULTRASOUND-GUIDANCE

Wolfgang Jaeger*, Igor Moskalev, Claudia Janssen, Tetsutaro Hayashi, Dirk Lange, Peter Black, Vancouver, Canada

MP2B-07 EARLY UNCLAMPING IN LAPAROSCOPIC PARTIAL NEPHRECTOMY IMPROVES EARLY ESTIMATED GLOMERULAR FILTRATION REDUCTION RATE

Susumu Akihama*, Kazuyuki Numakura, Hiroshi Tsuruta, Mitsuru Saito, Takamitsu Inoue, Shintaro Narita, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi, Akita, Japan

MP2B-08 COMPARISON OF TISSUE DAMAGE AFTER USE OF BIPOLAR SEALING DEVICES IN AN ANIMAL MODEL

Toshiro Suzuki*, Nagoya-shi, Japan, Teruyuki Ogawa, Matsumoto-shi, Japan, Ryohei Hattori, Toyonori Tsuzuki, Takashi Fujita, Naoto Sassa, Yoshihisa Matsukawa, Masashi Kato, Nagoya-shi, Japan, Kazuo Mizutani, Tokyo, Japan, Yasushi Yoshino, Tokunori Yamamoto, Momokazu Gotoh, Nagoya-shi, Japan

MP2B-09 COMPARISON OF THE ITRAINER AND STANDARD LAPAROSCOPIC TRAINER FOR BASIC LAPAROSCOPIC TASKS

Renai Yoon*, Adam Kaplan, Philip Bucur, Martin Hofmann, Michael del Junco, Reza Alipanah, Orange, CA, Elspeth M. McDougall, Vancouver, Canada, Jaime Landman, Orange, CA

MP2B-10 LAPAROSCOPIC ELECTRODE PLACEMENT ON THE PUDENDAL NERVE IN PIGS

Esra Foditsch*, Salzburg, Austria, Bogdan Hoinoiu, Cosmin Glameanu, Timisoara, Romania, Gunter Janetschek, Reinhold Zimmermann, Salzburg, Austria

MP2B-11 LONG-TERM FOLLOW UP OF ROBOTIC PYELOPLASTY IN THE PEDIATRIC POPULATION

Mathew Oommen, Janet Colli, Aaron Boonjindasup*, Christopher Keel, Philip Dorsey, Raju Thomas, New Orleans, LA

MP2B-12 ARE LAPAROSCOPIC ADRENALECTOMIES FEASIBLE FOR LARGER ADRENAL MASSES?

Aditi Kumar*, Janica Chavda, Tamer El-Husseiny, Nuwan Premachandra, Birmingham, United Kingdom, Sashi Kommu, London, United Kingdom, Aniruddha Chakravarti, birmingham, United Kingdom

MP2B-13 HYBRID ROBOTIC TRANSRECTAL NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES) PARTIAL NEPHRECTOMY IN THE PORCINE MODEL

Hossein Mirheydar*, Michael Liss, Ryan Kopp, Jason Woo, La Jolla, CA, James Masterson, San Diego, CA, Ramzi Jabaji, Kerrin Palazzi, Hak Lee, La Jolla, CA, Sean Stroup, San Diego, CA, Christopher Kane, Ithaar Derweesh, La Jolla, CA

MP2B-14 INITIAL EXPERIENCE WITH A NOVEL FASCIAL CLOSURE DEVICE: OPTION 3 TM

Ashish Parekh*, Kirk Tamaddon, Apurba Pathak, Los Angeles, CA

MP2B-15 INTRACORPOREAL RENAL SHRINKING WITH HYPERTONIC SALINE SOLUTION FOR SINGLE-SITE-NEPHRECTOMY: ASSESSMENT OF FEASIBILITY AND IMPACT ON THE INCISION FOR ORGAN REMOVAL

Homar Elias*, Hugo Quevedo, Cassio Andreoni, São Paulo, Brazil

MP2B-16 TRANSCOLONIC EXTRACTION OF THE KIDNEY FOLLOWING LAPAROSCOPIC NEPHRECTOMY: A SURVIVAL STUDY IN PIGS TO MINIMIZE FECAL CONTAMINATION

Richard Knight*, San Antonio, TX, Kyle Weld, Fort Sam Houston, TX

MP2B-17 DIFFERENCES IN PERFORMANCE ACROSS DIFFERENT SURGICAL SUB-SPECIALTIES, UTILIZING LAPAROSCOPIC AND ROBOTIC SIMULATORS

Ahmed Ghazi*, Jorge Carrillo, Anees Fazili, Emelian Scosyrev, Jean Joseph, Rochester, NY

MP2B-18 LAPAROSCOPIC PARTIAL NEPHRECTOMY WITHOUT ISCHEMIA USING A NEW 1,318 NM DIODE LASER IN A PORCINE SURVIVAL MODEL: FEASIBILITY AND HISTOLOGICAL RESULTS AFTER 4 WEEKS

Reinhold Zimmermann*, Lukas Lusuardi, Martina Hager, Salzburg, Austria, Bogdan Hoinoiu, Timisoara, Romania, Esra Foditsch, Gunter Janetschek, Salzburg, Austria

MP2B-19 A CLINICAL COMPARISON OF A NOVEL COMMERCIAL SINGLE PORT AND A HOMEMADE SINGLE PORT IN SINGLE PORT ENDOSCOPIC TOTAL EXTRAPERITONEAL REPAIR OF GROIN HERNIAS

Yao-Chou Tsai*, New Taipei City, Taiwan

MP2B-20 DOES PLAYING VIDEO GAMES IMPROVE YOUR LAPAROSCOPIC SKILLS? RESULTS FROM A SYSTEMATIC REVIEW OF LITERATURE

Hiro Ishii*, Southampton, United Kingdom, Chandra Shekhar Biyani, Yorkshire, United Kingdom, Jon Dyer, Bhaskar Somani, Southampton, United Kingdom

MP2B-21 COMPARATIVE OUTCOMES OF OPEN VERSUS LAPAROSCOPIC VERSUS ROBOTIC PYELOPLASTY FOR URETEROPELVIC JUNCTION OBSTRUCTION

Ugur Boylu*, Cem Basatac, Guven Turan, Fikret Fatih Onol, Eyup Gumus, Istanbul, Turkey

MP2B-22 IS LAPARASCOPIC RENAL SURGERY SAFE IN A DISTRICT GENERAL HOSPITAL?

Palaniappa Shanmugaraju*, Tsong Kwong, Croydon, United Kingdom

MP2B-23 MINIMALLY INVASIVE EXTIRPATIVE SURGERY FOR UPPER TRACT UROTHELIAL CARCINOMA: 10 YEAR SINGLE-INSTITUTION EXPERIENCE OF LAPAROSCOPIC AND ROBOT-ASSISTED NEPHROURETERECTOMY

Khushabu Kasabwala*, Andrew Tracey, Lisa Wolkin, Jennifer Yates, Ravi Munver, Hackensack, NJ

MP2B-24 IMPROVING POSTOPERATIVE PAIN FOLLOWING ROBOTIC-ASSISTED AND LAPAROSCOPIC UROLOGIC SURGERIES: A COMPARISON OF LIPOSOME BUPIVACAINE TO ROPIVACAINE DELIVERED BY THE ON-Q PAIN RELIEF SYSTEM

Paul W. Walker*, Michael A. White, Edwin E. Morales, San Antonio, TX, Uzoamaka O. Nwoye, Fort Sam Houston, TX, William J. Harmon, San Antonio, TX

MP2B-25 OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY OUTCOMES

AbdulRaouf Lamoshi, Mohamad Salkini*, Morgantown, WV

Wednesday, October 23, 2013   Moderated Poster Session MP01   2:30 pm–4:15 pm

ROBOTICS/LAPAROSCOPY: UPPER TRACT I

Room Rhythms 1 @ Sheraton New Orleans

Chair: Gunter Janetschek

Faculty: Matthew Gettman and Ashok Hemal

*Presenting author

MP01-01 IS THE ANATOMIC LOCATION OF RENAL MASS THE CONTRIBUTING FACTOR FOR POST PARTIAL NEPHRECTOMY RENAL FUNCTIONAL CHANGE?

Kang Sup Kim*, Yong Sun Choi, Yong Hyun Park, Seoul, Korea, Republic of, Yong-June Kim, cheongju, Korea, Republic of, Seok Ho Kang, Seoul, Korea, Republic of, Seok-Soo Byun, Seongnam, Korea, Republic of, Sung-Hoo Hong, Seoul, Korea, Republic of

MP01-02 INTERMEDIATE TERM ONCOLOGIC OUTCOMES OF RENAL CRYOABLATION: AN INTERNATIONAL MULTI-INSTITUTION ANALYSIS

Achim Lusch*, Philip Bucur, Zhamshid Okhunov, Orange, CA, Ithaar Derweesh, Michael A Liss, San Diego, CA, Louis R Kavoussi, New Hyde Park, NY, M Pilar Laguna, Jean J De La Rosette, Amsterdam, Netherlands, Matvey Tsivian, Thomas J Polascik, Durham, NC, H Christoph Klingler, Tobias Klatte, Vienna, Austria, Jaime Landman, Orange, CA

MP01-03 EARLY EXPERIENCE WITH ROBOTIC ANATROPHIC NEPHROLITHOTOMY FOR MANAGEMENT OF STAGHORN CALCULI

Sherita King*, Zachary Klaassen, Rabii Madi, William Shingleton, Augusta, GA

MP01-04 RENAL FUNCTION OUTCOMES FOLLOWING SELECTIVE ANGIOEMBOLIZATION FOR IATROGENIC VASCULAR LESIONS AFTER PARTIAL NEPHRECTOMY

Jeffrey Gahan, Mansi Gaitonde, Monic Morgan*, Jeffrey Cadeddu, Clayton Trimmer, Dallas, TX

MP01-05 A MODIFIED SUTURE TECHNIQUE USING A BARBED SUTURE IN RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY – A SINGLE SURGEON EXPERIENCE OF 150 CASES

Christian Wülfing*, Niclas Flechtenmacher, Serkan Filiz, Johannes Göckschu, David Marghawal, Hamburg, Germany

MP01-06 USE OF INDOCYANINE GREEN DYE WITH NEAR-INFRARED LIGHT FOR VASCULAR IDENTIFICATION AND CLAMPING DURING MINIMALLY INVASIVE PARTIAL NEPHRECTOMY: CASE-CONTROL STUDY

Luca Lunelli*, Eric Barret, Rafael Sanchez-Salas, Francois Rozet, Youness Ahallal, Petr Macek, Dominique Prapotnich, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP01-07 HYBRID TRANSVAGINAL NEPHRECTOMY- THREE CENTERS’ EXPANDING EXPERIENCE

Ioannis Georgiopoulos*, Iason Kyriazis, Panagiotis Kallidonis, Stavros Kontogiannis, Patras, Greece, Jens-Uwe Stolzenburg, Leipzig, Germany, Christian Schwentner, Tuebingen, Germany, Evangelos Liatsikos, Patras, Greece

MP01-08 856 ROBOTIC, LAPAROSCOPIC AND OPEN PARTIAL NEPHRECTOMIES FOR T1A RENAL MASSES: COMPARISON OF SURGICAL OUTCOMES AT A SINGLE INSTITUTION

Humberto Laydner*, Ahmad Kassab, Ali Khalifeh, Riccardo Autorino, Robert Stein, Amr Fergany, Jihad Kaouk, Cleveland, OH

MP01-09 ROBOT-ASSISTED PARTIAL NEPHRECTOMY IN 2500+ CONSECUTIVE CASES: A FIVE YEAR MULTI-INSTITUTIONAL EXPERIENCE FROM THE ROBOT-ASSISTED PARTIAL NEPHRECTOMY INTEGRATED DATABASE (RAPID) STUDY GROUP

Pengbo Jiang*, RAPID (Robot-Assisted Partial Nephrectomy Integrated Database Study Group), Hackensack, NJ

MP01-10 LAPAROSCOPIC CRYOABLATION FOR CLINICAL STAGE T1 RENAL MASSES: LONG-TERM ONCOLOGICAL AND FUNCTIONAL OUTCOMES AT THE MEDICAL COLLEGE OF WISCONSIN

Scott Johnson*, Khanh Pham, Milwaukee, WI, Frank Begun, Columbus, OH, Peter Langenstroer, Milwaukee, WI

MP01-11 DOES RENAL ARTERY AND VEIN CLAMPING IMPAIR SHORT OR LONG TERM RENAL FUNCTION AS COMPARED TO ARTERY ONLY CLAMPING? A NON-RANDOMIZED COMPARATIVE STUDY

Louis Krane*, Victor Romero, Ashok Hemal, Winston-Salem, NC

MP01-12 RENAL CELL CARCINOMA RECURRENCE AFTER LAPAROSCOPIC PARTIAL NEPHRECTOMY

Arvin George*, Paras Shah, Jessica Kreshover, Sammy El-Samra, Simpa Salami, Louis Kavoussi, New Hyde Park, NY

MP01-13 "MINI LAPAROSCOPIC" VERSUS "ROBOTIC ASSISTED LAPAROSCOPIC SINGLE SITE" PYELOPLASTY: PERIOPERATIVE AND COSMETIC RESULTS

Cristian Fiori, Riccardo Bertolo, Matteo Manfredi, Fabrizio Mele, Giovanni Cattaneo, DIletta Garrou, Daniele Amparore, Roberta Aimar, Enrico Checcucci, Francesco Porpiglia*, Orbassano Torino, Italy

MP01-14 COMPARISON OF TRADITIONAL AND MICRO-LAPAROSCOPIC PYELOPLASTY: A SINGLE INSTITUTION EXPERIENCE

Sapan Ambani*, J. Stuart Wolf Jr., Ann Arbor, MI

MP01-15 TRANSPERITONEAL PYELOPLASTY: MICROLAPAROSCOPY VERSUS CONVENTIONAL LAPAROSCOPY

Aaron Benson*, Trisha Juliano, Nashville, TN, Davis Viprakasit, Chapel Hill, NC, Ryan Pickens, S. Duke Herrell, Nashville, TN

MP01-16 SALVAGE ROBOTIC PARTIAL NEPHRECTOMY: A VIABLE APPROACH FOR MANAGEMENT OF LOCAL TUMOR RECURRENCE FOLLOWING FAILED NEPHRON SPARING SURGERY

Zachary Klaassen*, Junjian Huang, Sherita A. King, Qiang Li, W. Bruce Shingleton, Kelvin A. Moses, Martha K. Terris, Rabii Madi, Augusta, GA

MP01-17 MINIMALLY INVASIVE RENAL SURGERY IS ASSOCIATED WITH DECREASED HOSPITAL CHARGE

Mark Ball*, Hiten Patel, Jeffrey Mullins, Brian Matlaga, Mohamad Allaf, Baltimore, MD

MP01-18 EARLY UNCLAMPING SURGICAL TECHNIQUE FOR ROBOT-ASSISTED PARTIAL NEPHRECTOMY: A MULTICENTER PROSPECTIVE EXPERIENCE

Andrew Wagner, Boston, MA, Alireza Moinzadeh, Burlington, MA, Peter Chang, Andrew Percy, Boston, MA, Diana Mehedint, Terrance Creighton, Buffalo, NY, Christopher Lebeis, Burlington, MA, Thomas Schwaab*, Buffalo, NY

MP01-19 LAPAROSCOPIC AND ROBOTIC PARTIAL NEPHRECTOMY: COST ANALYSIS OF PERI-OPERATIVE AND POST-OPERATIVE OUTCOMES AT A SINGLE INSTITUTION

Aaron Boonjindasup*, Sree Mandava, Benjamin Woodson, Raju Thomas, Benjamin Lee, New Orleans, LA

MP01-20 IS CYSTATIN C USEFUL AS A BIOMARKER FOR ASSESSING AND STRATIFYING RENAL INJURY AFTER WARM ISCHEMIA FOLLOWING ROBOTIC PARTIAL NEPHRECTOMY

Ben Woodson*, Liang Wang, Sree Mandava, Benjamin Lee, New Orleans, LA

MP01-21 LAPAROSCOPIC PARTIAL NEPHRECTOMY VERSUS ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS OF FUNCTIONAL OUTCOMES

Kang Sup Kim*, Yong Sun Choi, Yong Hyun Park, Seoul, Korea, Republic of, Yong-June Kim, Cheongju, Korea, Republic of, Seok Ho Kang, Seoul, Korea, Republic of, Seok-Soo Byun, Seongnam, Korea, Republic of, Sung-Hoo Hong, Seoul, Korea, Republic of, Seung Hyun Jeon, ,

MP01-22 MULTICENTER COMPARISON OF PERIOPERATIVE TRENDS FOR ROBOTIC AND LAPAROSCOPIC PARTIAL NEPHRECTOMY

Michael Liss*, Kerrin Palazzi, La Jolla, CA, James Masterson, San Diego, CA, Reza Mehrazin, Memphis, TN, Sean Stroup, San Diego, CA, Ramzi Jabaji, Ryan Kopp, Hossein Mirheydar, Hak Lee, Christopher Kane, La Jolla, CA, James L'Esperance, San Diego, CA, Ithaar Derweesh, La Jolla, CA

MP01-23 NATIONAL TRENDS IN FOLLOW-UP ANATOMIC AND FUNCTIONAL IMAGING AFTER PYELOPLASTY: IS SUCCESS OVERESTIMATED?

Ryan Hsi*, Sarah Holt, John Gore, Jonathan Harper, Seattle, WA

MP01-24 UPPER QUADRANT PORT PLACEMENT FOR ROBOTIC-ASSISTED RENAL SURGERY: IMPLEMENTATION OF THE FLOATING ARM AND THE XL PROTYPE

Samer Totonchi*, Robert Elgin, Michael Monahan, Farmington Hills, MI, William Johnston III, Novi, MI

MP01-25 COMPARING RENAL FUNCTION AFTER OPEN AND ROBOTIC PARTIAL NEPHRECTOMY

Clinton Bahler*, Jason Sea, Rudy Bowens, Jagan Kansal, Christian Tabib, Chandru Sundaram, Indianapolis, IN

Wednesday, October 23, 2013   Moderated Poster Session MP02   2:30 pm–4:15 pm

EDUCATION & SIMULATORS

Room Rhythms 2 @ Sheraton New Orleans

Faculty: Elspeth McDougall and John Davis

*Presenting author

MP02-01 PRELIMINARY STRATIFICATION OF EXPERT VS NOVICE LAPAROSCOPISTS USING THE BASIC LAPAROSCOPIC UROLOGIC SURGERY (BLUS) CURRICULUM

Sree Harsha Mandava*, Benjamin Woodson, Philip Dorsey, Raju Thomas, Benjamin Lee, New Orleans, LA

MP02-02 CITATION ANALYSIS: DOES INSTITUTIONAL H-INDEX CORRELATE WITH A PROGRAM'S RANK IN UROLOGY?

Michael Johnson*, Jonathan Mobley, Sam Bhayani, Joel Vetter, Brian Benway, Saint Louis, MO

MP02-03 CONTENT AND FACE VALIDATION OF A CURRICULUM FOR ULTRASONIC PROPULSION OF RENAL CALCULI IN A HUMAN PHANTOM

Ryan Hsi*, Barbrina Dunmire, Bryan Cunitz, Xuemei He, Mathew Sorensen, Jonathan Harper, Michael Bailey, Thomas Lendvay, Seattle, WA

MP02-04 PERCEPTION OF UROLOGISTS PERFORMING LIVE CASE DEMONSTRATION (LCD) - TO BE OR NOT TO BE?

Simpa Salami*, Sammy Elsamra, Justin Friedlander, Arvin George, Brian Duty, Zeph Okeke, Arthur Smith, New Hyde Park, NY

MP02-05 UTILIZATION OF LEARNING RESOURCES AMONG UROLOGY RESIDENCY APPLICANTS

Kelly A. Healy*, Sanjay S. Kasturi, Demetrius H. Bagley, Philadelphia, PA

MP02-06 EXPERIENCE IN 3D LAPAROSCOPIC NEPHRECTOMY IN PORCINE MODEL

Alberto Jorge Camacho Castro*, México, Distrito Federal, Mexico, Victor Osornio, Mauricio Cantellano, Carlos Martínez, Gustavo Morales, Carlos Pacheco, Mexico, Distrito Federal, Mexico

MP02-07 EVALUATION OF THE LEARNING CURVE FOR THE AMS GREENLIGHT™ SIM AND DEVELOPMENT OF A VIRTUAL REALITY TRAINING CURRICULUM FOR GREEN LIGHT LASER PROSTATECTOMY

Abdullatif Aydina*, Gordon Muir, Mohammed Shamim Khan, Prokar Dasgupta, Kamran Ahmed, London, United Kingdom

MP02-08 CAN AT-HOME TRAINING RIVAL IN-LAB TRAINING IN THE ACQUISITION OF LAPAROSCOPIC SKILLS?

Ali Bahsoun*, Michael Michael, Saied Froghi, Kamran Ahmed, Prokar Dasgupta, London, United Kingdom

MP02-09 A DA VINCI S TO SI CURRICULUM ON A 3D VR ROBOTIC SURGICAL SIMULATOR MAY BE EFFICIENTLY EMPLOYED TO FACILITATE SURGEON TRANSITION

Ryan Speir*, Lacey, WA, Timothy Brand, Tacoma, WA

MP02-10 EFFECT OF EXPERT MENTORING ON THE ACQUISITION OF ROBOTIC SURGICAL SKILLS - A RANDOMISED CONTROLLED TRIAL

Daniel Hay*, Kamran Ahmed, Prokar Dasgupta, Ben Challacombe, London, United Kingdom

MP02-11 ASSESSMENT OF ROBOTIC SIMULATION PERFORMANCE BY UROLOGY TRAINEES IN RESIDENCY PROGRAMS

Abby Taylor*, Jacksonville, FL, Raaj Ruparel, Rochester, MN, Janil Patel, Jacksonville, FL, Vipul Patel, Orlando, FL, Todd Larson, Celebration, FL, Amy Lannen, Jacksonville, FL, Raymond Leveillee, Miami, FL, David Thiel, Jacksonville, FL

MP02-12 PRELIMINARY EXPERIENCE WITH THE USE OF THE DA VINCI SI ROBOTIC SURGERY SYSTEM IN PANAMA. RESULTS OF THE IMPLEMENTATION OF SURGERY CLINICAL PATHWAY FOR TRAINING

Marcos Young*, Leticia Ruiz, Alejandro Manduley, Elias Bodden, Panama, Panama, Octavio Castillo, Santiago, Chile, Brian Matlaga, Baltimore, MD

MP02-13 AN EFFECTIVE REPETITIVE TRAINING SCHEDULE TO ACHIEVE SKILL ACQUISITION IN NOVEL ROBOTIC VIRTUAL REALITY SIMULATOR

Seok Cho*, Sung Gu Kang, Kyung Sook Yang, Byung-Ju Ryu, Hoon Ah Jang, Seok Ho Kang, Jeong Gu Lee, Je Jong Kim, Jun Cheon, Koo Han Yoo, Seoul, Korea, Republic of, ,

MP02-14 DOES RESIDENT AND FELLOWSHIP TRAINING AFFECT OPERATIVE AND SHORT-TERM ONCOLOGIC AND FUNCTIONAL OUTCOMES IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY (RARP)?

Ziho Lee*, Shailen Sehgal, Reid Graves, Yu-Kai Su, Elton Llukani, Kelly Monahan, Alice Mcgill, Phillip Mucksavage, David Lee, Philadelphia, PA

MP02-15 CONSTRUCT, CONTENT AND FACE VALIDITY OF THE DA VINCI SURGICAL SIMULATOR

Adam C Calaway*, Jason C Sea, Chandru P Sundaram, Indianapolis, IN

MP02-16 OUTCOMES OF INDIANA UNIVERSITY UROLOGY WEEKEND ROBOTICS TRAINING PROGRAM

Jason C Sea*, Adam Calaway, Clinton D Bahler, Christopher Southwood, Chandru P Sundaram, Indianapolis, IN

MP02-17 COMPARISON OF COMPUTER GENERATED PERFORMANCE METRICS IN THE DAVINCI SKILLS SIMULATOR- WHICH DEMONSTRATE THE MOST CONSTRUCT VALIDITY?

Ryan Dorin*, Kyle Finnegan, Halil Kiziloz, Steven Shichman, Hartford, CT

MP02-18 ASSESSMENT OF ROBOTIC SIMULATION USE IN RESIDENCY PROGRAMS OF THE SOUTHEASTERN SECTION OF THE AMERICAN UROLOGIC ASSOCIATION

Abby Taylor*, David Thiel, Jacksonville, FL, Vipul Patel, Celebration, FL, Todd Larson, Seattle, WA, Amy Lannen, Jacksonville, FL, Raymond Leveilee, Coral Gables, FL

MP02-19 PERCEIVING A LIVE CASE DEMONSTRATION: PERCEPTION OF BENEFIT

Sammy Elsamra*, Hector Motato, Justin Friedlander, Daniel Moreira, Arvin George, Brian Duty, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP02-20 ELECTRONIC DATA COLLECTION FOR PATIENT-REPORTED OUTCOMES IN MEN WITH PROSTATE CANCER: ASSESSING EASE OF USE AND PATIENT SATISFACTION

Brian Benway*, Leslie McIntosh, Linda Black, Joanne Morley, Sheri Long, Patricia Carter, Elizabeth Jones, Alethea Paradis, Arnold Bullock, Gerald Andriole, Saint Louis, MO

MP02-21 IMPACT OF PAST LAPAROSCOPIC EXPERIENCE ON ROBOTIC PERFORMANCE

Roger Smith, Haidar Abdul-Muhsin*, Vipul Patel, Celebration, FL

MP02-22 UTILIZATION OF ROBOTIC SIMULATORS FOR UROLOGIC TRAINING

Edan Shapiro*, Ari Bergman, Rus Korets, Trushar Patel, Ketan Badani, New York, NY

MP02-23 A SYSTEMATIC REVIEW OF TECHNOLOGY-DRIVEN SIMULATORS FOR MEDICAL STUDENTS

Michael Michael, Stevenage, United Kingdom, Hamid Abboudi, Brighton, United Kingdom, Jean Ker, Dundee, United Kingdom, Kamran Ahmed, Prokar Dasgupta, London, United Kingdom, Ali Bahsoun*,

MP02-24 LAPAROSCOPIC RENAL RESECTION TRAINING IN CADAVERS EMBALMED USING THIEL'S METHOD: DEVELOPMENT AND EVALUATION OF SKILLS LEARNING

Sarvpreet Singh Ubee*, Wolverhampton, United Kingdom, Benjie Tang, Roos Eisma, Dundee, United Kingdom, Chandrashekhar Biyani, Wakefield, United Kingdom, Ghulam Nabi, Dundee, United Kingdom

MP02-25 CONSTRUCTION AND ASSESSMENT OF A NOVEL INDIGENOUS PCNL SIMULATOR: AN INNOVATIVE APPROACH TO TRAINING

Ashish Rawandale*, Lokesh Patni, Atul Mulay, Preeti Patil, Dhule, India

MP02-26 EFFECTS OF RESIDENCY TRAINING ON OPERATING ROOM : A REVIEW OF PROSTATE BIOPSIES IN A RESIDENT-RUN CLINIC AT A CITY HOSPITAL

Allison Polland*, New York, NY, Alfred Winkler, Elmhurst, NY

Wednesday, October 23, 2013   Moderated Poster Session MP03   2:30 pm–4:15 pm

BPH/LUTS I

Room Rhythms 3 @ Sheraton New Orleans

Chair: Brian Eisner

Faculty: Stephan Hruby and Leslie A. Dean

*Presenting author

MP03-01 UROBEAM™ DIODE LASER VAPORIZATION OF THE PROSTATE: MID-TERM OUTCOMES

Joao Padua Manzano*, Frederico Teixeira Barbosa, José Ricardo Cruz Silvino Jr, Luciano Salles Lage, Adalberto Andriolo Jr, Roberto Soler, Joaquim Francisco De Almeida Claro, Sao Paulo, Brazil

MP03-02 IS COMBINED PROSTATE RESECTION WITH CYSTOLITHOTRIPSY BENEFICIAL FOR BPH PATIENTS WITH BLADDER CALCULI? -A NATIONWIDE POPULATION-BASED STUDY

Eric Yi-Hsiu Huang*, Tzu-Ting Kuo, Hsiao-Jen Chung, Chih-Chieh Lin, Alex TL Lin, Kuang-Kuo Chen, Taipei, Taiwan

MP03-03 BASELINE CHARACTERISTICS PREDICT RISK OF PROGRESSION AND RESPONSE TO COMBINATION MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA

Michael Kozminski*, John Wei, Ann Arbor, MI, Jason Nelson, David Kent, Boston, MA

MP03-04 TWO-YEAR PROSPECTIVE, RANDOMIZED COMPARISON BETWEEN THE BIPOLAR PLASMA ENUCLEATION OF THE PROSTATE AND OPEN PROSTATECTOMY IN BPH CASES OVER 80 ML

Bogdan Geavlete*, Florin Stanescu, Cristian Moldoveanu, Marian Jecu, Leon Adou, Petrisor Geavlete, Bucharest, Romania

MP03-05 LEARNING CURVE OF MORCELLATION DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)

Jin Kyu Oh, Incheon, Korea, Republic of, Hahn-Ey Lee*, Jae Hyun Jung, Chang Wook Jeong, Jae-Seung Paick, Seung-June Oh, Seoul, Korea, Republic of

MP03-06 HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) OUTCOMES IN PATIENTS WITH PRIOR BENIGN PROSTATIC HYPERTROPHY (BPH) SURGERY

Ryan Pickens*, Nashville, TN, Amy Krambeck, Rochester, MN, Mitchell Humphreys, Scottsdale, AZ, Nicole Miller, Nashville, TN

MP03-07 LONG TERM IMPACT OF ROBOTIC ASSISTED RADICAL PROSTATECTOMY ON CONTINENCE AND LOWER URINARY TRACT SYMPTOMS (LUTS)

Adam Gordon, Harleen Dhaliwal, Douglas Skarecky, Kathyrn Osann, Blanca Morales, Thomas Ahlering*, Orange, CA

MP03-08 SERIAL MRI AND 3D RENDERING FOLLOWING TREATMENT OF BPH USING HIGH ENERGY WATER VAPOR THERAPY AND THE REZUM™ SYSTEM ; INITIAL RESULTS FROM THE FIRST-IN-MAN AND REZUM™ 1 CLINICAL TRIALS

Christopher Dixon*, NY, NY, Edwin Rijo-Cedano, La Romana, Dominican Republic, Dalibor Pacik, Vitislav Vit, Gabriele Varga, Brno, Czech Republic, Lance Mynderse, Dennis Hanson, Rochester, MN, Thayne Larson, Scottsdale, AZ

MP03-09 TRENDS IN RESIDENT INVOLVEMENT IN BPH PROCEDURES

Mark Ball*, Max Kates, Brian Matlaga, Baltimore, MD

MP03-10 HOLMIUM LASER ENUCLEATION/ABLATION OF THE PROSTATE IN PATIENTS PREVIOUSLY TREATED WITH RADIATION THERAPY FOR PROSTATE CANCER

Jessica E Paonessa*, Naeem Bhojani, James E Lingeman, Indianapolis, IN

MP03-11 A COMPARATIVE STUDY BETWEEN HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND TRANSURETHRAL RESECTION OF THE PROSTATE: 12 MONTH FOLLOW UP

Mohamed Etafy*, Gamal Morsi, Atef Hammouda, M Hammouda, Assiut, Egypt, Enmar Habib, Cairo, Egypt

MP03-12 REGIONAL DIFFERENCE IN IPSS, PV, AND PSA IN KOREAN MALE PATIENTS WITH LUTS

Sung Chul Kam*, Jae Hwi Choi, Seong Uk Jeh, Jeong Seok Hwa, Jae Seog Hyun, Jinju, Korea, Republic of

MP03-13 THE ROLE OF TRANSURETHRAL RESECTION OF PROSTATE IN TREATING PATIENTS WITH BENIGN PROSTATE HYPERPLASIA AND ELEVATED PROSTATE-SPECIFIC ANTIGEN

Jeong Man Cho*, Sun Choel Shin, Hee Ju Cho, Jung Yoon Kang, Tag Keun Yoo, Seoul, Korea, Republic of

MP03-14 LASER PROSTATECTOMY OF LARGE PROSTATES USING A NEW 1.9μM THULIUM LASER: RESULTS AFTER 1 YEAR FOLLOW-UP

David Zimmermann*, Patrick Honeck, Thomas Knoll, Gunnar Wendt-Nordahl, Sindelfingen, Germany

MP03-15 THREE-YEAR PROSPECTIVE, RANDOMIZED COMPARISON OF THE BIPOLAR PLASMA VAPORIZATION OF THE PROSTATE, MONOPOLAR AND BIPOLAR RESECTION IN MEDIUM SIZE BPH PATIENTS

Bogdan Geavlete*, Razvan Multescu, Dragos Georgescu, Florin Stanescu, Marian Jecu, Cristian Moldoveanu, Petrisor Geavlete, Bucharest, Romania

MP03-16 DETRUSOR WALL THICKNESS AS A POSSIBLE PREDICTOR OF PERSISTENT URINARY URGENCY AFTER TRANSURETHRAL RESECTION OF PROSTATE

Dong Soo Park*, Seung Ryeol Lee, Seongnam-si, Korea, Republic of

MP03-17 GREEN LASER PROSTATIC LASER VAPORIZATION IN PATIENTS OLDER THAN 80 YEARS. IS IT SAFE?

Pablo Contreras*, Buenos Aires, Argentina, Francisco Lopez, Ramiro Castilla, Carlos Ameri, Gonzalo Vitagliano, Osvaldo Mazza, Ciudad Autónoma de Buenos Aires, Argentina

MP03-18 DIODE LASER VAPORIZATION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA – COMPARING VAPORIZATION ALONE WITH VAPORIZATION PLUS SUBSEQUENT BIPOLAR TRANS-URETHRAL RESECTION AT 12 MONTHS FOLLOW-UP

Ferdinando De Marco*, Grottaferrata, Italy, Markus Rheinwald, Wessling, Germany, Thomas Bayer, Kempten, Germany

MP03-19 A PROSPECTIVE MULTICENTER RANDOMIZED STUDY COMPARING GREENLIGHT XPS™ LASER AND TRANSURETHRAL RESECTION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Alexander Bachmann*, Basel, Switzerland, Andrea Tubaro, Rome, Italy, Neil Barber, Camberley Surrey, United Kingdom, Frank d'Ancona, Nijmegen, Netherlands, Gordon Muir, London, United Kingdom, Ulrich Witzsch, Frankfurt, Germany, Marc-Oliver Grimm, Jena, Germany, Joan Benejam, Manacor, Spain, Jens-Uwe Stolzenburg, Leipzig, Germany, Anthony Riddick, Edinburgh, United Kingdom, Sascha Pahernik, Heidelberg, Germany, Johannes Hermanus Roelink, Almelo/Hengelo, Netherlands, Filip Ameye, Gent, Belgium, Christian Saussine, Strasbourg, France, Frank Bruyere, Tours, France, Wolfgang Loidl, Linz, Austria, Timothy Larner, Brighton, United Kingdom, Nirjan Gogoi, Dewsbury, United Kingdom, Richard Hindley, Hampshire, United Kingdom, Rolf Muschter, Rotenburg, Germany, Andrew Thorpe, Newcastle upon Tyne, United Kingdom, Nitin Shrotri, Kent, United Kingdom, Stuart Graham, London, United Kingdom, Moritz Franz Hamann, Kiel, Germany, Kurt Miller, Berlin, Germany, Martin Schostak, Magdeburg, Germany, Carlos Capitan, Madrid, Spain, Helmut Knispel, Berlin, Germany, James Andrew Thomas, Wales, United Kingdom

MP03-20 TRANSURETHRAL ENUCLEATION WITH BIPOLAR (TUEB) FOR PROSTATES OVER 50 ML : A SINGLE CENTER EXPERIENCE

Hayato Takeda*, Hiroyuki Shimizu, Yasutomo Suzuki, Mamoru Oki, Jun Hasegawa, Yukihiro Kondo, Tokyo, Japan

MP03-21 TISSUE EFFECTS RESULTING FROM ERASER LASER ENUCLEATION OF THE PROSTATE: IN VIVO INVESTIGATION

Lukas Lusuardi*, Martina Hager, Manuela Sieberer, Stephan Hruby, Birgit Kloss, Günter Janetschek, Salzburg, Austria

MP03-22 FACTORS PREDICTING OCCURRENCE OF TRANSIENT URINARY INCONTINENCE AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE

Dong Gil Shin*, Jeong Zoo Lee, Tae Gyeong Jeon, Tae Nam Kim, Busan, Korea, Republic of, Moon Kee Chung, Yangsan, Korea, Republic of, Chang Yell Lee, Busan, Korea, Republic of

MP03-23 EVALUATION OF SHORT TERM EFFICACY OF DIFFERENT ALFA ADRENERGIC BLOCKERS ON LUTS IN PATIENTS WITH SYMPTOMATIC BPH

Arup Mandal*, Sudheer Devana, Shrawan Singh, Ravimohan Mavuduru, Chandigarh, India

MP03-24 SAFETY AND EFFICACY OF REPEAT GREENLIGHT LASER THERAPY WITH THE XPS SYSTEM IN PATIENTS PREVIOUSLY TREATED WITH THE GREENLIGHT PV OR HPS SYSTEMS

Andrew Tracey*, Chris Wright, Shailja Mehta, Ravi Munver, Hackensack, NJ

MP03-25 INFLUENCE OF BODY MASS INDEX ON BENIGN PROSTATIC HYPERPLASIA-RELATED COMPLICATIONS IN PATIENTS UNDERGOING PROSTATECTOMY

Hisham Mosli*, Jeddah, Saudi Arabia

MP03-26 ROLE OF GREENLIGHT LASER IN THE SURGICAL MANAGEMENT OF BENIGN PROSTATIC ENLARGEMENT

Mahmood Hai*, Westland, MI

Wednesday, October 23, 2013   Moderated Poster Session MP04   2:30 pm–4:15 pm

PERCUTANEOUS NEPHROLITHOTOMY I

Room Grand Ballroom D @ Sheraton New Orleans

Chair: Peter Alken

Faculty: James Lingeman and Timothy Averch

*Presenting author

MP04-01 WITHOUT STONE CULTURE, INFECTIOUS KIDNEY ORGANISMS ARE MISIDENTIFIED IN ALMOST 1/4 OF PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY

Jessica E Paonessa*, Naeem Bhojani, James C Williams, Jr., Indianapolis, IN, Jessica A Mandeville, Reading, MA, James E Lingeman, Indianapolis, IN

MP04-02 MINI-PERC USING A 16 F PEEL-AWAY SHEATH

James Borin*, Jared Cohen, Janae Preece, Baltimore, MD

MP04-03 PERCUTANEOUS NEPHROLITHOTOMY ACCESS TRACT DILATION USING THE "VISUAL DILATOR SYSTEM" : AN INITIAL CLINICAL REPORT

Arvind K. Shah*, Kewei Xu, Jian Huang, Tianxin Lin, Hao Liu, Hai Huang, Chun Jiang, Guangzhou, China, People's Republic of

MP04-04 CURRENT PRACTICES IN PERCUTANEOUS NEPHROLITHOTOMY AMONG ENDOUROLOGISTS

Sri Sivalingam*, Shannon Cannon, Stephen Nakada, Madison, WI

MP04-05 DOES IV ACETAMINOPHEN GIVEN DURING PERCUTANEOUS NEPHROLITHOTOMY REDUCE POST-OPERATIVE PAIN?

Brian T. Kadow*, Yaniv Shilo, Julie M. Riley, Stephen V. Jackman, Timothy D. Averch, Pittsburgh, PA

MP04-06 FACTORS EFFECTING DEVELOPMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AFTER PERCUTANEOUS NEPHROLITHOTOMY

Emrah Yuruk, Murat Binbay*, Istanbul, Turkey, Mahir Seyrek, Canakkale, Turkey, Tolga Akman, Yalcin Berberoglu, Ahmet Muslumanoglu, Istanbul, Turkey

MP04-07 INTERVENTIONAL RADIOLOGIST-DIRECTED PERCUTANEOUS RENAL ACCESS PERFORMED AT AN OUTSIDE INSTITUTION IS RARELY ACCEPTABLE FOR PERCUTANEOUS NEPHROLITHOTOMY

Andrew Callen*, Thomas Chi, Joe Miller, Marshall Stoller, San Francisco, CA

MP04-08 LOW TRANSFUSION RATE ASSOCIATED WITH PERCUTANEOUS NEPHROLITHOTOMY

Andrew Callen*, Thomas Chi, Joe Miller, Marshall Stoller, San Francisco, CA

MP04-09 ANALYSIS OF THE UTILITY OF STONE GRAM STAIN IN INFECTED UROLITHIASIS TREATED WITH PERCUTANEOUS NEPHROLITHOTOMY

Patrick Cockerill*, Marcelino Rivera, Amy Krambeck, Rochester, MN

MP04-10 ENDOSCOPIC-GUIDED PERCUTANEOUS NEPHROLITHOTOMY: A TECHNIQUE TO REDUCE RADIATION DOSE

Andrea G. Lantz*, Padraic O'Malley, Michael Ordon, Jason Y. Lee, Toronto, Canada

MP04-11 COMPLICATIONS AND ANALGESIC USE FOLLOWING UPPER POLE ACCESS FOR PERCUTANEOUS NEPHROLITHOTOMY

Caleb C Ng, Caroline L Wallner, Gene O Huang, Steven R Engebretsen, Roger Li, Michelle A Lightfoot*, Don C Arnold II, Gaudencio Olgin, Muhannad M Alsyouf, Javier L Arenas, D Duane Baldwin, Loma Linda, CA

MP04-12 PIONEERING OUTPATIENT PCNL: THE QUEEN'S/MCGILL EXPERIENCE

Darren Beiko*, Andrea Kokorovic, Gregory Roberts, Kingston, Canada, Mohamed Elkoushy, Sero Andonian, Montreal, Canada

MP04-13 ANTIMICROBIAL USAGE IN PERCUTANEOUS NEPHROLITHOTOMY: INFECTIOUS AND ANTIBIOTIC RELATED COMPLICATIONS

Boyd Viers*, Amy Krambeck, Rochester, MN

MP04-14 DESCRIPTION AND EVALUATION OF A NOVEL LASER-GUIDED PERCUTANEOUS ACCESS TECHNIQUE IN A BENCHTOP MODEL

Jacob A Martin, Michael J Lee, Janna M Vassantachart, Gaudencio Olgin, Steven R Engebretsen, Gene O Huang, Michelle A Lightfoot*, Don C Arnold II, Jason C Smith, D Duane Baldwin, Loma Linda, CA

MP04-15 MULTICENTER VALIDATION OF S.T.O.N.E. NEPHROLITHOMETRY

Zhamshid Okhunov*, Orange, CA, Daniel Moreira, Arvin George, Sammy Elsamra, New Hyde Park, NY, Brian Duty, Portland, OR, Hector Motato, New Hyde Park, NY, Edan Shapiro, NY, NY, Achim Lusch, Fotima Asqarova, Orange, CA, Chad Tracy, Iowa city, IA, Mantu Gupta, NY, NY, Vincent Bird, Gainsville, FL, Jorge Moreno, Mexico, Mexico, Kevan Sternberg, Vermont, VT, Arthur Smith, New Hyde Park, NY, Jaime Landman, Orange, CA, Zeph Okeke, New Hyde Park, NY

MP04-16 GUY'S STONE SCORE: PREDICTING OUTCOMES AND COMPLICATIONS OF PERCUTANEOUS NEPHROLITHOTOMY

Fabio C. Vicentini, Giovanni S. Marchini*, Eduardo Mazzucchi, Joaquim F. A. Claro, Miguel Srougi, São Paulo, Brazil

MP04-17 PREVALENCE OF MULTIDRUG RESISTANT BACTERURIA IN PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY

Omer Raheem*, San Diego, CA, William Shi, San Diego , CA, Craig Schallhorn, Lindsay Kiyawa, David Wenzler, Charles Lakin, Roger Sur, San Diego, CA

MP04-18 IMPACT OF PERIOPERATIVE ANTICOAGULATION ON INCIDENCE OF BLEEDING COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY

Elizabeth Johnson, Lebanon, NH, Seth Bechis*, Sameer Deshmukh, Boston, MA, Paholo Barboglio-Romo, Lebanon, NH, Brian Eisner, Boston, MA, Vernon Pais, Lebanon, NH

MP04-19 SEOUL NATIONAL UNIVERSITY RENAL STONE COMPLEXITY SCORE FOR PREDICTING STONE-FREE RATE AFTER PERCUTANEOUS NEPHROLITHOTOMY

Min Soo Choo*, Chang Wook Jeong, Seoul, Korea, Republic of, Jin-Woo Jung, Byung Ki Lee, Yong Hyun Park, Sangchul Lee, Seong Jin Jeong, Seok-Soo Byun, Sang Eun Lee, Seongnam, Korea, Republic of

MP04-20 STONE FREE AT THE END OF PCNL: SURGEON'S ESTIMATION VS. POSTOPERATIVE IMAGING

Itay Sagy*, McKalba-Batarin Kaltungo, Marc Lubin, Einav Cohen, Ronen Holland, Pinchas M. Livne, David Lifshitz, Petach Tikva, Israel

MP04-21 MULTIMODAL STRATEGY FOR THE PREVENTION OF INFECTIOUS COMPLICATIONS OF PERCUTANEOUS SURGERY: OUR EXPERIENCE

Cesare Marco Scoffone*, Cecilia Maria Cracco, Torino, Italy

MP04-22 RETROSPECTIVE REVIEW OF THORACIC COMPLICATIONS FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY PROCEDURES

Deirdre Connolly*, Joseph Caputo, Justina Tam, Crista Cerrone, Jonathan Melquist, Kevin Gioia, David Schulsinger, Stony Brook, NY

MP04-23 EXPERIENCE WITH ‘ULTRA-MINI’ PCNL

Madhu Agrawal*, Agra, India

MP04-24 EFFECTS OF SEMI-FLANK POSITION PERCUTANEOUS NEPHROLITHOTOMY: COMPARISON WITH PRONE POSITION PROCEDURE

Jae Young Choi*, Bum Soo Kim, Jun Nyung Lee, Se Yun Kwon, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Tae Gyun Kwon, Sung Kwang Chung, Bup Wan Kim, Yoon Kyu Park, Jae Soo Kim, Daegu, Korea, Republic of

MP04-25 A LOW-CALIBER PERCUTANEOUS NEPHROLITHOTOMY SYSTEM (MICROPERC) FOR THE TREATMENT OF KIDNEY STONES

Ugur Boylu*, Cem Basatac, Abdurrahman Inkaya, Fikret Fatih Onol, Eyup Gumus, Istanbul, Turkey

MP04-26 COMPLICATIONS OF PCNL ACCORDING TO MODIFIED CLAVIEN-DINDO SYSTEM

Guido Giusti*, Silvia Proietti, Roberto Peschechera, Davide Giraudo, Gianluigi Taverna, Pierpaolo Graziotti, Rozzano (MI), Italy

Wednesday, October 23, 2013   Moderated Poster Session MP05   2:30 pm–4:15 pm

IMAGING & NEW TECHNIQUES I

Room Grand Chenier @ Sheraton New Orleans

Chair: Mordechai Duvdevani

Faculty: Lee Richstone and Oscar Fugita

*Presenting author

MP05-01 INDOCYANINE GREEN SENTINEL LYMPHADENECTOMY DURING ROBOTIC PROSTATECTOMY: RESULTS IN 50 PATIENTS

Ted Manny*, Ashok Hemal, Winston-Salem, NC

MP05-02 A NOVEL APPROACH FOR THE TREATMENT OF RADIATION-INDUCED HEMORRHAGIC CYSTITIS WITH THE GREENLIGHT™ XCELERATED PERFORMANCE SYSTEM (XPS) LASER: A LITERATURE REVIEW AND CASE SERIES

Daniel Martinez*, Cesar Ercole, Justin Parker, Bryan Allen, Mary K. Hall, Tampa, FL

MP05-03 NATURAL HISTORY OF SMALL INDEX LESIONS IDENTIFIED ON MULTIPARAMETRIC PROSTATE MRI: RECOMMENDATIONS FOR INTERVAL IMAGING FOLLOW-UP

Soroush Rais-Bahrami*, Baris Turkbey, Ardeshir Rastinehad, Annerleim Walton-Diaz, Anthony Hoang, M. Minhaj Siddiqui, Lambros Stamatakis, Hong Truong, Jeffrey Nix, Srinivas Vourganti, Kinzya Grant, Maria Merino, Bradford Wood, Peter Choyke, Peter Pinto, Bethesda, MD

MP05-04 A NOVEL USE OF NEAR INFRARED FLUORESCENCE IMAGING DURING ROBOTIC SURGERY TO IDENTIFY AREAS OF INTEREST MARKED BY WHITE LIGHT OF ENDOSCOPIC INSTRUMENTS

Mark Hockenberry*, Zachary Smith, Reid Graves, Abdo Kabarriti, Phillip Mucksavage, Philadelphia, PA

MP05-05 LONG-TERM OUTCOMES FOR PARALLEL URETERAL STENTS IN PATIENTS WITH URETERAL OBSTRUCTION SECONDARY TO PELVIC MALIGNANCY

Bailey Zampella*, Yungkhan Tan, Natasha Leigh, Crystal Castaneda, Mantu Gupta, New York, NY

MP05-06 IMPROVING THE EFFICACY OF LASER FLEXIBLE CYSTOSCOPY LISTS FOR NON-MUSCLE INVASIVE BLADDER CANCER

Tharsika Karunakaran, Samir Mehta*, Jacques Roux, Stuart Graham, London, United Kingdom

MP05-07 LOW AND CONVENTIONAL-DOSE COMPUTED TOMOGRAPHY FOR THE DETECTION OF URIC ACID STONES

Gaudencio Olgin*, Jason C Smith, Caroline L Wallner, Steven R Engebretsen, Gene O Huang, David J Culpepper, Andrew T Mai, Caleb C Ng, Jonathan D Creech, Christopher S Chung, Don C Arnold II, D Duane Baldwin, Loma Linda, CA

MP05-08 ANATOMIC KIDNEY SEGMENTATION SYSTEM TO DESCRIBE TUMOUR LOCATION FOR NEPHRON-SPARING SURGERY

Rocco Papalia, Rome, Italy, Andre Luis de Castro Abreu*, Los Angeles, CA, Valeria Panebianco, Rome, Italy, Andre K. Berger, Vinay Duddalwar, Los Angeles, CA, Giuseppe Simone, Rome, Italy, Scott Leslie, Los Angeles, CA, Salvatore Guaglianone, Rome, Italy, Tapas Tejura, Los Angeles, CA, Mariaconsiglia Ferriero, Carlo Catalano, Rome, Italy, Mihir Desai, Los Angeles, CA, Michele Gallucci, Rome, Italy, Inderbir Gill, Los Angeles, CA

MP05-09 TRANSRECTAL ULTRASOUND VERSUS CT SCAN IN THE ESTIMATION OF PROSTATIC VOLUME

Igor Sorokin*, Robert Tartaglione, Allen Herr, Paul Feustel, Laura Chang-Kit, Albany, NY

MP05-10 THE PREDICTION OF POSTOPERATIVE TOTAL RENAL FUNCTION BY RENAL CORTEX VOLUMETRY WITH MULTIDETECTOR COMPUTED TOMOGRAPHY (MDCT) AFTER NEPHRECTOMY

Shuji Isotani*, Masahiro Inoue, Itabashi, Tokyo, Japan, Hiroshi Shimoyama, Yasuhiro Noma, Bunkyo, Tokyo, Japan, Shino Tokiwa, Keisuke Saito, Takashi Yoshi, Hisamitsu Ide, Satoru Muto, Koji Takeshita, Itabashi, Tokyo, Japan, Shigeo Horie, Bunkyo, Tokyo, Japan, Raizo Yamaguchi, Itabashi, Tokyo, Japan

MP05-11 RADIATION EXPOSURE DURING IMAGE-GUIDED ABLATION OF SMALL RENAL MASSES: A MULTI-CENTER CHARACTERIZATION OF RISK FACTORS

Chad R. Tracy*, Amit Gupta, Iowa City, IA, Jeffrey Gahan, Dallas, TX, Zhamshid Okhunov, South Orange, CA, Sammy E Elsamra, Nithin Theckumparampil, New Hyde Park, NY, Maurilio Garcia-Gil, Dallas, TX, Shiliang Sun, Iowa City, IA, Igor Lubko, New Hyde Park, NY, Sandy Lall, South Orange, CA, Louis R. Kavoussi, New Hyde Park, NY, Jaime Landman, South Orange, CA, Jeffrey A. Cadeddu, Dallas, TX

MP05-12 NOVEL USE OF INDOCYANINE GREEN FOR IDENTIFICATION OF SENTINEL LYMPH NODES AND MESENTERIC ANGIOGRAPHY TO ASSESS BOWEL VASCULARITY DURING ROBOTIC RADICAL CYSTECTOMY WITH INTRACORPOREAL URINARY DIVERSION

Ted Manny*, Ashok Hemal, Winston-Salem, NC

MP05-13 DEFINING THE ROLE OF INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY DURING INFERIOR VENA CAVAL TUMOR THROMBECTOMY IN RENAL CELL CARCINOMA

Mark Ball*, Vivek Arora, Mary Beth Brady, Ashish Shah, James Black, Mohamad Allaf, Baltimore, MD

MP05-14 ONCOLOGIC RESULTS OF PERCUTANEOUS RENAL CRYOABLATION AT A MEDIAN FOLLOW-UP OF 24 MONTHS

Anees Fazili*, Tiffany Lee, Sriram Venigalla, Louis Eichel, Rochester, NY

MP05-15 REPEAT PERCUTANEOUS CT-GUIDED CRYOABLATION FOR LOCALLY RECURRENT RENAL CELL CARCINOMA

Zhamshid Okhunov*, Samuel Juncal, Arvin George, Orange, CA, Sammy Elsamra, New Hyde Park, CA, Daniel Moreira, New Hyde Park, NY, Nithin Theckumparampil, Orange, CA, Martin Hofmann, , , Fotima Asqarova, Puja Patel, Orange, CA, Louis Kavoussi, Igor Lobko, New Hyde Park, NY, Jaime Landman, Orange, CA

MP05-16 DEVELOPMENT OF A TARGETTED PHOTOIMMUNOTHERAPY PLATFORM IN THE MANAGEMENT OF BLADDER CANCER

Srinivas Vourganti*, Michael Weintraub, Quentin Li, Piyush Agarwal, Bethesda, MD

MP05-17 INTEROBSERVER RELIABILITY AND REPRODUCIBILITY OF S.T.O.N.E. NEPHROLITHOMETRY FOR RENAL CALCULI

Zhamshid Okhunov*, Alberto Perez-Lanzac, Mohammad Helmy, Ashleigh Menhadji, Philip Bucur, Surendra Kolla, Jane Cho, Kathy Osann, Achim Lusch, Jaime Landman, Orange, CA

MP05-18 ENDOVASCULAR COIL OCCLUSION (ECO) - THE REAL ALTERNATIVE METHOD FOR VENOUS LEAK CORRECTION

Dmitriy Kurbatov*, Alexandr Lepetukhin, Ivan Sitkin, Sergey Dubsky, Moscow, Russian Federation

MP05-19 MR FUSION PROSTATE BIOPSIES ARE FEASIBLE AND USEFUL IN A BUSY UROLOGIC PRACTICE

David Hatcher*, Joshua Cohn, Chicago, IL, Robert Silvers, Michael McGuire, Evanston, IL

MP05-20 COMPARISON OF RELIABILITY OF THE RENAL NEPHROMETRY SCORE BETWEEN RADIOLOGISTS AND UROLOGISTS

Samay Jain*, Khaled Shahrour, Toledo, OH

MP05-21 COMBINED PATIENT AND STONE MORPHOMETRY ENHANCE PREDICTION OF STONE COMPOSITION

Kara L Watts*, Tian C Zhou, Joseph Divito, David M Hoenig, Bronx, NY

MP05-22 PREOPERATIVE PLANNING WITH NON-CONTRAST COMPUTED TOMOGRAPHY IN THE PRONE AND SUPINE POSITION FOR PERCUTANEOUS NEPHROLITHOTOMY: A PRACTICAL OVERVIEW

Giovanni S. Marchini*, Fernanda Berto, Fabio C. Vicentini, Eduardo Mazzucchi, Miguel Srougi, São Paulo, Brazil

MP05-23 THE FIRST UNITED STATES SERIES USING THE TRANSURETHRAL SUPRAPUBIC ENDO-CYSTOSTOMY DEVICE FOR SUPRAPUBIC CATHETER INSERTION

Robert Larke*, Vassilis Siomos, Brian Flynn, Aurora, CO

MP05-24 RENAL CALCULI AND PLAIN IMAGING-RADIOLUCENT OR RADIO OPAQUE?

Paul Healy*, Dublin, Ireland, Saraswathy Suresh Babu, Leicester, United Kingdom, Priya Kumar, Preston, United Kingdom, Masood Khan, Leicester, United Kingdom

MP05-25 PERCUTANEOUS NEPHROSTOMY MADE EASY: ELECTROMAGNETIC NEEDLE GUIDANCE WITH TRACKED ULTRASOUND SNAPSHOTS IN A SIMULATION MODEL

Michael Fuoco*, Tamas Ungi, Rob Siemens, Gabor Fichtinger, Darren Beiko, Kingston, Canada

MP05-26 INCIDENCE AND DIAGNOSIS OF RENAL ARTERY PSEUDOANEURYSM FOLLOWING LAPAROSCOPIC AND ROBOT-ASSISTED PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW OF THE LITERATURE

Samay Jain, Toledo, OH, Andrew Tracey*, Nina Harkhani, Jennifer Yates, Ravi Munver, Hackensack, NJ

Wednesday, October 23, 2013   Video Session V01   2:30 pm–4:30 pm

ROBOTICS: UPPERTRACT I

Room Armstrong @ Sheraton New Orleans

Faculty: Michael Conlin and Michael Stiflelman

*Presenting author

V01-01 APPLICATION OF NEAR-INFRARED FLUORESCENCE IMAGING IN ROBOT-ASSISTED SURGERY

Melanie Gan*, Aalst, Belgium, Alessandro Volpe, Novara, Italy, Vincenzo Ficarra, Padua, Italy, Geert De Naeyer, Aalst, Belgium, Michael Stifelman, New York, NY, Alexandre Mottrie, Aalst, Belgium

V01-02 RERESECTION OF A GROSS POSITIVE SURGICAL MARGIN DURING ROBOTIC PARTIAL NEPHRECTOMY: LESSONS LEARNT

Jitendra Jagtap*, Raguram Ganesamoni, Jigish Vyas, Shashikant Mishra, Arvind Ganpule, Nadiad, India, Mihir Desai, Los Angeles, CA, Ravindra Sabnis, Mahesh Desai, Nadiad, India

V01-03 "ZERO ISCHEMIA" ROBOTIC ASSISTED PARTIAL NEPHRECTOMY FOR TUMORS WITH HIGH NEPHROMETRY SCORE

Giuseppe Simone*, Rocco Papalia, Mariaconsiglia Ferriero, Salvatore Guaglianone, Michele Gallucci, Rome, Italy

V01-04 ROBOT ASSISTED LAPAROSCOPIC TRANSMESOCOLIC PYELOPLASTY

Bilal Firat Alp, Seref Basal*, Ankara, Turkey, Zafer Demirer, Eskisehir, Turkey, Ali Guragac, Ankara, Turkey, Sami Uguz, Agri, Turkey, Ercan Malkoc, Corlu, Turkey, Ibrahim Yidirim, Ankara, Turkey

V01-05 MANAGEMENT OF DOUBLE COLLECTING SYSTEM WITH BOTH UPJ OBSTRUCTION AND URETERAL STONE

Ilter Tufek*, Omer Burak Argun, Selcuk Keskin, Ahmet Sahin, Ali Riza Kural, Istanbul, Turkey

V01-06 ROBOT-ASSISTED LAPAROSCOPIC HEMINEPHRECTOMY FOR A NON-FUNCTIONING UPPER MOIETY: LESSONS LEARNT FROM 3 CASES

Paul Sturch*, Matt Bultitude, Declan Cahill, Prokar Dasgupta, Ben Challacombe, London, United Kingdom

V01-07 ROBOT-ASSISTED PARTIAL CYSTECTOMY IN TREATMENT OF A BLADDER PARAGANGLIOMA OF THE URINARY BLADDER

Michael Weintraub*, Minhaj Siddiqui, Srinivas Vourganti, Brian Shuch, Jeffrey Nix, Chris Ricketts, W. Marston Linehan, Piyush K. Agarwal, Bethesda, MD

V01-08 ROBOT-ASSISTED LAPAROSCOPIC URETEROURETEROSTOMY FOR RETROCAVAL URETER

Scott Tobis, Anees Fazili*, Guan Wu, Jean Joseph, Rochester, NY

V01-09 ROBOTIC PARTIAL NEPHRECTOMY IN A PELVIC KIDNEY MASS: SURMOUNTING ANATOMIC CHALLENGES

Vikram Narayan*, Joseph Ellen, Christopher Nelsen, Li-Ming Su, Gainesville, FL

V01-10 ROBOTIC RIGHT ADRENALECTOMY FOR LARGE PHEOCHROMOCYTOMA

Gautam Jayram*, Petra Szima-Cotter, Mohamad Allaf, Misop Han, Baltimore, MD

V01-11 COMPARATIVE TECHNIQUES FOR MAINTAINING HEMOSTASIS DURING LAPAROSCOPIC/ROBOTIC ASSISTED PARTIAL NEPHRECTOMY

Jagan Kansal*, Jason C Sea, Clinton D Bahler, Chandru P Sundaram, Indianapolis, IN

V01-12 ROBOTIC RIGHT NEPHRECTOMY AND INFERIOR VENA CAVA TUMOR THROMBECTOMY WITH CAVAL PATCH GRAFT RECONSTRUCTION

Ziho Lee*, Christopher Reilly, Blake Moore, Daniel Parker, Linsey Parkes, Eric Choi, Jack Mydlo, Daniel Eun, Philadelphia, PA

Wednesday, October 23, 2013   Video Session V02   2:30 pm–4:30 pm

PERCUTANEOUS SURGERY

Room Grand Ballroom E @ Sheraton New Orleans

Chair: Guido Kamphuis

Faculty: Mark Cynk and Ningchen Li

*Presenting author

V02-01 TUBELESS, PRONE-FLEXED PERCUTANEOUS NEPHROLITHOTOMY: TECHNIQUE FOR TETHERED DOUBLE-J URETERAL STENT INSERTION

Kirsten Foell*, R. John D'A. Honey, Toronto, Canada

V02-02 ONE STAGE PCNL FOR STAGHORN CALCULI BY 3 ACCESSES

Zhang Shudong*, Beijing, China, People's Republic of

V02-03 TIPS AND TRICKS FOR PERCUTANEOUS NEPHROLITHOTRIPSY

Ioannis Georgiopoulos*, Iason Kyriazis, Panagiotis Kallidonis, Stavros Kontogiannis, Evangelos Liatsikos, Patras, Greece

V02-04 LASER ENDOPYELOTOMY

Prem Kumar*, Mohan Keshavamurthy, Shakir Tabrez, Uday Bhaskar, Mohan Balaiah Ashwathaiah, Bangalore, India

V02-05 RETROGRADE ACCESS VERSUS CLASSIC PERCUTANEOUS CYSTOLITHOLAPAXY IN BLADDER STONE MANAGEMENT

Shahrokh Sakhaei, Kermanshah, Iran, Babak Kazemzadehazad*, Tehran, Iran

V02-06 TECHNIQUE OF PERCUTANEOUS TREATMENT IN THE SUPINE POSITION OF A RENAL DIVERTICULUM

Ioannis Kartalas Goumas*, Emanuele Itri, Francesco Dell'Aglio, Fabrizio Pozzoni, Lorenzo Innocenti, Gianpaolo Zanetti, Vimercate, Italy

V02-07 MICROPERCUTANEOUS NEPHROLITHOTOMY GUIDED BY RETROGRADE FLEXIBLE URETEROSCOPY: PRELIMINARY EXPERIENCE

Cesare Marco Scoffone*, Fabiola Liberale, Cecilia Maria Cracco, Torino, Italy

V02-08 MICROPERCUTANEOUS NEPHROLITHOTOMY (MICROPERC): THE FIRST ITALIAN EXPERIENCE

Giampaolo Bianchi*, Alessio Zordani, Marco Rosa, Riccardo Galli, Modena, Italy, Ahmed Ghaith, Tanta, Egypt, Corradino Di Pietro, 41124, Italy, Salvatore MIcali, Modena, Italy

V02-09 PERCUTANEOUS PLACEMENT OF A SAFETY GUIDEWIRE AT NO COST

Mohammed Lezrek*, Khalil Bazine, Ahmed Fethi, Hicham Tazi, Mohammed Alami, Meknes, Morocco

V02-10 A SECOND SIMULTANEOUS PERCUTANEOUS RENAL TRACT WITH THE RIGID URETEROSCOPE

Mohammed Lezrek*, Khalil Bazine, Adil Slimani Alaoui, Hicham Tazi, Mohammed Alami, Meknes, Morocco

V02-11 THORACIC LITHIASIS: AN UNUSUAL COMPLICATION OF PERCUTANEOUS RENAL SURGERY

Mohammed Lezrek*, Hicham Tazi, Adil Slimani Alaoui, Khalil Bazine, Mohammed Alami, Meknes, Morocco

V02-12 A NEW TECHNIQUE OF PERCUTANEOUS ENDOSCOPIC NEPHROPEXY

Mohammed Lezrek*, Khalil Bazine, Hicham Tazi, Adil Slimani Alaoui, Mohammed Alami, Meknes, Morocco

Wednesday, October 23, 2013   Video Session V03   2:30 pm–4:30 pm

LAPAROSCOPIC EDUCATION, SIMULATORS, FEMALE UROLOGY

Room Nottoway @ Sheraton New Orleans

Chair: Sri Sivalingam

Faculty: Howard N. Winfield and Robert Figenshau

*Presenting author

V03-01 PLACEMENT OF METALLIC URETERAL STENTS - ANTEGRADE, RETROGRADE AND URINARY DIVERSION APPROACHES

Ioannis Georgiopoulos*, Iason Kyriazis, Panagiotis Kallidonis, Patras, Greece, Jens-Uwe Stolzenburg, Leipzig, Germany, Evangelos Liatsikos, Patras, Greece

V03-02 A PRACTICAL TRAINING SYSTEM OF LAPAROSCOPIC SURGERY

Hideo Yuki*, Miki Fuse, Tomoya Mizuno, Akinori Masuda, Hironori Betsunoh, Hideyuki Abe, Masahiro Yashi, Yoshitatsu Fukabori, Tomonori Yamanishi, Takao Kamai, Mibu-machi, Japan

V03-03 A GLOVE MODEL FOR ACQUIRING SKILLS OF ENDOUROLOGIC STONE MANIPULATION

Mohammed Lezrek*, Hicham Tazi, Adil Slimani Alaoui, Khalil Bazine, Mohammed Alami, Meknes, Morocco

V03-04 PERCUTANEOUS CALYX PUNCTURE SIMULATION IN A GLOVE MODEL

Mohammed Lezrek*, Hicham Tazi, Adil Slimani Alaoui, Khalil Bazine, Mohammed Alami, Meknes, Morocco

V03-05 MANAGEMENT OF STRESS URINARY INCONTINENCE AND VAGINAL PROLAPSE USING A SELF-TAILORED POLYPROPYLENE MESH

Mohammed Lezrek*, Omar Laghzaoui Boukaidi, Adil Slimani Alaoui, Khalil Bazine, Mohammed Alami, Meknes, Morocco

V03-06 FOUR PORT ROBOTIC SACROCOLPOPEXY: DEMONSTRATION OF A NOVEL TECHNIQUE AND FEASIBILITY

Christopher Tenggardjaja*, Nitya Abraham, Georges Haber, Raymond Rackley, Cleveland, OH

V03-07 ROBOTIC ASSISTED VESICOVAGINAL FISTULA REPAIR WITH EXCISION OF MESH AND SIMULTANEOUS INTRAVESICAL URETERAL REIMPLANT

Jeffrey Marotte*, Conway, AR, Wilson Alobuia, Little Rock, AR

V03-08 THE MANAGEMENT OF COMPLEX RENAL MASSES BY EX - VIVO PARTIAL NEPHRECTOMY AND AUTO - TRANSPLANTATION: CASE SERIES AND VIDEO PRESENTATION

Jasmir Nayak*, Joshua Koulack, Thomas McGregor, Winnipeg, Canada

V03-09 LAPAROSCOPIC REPAIR OF POST RADICAL CYSTECTOMY PARASTOMAL HERNIA

Manickam Ramalingam*, Kallappan Senthil, Anandan Murugesan, Mizar Ganapathy Pai, Coimbatore, India

V03-10 COMPILATION OF TWO CASES OF INVERTED PAPILLOMA THAT MIMICS TRANSITIONAL CELL NEOPLASIA IN YOUNG MEN PATIENTS; OUR TUR-BT EXPERIENCE

Serdar Yalcin*, Bilal Firat Alp, Sercan Yilmaz, Ibrahim Yildirim, Ankara, Turkey

V03-11 ROBOTIC ASSISTED MICROSURGICAL REPAIR OF TESTICULAR ARTERIAL INJURY

Jamin Brahmbhatt, Ahmet Gudeloglu*, Sijo Parekattil, Winter Haven, FL

Wednesday, October 23, 2013   Moderated Poster Session MP06   4:30 pm–6:15 pm

ROBOTICS/LAPAROSCOPY: PROSTATE, LOWER TRACT I

Room Rhythms 1 @ Sheraton New Orleans

Chair: Inderbir Gill

Faculty: David Albala and Changjun Yin

*Presenting author

MP06-01 OPEN OR ROBOT-ASSISTED RADICAL PROSTATECTOMY AS THE PRIMARY TREATMENT OF HIGH-RISK PROSTATE CANCER: ONCOLOGIC OUTCOMES AND INCIDENCE OF SUBSEQUENT THERAPIES

Mary Achim*, Brian Chapin, Surena Matin, John Davis, Houston, TX

MP06-02 DOES LIGASURE VESSEL SEALING SYSTEM PROVIDES SAFE AND EFFECTIVE SOLUTION ON SECURING DORSAL VEIN IN LAPAROSCOPIC RADICAL PROSTATECTOMY?

Onur Kaygisiz, Yakup Kordan, Bursa, Turkey, Cabir Alan, Çanakkale, Turkey, Burhan Coskun, Ömür Günseren, Bursa, Turkey, Ali Erhan Eren, Çanakkale, Turkey, Berna Aytaç, Hakan Vuruþkan*, Bursa, Turkey

MP06-03 OUTPATIENT ROBOTIC RADICAL PROSTATECTOMY: THE USC EXPERIENCE

Andre Berger*, Andre Luis de Castro Abreu, Arnaud Marien, Dennis J. Lee, Sheaumei Tsai, Scott Leslie, Raed Azhar, Sumeet Syan, Mihir M. Desai, Monish Aron, Inderbir S. Gill, Los Angeles, CA

MP06-04 THE IMPACT OF OBESITY ON THE COMPLICATION AND SUCCESS RATES IN LAPAROSCOPIC RADICAL PROSTATECTOMY

Onur Kaygisiz, Yakup Kordan, Hakan Vuruskan*, Ömür Günseren, Burhan Coskun, Hakan Kilicarslan, Berna Aytaç, Ismet Yavascaoglu, Bursa, Turkey

MP06-05 PELVIC LYMPHADENECTOMY IN INTERMEDIATE TO HIGH-RISK PROSTATE CANCER PATIENTS: A COMPARISON OF ROBOTIC AND OPEN APPROACHES

Andrew Michigan*, Don T. Bui, Fray F. Marshall, John G. Pattaras, Atlanta, GA

MP06-06 GLEASON SCORE 6 PROSTATE CANCER AND PRESENCE OF EXTRAPROSTATIC EXTENSION

Aria A. Razmaria*, Chciago, IL, Edris Negron, Gladell P. Paner, Chicago, IL, Michael McGuire, Evanston, IL, Gregory P. Zagaja, Arieh L. Shalhav, Scott E. Eggener, Chicago, IL

MP06-07 VIDEO ASSISTED DOCKING OF THE DA VINCI SURGICAL SYSTEM PATIENT CART

Saum Ghodoussipour, Kristen Coffey, Tamim Khaddash, John Gaughan, Zachary Smith*, Philadelphia, PA, Michael Louie, Chino, CA, Phillip Mucksavage, Philadelphia, PA, Aaron Bernie, ,

MP06-08 ROBOTIC ASSISTED RADICAL PROSTATECTOMY IN BIOPSY PROVEN HIGH-GRADE PROSTATE CANCER: EXPERIENCE FROM TWO TERTIARY CENTERS WITH GLEASON DOWNGRADING AT FINAL PATHOLOGY ASSESSMENT

Naif Alhathal, Assaad El-Hakim*, Montreal, Canada, Vladimir Mouraviev, David M Albala, Matt Kardjian, Syracuse, NY, Pierre-Alain Hueber, Kevin C Zorn, MONTREAL, Canada

MP06-09 POTENCY OUTCOMES OF ANATOMICAL GRADING OF NERVE SPARING (NS) DURING ROBOT ASSISTED RADICAL PROSTATECTOMY (RARP)

Oscar Schatloff, Zerifin, Israel, Haidar Abdul-Muhsin, Srinivas Samavedi*, Celebration, FL, Rafael Coelho, Sao Paulo, Brazil, Bernardo Rocco, Milan, Italy, Kenneth Palmer, Vipul Patel, Celebration, FL

MP06-10 OBJECTIVE PERIOPERATIVE PARAMETERS PREDICT LENGTH OF STAY FOR ROBOTIC-ASSISTED RADICAL PROSTATECTOMIES

Ariel Schulman*, Robert Lacivita, Peter Homel, Piyush Gupta, David Silver, Brooklyn, NY

MP06-11 SINGLE INSTITUTION OUTCOMES OF AFRICAN AMERICANS FOLLOWING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY

Samuel Ohlander*, Victor Gappmaier, Leslie Deane, Chicago, IL

MP06-12 COMBINED OPERATION OF ROBOT-ASSISTED RADICAL PROSTATECTOMY AND LAPAROSCOPIC NEPHROURETERECTOMY

Yoko Kyono*, Kazunori Hattori, Kohsuke Hishiki, Kazuhito Matsushita, Masaki Shimbo, Fumiyasu Endo, Kenichi Tobisu, Osamu Muraishi, Tokyo, Japan

MP06-13 THE SURGICAL LEARNING CURVE FOR PROSTATE CANCER CONTROL AFTER ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: EXPERIENCE OF A SINGLE SURGEON OF 500 CASES IN TAIWAN

Yen-chuan Ou*, CK Yang, Taichung, Taiwan

MP06-14 LONG TERM STABILITY OF PEAK FLOW RATES ACROSS AGES OR IN MEN WITH BASELINE PFR<10 FOLLOWING ROBOTIC ASSISTED RADICAL PROSTATECTOMY (RARP)

Harleen Dhaliwal, Adam Gordon, Douglas Skarecky, Kathyrn Osann, Blanca Morales, Thomas Ahlering*, Orange, CA

MP06-15 GRADED ANATOMIC NERVE SPARING DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY (RARP)

Ziho Lee*, Shailen Sehgal, Reid Graves, Yu-Kai Su, Elton Llukani, Kelly Monahan, Alice Mcgill, David Lee, Philadelphia, PA

MP06-16 COMPARISON OF ONCOLOGICAL OUTCOMES BETWEEN RETROPUBIC RADICAL PROSTATECTOMY AND ROBOT-ASSISTED RADICAL PROSTATECTOMY: AN ANALYSIS STRATIFIED BY SURGICAL EXPERIENCE

Jinsung Park*, Dae-Seon Yoo, Daejeon, Korea, Republic of, Seong Cheol Kim, Busan, Korea, Republic of, Sejun Park, Hanjong Ahn, Seoul, Korea, Republic of

MP06-17 SURGICAL TEAM ASSESSMENT OF THE OF THE 3D VIDEO SYSTEM AS USED IN LAPAROSCOPIC RADICAL PROSTATECTOMIES

Bogdan Petrut*, Hogea Maximilian, Vlad Schi&#539;cu, Andrei Kozan, Tiberiu Calistru, Alb Alexandra, Vasile Buda, Cluj Napoca, Romania

MP06-18 10 YEARS OF ROBOTIC UROLOGIC SURGERY AT AN ACADEMIC MEDICAL CENTER: A RETROSPECTIVE ANALYSIS OF CASE TRENDS AND PATTERNS

Gregory Mitchell*, Christopher Keel, Philip Dorsey, New Orleans, LA, Erik Castle, Scottsdale, AZ, Rodney Davis, Little Rock, AR, Raju Thomas, Benjamin Lee, New Orleans, LA

MP06-19 USE OF TRANEXAMIC ACID IN ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY – OUTCOMES AND COMPLICATIONS

Sarvpreet Ubee*, Masilamani Selvan, Phillip El-Dalil, Jane Boddy, Bhagyashree Netke, Rangaswamy Chandrashekar, Peter Cooke, Wolverhampton, United Kingdom

MP06-20 LEARNING CURVE AND PERIOPERATIVE OUTCOMES OF ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY IN 200 INITIAL JAPANESE CASES BY A SINGLE SURGEON

Takeshi Hashimoto*, Kunihiko Yoshioka, Jun Nakashima, Kazunori Namiki, Yutaka Horiguchi, Choichiro Ozu, Masaaki Tachibana, Tokyo, Japan

MP06-21 PELVIC LYMPH NODE YIELD IN ROBOTIC PROSTATECTOMY: EXTRAPERITONEAL VS. TRANSPERITONEAL APPROACH

Ashley Brandon*, Boston, MA, Abdul Babaeer, Ingolf Tuerk, Brighton, MA

MP06-22 NOVEL TECHNIQUE PREVENTS LYMPHOCELES FOLLOWING TRANSPERITONEAL ROBOTIC ASSISTED PELVIC LYMPH NODE DISSECTION: PERITONEAL FLAP INTERPOSITION

Christopher Lebeis*, Andrea Sorcini, David Canes, Alireza Moinzadeh, Burlington, MA

MP06-23 IDENTIFICATION OF FAVORABLE RISK FACTORS IN PATIENTS WITH POSITIVE SURGICAL MARGIN AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY

Yun-Sok Ha*, North Brunswick, NJ, Dong Il Kang, Busan, Korea, Republic of, Jeong Hyun Kim, Chuncheon, Korea, Republic of, Jae Young Joung, Goyang, Korea, Republic of, Ji Hyeong Yu, Seoul, Korea, Republic of, Wun-Jae Kim, Cheongju, Korea, Republic of, Isaac Kim, New Brunswick, NJ

MP06-24 RISK FACTORS OF POSITIVE SURGICAL MARGINS ON THE APEX OF PROSTATE ON ROBOT-ASSISTED LAPAROSCOPIC PROSTATECTOMY

Risa Muneishi*, Ryuta Tanimoto, Yasuyuki Kobayashi, Motoo Araki, Shin Ebara, Toyohiko Watanabe, Yasutomo Nasu, Hiromi Kumon, Okayama, Japan

MP06-25 DOES SURGEON SUBJECTIVE NERVE SPARING SCORE PREDICT RECOVERY OF ERECTILE FUNCTION FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY?

Sung Gu Kang*, Seoul, Korea, Republic of, Abdul Haidar, Orlando, FL, Srinivas Samavedi, Kenneth Palmer, Celebration, FL, Jun Cheon, Seoul, Korea, Republic of, Vipul Patel, Celebration, FL

MP06-26 IMPACT OF LENGTH OF POSITIVE SURGICAL MARGINS (PSM) ON BIOCHEMICAL RECURRENCE (BCR) AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY (RARP), IN A SINGLE CENTER SERIES WITH FOLLOW-UP OF AT LEAST FIVE YEARS

Prasanna Sooriakumaran*, Achilles Ploumidis, Leif Haendler, Tommy Nyberg, Mats Olsson, Stefan Carlsson, Gunnar Steineck, Peter Wiklund, Worcester Park, United Kingdom

Wednesday, October 23, 2013   Moderated Poster Session MP07   4:30 pm–6:15 pm

ESWL/UROLITHIASIS

Room Rhythms 2 @ Sheraton New Orleans

Chair: Christian Chaussey

Faculty: Brian Matlaga and Achim Loske

*Presenting author

MP07-01 ESWL TREATMENT IN GERMANY IN 2013: RESULTS FROM A NATION-WIDE HOSPITAL SURVEY

Wolfgang Brummeisl*, Christian Chaussy, Regensburg, Germany, Jens Rassweiler, Heilbronn, Germany, Thomas Knoll, Sindelfingen, Germany, Andreas Gross, Hamburg, Germany, Kai Koehrmann, Mannheim, Germany, Wolf Wieland, Hans-Martin Fritsche, Regensburg, Germany

MP07-02 TRIPLE D SCORE IS A READILY INTERPRETED SINGLE SCORE THAT PREDICTS SHOCKWAVE LITHOTRIPSY STONE FREE RATES FOR RENAL CALCULI

Timothy Tran*, Kathryn McGillen, Eugene Cone, Shadi Al Ekish, Damian Dupuy, Gyan Pareek, Providence, RI

MP07-03 A NON-INFERIORITY TRIAL COMPARING THE COMBINATION OF ETORICOXIB AND DICLOFENAC AGAINST PETHIDINE AS ANALGESIA DURING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY

Cheuk Fan Shum*, Amit Mukherjee, Chin Hu Ong, Tow Poh Lim, Chang Peng Colin Teo, Singapore, Singapore

MP07-04 TO ASSESS THE EFFECTS OF DIFFERENT TREATMENT PROTOCOLS ON THE DEGREE OF RENAL INJURY IN PATIENTS WITH RENAL STONES RECEIVING SHOCKWAVE LITHOTRIPSY

Ye Lu*, Wai Man Yuen, Danny Gohel, Chi Fai Ng, Hong Kong, Hong Kong

MP07-05 IN VIVO STONE COMMINUTION PRODUCED BY A MODIFIED ACOUSTIC LENS FOR ELECTROMAGNETIC LITHOTRIPTERS

Andreas Neisius*, Nathan Smith, Nicholas Kuntz, Tim Schykowski, Gaston Astroza, Richard Shin, Ramy Youssef, Muhammad Iqbal, Michael Ferrandino, Michael Lipkin, W. Neal Simmons, Glenn Preminger, Pei Zhong, Durham, NC

MP07-06 ENERGY AND PULSE REPETITION FREQUENCY DEPENDENT TISSUE INJURY PRODUCED BY A MODIFIED ACOUSTIC LENS FOR ELECTROMAGNETIC LITHOTRIPTERS

Andreas Neisius*, Nathan Smith, Nicholas Kuntz, Tim Schykowski, Gaston Astroza, Richard Shin, Ramy Youssef, Muhammad Iqbal, Michael Ferrandino, Michael Lipkin, W. Neal Simmons, Glenn Preminger, Pei Zhong, Durham, NC

MP07-07 A NOVEL METHOD OF EXTRACORPOREAL LITHOTRIPSY WITHOUT SHOCK WAVES: IN VITRO FRAGMENTATION OF ARTIFICIAL AND HUMAN CALCULI

Adam Maxwell*, Bryan Cunitz, Wayne Kreider, Oleg Sapozhnikov, Ryan Hsi, Mathew Sorensen, Jonathan Harper, Michael Bailey, Seattle, WA

MP07-08 HYPOTHERMIA (ICE PACK) VERSUS CYCLOOXYGENASE 2 SELECTIVE INHIBITOR AS PAIN CONTROL FOR POST-EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY PATIENTS

Ernesto Manuel Jr. Romero M.D.*, Omar Cortes, M.D., FPUA, FPCS, Michael Eufemio Jr. Macalalag, M.D., FPUA, FPCS, FPSO, Quezon City, Philippines

MP07-09 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY WITH DORNIER LITHOTRIPTER S: LONG TERM SIDE EFFECTS ASSESSMENT AFTER 10 YEARS OF FOLLOW UP

Marco Rosa*, Alessio Zordani, Maria Chiara Sighinolfi, Alessandro Mofferdin, Riccardo Galli, Salvatore MIcali, Giampaolo Bianchi, Modena, Italy

MP07-10 EFFECT OF ROWATINEX ON URINARY CALCULUS CLEARANCE AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY

Won Sik Jeong*, Won Sik Ham, Hong Sang Moon, Tchun Yong Lee, Sung Yul Park, Kyung Hyun Moon, Seoul, Korea, Republic of

MP07-11 THE EFFECT OF PREOPERATIVE COUNSELING ON PATIENT PREFERENCE IN MANAGEMENT OF ASYMPTOMATIC RENAL CALCUL

Gregory Lieser*, Giovanni Marchini, Carl Sarkissian, Julie Cheng, Manoj Monga, Cleveland, OH

MP07-12 VALIDATION OF A CLINICAL NOMOGRAM TO PREDICT SUCCESSFUL SINGLE TREATMENT SHOCKWAVE LITHOTRIPSY OF RENAL AND URETERAL CALCULI

Andrea G. Lantz*, Daniela Ghiculete, Kirsten Foell, Tarek Alzahrani, R. John Honey, Kenneth T. Pace, Toronto, Canada

MP07-13 OPTICAL COUPLING CONTROL IN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY: FIRST CLINICAL EXPERIENCE

Geert Tally*, Kapellen, Belgium

MP07-14 IS SCREENING PATIENTS FOR URINARY TRACT INFECTIONS BEFORE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY USING URINE DIPSTICK NECESSARY?

Ben Tschobotko, Milad Hanna*, Ranan DasGupta, London, United Kingdom

MP07-15 EARLY OUTCOMES AND PREDICTORS OF TREATMENT SUCCESS AFTER SINGLE SESSION EXTRA-CORPORAL SHOCK WAVE LITHOTRIPSY (ESWL) FOR UROLITHIASIS

Mano Roy, Danjuma U Kalba*, Nir Polak, Ronen Holland, Pinhas M Livne, David Lifshitz, Tel Aviv, Israel

MP07-16 INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS FOR PROTECTION FROM RENAL DAMAGE DUE TO EXTRACORPOREAL SHOCKWAVE THERAPY

Bilal Firat Alp*, Ankara, Turkey, Ercan Malkoc, Tekirdag, Turkey, Zafer Demirer, Eskisehir, Turkey, Ali Guragac, Ahmet Guven, Ayhan Ozcan, Ibrahim Yildirim, Ankara, Turkey

MP07-17 DOES OZONE THERAPY HAVE PROTECTIVE EFFECT ON RENAL DAMAGE CAUSED BY EXTRACORPOREAL SHOCKWAVE THERAPY?

Ercan Malkoc*, Tekirdag, Turkey, Bilal Firat Alp, Ankara, Turkey, Sami Uguz, Agri, Turkey, Ali Guragac, Ankara, Turkey, Ferhat Ates, Istanbul, Turkey, Bulent Uysal, Yasemin Gulcan Kurt, Ayhan Ozcan, Ibrahim Yildirim, Ankara, Turkey, Kenan Karademir, Istanbul, Turkey

MP07-18 VALPROIC ACID TREATMENT IN RENAL DAMAGE DUE TO EXTRACORPOREAL SHOCKWAVE THERAPY

Zafer Demirer*, Eskisehir, Turkey, Ercan Malkoc, Tekirdag, Turkey, Bilal Firat Alp, Ankara, Turkey, Sami Uguz, Agri, Turkey, Yavuz Poyrazoglu, Ankara, Turkey, Hasan Kocoglu, Kocaeli, Turkey, Emin Oztas, Yasemin Gulcan Kurt, Ayhan Ozcan, Seref Basal, Ibrahim Yildirim, Ankara, Turkey

MP07-19 CHANGE OF OXIDATIVE STRESS BEFORE AND AFTER ESWL FOR PATIENTS WITH RENAL STONE

Saint Shiou-Sheng Chen*, Allen W. Chiu, Taipei, Taiwan

MP07-20 COMPARISON EARLY WITH DELAYED LITHOTRIPSY IN COLIC PATIENTS WITH SOLITARY URETER CALCULI

Han Jung*, Sang-Jin Yoon, Khae-Hawn Kim, Tae-Beom Kim, Jin-Kyu Oh, Kyung Jin Chung, Kwang Taek Kim, Incheon, Korea, Republic of

MP07-21 NEUTROPHIL GELATINASE-ASSOCIATED LYPOCALIN (NGAL) VALUES CHANGE BEFORE AND AFTER SHOCK WAVE LITHOTRIPSY

Alessandro D'addessi*, Matteo Vittori, Silvia Baroni, Chiara De Waure, Matteo Raponi, Aniello Primiano, Francesco Sessa, Giuseppe Palermo, Pierfrancesco Bassi, Rome, Italy

MP07-22 SELECTIVE LUNG INTUBATION MAY IMPROVE STONE TARGETING DURING SECONDARY SWL

Vitaly Sherman, Shmuel Roizman*, Amnon Zisman, Amir Cooper, Zoya Haitov, Yoram I. Siegel, Zerifin, Israel

MP07-23 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY(ESWL) FOR THE TREATMENT OF RENAL COLIC INDUCED BY URETERAL STONES

Huang Donglong*, Shenzhen, China, People's Republic of

MP07-24 FIRST YEAR'S EXPERIENCE WITH A DORNIER GEMINI MULTIFUNCTIONAL LITHOTRIPTOR

Geert Tally*, Kapellen, Belgium

MP07-25 WITH THE ERA OF ADVANCED ENDOSCOPIC TECHNOLOGY, IS ESWL STILL NEEDED?

Hamed El-Darawany*, Alkhobar, Saudi Arabia

MP07-26 REGIONAL VARIATION IN THE SURGICAL MANAGEMENT OF KIDNEY STONE DISEASE IN THE PROVINCE OF ONTARIO

Michael Ordon*, R. John D'A. Honey, Kenneth T. Pace, Toronto, Canada

Wednesday, October 23, 2013   Moderated Poster Session MP08   4:30 pm–6:15 pm

ROBOTICS/LAPAROSCOPY: PROSTATE/BLADDER I

Room Rhythms 3 @ Sheraton New Orleans

Chair: Allen Chiu

Faculty: James Borin and Andres Hernandez Porras

*Presenting author

MP08-01 ROBOTIC RADICAL CYSTECTOMY WITH TOTALLY INTRACORPOREAL URINARY DIVERSION: PRELIMINARY RESULTS

Mariaconsiglia Ferriero*, Giuseppe Simone, Rocco Papalia, Salvatore Guaglianone, Rome, Italy, Mihir Desai, Inderbir Gill, Los Angeles, CA, Michele Gallucci, Rome, Italy

MP08-02 THE FIRST NATIONAL EXPERIENCE OF INTRAVESICAL INJECTION OF THE TRACEIT™ TISSUE MARKER UNDER A LOCAL ANESTHESIA FOR IMAGING VISUALIZATION OF MUSCLE-INVASIVE BLADDER CANCER FOR THE TARGETED IMRT

Joel Bass*, Po Lam, Christopher Pieczonka, Syracuse, NY, Patrick Campbell, Waltham, MA, David Albala, Howard Williams, Vladimir Mouraviev, Neil Mariados, Syracuse, NY

MP08-03 ROBOTIC RADICAL CYSTECTOMY AND COMPLETELY INTRACORPOREAL URINARY DIVERSION: THE USC EXPERIENCE

Andre Berger*, Andre Luis de Castro Abreu, Adrian Fairey, Sheaumei Tsai, Mehrdad Alemozaffar, Alvin Goh, Hamed Hamadi, Dennis J. Lee, Scott Leslie, Raed Azhar, Sumeet Syan, Monish Aron, Inderbir S. Gill, Mihir M. Desai, Los Angeles, CA

MP08-04 COMPARISON OF OUTCOMES BETWEEN INTRACORPOREAL AND EXTRACORPOREAL ILEAL CONDUITS IN 164 CONSECUTIVE ROBOT-ASSISTED RADICAL CYSTECTOMIES

Anees Fazili*, Helen Levey, Justin Houman, Changyong Feng, Hani Rashid, Guan Wu, Rochester, NY

MP08-05 THE EFFECT OF SURGEON VOLUME ON THE MORBIDITY OF RADICAL CYSTECTOMY IN THE UNITED STATES: A CONTEMPORARY POPULATION-BASED ANALYSIS

Jeffrey Leow*, Wei Jiang, Stephen Reese, Stuart Lipsitz, Boston, MA, Benjamin Chung, Stanford, CA, Steven Chang, Boston, MA

MP08-06 EFFECTS OF OPIOID-BASED ANALGESICS AND THE UTILIZATION OF THE ROBOTIC SYSTEM ON THE DURATION OF POSTOPERATIVE ILEUS FOLLOWING RADICAL CYSTECTOMY WITH ILEAL CONDUIT

Kyo Chul Koo*, Sey Kiat Lim, Tae Young Shin, Young Eun Yoon, Sang Woon Kim, Koon Ho Rha, Seoul, Korea, Republic of

MP08-07 PATIENT SURVIVAL COMPARISON BETWEEN CONVENTIONAL VS. OTHER VARIANT SUBTYPES OF BLADDER UROTHELIAL CARCINOMA

Ahmed Abd El Latif*, Beni Suef, Egypt, Ranko Miocinovic, Detroit, MI, Adrian Hernandez, Ryan Berglund, Cleveland, OH

MP08-08 PRE-PERITONEAL LAPAROSCOPIC PARTIAL CYSTECTOMY OF THE BLADDER PHEOCHROMOCYTOMA (WITH VIDEO)

Xiaojun Tian*, Lulin Ma, Yi Huang, Beijing, China, People's Republic of

MP08-09 LAPAROSCOPIC RADICAL CYSTECTOMY FOR BLADDER CANCER: FOLLOW-UP OF 53 CASES IN SINGLE CENTER

Jianlin Huang*, Yong Liao, Mingxing Qiu, Chengdu, China, People's Republic of

MP08-10 MATCHED-COMPARISON OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY: EXPERIENCE FROM A SINGLE INSTITUTION

Sailaja Pisipati*, Datesh Daneshwar, Elizabeth Waine, Christian Bach, David Gillatt, Anthony Koupparis, Edward Rowe, Bristol, United Kingdom

MP08-11 ROBOTIC VERSUS LAPAROSCOPIC INTRACORPOREAL URINARY DIVERSION AFTER RADICAL CYSTECTOMY

Idir Ouzaid*, Riccardo Autorino, Emad Rizkala, Dinesh Samarasekera, Vishnuvardhan Ganesan, Robert Stein, Jihad Kaouk, Georges-Pascal Haber, Cleveland, OH

MP08-12 CONTEMPORARY OUTOMES OF ROBOT ASSISTED RADICAL CYSTECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION

Ryan Dorin*, Halili Kiziloz, Kyle Finnegan, Joseph Wagner, Anoop Meraney, Hartford, CT

MP08-13 LAPAROSCOPIC RADICAL CYSTECTOMY WITH ILEAL CONDUIT: THE FIRST EXPERIENCE FROM SOUTH AFRICA

Sunil Sinha*, Cape Town, South Africa

MP08-14 COMPARITIVE OUTCOMES OF STUDER ILEAL NEOBLADDER AND BRICKER ILEAL CONDUIT URINARY DIVERSION AFTER LAPAROSCOPIC RADICAL CYSTECTOMY: EIGHT-YEAR FOLLOW-UP OF 77 CASES

Jianfei Ye*, Jianfei Ye, Lulin Ma, Beijing, China, People's Republic of

MP08-15 A COMPARISON OF ROBOTIC AND OPEN RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA IN OCTOGENARIANS

Amar Singh*, Sarah Hunt, Argil Wheelock, Norman Galen, Colin Goudelocke, Juan Class, Chattanooga, TN

MP08-16 MINIMALLY-INVASIVE URETERAL REIMPLANTATION: A SINGLE INSTITUTION FIVE-YEAR EXPERIENCE

Samuel Kaffenberger*, Aaron Benson, Ryan Pickens, S. Duke Herrell, Nashville, TN

MP08-17 LAPAROSCOPIC RADICAL CYSTECTOMY WITH INTRACORPOREAL CONSTRUCTION OF ORTHOTOPIC SIGMOID NEOBLADDER: TECHNIQUES AND RESULTS

Hao Liu, Tianxin Lin, Kewei Xu, Chun Jiang, Jinli Han, Hai Huang, Wen Dong, Xinxiang Fan, Hao Yu, Jian Huang*, Guangzhou, China, People's Republic of

MP08-18 LAPAROSCOPIC ILEOCYSTOPLASTY IN NEUROGENIC BLADDERS - IDEAL ILEAL LENGTH REDEFINED

Manickam Ramalingam*, Anandan Murugesan, Kallappan Senthil, Mizar Ganapathy Pai, Coimbatore, India

MP08-19 CLINICAL SIGNIFICANCE OF RADICAL CYSTECTOMY WITH EXTENDED LYMPHADENECTOMY AND INFLUENCING FACTORS ASSOCIATED WITH RECURRENCE OF BLADDER CANCER

Gongxian Wang*, NanChang, China, People's Republic of

MP08-20 80 IS THE NEW 60: ROBOTIC CYSTECTOMY IN OCTOGENARIANS AFFORDS PATIENTS STANDARD OF CARE WITH LIMITED COMPLICATIONS

Elizabeth Phillips, Vik Uberoi, Boston, MA, Audley Osbourne, Lewiston, ME, Ingolf Tuerk, Brighton, MA, Chris Hoover*, ,

MP08-21 REPAIR OF IATROGENIC URINARY TRACT INJURY USING THE SAME MINIMALLY-INVASIVE TECHNIQUE AS THE ORIGINAL PROCEDURE

Dana Kivlin*, Michael Hanzly, Jamison Jaffe, Justin Harmon, Philadelphia, PA

MP08-22 INITIAL EXPERIENCE OF ROBOTIC-ASSISTED RADICAL CYSTECTOMY WITH INTRA-CORPOREAL URINARY DIVERSION: A COMPARISON WITH EXTRA-CORPOREAL METHOD

Sailaja Pisipati*, Datesh Daneshwar, Christian Bach, Elizabeth Waine, David Gillatt, Edward Rowe, Anthony Koupparis, Bristol, United Kingdom

MP08-23 NOVEL LAPAROSCOPE DEFOGGING AND CLEANING DEVICE FOR ROBOT-ASSISTED LAPAROSCOPIC PROSTATECTOMY (RALP)

Carson Wong*, Middleburg Heights, OH, Xiao Gu, Yangzhou, China, People's Republic of, Motoo Araki, Okayama, Japan, Sara Heider, Middleburg Heights, OH

MP08-24 INCIDENCE AND SEVERITY OF SURGICAL COMPLICATIONS IN MINIMALLY INVASIVE RADICAL PROSTATECTOMY

Ana Maria Autran-Gomez*, Rafael Sanchez-Salas, Dominique Prapotnich, Paris, France, Fernando Secin, Buenos Aires, Argentina, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP08-25 BLADDER ASPECT RATIO AND VESICO-URETHRAL ANASTOMOSIS POSITION ON POSTOPERATIVE CYSTOGRAPHY AS THE PREDICTIVE FACTORS OF URINARY CONTINENCE RECOVERY AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY

Nobuyuki Nakajima*, Yuuki Shimizu, Taro Higure, Mamoru Fukuda, Masayoshi Kawakami, Masahiro Nitta, Kazuya Hanai, Akio Hoshi, Takeshi Nomoto, Toshiro Terachi, Isehara, Japan

MP08-26 REAL- VISUAL TISSUE STIFFNESS FEEDBACK IN MINIMALLY INVASIVE SURGERY

Gautam Mehra*, Min Li, Geoffrey Lane, Kaspar Althoefer, Prokar Dasgupta, London, United Kingdom

Wednesday, October 23, 2013   Moderated Poster Session MP09   4:30 pm–6:15 pm

TUR SURGERY

Room Grand Ballroom D @ Sheraton New Orleans

Faculty: John Honey and Darren Bieko

*Presenting author

MP09-01 HISTOTRIPSY EFFECTS ON THE BLADDER TRIGONE: FUNCTIONAL AND HISTOLOGIC CONSEQUENCES IN THE CANINE MODEL

Christopher Allam, J. Erby Wilkinson, Xu Cheng, Kimberly Ives, Timothy Hall, William Roberts*, Ann Arbor, MI

MP09-02 EN BLOC TURB WITH PLASMAKINETIC BUTTON TURIS: IS A BETTER TREATMENT OPTION?

Barbara Cristina Gentile*, Roberto Giulianelli, Luca Albanesi, Francesco Attisani, Gabriella Mirabile, Francesco Pisanti, Manlio Schettini, David Granata, Rome, Italy

MP09-03 FOUR-YEAR NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE RATES – A PROSPECTIVE, RANDOMIZED COMPARISON BETWEEN HEXAMINOLEVULINATE BLUE LIGHT AND STANDARD WHITE LIGHT CYSTOSCOPY

Bogdan Geavlete*, Razvan Multescu, Dragos Georgescu, Marian Jecu, Florin Stanescu, Cristian Moldoveanu, Petrisor Geavlete, Bucharest, Romania

MP09-04 CLASSIFICATION AND ENDOSCOPIC REPAIR OF INFRAVESICAL OBSTRUCTION AFTER HIFU

Stefan Thueroff*, Munich, Germany, Christian Chaussy, Regensburg, Germany

MP09-05 HIGH INTENSITY FOCUSED ULTRASOUND IN INCIDENTAL PROSTATE CANCER - A NON INVASIVE CURATIVE THERAPY-

Stefan Thueroff*, Derya Tilki, Munich, Germany, Christian Chaussy, Regensburg, Germany

MP09-06 A RANDOMIZED COMPARATIVE EFFECTIVENESS TRIAL ON TRANSURETHRAL ENUCLEATION WITH OLYMPUS BUTTON ELECTRODE (B-TUEP)VERSUS “TRADITIONAL LOOP” GYRUS PK FOR THE TREATMENT OF CLINICAL OBSTRUCTING BENIGN PROSTATE HYPERPLASIA. RUA'S EXPERIENCEA RANDOMIZED COMPA

Barbara Cristina Gentile*, Roberto Giulianelli, Luca Albanesi, Francesco Attisani, Gabriella Mirabile, Francesco Pisanti, Manlio Schettini, Rome, Italy

MP09-07 TRANSURETHRAL ENUCLEATION AND RESECTION FOR PROSTATIC HYPERPLASIA BEYOND 80 CC

Kenji Kawamura*, Ishikawa, Japan

MP09-08 2-MICRON LASER TRANSURETHRAL RESECTION OF REPEATED RECURRENCE OF MULTIPLE NON-MUSCLE INVASIVE BLADDER TUMORS: SINGLE-CENTER EXPERIENCE

Yanbo Wang, Jingjing Guan, Min Liu, Haifeng Zhang, Chunxi Wang*, Changchun, China, People's Republic of

MP09-09 HOLMIUM LASER ENUCLEATION OF THE PROSTATE VERSUS PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CHRONIC URINARY RETENTION

Christopher Jaeger*, Christopher Mitchell, Lance Mynderse, Amy Krambeck, Rochester, MN

MP09-10 FACTORS AFFECTING DE NOVO URINARY RETENTION AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE

Sung Han KIM, Kyanggi, Korea, Republic of, Minsoo Choo, Jae-Seung Paick, Hahn-Ey LEE*, Seung-June OH, Seoul, Korea, Republic of

MP09-11 MEDIUM TERM OUTCOME OF BIPOLAR PLASMA VAPORIZATION IN PROSTATE CANCER PATIENTS – A PALLIATIVE MODALITY OF PRESERVING SPONTANEOUS VOIDING

Bogdan Geavlete, Cristian Moldoveanu, Gheorghe Nita, Florin Stanescu, Marian Jecu, Petrisor Geavlete*, Bucharest, Romania

MP09-12 A PROSPECTIVE COMPARISON BETWEEN NBI AND STANDARD WHITE LIGHT CYSTOSCOPY IN CASES OF NON-MUSCLE INVASIVE BLADDER CANCER

Bogdan Geavlete, Marian Jecu, Florin Stanescu, Cristian Moldoveanu, Leon Adou, Petrisor Geavlete*, Bucharest, Romania

MP09-13 SALVAGE HOLMIUM LASER ENUCLEATION OF PROSTATE TO TREAT RECURRING BENIGN PROSTATIC HYPERPLASIA

Jin Kyu Oh*, Incheon, Korea, Republic of, Hahn Ey Lee, Seoul, Korea, Republic of, Jungbum Bae, Goyang, Korea, Republic of, Chang Wook Jeong, Jae-Seung Paick, Seung-June Oh, Seoul, Korea, Republic of

MP09-14 THREE-YEAR IMPACT OF COMBINED NARROW BAND IMAGING CYSTOSCOPY AND BIPOLAR PLASMA VAPORIZATION IN LARGE NON-MUSCLE INVASIVE BLADDER TUMORS’ CASES – A PROSPECTIVE, RANDOMIZED COMPARISON TO THE STANDARD APPROACH

Bogdan Geavlete*, Razvan Multescu, Dragos Georgescu, Florin Stanescu, Marian Jecu, Cristian Moldoveanu, Petrisor Geavlete, Bucharest, Romania

MP09-15 EVALUATION AND PREDICTION OF POSTOPERATIVE COMPLICATIONS AFTER PRIMARY TURB FOR NON-MUSCLE INVASIVE-BLADDER CANCER (NMIBC)

Rafael Sanchez-Salas*, Ana Maria Autran-Gomez, Dominique Prapotnich, Paris, France, Fernando Secin, Buenos Aires, Argentina, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP09-16 VISUAL INTERNAL URETHROTOMY FOR URETHRAL STRICTURE RECURRENCE AFTER PERINEAL BULBOPROSTATIC ANASTOMOSIS: WHO WILL BE SUITABLE?

Dong Soo Park*, Seung Ryeol Lee, Seongnam-si, Korea, Republic of

MP09-17 TWO YEARS ENDOSCOPIC RESECTION OF BLADDER WITH PHOTODYNAMIC BLUE LIGHT: PRELIMINARY RESULTS

Tommaso Brancato*, Roma, Italy, Francesca Suriano, Roberto D'Ascenzo, Pietro Nupieri, Gianni Paulis, Giuseppe Orsolini, Albano Laziale Roma, Italy, Rosaria Alvaro, Roma, Italy

MP09-18 SHOULD WE STOP ASPIRIN BEFORE TURP?

Alireza Farshi Haghro*, Tabriz, Iran

MP09-19 THE ROLE OF URODYNAMICS PRIOR TO HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN MEN WITH BPH: A SERIES OF OVER 300 PATIENTS

Chinedu Mmeje*, Rafael Nunez-Nateras, Meng-Ru Cheng, Yu-Hui Chang, Mitchell Humphreys, Phoenix, AZ

MP09-20 TRANSURETHRAL LOW ENERGY HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) – A COMPARISON OF SINGLE SURGEON PERFORMANCE IN THE BEGINNING AND IN THE PRESENT

Philip Emanuel Rieker*, Jan T. Klein, Michael Schulze, Marcel Hruza, Koray Genisoglu, Jens J. Rassweiler, Heilbronn, Germany

MP09-21 OVERCOMING THE LEARNING CURVE: A PERFORMANCE IMPROVEMENT ANALYSIS OF 210 CONSECUTIVE ANTEROPOSTERIOR DISSECTION HOLEP

Fumiyasu Endo*, Masaki Shimbo, Kazuhito Matsushita, Kohsuke Hishiki, Yoko Kyono, Akiko Fujisaki, Takayuki Sugimura, Kazunori Hattori, Kenichi Tobisu, Osamu Muraishi, Tokyo, Japan

MP09-22 OUT-PATIENT TRANSURETHRAL LASER ABLATION (TULA) OF UROTHELIAL TUMOURS USING THE 1470 NM DIODE LASER

Sachin Agrawal*, Uwais Mufti, Rosemarie Richards, David Hrouda, Altaf Shamsuddin, London, United Kingdom

MP09-23 HARD NODULE RESISTANT TO MORCELLATION DURING HOLMIUM LASER ENUCLEATION OF PROSTATE

Jungbum Bae*, Goyang, Korea, Republic of, Hahn-Ey Lee, Kyung Chul Moon, Seung-June Oh, Seoul, Korea, Republic of

MP09-24 OUR EXPERIENCE OF PHOTOSELECTIVE VAPORISATION OF THE PROSTATE (PVP): A SINGLE INSTITUTIONAL STUDY OF 168 PATIENTS

Salil Umranikar*, Solihull, United Kingdom, Salahuddin Ghiblawi, Shrewsbury, United Kingdom

MP09-25 ENDOUROLOGY AND FOREIGN BODIES IN THE BLADDER: HISTORICAL REVIEW

Michael Moran*, Tucson, AZ

Wednesday, October 23, 2013   Moderated Poster Session MP10   4:30 pm–6:15 pm

IMAGING & NEW TECHNIQUES II

Room Grand Chenier @ Sheraton New Orleans

Chair: David Hoenig

Faculty: Madhu S Agrawal and Art Rastinhad

*Presenting author

MP10-01 IMPACT OF RENAL NEPHROMETRY SCORE ON RENAL BIOPSY UTILITY: ANALYSIS OF THE TRACE REGISTRY DATA

Jason Bylund, Lexington, KY, Jaime Landman, Irvine, CA, Stephen Savage, Charleston, SC, Peter Clark, Stanley Herrell, Nashville, TN, Chad LaGrange, Omaha, NE, David Schulsinger, Stony Brook, NY, Stephen Strup*, Lexington, KY

MP10-02 PROSTATE HISTOSCANNING AS A TOOL FOR DECISION MAKING IN PROSTATE CANCER THERAPEUTICS

Petr Macek*, Eric Barret, Rafael Sanchez-Salas, Marc Galiano, Luca Lunelli, Youness Ahallal, Laurent Mascle, Camilo Giedelman, Josep M Gaya, Dominique Prapotnich, Francois Rozet, Xavier Cathelineau, Paris, France

MP10-03 LABEL-FREE DETECTION OF POSITIVE SURGICAL MARGINS DURING RADICAL PROSTATECTOMY USING COHERENT ANTI-STOKES RAMAN SCATTERING MICROSCOPY

Alvin Goh*, Xiaoyun Xu, Houston, TX, Liang Gao, Rockingham, VT, Haijun Zhou, Michael Thrall, Xi Wang, Xu Chen, Zhengfan Liu, Houston, TX, Ganesh Palapattu, Ann Arbor, MI, Stephen Wong, Houston, TX

MP10-04 OFFICE-BASED IMAGED-GUIDED PERCUTANEOUS CRYOABLATION OF CLINICAL T1A RENAL MASSES: EXPERIENCE OF A SINGLE PRIVATE-PRACTICE UROLOGIST IN THE COMMUNITY SETTING

James Siegert*, Cameron Jirschele, Thai Nguyen, Joliet, IL

MP10-05 FINE TILT TUNING OF A LAPAROSCOPIC CAMERA BY LOCAL MAGNETIC ACTUATION: TWO-PORT LAPAROSCOPIC NEPHRECTOMY EXPERIENCE ON HUMAN CADAVERS

Ryan Pickens*, Knoxville, TN, Massimliano Simi, Duke Herrell, Pietro Valdastri, Nashville, TN

MP10-06 POST-TREATMENT IMAGING CHARACTERISTICS OF RENAL MASSES AFTER CRYOABLATION: RESULTS FROM A MULTI-INSTITUTIONAL DATABASE

James Rosoff, charleston, SC, Jaime Landman, Irvine, CA, S. Duke Herrell, Peter Clark, Nashville, TN, Stephen Strup, Lexington, KY, Chad LaGrange, Albequerque, NM, David Schulsinger, Stony Brook, NY, Stephen Savage*, Charleston, SC

MP10-07 A NEW METHOD TO ESTIMATE URINARY STONE SIZE: SEGMENTATION ALGORITHM-BASED CT

Xiaobo Ding*, Liang Chen, Jiping Wang, Changchun, China, People's Republic of, Gang Jin, Herbin, China, People's Republic of

MP10-08 PROSPECTIVE COMPARISON OF FLEXIBLE FIBEROPTIC CO2 LASER AND STANDARD MONOPOLAR CAUTERY FOR ROBOTIC MICROSURGICAL DENERVATION OF THE SPERMATIC CORD PROCEDURE

Landon Trost, Ahmet Gudeloglu*, Jamin Brahmbhatt, Sijo Parekattil, Winter Haven, FL

MP10-09 LASER ACTIVATED NANOPARTICLE ABLATION OF PROSTATE CANCER: A PILOT STUDY IN HUMANS

Joshua Stern*, Larchmont, NY, Elena Elena Sazykina, Mexico City, Mexico, Jon Schwartz, Houston, TX

MP10-10 DIAGNOSTIC EFFICACY OF CONTRAST-ENHANCED ULTRASOUND FOR SOLID RENAL TUMOR

Ill Young Seo*, Tae Hoon Oh, Jae Whan Lee, Iksan, Korea, Republic of

MP10-11 CONTEMPORARY UROLOGIC MINI-LAPAROSCOPY: INDICATIONS, TECHNIQUES AND SURGICAL OUTCOMES IN A MULTI-INSTITUTIONAL EUROPEAN COHORT

Riccardo Autorino*, Cleveland, OH, Francesco Porpiglia, Orbassano, Italy, Vincenzo Pagliarulo, Bari, Italy, Alessandro Volpe, Novara, Italy, Mario Falsaperla, Catania, Italy, Antonio Celia, Bassano del Grappa, Italy, Alberto Breda, Barcelona, Italy, Francesco Greco, Halle/Salle, Germany, Antonio Cicione, Braga, Portugal, Marco De Sio, Napoli, Italy, Alberto Saita, Catania, Italy, Angelo Venneri Becci, Bari, Italy, Monica Zacchero, Novara, Italy, Riccardo Bertolo, Orbassano, Italy, Paolo Fornara, Halle/Salle, Germany, Christian Fiori, Orbassano, Italy, Carlo Terrone, Novara, Italy, Estevao Lima, Braga, Portugal, Jens Rassweiler, Heilbronn, Germany

MP10-12 COMPARISON OF LAPAROSCOPIC AND PERCUTANEOUS APPROACHES FOR CRYOABLATION OF SMALL RENAL CORTICAL NEOPLASM

Zhamshid Okhunov*, Jaime Landman, Orange, CA, Peter Clark, Duke Herrell, Nashville, TN, Stephen Savage, Charlston, SC, Stephen Strup, Lexington, KY, David Schulsinger, NY, NY, Chad LaGrange, Omaha, NE

MP10-13 THREE-DIMENSIONAL VERSUS STANDARD LAPAROSCOPY: COMPARATIVE ASSESSMENT USING A VALIDATED PROGRAM FOR LAPAROSCOPIC UROLOGIC SKILLS

Riccardo Autorino*, Cleveland, OH, Antonio Cicione, Braga, Portugal, Alberto Breda, Barcelona, Spain, Marco De Sio, Napoli, Italy, Rocco Damiano, Catanzaro, Italy, Francesco Greco, Halle/Salle, Germany, Ferdinando Fusco, Napoli, Italy, Emanuel Carvalho-Dias, Paulo Mota, Crisitina Noguiera, Pedro Pinho, Braga, Portugal, Vincenzo Mirone, Napoli, Italy, Jens Rassweiler, Heilbronn, Germany, Estevao Lima, Braga, Portugal

MP10-14 COMPLETE HIFU IN LOCALIZED PROSTATE CANCER

Christian Chaussy*, Regensburg, Germany, Derya Tilki, Stefan Thueroff, Muenchen, Germany

MP10-15 SUCCESS OF PERCUTANEOUS ABLATION FOR RENAL CELL CARCINOMA IS DEPENDENT ON TUMOR SIZE: A MULTI-INSTITUTIONAL STUDY

Sara Best*, E. Jason Abel, Madison, WI, Ali Khalifeh, Cleveland, OH, Meghan Lubner, Sutchin Patel, Stephen Nakada, Madison, WI, Jihad Kaouk, Cleveland, OH

MP10-16 DOES STRENGTH OF MRI SCANNER AND BETWEEN BIOPSY AND EMRI SIGNIFICANTLY INFLUENCE THE ABILITY OF ENDORECTAL MAGNETIC RESONANCE IMAGING (EMRI) TO PREDICT EXTRACAPSULAR EXTENSION (ECE) AND SEMINAL VESICLE INVASION (SVI) IN PATIENTS WITH CLINICALLY LOCAL

Ziho Lee*, Shailen Sehgal, Reid Graves, Yu-Kai Su, Elton Llukani, Kelly Monahan, Alice Mcgill, David Lee, Philadelphia, PA

MP10-17 HISTOPATHOLOGICAL DIFFERENCES BETWEEN PROSTATE CANCER FOCI THAT ARE DETECTED AND MISSED USING MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN KOREAN PATIENTS

Jae Dong Chung*, Seung Hyun Ahn, Jong Kyou Kwon, Tae-Hyoung Kim, Soon Chul Myung, Young Tae Moon, Kyung Do Kim, In Ho Chang, Seoul, Korea, Republic of

MP10-18 INTRAOPERATIVE OPTICAL BIOPSY DURING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY USING CONFOCAL LASER ENDOMICROSCOPY: INITIAL FEASIBILITY STUDY

Joseph Liao*, Daniel Bui, Jen-Jane Liu, Kathleen Mach, Stanford, CA, Theodore Harris, Palo Alto, CA, John Leppert, Stanford, CA

MP10-19 FOCAL THERAPY OF LOCALIZED RENAL CELL CARCINOMA. INTERSTITIAL LASER COAGULATION

Oleg Teodorovich, Stanislav Naryshkin*, Gennady Borisenko, Elena Rasshchupkina, Alina Ivannikova, Andrey Ryazantsew, David Kochiev, Moscow, Russian Federation

MP10-20 THE DIAGNOSTIC ACCURACY OF MULTIDETECTOR COMPUTED TOMOGRAPHY WITH MULTIPLANAR REFORMATTED IMAGING AND VIRTUAL CYSTOSCOPY IN THE EARLY DETECTION AND EVALUATION OF BLADDER CARCINOMA: COMPARISON WITH CONVENTIONAL CYSTOSCOPY

Amr Abdel Hamid*, El Minia, Egypt

MP10-21 WHITE LIGHT AND NARROW BAND IMAGE OF BLADDER UROTHELIAL CARCINOMA: COLOR COMPONENT ANALYSIS

Yi-Chia Lin*, Chen-Kun Liaw, Te-Fu Tsai, Kuang-Yu Chou, Hung-En Chen, Thomas I.S. Hwang, Taipei, Taiwan

MP10-22 RADIATION EXPOSURE ASSOCIATED WITH DEDICATED RENAL MASS COMPUTER TOMOGRAPHY PROTOCOL: IMPACT OF PATIENT CHARACTERISTICS

Matvey Tsivian, Michael Abern, Peter Qi, John Yoo, Paul Evans, Charles Kim, Michael Lipkin, Thomas Polascik, Michael Ferrandino*, Durham, NC

MP10-23 COMPARISON OF ONCOLOGIC OUTCOMES BETWEEN SUBJECTS UNDERGOING ON AND OFF CLAMP LAPAROSCOPIC PARTIAL NEPHRECTOMY

Paras Shah*, Arvin George, Louis Kavoussi, Manaf Alom, Sammy Elsamra, Soroush Rais-Bahrami, Nikhil Waingankar, New Hyde Park, NY

MP10-24  IN VITRO COMPARISON OF A NOVEL FACILITATED ULTRASOUND TECHNOLOGY VERSUS STANDARD TECHNIQUE APPROACH FOR PERCUTANEOUS RENAL BIOPSY

Ashleigh Menhadji*, Vien Nguyen, Jane Cho, Ringo Chu, Kathyrn Osann, Philip Bucur, Puja Patel, Achim Lusch, Orange, CA, Elspeth McDougall, Vancouver, Canada, Jaime Landman, Orange, CA

MP10-25  IN VITRO COMPARISON OF A STANDARD AND NOVEL ECHOGENIC NEEDLE FOR ULTRASOUND-GUIDED PERCUTANEOUS RENAL BIOPSY

Ashleigh Menhadji, Vien Nguyen*, Jane Cho, Ringo Chu, Kathyrn Osann, Philip Bucur, Puja Patel, Achim Lusch, Orange, CA, Elspeth McDougall, Vancouver, Canada, Jaime Landman, Orange, CA

MP10-26 VIDEO ASSISTED DOCKING OF THE DA VINCI SURGICAL SYSTEM PATIENT CART

Saum Ghodoussipour*, Kristen Coffey, Tamim Khaddash, John Gaughan, Philadelphia, PA, Michael Louie, Irvine, CA, Phillip Mucksavage, Philadelphia, PA

Wednesday, October 23, 2013   Video Session V04   4:30 pm–6:00 pm

BPH & ROBOTICS: LOWER TRACT

Room Armstrong @ Sheraton New Orleans

Chair: Stavros Gravas

Faculty: Li-Ping Xie and Andrew Fuller

*Presenting author

V04-01 TREATMENT OF LARGE VOLUME BPH WITH “SANDWICH” TECHNIQUE: DIODE LASER VAPORIZATION COMBINED WITH BIPOLAR PLASMA KINETIC TRANSURETHRAL RESECTION

Joao Padua Manzano*, Frederico Teixeira Barbosa, Gabriel Moulin Gouvea, Adalberto Andriolo Jr, Roberto Soler, Joaquim Francisco De Almeida Claro, Sao Paulo, Brazil

V04-02 THE USE OF THE EVOLVE™ 300 DUAL DIODE LASER FOR THE MINIMALLY INVASIVE TREATMENT OF BENIGN PROSTATIC ENLARGEMENT: TECHNIQUE AND PRELIMINARY RESULTS

Ioannis Kartalas Goumas*, Emanuele Itri, Francesco Dell'Aglio, Fabrizio Pozzoni, Lorenzo Innocenti, Gianpaolo Zanetti, Vimercate, Italy

V04-03 HOLEP: POINT OF TECHNIQUE, TIPS AND TRICKS

Ivano Vavassori*, Yasser Hussein, Giovanni Giliberto, Luca Cau, Francesca Ceresoli, Treviglio, Italy

V04-04 B-TUEP: PLASMA ENUCLEATION USING OLYMPUS BUTTON ELECTRODE IN BPH

Francesco Pisanti*, Luca Albanesi, Francesco Attisani, Barbara Cristina Gentile, Luca Mavilla, Gabriella Mirabile, Manlio Schettini, Roberto Giulianelli, Rome, Italy

V04-05 TRANSURETHRAL "ONE-PIECE" ENUCLEATION WITH BIPOLAR; SIMPLE AND RATIONAL SURGICAL PROCEDURE FOR BENIGN PROSTATIC HYPERPLASIA

Takao Mishima*, Tadashi Matsuda, Hirakata, Japan, Jiro Harada, Kenta Takayasu, Gen Kawa, Osaka, Japan, Shigenori Kurumada, Atsushi Yoshimizu, Niigata, Japan

V04-06 SAFETY IS OUR TOP PRIORITY: TIPS AND TRICKS FOR SAFE MORCELLATION DURING HOLEP

Hahn-Ey Lee*, Myong Kim, Jae-Seung Paick, Seung-June Oh, Seoul, Korea, Republic of

V04-07 TRANSURETHRAL RESECTION OF THE PROSTATE WITHOUT POSTOPERATIVE IRRIGATION

Mohammed Lezrek*, Khalil Bazine, Adil Slimani Alaoui, Hicham Tazi, Mohammed Alami, Meknes, Morocco

V04-08 ROBOTIC SUPRAPUBIC PROSTATECTOMY: AN INTRAVESICAL APPROACH

Marc Bjurlin*, Arielle Miller, Suzannah Sorin, Benjamin Brucker, Michael Stifelman, New York, NY

V04-09 ROBOTIC ASSISTED LAPAROSCOPIC PARTIAL CYSTECTOMY WITH CYSTOSCOPIC GUIDANCE FOR URACHAL CARCINOMA

Jacob Khurgin*, Ronak Gor, Justin Harmon, Philadelphia, PA

V04-10 A SERIES BEGINNING: ROBOTIC CYSTOLITHOTOMY AND SIMPLE PROSTATECTOMY

Peter Chang*, Daniel Welchons, Peter Steinberg, Andrew Wagner, Boston, MA

V04-11 COMBINED ROBOTIC AND LAPAROSCOPIC REPAIR OF COLO-VESICAL FISTULA DUE TO SIGMOID DIVERTICULITIS

Haluk Akpinar*, Fatih Altunrende, Mehmet Hakan Tekelioglu, Erdal Ergin, Istanbul, Turkey

V04-12 THULIUM LASER ENUCLEATION AS CONSERVATIVE RESECTION OF PROSTATIC URETHRA UROTHELIAL CANCER NEAR SPHINCTER

Shih-Che Tseng*, Wei-Ting Kuo, Jentai Lin, Kaohsiung, Taiwan

Wednesday, October 23, 2013   Video Session V05   4:30 pm–6:00 pm

LAPAROSCOPY/ROBOTICS: PROSTATE, BLADDER & LOWER TRACT I

Room Grand Ballroom E @ Sheraton New Orleans

Faculty: Jorge Gutierrez-Aceves and Bannakij Lojanapiwat

*Presenting author

V05-01 APPLICATION OF SINGLE NEEDLE RUNNING SUTURE BY TWO HANDS IN LAPAROSCOPIC RADICAL PROSTATECTOMY

Ma Lulin*, Zhang Shudong, Qiu Min, Beijing, China, People's Republic of

V05-02 IATROGENIC DIRECT RECTAL INJURY: AN UNUSUAL COMPLICATION DURING SUPRAPUBIC CYSTOSTOMY INSERTION AND ITS LAPAROSCOPIC MANAGEMENT

Theodoros Tokas*, Ali Serdar Gözen, Rakesh Rajmohan, Bernardo Aguilar-Davidov, Jens Rassweiler, Heilbronn, Germany

V05-03 PELVIC LYMPH NODE DISSECTION IN LAPAROSCOPIC RADICAL CYSTECTOMY - THREE-YEAR RESULTS

Wing Hang Au*, Chi-Fai Kan, Ho-Yin Ngai, Lap-Yin Ho, Steve Wai-Hee Chan, Kowloon, Hong Kong

V05-04 EXTRAPERITONEAL VERUS TRANSPERITONEAL PELVIC LYMPH NODE DISSECTION IN LAPAROSCOPIC RADICAL PROSTATECTOMY

Trevor Churk Fai Li*, Wai Hee Steve Chan, kowloon, Hong Kong

V05-05 LAPAROSCOPIC CLOSURE OF FAILED MITROFANOFF CATHETERISABLE STOMA - IS IT FEASIBLE

Manickam Ramalingam*, Kallappan Senthil, Anandan Murugesan, Mizar Ganapathy Pai, Coimbatore, India

V05-06 LAPAROSCOPIC URETEROCYSTOPLASTY WITH FASHIONING OF URETER

Manickam Ramalingam*, Kallappan Senthil, Anandan Murugesan, Mizar Ganapathy Pai, Coimbatore, India

V05-07 LAPAROSCOPIC EXCISION OF A BLADDER CARCINOID TUMOR

Abraham Kurien*, Nagarajan Palaniappan, Ranjit Vijayan, Ashish Verma, Chennai, India

V05-08 ROBOTIC-ASSISTED INGUINAL LYMPHADENECTOMY FOR URETHRAL CARCINOMA

Thomas Frye*, Alex Gorbonos, Springfield, IL

V05-09 ROBOTIC RADICAL PROSTATECTOMY FOLLOWING SLEEVE GASTRECTOMY WITH CONCOMITANT ABDOMINOPLASTY CASE REPORT

René Sotelo*, Juan Castro, Ruben Contreras, Oswaldo Carmona, Javier Manrique, Robert De Andrade, Golena Fernandez, Roberto Garza, Roberto Cisneros, Caracas, Venezuela, Mihir Desai, Los Angeles, CA

V05-10 ROBOTIC ASSISTED LAPAROSCOPIC REPAIR OF IATROGENIC BLADDER INJURY

Ahmet Gudeloglu*, Jamin Brahmbhatt, Sijo Parekattil, Winter Haven, FL

V05-11 ROBOTIC POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION WITH ASSOCIATED DUPLICATED INFERIOR VENA CAVA

Christopher Keel*, Erik Castle, Benjamin Woodson, Raju Thomas, New Orleans, LA

V05-12 ROBOTIC BLADDER BOARI FLAP RECONSTRUCTION FOR REPLACEMENT OF DISTAL URETER

Mathew Oommen, Janet Colli, Ashley Bowen, Kush Patel, Philip Dorsey*, Andrew Pridjian, Raju Thomas, New Orleans, LA

Wednesday, October 23, 2013   Video Session V06   4:30 pm–6:00 pm

IMAGING & NEW TECHNIQUES

Room Nottoway @ Sheraton New Orleans

Chair: Brian R. Matlaga

Faculty: Michael E. Lipkin and Mordechai Duvdevani

*Presenting author

V06-01 EN-BLOC RESECTION OF NON-MUSCLE INVASIVE BLADDER TUMORS WITH A NOVEL HYBRID INSTRUMENT (HYBRIDKNIFE®)

Christian Schwentner*, Tuebingen, Germany

V06-02 “5-PANG SYSTEM”-VERSION 2: A MULTIUTILITY SYSTEM FOR PERCUTANEOUS RENAL ACCESS

Ashish Rawandale*, Lokesh Patni, Preeti Patil, Dhule, India

V06-03 A PERITONEAL WALL ANCHOR TECHNIQUE USING A NEW DEVICE FOR LAPAROSCOPY-ASSISTED CATHETER PLACEMENT IN PERITONEAL DIALYSIS

Yoshiyuki Miyaji*, Keita Hirata, Hiroyasu Takasaki, Seitetsu Kin, Aya Takahara, Kazuhiko Fukumoto, Mikako Kaifu, Tomohiro Fujii, Yoshimasa Jo, Teruhiko Yokoyama, Atsushi Nagai, Kurashiki, Japan

V06-04 URETERIC AND BLADDER ENDOSCOPIC SUTURING IN NEPHROURETERECTOMY WITH ENDOSCOPIC URETERAL DETACHMENT: INITIAL EXPERIENCE

Mohammed Lezrek*, Hicham Tazi, Adil Slimani Alaoui, Khalil Bazine, Mohammed Alami, Meknes, Morocco

V06-05 INSERTION OF TWO MEMOKATH 051 TO STENT THE WHOLE URETER

Andreas Bourdoumis, Stefanos Kachrilas*, Junaid Masood, Noor Buchholz, London, United Kingdom

V06-06 INSERTION OF URETERIC ALLIUM STENT

Stefanos Kachrilas*, Andreas Bourdoumis, Junaid Masood, Noor Buchholz, London, United Kingdom

V06-07 FOCAL SALVAGE CRYOSURGERY FOR PROSTATE CANCER IN A POST RADIATION THERAPY PATIENT: TECHNIQUE

Aaron Katz*, Ajayram Ullal, Anne Darves-Bornoz, Maureen Regan, Scott Quarrier, Mineola, NY

V06-08 ROBOTIC RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE I TESTIS CANCER

Gautam Jayram*, Mark Ball, Trinity Bivalacqua, Mohamad Allaf, Baltimore, MD

V06-09 FEASIBILITY OF INTERNAL ORGAN RETRACTOR SYSTEM FOR UROLOGIC LAPAROENDOSCOPIC SINGLE-SITE SURGERY: INITIAL EXPERIENCES IN 17 PATIENTS

Wonho Jung*, Seol Ho Choo, Seong Soo Jeon, Hyung Keun Park, Deok Hyun Han, Seoul, Korea, Republic of

V06-10 SINGLE PORT LAPAROSCOPIC DONOR NEPHRECTOMY: FIRST CASE REPORT IN THAILAND

Wisoot Kongchsreonsombat*, Bangkok, Thailand

V06-11 ROBOTIC-ASSISTED LAPAROSCOPIC TRANSABDOMINAL VASOVASOSTOMY

Dinesh Samarasekera*, Riccardo Autorino, Christopher Starks, Edmund S Sabanegh, Jihad H Kaouk, Cleveland, OH

Thursday, October 24, 2013   Moderated Poster Session MP11   2:30 pm–4:15 pm

ROBOTICS/LAPAROSCOPY: UPPER TRACT II

Room Rhythms 1 @ Sheraton New Orleans

Chair: Tadashi Matsuda

Faculty: Michelle Gallucci and J. Stuart Wolf

*Presenting author

MP11-01 REVIEW OF MANAGEMENT OF BILATERAL RENAL MASSES: ONCOLOGIC AND FUNCTIONAL OUTCOMES

Ben Woodson*, Sree Mandava, Phil Dorsey, Benjamin Lee, New Orleans, LA

MP11-02 ROBOTIC PARTIAL NEPHRECTOMY: INTERMEDIATE ONCOLOGIC & FUNCTIONAL OUTCOMES AT 58 MONTHS

Ben Woodson*, Sree Mandava, Michael Maddox, Alex Beazer, Benjamin Lee, New Orleans, LA

MP11-03 RETROPERITONEAL LAPAROSCOPIC SURGERY FOR THE PARAPELVIC CYST£°A SINGLE CENTER¡¯S EXPERIENCE

Qi Hui Chen, Zhi Hua Lu, Xiao Qing Wang*, Changchun, China, People's Republic of

MP11-04 PRACTICAL AND INTUITIVE SURGICAL APPROACH RENAL RANKING (SARR) TO PREDICT OUTCOMES IN THE TREATMENT OF RENAL TUMORS: A NOVEL SCORE TOOL

Matheus Tannus, Salvador, Brazil, Suzan Goldman, Cassio Andreoni*, Sao Paulo, Brazil

MP11-05 THE INTRAOPERATIVE TRENDS FOR RADICAL AND PARTIAL NEPHRECTOMIES IN LOCALIZED CANCER IN LARGE UROLOGY GROUP

David Albala*, Colin O'Keefe, Po Lam, Andres Madissoo, Angelo DeRosalia, Elan Salzhauer, Harvey Sauer, Ilija Aleksic, Vladimir Mouraviev, Syracuse, NY

MP11-06 ROBOTIC PARTIAL NEPHRECTOMY IN RENAL UNITS WITH MULTIPLE RENAL ARTERIES

Kyrollis Attalla*, Emad Rizkala, Riccardo Autorino, Ali Khalifeh, Dinesh Samarasekera, Humberto Laydner, Georges Pascal-Haber, Robert Stein, Jihad Kaouk, Cleveland, OH

MP11-07 FIRST CLINICAL USE OF THE 3 DIMENSION (3D) HIGH DEFINITION (HD) ENDOEYE FLEX LAPAROSCOPIC TECHNOLOGY AND EVALUATION OF IMPAIRING SYMPTOMS USING A VALIDATED SIMULATOR SICKNESS QUESTIONNAIRE (SSQ) QUESTIONNAIRE DURING LAPAROSCOPIC PYELOPLASTY

Fernando Kim, David Sehrt, Wilson Molina*, Kyle Rove, Jason Phillips, Aurora, CO

MP11-08 POSTERIOR RETROPERITONEOSCOPIC ADRENALECTOMY FOR ADRENAL TUMORS

Zhong Wu*, Hao Wen Jiang, Chen-Chen Feng, Peng Gao, Lu Jia Wang, Qiang Ding, Shanghai, China, People's Republic of

MP11-09 HAND ASSISTED RETROPERITONEOSCOPIC NEPHROURETERECTOMY WITH BLADDER CUFFING AFTER BOTH PRE- AND RETRO-PERITONEAL PERIVESICAL BALLOONING

Kwang Taek Kim*, Chang Hee Kim, Khae Hawn Kim, Sang Jin Yoon, Incheon, Korea, Republic of

MP11-10 RENAL RECURRENCE AFTER ZERO ISCHEMIA PARTIAL NEPHRECTOMY

Rocco Papalia*, Giuseppe Simone, Mariaconsiglia Ferriero, Salvatore Guaglianone, Manuela Costantini, Michele Gallucci, Rome, Italy

MP11-11 UROLOGIC RECONSTRUCTIVE SURGERY OF THE UPPER TRACT: IMPACT OF THE ROBOT

Aaron Boonjindasup*, Daniel Rittenberg, Eric Shaw, Phillip Dorsey, Raju Thomas, New Orleans, LA

MP11-12 MINIMALLY INVASIVE PARTIAL NEPHRECTOMY WITHOUT HILAR CLAMPING IN PATIENS WITH SOLITARY KIDNEY

Papalia Rocco*, Giuseppe Simone, Mariaconsiglia Ferriero, Salvatore Guaglianone, Manuela Costantini, Michele Gallucci, Rome, Italy

MP11-13 SAFETY AND FEASIBILITY OF A NEW ABSORBABLE CLIP DURING SLIDING CLIP RENORRHAPHY IN ROBOTIC PARTIAL NEPHRECTOMY

Christopher Reilly*, Elton Llukani, Blake Moore, Ziho Lee, Jack Mydlo, Daniel Eun, Philadelphia, PA

MP11-14 PNEUMOVESICUM APPROACH TO EN-BLOC LAPAROSCOPIC NEPHROURETERECTOMY WITH BLADDER CUFF EXCISION FOR UPPER TRACT UROTHELIAL CANCER: INITIAL EXPERIENCES OF 7 CASES

Mohammed Bhuiyan*, MF Islam, ZH Bhuiyan, KMH Tawhid, NIU Ahmed, K Salahuddin, Dhaka, Bangladesh

MP11-15 ROBOTIC UROLOGIC SURGERY IN THE ELDERLY: IS THERE AN INCREASED RISK OF COMPLICATIONS?

Kristen Scarpato*, Farmington, CT, Halil Kiziloz, Kyle Finnegan, Ryan Dorin, Steven Shichman, Anoop Meraney, Joseph Wagner, Stuart Kesler, Hartford, CT

MP11-16 RENAL NEPHROMETRY SCORE PREDICTS RENAL PARENCHYMAL ATROPHY AFTER ROBOTIC PARTIAL NEPHRECTOMY

Young Eun Yoon*, Kyung Hwa Choi, Kyo Chul Koo, Joo Yong Lee, Won Sik Ham, Koon Ho Rha, Young Deuk Choi, Woong Kyu Han, Seoul, Korea, Republic of

MP11-17 COMPLICATIONS IN LAPAROSCOPIC UROLOGY: 8 YEARS’ EXPERIENCE WITH 793 CASES

Oner Sanli, Tzevat Tefik*, Tayfun Oktar, Mazhar Ortac, Selcuk Erdem, Emre Salabas, Mohammad Khodr, Serkan Karakus, Asif Sadiqli, Feyyaz Ural, Baris Yucel, Faruk Ozcan, Ismet Nane, Murat Tunc, Istanbul, Turkey

MP11-18 ROUTINE EN BLOCK STAPLING OF THE RENAL HILUM DURING LAPAROSCOPIC NEPHRECTOMY IS SAFE AND EFFECTIVE

David Albala*, Harvey Sauer, Po Lam, Elan Salzhauer, Angelo Rosalio, Jeffrey Sekula, Benjamin McHone, Vladimir Mouraviev, Syracuse, NY

MP11-19 MINIMAL-MARGIN ROBOTIC PARTIAL NEPHRECTOMY: ZERO-ISCHEMIA TECHNIQUE

Andre Berger*, Andre Luis de Castro Abreu, Dennis J. Lee, Sheaumei Tsai, Scott Leslie, Raed Azhar, Sumeet Syan, Mihir M. Desai, Monish Aron, Inderbir S. Gill, Los Angeles, CA

MP11-20 RETROPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR ¡°R.E.N.A.L NEPHROMETRY SCORE 7 TO 9¡± HILAR TUMORS

Ben Xu*, Qian Zhang, Jie Jin, Beijing, China, People's Republic of

MP11-21 LAPAROSCOPIC VERSUS OPEN SURGERY FOR RENAL MASSES WITH LEVEL I TO II TUMOR THROMBUS:THE LARGEST SERIES OF RETROPERITONEAL EXPERIENCE FROM UROLOGICAL CANCER CENTER OF CHINA

Ben Xu*, Qian Zhang, Jie Jin, Beijing, China, People's Republic of

MP11-22 LAPAROSCOPIC ANATROPHIC NEPHROLITHOTOMY FOR MANAGEMENT OF COMPLETE STAGHORN RENAL STONE: CLINICAL EFFICACY AND INTERMEDIATE-TERM FUNCTIONAL OUTCOME

Alireza Aminsharifi, Firoozeh Afsar*, Shiraz, Iran

MP11-23 A COMPARISON OF LAPAROSCOPIC VERSUS ROBOTIC PARTIAL NEPHRECTOMY PERIOPERATIVE OUTCOMES: A SINGLE SURGEON ANALYSIS

Junjian Huang*, Zachary Klaassen, Qiang Li, W. Bruce Shingleton, Kelvin A. Moses, Martha K. Terris, Rabii Madi, Augusta, GA

MP11-24 COMPARISON BETWEEN RETROPERITONEAL LAPAROSCOPIC AND OPEN DISMEMBERED PYELOPLASTY(WITH 63 CASES)

Min Qiu*, Beijing, China, People's Republic of

MP11-25 ROBOTIC PARTIAL NEPHRECTOMY FOR ANTERIOR VERSUS POSTERIOR TUMORS: ANALYSIS OF PERIOPERATIVE OUTCOMES

Gordon Fifer*, Michael Woods, Matthew Nielsen, Eric Wallen, Mathew Raynor, Chapel Hill, NC

MP11-26 NORMOTENSIVE LAPAROSCOPIC ZERO ISCHEMIA PARTIAL NEPHRECTOMY WITHOUT HILAR PREPARATION: INITIAL EXPERIENCE OF ONE SINGLE SURGEON IN LOW VOLUME FACILITY

Hitoshi Yanaihara*, Fuminari Hanashima, Hiroshi Kaguyama, Koichirou Ogihara, Hirofumi Sakamoto, Kayo Aonuma, Kaori Matsuda, Yoko Nakahira, Hirotaka Asakura, Saitama, Japan

Thursday, October 24, 2013   Moderated Poster Session MP12   2:30 pm–4:15 pm

URETEROSCOPY I

Room Rhythms 2 @ Sheraton New Orleans

Chair: Marius Conradie

Faculty: Petrisor Geavlete and Gerhard Fuchs

*Presenting author

MP12-01 IN VIVO AND EX VIVO COMPARISON OF OPTICS AND PERFORMANCE OF A NOVEL DUAL CHANNEL FIBEROPTIC URETEROSCOPE

Achim Lusch*, Zhamshid Okhunov, Renai Yoon, Michael A Del Junco, Ramtin Khanipour, Ashleigh Menhadji, Jaime Landman, Orange, CA

MP12-02 DOES PREOPERATIVE STENTING, ANESTHESIA AND STONE SIZE IMPACT IN-SITU TREATMENT OF LOWER POLE STONES?

Sri Sivalingam*, Priyanka Sehgal, Stephen Nakada, Madison, WI

MP12-03 URETEROSCOPY WITH LASER LITHOTRIPSY IN PATIENTS WITH NEUROLOGIC CONDITIONS AND NEUROGENIC BLADDER: SAFETY AND EFFICACY

Didi Pathak*, Mark Katz, Richard Babayan, David Wang, Boston, MA

MP12-04 A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY OF FLEXIBLE URETEROSCOPY FOR PROXIMAL URETERAL STONES <2 CM

Elias Hyams, Lebanon, NH, Manoj Monga, Cleveland, OH, Margaret Pearle, Dallas, TX, Vernon Pais, Lebanon, NH, Glenn Preminger, Michael Lipkin, Durham, NC, James Lingeman, Indianapolis, IN, Brian Eisner, Boston, MA, Ojas Shah, New York, NY, Roger Sur, San Diego, CA, Michelle Semins, Pittsburgh, PA, Dean Assimos, Birmingham, AL, Brian Matlaga*, Baltimore, MD

MP12-05 CONTEMPORARY PRACTICE PATTERNS IN THE MANAGEMENT OF ACUTE OBSTRUCTING URETERAL STONES: A SURVEY OF ENDOUROLOGISTS

Sri Sivalingam*, Ian Stormont, Stephen Nakada, Madison, WI

MP12-06  IN- VIVO EVALUATION OF A REVERSE THERMOSENSATIVE POLYMER FOR URETEROSCOPY WITH LASER LIHTOTRIPSY: PORCINE MODEL

Jonathan Mobley*, Goutham Vemana, Robert Figenshau, Gerald Andriole, Marshall Strother, Joel Vetter, Brian Benway, St. Louis, MO

MP12-07 FLEXIBLE URETEROSCOPY WITH A URETERAL ACCESS SHEATH: WHEN TO STENT?

Bryan Hinck*, Fabio Torricelli, Shubha De, Mark Noble, Manoj Monga, Cleveland, OH

MP12-08 DOES TUMOR SIZE INFLUENCE THE ACCURACY OF URETEROSCOPIC BIOPSY FOR UPPER TRACT UROTHELIAL CARCINOMA?

Sima Porten, Andrew Park, Charles Guo, Ashish Kamat, Lianchun Xiao, Surena Matin*, Houston, TX

MP12-09 A CRITICAL EVALUATION OF THE THERMEDX FLUID MANAGEMENT SYSTEM (TFMS) IN A URETEROSCOPIC (URS) MODEL

Shubha De, Fabio Torricelli, Ganesh Kartha*, Carl Sarkissian, Manoj Monga, Cleveland, OH

MP12-10 URETEROSCOPIC MANAGEMENT OF LARGE (>2 CM) UPPER TRACT UROTHELIAL CARCINOMA

Nir Kleinmann*, Scott G Hubosky, Kelly A Healy, Marluce Bibbo, Demetrius H Bagley, Philadelphia, PA

MP12-11 ENDOSCOPIC FORCEPS FOR URETEROSCOPY: A COMPARATIVE IN VITRO ANALYSIS

Giovanni Marchini, Raman Unnikrishnan*, Shubha De, Carl Sarkissian, Manoj Monga, Cleveland, OH

MP12-12 A COMPARISON OF FLUOROLESS AND CONVENTIONAL URETEROSCOPY

Gaudencio Olgin*, Gene O Huang, Steven R Engebretsen, Don C Arnold II, D Duane Baldwin, Loma Linda, CA

MP12-13 UPPER TRACT URETEROSCOPIC LASER LITHOTRIPSY: A CASE MATCHED COMPARISON BETWEEN CALCIUM OXALATE MONOHYDRATE VERSUS CALCIUM OXALATE DIHYDRATE STONES

Priyanka Sehgal*, Sri Sivalingam, Kristina Penniston, Stephen Nakada, Madison, WI

MP12-14 NEEDLEOSCOPY: THE INCORPORATION OF A NEW TECHNOLOGY FOR THE MANAGEMENT OF PEDIATRIC URETERAL CALCULI

Daniel Martinez*, Tampa, FL, Hubert Swana, Mark Rich, Orlando, FL

MP12-15 ERGONOMICALLY ENHANCED FLEXIBLE ENDOSCOPY SYSTEM: DESIGN, CONTROL AND PHANTOM TESTING

Linan Zhang, Tianjin, China, People's Republic of, Rahul Khare, Aaron Martin, Kyle Wu, Kevin Cleary, Craig Peters*, Washington, DC

MP12-16 NEPHRON SPARING ENDOSCOPIC APPROACH FOR UPPER TRACT LOW GRADE TRANSITIONAL CELL CARCINOMA COMPARED TO NEPHROURETERECTOMY: MID TERM FOLLOW-UP RESULTS

Azik Hoffman, Danjuma U Kalba*, Ofer Yossepowitch, Dov Lask, Pinhas M Livne, Ronen Holland, David Lifshitz, Tel Aviv, Israel

MP12-17 ENDOSCOPIC MANAGEMENT OF GENITOURINARY FOREIGN BODIES: WASHINGTON UNIVERSITY CASE SERIES

Joseph Song*, St Louis, MO, Youssef Tanagho, Saint Louis, MO, Mohammed Haseebuddin, Brian Benway, St Louis, MO, Alana Desai, Sam Bhayani, Robert Figenshau, Saint Louis, MO

MP12-18 URETEROSCOPY VIA AN ORTHOTOPIC NEOBLADDER: SURGICAL TECHNIQUES AND COMMON PITFALLS

Marcelino Rivera*, Amy Krambeck, Rochester, MN

MP12-19 FLEXIBLE URETERORENOSCOPY FOR STONES: SAFE AND EFFECTIVE EVEN DURING THE INITIAL LEARNING CURVE

Francesco Berardinelli, Luca Cindolo, Petros Sountoulides*, Fabrizio Pellegrini, Fabio Neri, Fabiola Tanburro, Luigi Schips, Vasto, Italy

MP12-20 COMPLICATIONS OF FLEXIBLE URETERORENOSCOPY CLASSIFIED BY THE MODIFIED CLAVIEN GRADING SYSTEM (A SINGLE CENTER'S EXPERIENCE OVER 10 YEARS)

Saeed M. Al-Qahtani*, Julien Letendre, Sabrina Benbouzid, Gauthier Raynal, Achilles Ploumidis, Sixtina De medina, Mohamed Tligui, Olivier Traxer, Paris, France

MP12-21 URETEROSCOPIC BIOPSY OF UPPER TRACT UROTHELIAL CARCINOMA: COMPARISON OF BASKET AND FORCEPS

Nir Kleinmann*, Kelly Healy, Scott Hubosky, Philadelphia, PA, David Margel, Toronto, Canada, Marluce Bibbo, Demetrius Bagley, Philadelphia, PA

MP12-22 RIGID, FLEXIBLE? WHY NOT SIMULTANEOUSLY BOTH?

Jorge Campos Castellanos*, Huixquilucan, Mexico

MP12-23 VARIABLES AFFECTING RADIATION EXPOSURE IN PATIENTS UNDER GOING ENDO-UROLOGICAL PROCEDURES

Samuel Parker*, Sashi Kommu, Munir Ahmed, London, United Kingdom

MP12-24 DOES URETERAL ACCESS SHEATH USE CONTRIBUTE TO POOR OUTCOME DURING URETEROPYELOSCOPY? WHAT SIZE OF STONE BURDEN INCREASES RISK OF POOR OUTCOME? THE UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER EXPERIENCE

Maxx Gallegos*, Maire Brennen, Michael Yap, Stephanie Tran, Antonia Harford, Susan Paine, Michael Davis, Albuquerque, NM

MP12-25 ENDOSCOPIC MANAGEMENT OF UPPER URINARY TRACT TCC USING THE 1470 NM DIODE LASER

Sachin Agrawal*, Taufiq Shaikh, David Hrouda, Altaf Shamsuddin, london, United Kingdom

MP12-26 A QUALITY AUDIT OF UPPER RENAL TRACT UROTHELIAL BIOPSY: OUR INITIAL EXPERIENCE OF BIGOPSY FORCEPS

Basharat Hussain*, Wai Man Chow, Manchester, United Kingdom, Khalid Ahmed, Oldham, United Kingdom, John Calleary, Manchester, United Kingdom, Mukesh Gupta, Oldham, United Kingdom, Jacob Cherian, Manchester, United Kingdom, Zahid Hussain, Arun Jain, Ramesh Vennam, Raveendra Surange, Oldham, United Kingdom

Thursday, October 24, 2013   Moderated Poster Session MP13   2:30 pm–4:15 pm

ENDOUROLOGY & NEW TECHNOLOGIES I

Room Rhythms 3 @ Sheraton New Orleans

Chair: Muhammad Shamim Khan

Faculty: Eric Wallen and Wei Xue

*Presenting author

MP13-01 A MODIFIED RENAL NEPHROMETRY SCORE PREDICTS ONCOLOGIC OUTCOMES FOR RADIO FREQUENCY ABLATION

Jeffrey Gahan*, Michael Richter, Casey Seideman, Danny Chan, Mathew Weaver, Dallas, TX, Ephrem Olweny, New Bruswick, NJ, Jeffrey Cadeddu, Dallas, TX

MP13-02 LONG-TERM OUTCOMES IN HEALTHY ADULTS FOLLOWING RADIOFREQUENCY ABLATION OF T1A RENAL TUMORS

Yunbo Ma, Selhattin Bedir, Monica Morgan*, Jeffrey Cadeddu, Jeffrey Gahan, Dallas, TX

MP13-03 POST URETERAL STENT REMOVAL SYMPTOMS

Nithin Theckumparampil*, Sammy Elsamra, Hector Motato, Arvin George, New Hyde Park, NY, Justin Friedlander, Ne, NY, Jay Motola, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP13-04 EFFECTIVENESS OF A SEGMENTAL THERMO-EXPANDABLE METAL ALLOY SPIRAL STENT (MEMOKATH 051^TM) AND SELF-EXPANDABLE COVERED METALLIC STENT (UVENTA^TM) IN THE MANAGEMENT OF URETERAL OBSTRUCTION

Kang Sup Kim*, Yong Sun Choi, Sung-Hoo Hong, Hyuk Jin Cho, Tae Kon Hwang, Seoul, Korea, Republic of

MP13-05 COMPARISON OF OUTCOMES IN PATIENTS UNDERGOING PERCUTANEOUS RENAL CRYOABLATION WITH SEDATION VERSUS GENERAL ANESTHESIA

Samuel Juncal*, Zhamshid Okhunov, Michael Ordon, Achim Lusch, Philip Bucur, Orange, CA, Arvin George, Fatima Askarova, Louis Kavoussi, New York, NY, Cassio Andreoni, São Paulo, Brazil, Jaime Landman, Orange, CA

MP13-06 EVALUATION OF CLINICAL OUTCOMES FOR PATIENTS WITH NONDIAGNOSTIC BIOPSY DURING CRYOABLATION OF RENAL CORTICAL NEOPLASMS

Samuel Juncal*, Michael Ordon, Zhamshid Okhunov, Achim Lusch, Orange, CA, Cassio Andreoni, São Paulo, Brazil, Jaime Landman, Orange, CA

MP13-07 HYDROPHILIC GUIDEWIRES: EVALUATION AND COMPARISON OF THEIR PROPERTIES AND SAFETY

Fabio Torricelli, Shubha De*, Carl Sarkissian, Manoj Monga, Cleveland, OH

MP13-08 DOES DIAZEPAM ALTER PAIN PERCEPTION DURING PROSTATE BIOPSY?

Jonathan D Creech, David J Culpepper, Gene O Huang, Caroline L Wallner, Steven R Engebretsen, Gaudencio Olgin, Don C Arnold II, Roger Li*, Michelle A Lightfoot, Herbert C Ruckle, D Duane Baldwin, Loma Linda, CA

MP13-09 INTRAOPERATIVE FROZEN SECTION ANALYSIS: PRACTICE PATTERNS OF HIGH-VOLUME SURGEONS PERFORMING ROBOT-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY

Nina Harkani*, Khushabu Kasabwala, Pengbo Jiang, Jennifer Yates, Ravi Munver, Hackensack, NJ

MP13-10 SHIM VS. SHAM SCORE: PREOPERATIVE ERECTILE FUNCTION IS IN THE EYE OF THE BEHOLDER

Peter Sunaryo*, Nina Harkhani, Pengbo Jiang, Jennifer Yates, Ravi Munver, Hackensack, NJ

MP13-11 CURRENT PATTERNS OF PRESENTATION AND TREATMENT OF RENAL MASSES: A CROES PROSPECTIVE STUDY

M. Pilar Laguna*, Amsterdam, Netherlands, Ferran Algaba, Barcelona, Spain, Jeffrey Cadeddu, Dallas, TX, Ralph Clayman, Irvine, CA, Inderbir Gill, Los Angeles, CA, Guillermo Gueglio, Buenos Aires, Argentina, Markus Hohenfellner, Heidelberg, Germany, Adrian Joyce, Leeds, United Kingdom, Jaime Landman, Irvine, CA, Benjamin Lee, New Orleans, LA, Hein Van Poppel, Leuven, Belgium

MP13-12 START OF SALVAGE TREATMENT FOR PERSISTENT POSITIVE BIOPSIES AFTER HIFU

Rafael Sanchez-Salas*, Dominique Prapotnich, Paris, France, Fernando Secin, Buenos Aires, Argentina, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP13-13 THE SECOND “-OUT”: A SURGICAL SAFETY CHECKLIST FOR LENGTHY ROBOTIC SURGERIES

Joseph Song*, Goutham Vemana, Jonathan Mobley, Sam Bhayani, St Louis, MO

MP13-14 TANDEM URETERAL STENTS FOR THE DECOMPRESSION OF MALIGNANT AND BENIGN OBSTRUCTIVE UROPATHY

Sammy Elsamra*, Hector Motato, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP13-15 AUTO TRANSPLANTATION – AN EXCELLENT TECHNIQUE FOR COMPLEX URETERAL AND RENAL VASCULAR PATHOLOGY

Richard Johnston*, Natalya Lopushnyan, Thomas Hefty, Paul Kozlowski, Seattle, WA

MP13-16 RELIABILITY OF THE CT-SCAN PERCUTANEOUS BIOPSY FOR SMALL RENAL MASSES

Alexandre Ingels*, Eric Barret, Francois Audenet, Luca Lunelli, Guilherme Prada Costa, Francois Rozet, Marc Galiano, Rafael Sanchez-Salas, Stephane Lenoir, Pierre Validire, Xavier Cathelineau, Paris, France

MP13-17 THE USE OF A THERMOEXPANDABLE METAL ALLOY STENT IN THE MINIMALLY INVASIVE TREATMENT OF RETRO PERITONEAL FIBROSIS - A SINGLE CENTRE EXPERIENCE

Andreas Bourdoumis, Stefanos Kachrilas*, Sona Kapoor, Faruquz Zaman, Shafi Wardak, Athanasios Papatsoris, Noor Buchholz, Junaid Masood, London, United Kingdom

MP13-18 ESTABLISHMENT AND QUANTITATIVE ANALYSIS OF AN ORTHOTOPIC MURINE BLADDER CANCER MODEL

Lingbo Yang, Yuchuan Hou*, Changchun, China, People's Republic of

MP13-19 ACTIVE SURVEILLANCE OF RENAL MASSES: AN ANALYSIS OF GROWTH KINETICS AND CLINICAL OUTCOMES STRATIFIED BY RADIOLOGICAL CHARACTERISTICS AT DIAGNOSIS

Ryan Dorin*, Max Jackson, Halil Kiziloz, Kyle Finnegan, Stuart Kesler, Anoop Meraney, Steven Shichman, Hartford, CT

MP13-21 PERCUTANEOUS RADIOFREQUENCY ABLATION VERSUS PERCUTANEOUS CRYOABLATION: A 10 YEAR SINGLE CENTER EXPERIENCE AFTER ABLATION FOR RENAL CELL CARCINOMA

Dinesh Samarasekera*, Ali Khalifeh, Riccardo Autorino, Jihad Kaouk, Cleveland, OH

MP13-23 ANALYZING COSTS OF KIDNEY CANCER SURGERY: IN-DEPTH ANALYSIS OF PROVIDERS WITHIN A SINGLE INSTITUTION

Blake Hamilton*, Salt Lake City, UT

MP13-24 CLINICOPATHOLOGIC CHARACTERISTICS OF PROSTATE CANCER IN KOREAN MEN: IMPACT OF PSA SCREENING

Wansuk Kim*, Busan, Korea, Republic of, Cheryn Song, Hanjong Ahn, Seoul, Korea, Republic of

MP13-25 PSA BOUNCE REDUCED THE RISK OF BIOCHEMICAL FAILURE AFTER IODINE-125 BRACHYTHERAPY

Takuya Sadahira*, Ryuta Tanimoto, Yasuyuki Kobayashi, Shin Ebara, Yasutomo Nasu, Hiromi Kumon, Okayama, Japan

MP13-26 EFFECTS OF NATIVE NEPHRECTOMY ON BLOOD PRESSURE IN PATIENTS WITH ADPKD AFTER RENAL TRANSPLANTATION

Leah Chiles*, Patrick Lowry, Mohanram Narayanan, Daniel Jupiter, Temple, TX

Thursday, October 24, 2013   Moderated Poster Session MP14   2:30 pm–4:15 pm

UROLITHIASIS I

Room Grand Ballroom D @ Sheraton New Orleans

Chair: Hyung Keun Park

Faculty: Robert Marcovich and Joel Aldana

*Presenting author

MP14-01 RADIATION PRACTICE PATTERNS AND EXPOSURE IN THE HIGH-VOLUME ENDOUROLOGIST

Anne Dudley*, Michelle Semins, Pittsburgh, PA

MP14-02 TURKISH ROBOT ROBOFLEXAVICENNA FOR FLEXIBLE URETERORENOSCOPIC SURGERY: INITIAL MULTI-CENTRIC ANALYSIS

Remzi Saglam, Ahmet Y. Muslumanoglu*, Emrah Yuruk, Zafer Tokatli, Ahmet Sinan Kabakci, Mut Safak, Ankara, Turkey, Abdullah Armagan, Istanbul, Turkey, Atilla Semercioz, Murat Binbay, Ankara, Turkey

MP14-03 EXPULSIVE THERAPY VERSUS EARLY ENDOSCOPIC STONE REMOVAL IN ACUTE RENAL COLIC: A COMPARISON OF INDIRECT COSTS

Casey A. Dauw, M.D.*, Brent K. Hollenbeck, M.D., M.S., Samuel R. Kaufman, M.A., Jeffrey S. Montgomery, M.D., M.H.S.A., Alon Z. Weizer, M.D., William W. Roberts, M.D., Gary J. Faerber, M.D., J. Stuart Wolf, Jr., M.D., John M. Hollingsworth III, M.D., M.S., Ann Arbor, MI

MP14-04 VALIDITY OF ADMINISTRATIVE CODING FOR PREGNANT PATIENTS WITH UROLITHIASIS

Anne Dudley*, Julie Riley, Michelle Semins, Pittsburgh, PA

MP14-05 ENDOSCOPIC, PATHOLOGIC AND RADIOGRAPHIC CHARACTERISTICS OF URIC ACID STONE FORMERS

Boyd Viers*, Xiangling Wang, Xujian Li, Terri Vrtiska, John Lieske, Amy Krambeck, Rochester, MN

MP14-06 STONE DISEASE IN LIVING - RELATED RENAL DONORS: LONG - TERM OUTCOMES FOR TRANSPLANT DONORS AND RECIPIENTS

Sarah Coleman*, Emad Rizkala, Christine Tran, Isac Wahib, David Goldfarb, Stuart Flechner, Manoj Monga, Cleveland, OH

MP14-07 COST EFFECTIVENESS COMPARISON OF RENAL CALCULI TREATED WITH URETEROSCOPY WITH LASER LITHOTRIPSY VERSUS SHOCK WAVE LITHOTRIPSY

Eugene Cone, Durham, NC, Brian Eisner, Michal Ursiny, Boston, MA, Gyan Pareek*, Providence, RI

MP14-08 PATIENT EXPERIENCES AND PREFERENCES WITH DIFFERENT URETERAL STENT REMOVAL TECHNIQUES

Roger Low, Sacramento, CA, Mike Nguyen, Los Angeles, CA, Manoj Monga*, Cleveland, OH

MP14-09 CONCURRENT VALIDITY OF THE WISCONSIN STONE QUALITY OF LIFE SURVEY

Kristina Penniston, Rachel Bell, Stephen Nakada*, Madison, WI

MP14-10 THE GEOMETRIC COMPLEXITY INDEX: A NEW MEASURE OF STONE BURDEN

Michael Conlin*, Brian Duty, Gregory Adams, Matthias Schabel, Eugene Fuchs, Portland, OR

MP14-11 EFFICACY OF TAMSULOSIN IN THE MANAGEMENT OF LOWER URETERAL STONES: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF 100 PATIENTS

Abdulla Al-Ansari*, Abdulla Al-Naimi, Abdulkader Alobaidy, Khalid Assadiq, Mohamed Azmi, Doha, Qatar, Ahmed Shokeir, Almansoura, Egypt

MP14-12 EFFECT OF TAMSULOSIN ON STONE EXPULSION IN PROXIMAL URETERAL CALCULI: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL

Jinsung Park*, Seung Hyo Woo, Daejeon, Korea, Republic of, Seung Wook Lee, Guri, Korea, Republic of

MP14-13 NO DIFFERENCE IN 24-HOUR URINE PARAMETERS BETWEEN PATIENTS WITH OBSTRUCTING AND NON-OBSTRUCTING UROLITHIASIS PRESENTING TO A TERTIARY REFERRAL CENTER

Tarek Alzahrani*, Daniela Ghiculete, Andrea G Lantz, Kenneth T Pace, Jason Y Lee, R. John Honey, Toronto, Canada

MP14-14 PATIENT EDUCATION AND THE IMPACT ON URETEROSCOPY EXPERIENCE

Nathan Grunewald, Alison Marciniak, Carley Davis*, Milwaukee, WI

MP14-15 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF SILODOSIN TO FACILITATE MEDICAL EXPULSION OF URETERAL CALCULI

Roger Sur*, San Diego, CA, Scott Olsen, Salt Lake City, UT, Ojas Shah, New York, NY

MP14-16 MODIFIED SEOUL NATIONAL UNIVERSITY RENAL STONE COMPLEXITY SCORE FOR RETROGRADE INTRARENAL SURGERY: EVALUATION WITH SINGLE SURGEON′S COHORT

Byung Ki Lee*, Jin-Woo Jung, Yong Hyun Park, Sangchul Lee, Seok-Soo Byun, Sang Eun Lee, Seongnam, Korea, Republic of, Chang Wook Jeong, Seoul, Korea, Republic of

MP14-17 URETEROSCOPY FOR THE MANAGEMENT OF UPPER URETERAL CALCULI; WHETHER MUCOSAL IMPACTED STONES OR NOT, DOES IT MATTER?

Dong-Hoon Lim, MIn-Seok Kim*, Joon Roh, Chul-Sung Kim, Dong-Hoon Yoo, Ju-Sung Kim, Sang-joon Jun, Gwangju, Korea, Republic of

MP14-18 MEDICAL EXPULSION THERAPY IS UNDERUTILIZED IN WOMEN PRESENTING TO AN EMERGENCY DEPARTMENT WITH ACUTE URINARY STONE DISEASE

Herman Bagga*, Ayesha Appa, Ralph Wang, Thomas Chi, Joe Miller, Jersey Neilson, Rebecca Smith-Bindman, Marshall Stoller, San Francisco, CA

MP14-19 IN VITRO EVALUATION OF THE URONET® STONE FRAGMENT RETRIEVER FOR PERCTUANEOUS NEPHROLITHOTOMY

Kelly A. Healy*, Ryan C. Cleary, Demetrius H. Bagley, Philadelphia, PA

MP14-20 THE IMPACT OF FISH OIL SUPPLEMENTATION ON ENDOGENOUS OXALATE SYNTHESIS AND URINARY OXALATE EXCRETION

Jessica Lange*, Winston-Salem, NC, Patrick Mufarrij, Washington, D.C., DC, Linda Easter, Winston-Salem, NC, John Knight, Ross Holmes, Dean Assimos, Birmingham, AL

MP14-21 HOW LONG IT TAKES TO LEARN TO USE ROBOFLEXAVICENA FOR FLEXIBLE URETERORENOSCOPY, COMPARISON OF AN EXPERIENCED FLEXIBLE URS USERS AND TRAINEES

Zafer Tokatli*, Ankara, Turkey, Ahmet Yaser Muslumanoglu, Murat Binbay, Abdülkadir Tepeler, Istanbul, Turkey, Evren Süer, Remzi Saglam, Ankara, Turkey

MP14-22 TRENDS AND DEMOGRAPHICS IN STONE COMPOSITION - TRANSITION FROM NON-URIC ACID TO URIC ACID STONES

Kara L Watts*, Tian C Zhou, Joseph Divito, David M Hoenig, Bronx, NY

MP14-23 TOTAL CHOLESTEROL AS A SERUM BIOMARKER OF HYPERCALCIURIA IN PATIENTS WITH KIDNEY STONES

Raman Unnikrishnan*, Fabio Torricelli, Shubha De, Nima Almassi, Carl Sarkissian, Ina Li, Manoj Monga, Cleveland, OH

MP14-24 DEFINING VARIATION IN URINARY OXALATE IN HYPEROXALURIC STONE-FORMERS

Jodi Antonelli, Justin Friedlander*, Dallas, TX, Craig Langman, Chicago, IL, John Poindexter, Beverley Huet, Margaret Pearle, Dallas, TX

MP14-25 GOUT, STONE COMPOSITION AND URINARY STONE RISK: A CASE MATCHED COMPARATIVE STUDY

Ryan Mori*, Shubha De, Giovanni Marchini, Carl Sarkissian, Devin Tian, Manoj Monga, Cleveland, OH

MP14-26 RETROGRADE INTRARENAL SURGERY (RIRS) VS MINIMALLY INVASIVE PERCUTANEOUS NEPHROLITHOTRIPSY (MPNL) FOR RENAL STONES BETWEEN 1 TO 2 CM: A PROSPECTIVE COMPARATIVE STUDY

Rajesh Kukreja*, Indore, India

Thursday, October 24, 2013   Moderated Poster Session MP15   2:30 pm–4:15 pm

ROBOTICS/LAPAROSCOPY: PROSTATE, LOWER TRACT II

Room Grand Chenier @ Sheraton New Orleans

Chair: Ben Challacombe

Faculty: Thomas Ahlering and Duane Baldwin

*Presenting author

MP15-01 TIPS TO AVOID POSITIONING INJURY TO THE PATIENT AND ASSISTANT DURING ROBOTIC SURGERY

James Borin*, Jeff McDaniel, Baltimore, MD

MP15-02 FUNCTIONAL AND ONCOLOGICAL OUTCOMES OF ROBOTIC ASSISTED RADICAL PROSTATECTOMY (RARP) LEARNING CURVE ANALYSIS OF 418 CONSECUTIVE PATIENTS WITH UP TO 7 YEAR FOLLOW-UP

Philippe Violette*, Stephen Pautler, London, Canada

MP15-03 ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER: QUALITY OF LIFE OUTCOMES IN MEN WHO ELECT SURGERY AS PRIMARY THERAPY

Hoyt Doak*, Farmington, CT, Ryan Dorin, Halil Kiziloz, Joseph Wagner, Hartford, CT

MP15-04 ONCOLOGIC OUTCOMES FOLLOWING ROBOT ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY IN OBESE PATIENTS WITH NON-ORGAN CONFINED PROSTATE CANCER

Edris Negron*, Kyle Richards, Joshua Cohn, Scott Eggener, Gregory Zagaja, Arieh Shalhav, Chicago, IL

MP15-05 DOES SIMULTANEOUS EXTRAPERITONEAL LAPAROSCOPIC HERNIA REPAIR INFLUENCE MORBIDITY AND PAIN LEVELS AFTER EXTRAPERITONEAL LAPAROSCOPIC RADICAL PROSTATECTOMY?

Ali Gözen*, Theodoros Tokas, Heilbronn, Germany, Gökhan Atis, istanbul, Turkey, Marcel Hruza, Jens Rassweiler, Heilbronn, Germany

MP15-06 POPULATION-BASED DETERMINANTS OF RADICAL PROSTATECTOMY OPERATIVE

Stacey Carter*, Los Angeles, CA, Stuart Lipsitz, Boston, MA, Ya-Chen Shih, Chicago, IL, Paul Nguyen, Quoc-Dien Trinh, Boston, MA, Jim Hu, Los Angeles, CA

MP15-07 DRAINS ARE NOT NECESSARY IN THE MAJORITY OF ROBOTIC UROLOGIC PROCEDURES

Daniel Gilbert*, Jordan Angell, Ronney Abaza, Dublin, OH

MP15-08 IS THE SURGICAL, ONCOLOGIC AND FUNCTIONAL OUTCOMES OF RALP AFFECTED BY THE PERIOD OF AFTER TURP?

Sang Woon Kim*, Kyo Chul Koo, Young Eun Yoon, Yong Seung Lee, Joo Yong Lee, Woong Kyu Han, Byung Ha Chung, Koon Ho Rha, Seoul, Korea, Republic of

MP15-09 A COMPARATIVE STUDY OF LAPAROSCOPIC RADICAL PROSTATECTOMY BY EXTRAPERITONEAL VS SINGLE-PORT TRANSVESICAL APPROACH FOR LOW-RISK

Xin Gao*, Ke Li, Dongen Jiang, Jelin Li, Li Lu, Guangzhou, China, People's Republic of

MP15-10 BLADDER NECK CONTRACTURE – INCIDENCE AND MANAGEMENT FOLLOWING CONTEMPORARY ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY TECHNIQUES

Jaspreet Parihar*, Isaac Kim, New Brunswick, NJ

MP15-11 D'AMICO RISK STRATIFICATION CORRELATES WITH PERIOPERATIVE COMPLICATION RATES FOLLOWING ROBOTIC PROSTATECTOMY

Katherine Rotker*, Michael Maddox, Shadi Al Ekish, Gyan Pareek, Dragan Golijanin, Joseph Renzulli, Providence, RI

MP15-12 INCIDENCE OF CORNEAL ABRASION FOLLOWING ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY AT A SINGLE HIGH-VOLUME INSTITUTION

Michael Large, Edris Negron*, Joshua A. Cohn, Gregory Zagaja, Scott Eggener, Arieh Shalhav, Chicago, IL

MP15-13 PREDICTIVE FACTORS OF BIOCHEMICAL RECURRENCE IN MEN WITH SEMINAL VESICLE INVASION

Edan Shapiro*, Matthew Pagano, Kyle Scarberry, Trushar Patel, Ari Bergman, Arindam RoyChoudhury, James McKiernan, Mitchell Benson, Ketan Badani, New York, NY

MP15-14 NOVEL UROFLOW STOP TEST AT OF CATHETER REMOVAL IS A STRONG PREDICTOR OF EARLY URINARY CONTINENCE RECOVERY FOLLOWING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY

Assaad El-Hakim*, Naif Alhathal, Talal Al-Qaoud, Ginette Gagné, Suzanne Larocque, Ronald Denis, Kevin C Zorn, Montreal, Canada

MP15-15 ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: INITIAL EXPERIENCE AND THE LEARNING CURVE

Kau Han Lee*, Chien-Liang Liu, Steven K Huan, Tainan, Taiwan

MP15-16 ROBOT-ASSISTED SALVAGE RADICAL PROSTATECTOMY AFTER RADIATION FAILURE: INITIAL RESULTS AND SHORT-TERM FUNCTIONAL OUTCOMES

Wei-Chun Weng*, Chun-Kuang Yang, Yen-Chuan Ou, Taichung, Taiwan

MP15-17 LONG-TERM ONCOLOGICAL RESULTS OF RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A SINGLE-CENTRE EXPERIENCE

Youness Ahallal*, Rafael Sanchez-Salas, Laurent Mascle, Luca Lunelli, Petr Macek, Camilo Giedelman, Dominique Prapotnich, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP15-18 ROBOTIC SIMPLE PROSTATECTOMY FOR SEVERE BENIGN PROSTATIC HYPERPLASIA

Wesley White, Knoxville, TN, David Thiel, Jacksonville, FL, James Bienvenu*, Frederick Klein, Bedford Waters, Knoxville, TN

MP15-19 ROBOTIC-ASSISTED LAPAROSCOPIC VERSUS OPEN URETERAL REIMPLANTATION: A SINGLE INSTITUTION MATCHED COHORT REVIEW

David Duchene*, Daniel Zainfeld, Kirk Redger, Andrew Windsperger, Kansas City, KS

MP15-20 ANALYSIS OF FACTORS PREDICTING RECOVERY OF ERECTILE FUNCTION AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY

Bi Hai*, Ma Lu-lin, Hou Xiao-fei, Beijing, China, People's Republic of

MP15-21 ANALYSIS OF ROBOT ASSISTED RADICAL PROSTATECTOMY COMPLICATIONS ACCORDING TO DURATION OF FOLLOW-UP

Ahmed Ghazi*, Nandini Venkateswaran, Vineet Agrawal, Emelian Scosyrev, Jean Joseph, Rochester, NY

MP15-22 EFFECT OF PUBOPELVIC ANGLE ON SURGICAL OUTCOMES IN RETROPUBIC AND ROBOT-ASSISTED RADICAL PROSTATECTOMY

Kyungtae Ko*, Woo Suk Choi, Ja Hyeon Ku, Hyeon Hoe Kim, Cheol Kwak, Seoul, Korea, Republic of

MP15-23 CONTEMPORARY SERIES OF ROBOTIC ASSISTED DISTAL URETERAL RECONSTRUCTION UTILIZING SIDE DOCKING POSITION

Julie Riley*, Albuquerque, NM, Yaniv Shilo, Michael Ost, Pittsburgh, PA

MP15-24 MULTI-INSTITUTIONAL OUTCOMES OF ROBOTIC-ASSISTED LAPAROSCOPIC DISTAL URETERAL REIMPLANTATION

Tracy Marien, New york, NY, Darko Kröpfl, Lukas Hohenhorst, Essen, Germany, Matthew Bilbily*, New york, NY, Gaurav Rao, Buffalo, NY, Ojas Shah, Michael Stifelman, New york, NY

MP15-25 IS R.E.N.A.L NEPHROMETRY SCORING SYSTEM ASSOCIATED WITH THE OUTCOME OF LPN?

Masahiro Sugiura*, Kazuhiro Araki, Kyokusin Ho, Masahiko Inahara, Ichihara, Japan, Syuko Cho, Nobuyuki Sekita, Chiba, Japan, Hiroshi Masuda, Yukio Naya, Ichihara, Japan

MP15-26 RENAL HILAR CLEARANCE (DENERVATION) AS A TREATMENT FOR INTRACTABLE/ REFRACTORY HYPERTENSION

Shakir Tabrez, Mohan keshavmurthy, Prem kumar*, Uday Bhaskar, Mohan Balaiah Ashwathaiah, Bangalore, India

Thursday, October 24, 2013   Video Session V07   2:30 pm–4:30 pm

LAPAROSCOPY: UPPER TRACT I

Room Armstrong @ Sheraton New Orleans

Chair: Jaime Landman

Faculty: Byong Chang Jeong and Joseph Liao

*Presenting author

V07-01 RETROPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR COMPLETELY INTRARENAL TUMOR

Ma Lulin*, Zhang Shudong, Beijing, China, People's Republic of

V07-02 LAPAROSCOPIC RESOLUTION OF VASCULAR COMPLICATIONS IN RETROPERITONEAL LAPAROSCOPIC NEPHRECTOMY

Zhang Shudong*, Ma Lulin, Beijing, China, People's Republic of

V07-03 LAPAROSCOPIC DONOR NEPHRECTOMY: MANAGING COMPLEX VENOUS ANOMALIES

Ahmed Mansour*, Ibrahim Eraky, Ahmed R. El-Nahas, Bedeir Ali-El-dein, Ahmed Shokeir, Mansoura, Egypt

V07-04 A STANDARDIZED SUTURE TECHNIQUE USING A BARBED SUTURE IMPROVES EFFICACY AND SAFETY IN RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY

Christian Wülfing*, Niclas Flechtenmacher, Serkan Filiz, Johannes Göckschu, Jörn Bode, David Marghawal, Hamburg, Germany

V07-05 CLAMPLESS LAPAROSCOPIC PARTIAL NEPHRECTOMY: OUR TECHNIQUE

Ioannis Georgiopoulos*, Iason Kyriazis, Panagiotis Kallidonis, Stavros Kontogiannis, Evangelos Liatsikos, Patras, Greece

V07-06 RETROPERITONEOSCOPIC DISMEMBERED PYELOPLASTY IN THE TREATMENT OF PUJ OBSTRUCTION- OUR EXPERIENCE WITH 60 CASES

Venugopal Ganapathy*, Haris C H, Thiruvananthapuram, India, Sudin S R, Kollam, India, Navin C Angus, Ginson V George, Sandeep Krishnan, Thiruvananthapuram, India, Suchindra P Unni, Kochi, India, Jibu K Pillai, Thiruvananthapuram, India, Jithunath M R, Thrissur, India

V07-07 LAPAROSCOPIC PYELOLITHOTOMY IN A HORSE SHOE KIDNEY IN THE ERA OF PCNL AND RIRS

Manickam Ramalingam*, Kallappan Senthil, Anandan Murugesan, Mizar Ganapathy Pai, Coimbatore, India

V07-08 LAPAROSCOPIC URETEROCALICOSTOMY:– PELVICURETERIC JUNCTION OBSTRUCTION IN INTRARENAL PELVIS WITH MULTIPLE SECONDARY CALCULI

Vikas Agarwal*, Atul Goswami, Delhi, India

V07-09 LAPAROSCOPIC CYTOREDUCTIVE NEPHRECTOMY: MPUH EXPERIENCE

Amit Bhattu*, Nadiad, Gujarat, India, Shashikant Mishra, Arvind Ganpule, Jitendra Jagtap, Raguram Ganesamoni, Jigish vyas, Ravindra Sabnis, Mahesh Desai, Nadiad, India

V07-10 NEPHRON-SPARING SURGERY FOR RENAL TUMORS USING PARENCHYMAL CLAMPING

Mohammed Lezrek*, Khalil Bazine, Hicham Tazi, Adil Slimani Alaoui, Mohammed Alami, Meknes, Morocco

V07-11 ROBOTIC ASSISTED LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE I NONSEMINOMATOUS GERM CELL TUMOR: PORT PLACEMENT AND SURGICAL TECHNIQUE

Dinesh Samarasekera*, Maria C Mir, Riccardo Autorino, Joseph Klink, Andrew J Stephenson, Jihad H Kaouk, Cleveland, OH

Thursday, October 24, 2013   Video Session V08   2:30 pm–4:30 pm

LAPAROSCOPY/ROBOTICS: PROSTATE, BLADDER & LOWER TRACT II

Room Grand Ballroom E @ Sheraton New Orleans

Chair: Mathew C. Raynor

Faculty: Sri Sivalingham and Jonathan Silverstein

*Presenting author

V08-01 LAPAROSCOPIC URETEROURETEROSTOMY FOR THE MANAGEMENT OF OBSTRUCTIVE UROPATHY CAUSED BY CONGENITAL URETERIC ENTRAPMENT IN THE ILIAC BONE

Alireza Aminsharifi*, Shiraz, Iran

V08-02 LAPAROSCOPIC REPAIR OF VESICOUTERINE FISTULA USING TACHOSILTM SPONGE

Roberto Sanseverino*, Tommaso Realfonso, Oliver Intilla, Umberto Di Mauro, Giovanni Molisso, Giorgio Napodano, Nocera Inferiore, Italy

V08-03 LAPAROSCOPIC TREATMENT OF BLADDER DIVERTICULA: THE PROCEDURE STEP BY STEP

Filippo Nigro, Paolo Ferrarese, Enrico Scremin, Giuseppe Benedetto, Ciro Ammendola, Andrea Tasca*, Vicenza, Italy

V08-04 CYSTOSCOPY-ASSISTED LAPAROSCOPIC PARTIAL CYSTECTOMY FOR TREATMENT OF BLADDER ENDOMETRIOSIS

João Cabral*, Isaac Braga, Nuno Azevedo, Avelino Fraga, Frederico Branco, Luís Osório, Porto, Portugal

V08-05 LAPAROSCOPIC VESICULECTOMY – A FEASIBLE TECHNIQUE TO MANAGE A RARE PATHOLOGY

Daniel Oliveira-Reis*, Isaac Braga, Nuno Azevedo, Avelino Fraga, Severino Ribeiro, José Soares, Luís Osório, Porto, Portugal

V08-06 LAPAROSCOPIC PYELOURETEROSTOMY WITH RECIPIENTS URETER IN A TRANSPLANTED KIDNEY WITH URETERAL STRICTURE

Dmitry Perlin*, Ilya Alexandrov, Alexey Nikolaev, Olga Shevchenko, Vladislav Efremov, Voljsky, Russian Federation

V08-07 ROBOT ASSISTED MANAGEMENT OF OBSTRUCTING PROSTATE GLANDS GREATER THAN 150 GM

Mathew Oommen, Kush Patel, Philip Dorsey*, Janet Colli, Michael Pinsky, Benjamin Lee, Raju Thomas, New Orleans, LA

V08-08 TRANSVESICAL LAPAROSCOPIC CLOSURE OF URETHROVESICAL FISTULAE

Gamal Ghoniem, Zhamshid Okhunov*, Jordan Siegel, Mina Samaan, Orange, CA, Hanul Choi,

V08-09 ODDITIES OF THE PELVIS: MANAGEMENT OF ATYPICAL MASSES IN THE PELVIS

Jonathan Melquist*, Rosa Park, Stony Brook, NY, Rahuldev Bhalla, New Bruinswick, NJ

V08-10 ROBOT-ASSISTED LAPAROSCOPIC EXTRAVESICAL BLADDER DIVERTICULECTOMY WITH URETERAL RECONSTRUCTION

Samay Jain*, Khaled Shahrour, Toledo, OH

V08-11 ROBOTIC URETERONEOCYSTOSTOMY WITH PSOAS HITCH FOR DISTAL URETERAL THERMAL INJURY

Omer Burak Argun*, Ilter Tufek, Selcuk Keskin, Hakan Ozveri, Ahmet Sahin, Ali Riza Kural, Istanbul, Turkey

V08-12 THE USE OF 30-DEGREE CAMERA IN UP POSITION FOR DORSAL VEIN CONTROL DURING ROBOT ASSISTED RADICAL PROSTATECTOMY (RARP)

Omer Burak Argun*, Ilter Tufek, Selcuk Keskin, Ahmet Sahin, Ali Riza Kural, Istanbul, Turkey

Thursday, October 24, 2013   Video Session V09   2:30 pm–4:30 pm

URETEROSCOPY

Room Nottoway @ Sheraton New Orleans

Chair: Paul Van Cangh

Faculty: Yeh Hong Tan and Brian Duty

*Presenting author

V09-01 EXTRACORPOREAL LITHOTRIPSY ENDOSCOPICALLY CONTROLLED BY URETERORENOSCOPY (LECURS) USING DIGITAL URETERORENOSCOPE FOR THE TREATMENT OF KIDNEY STONES. A CASE SERIES

Julien Letendre*, Olivier Traxer, Paris, France

V09-02 LOWER- MIDDLE CALYX PATHOLOGY AND A NOVEL ENDOSCOPE CONCEPT

Jorge Campos Castellanos*, Huixquilucan, Mexico

V09-03 A NOVEL CONCEPT FOR ENDOUROLOGY INSTRUMENTATION

Jorge Campos Castellanos*, Huixquilucan, Mexico

V09-04 A PRECLINICAL FEASIBILITY STUDY OF RETROGRADE ENDOPYELOPLASTY

Mohammed Lezrek*, Hicham Tazi, Adil Slimani Alaoui, Khalil Bazine, Mohammed Alami, Meknes, Morocco

V09-05 URETERAL STONE RETROPULSION PREVENTION DURING AN URETEROSCOPIC LITHOTRIPSY USING A NOVEL REVERSE THERMO-SENSITIVE WATER-SOLUBLE POLYMER

Alberto Perez-Lanzac de Lorca*, Jesus Rosety Rodriguez, Angela Conde Giles, Cristina Leon Delgado, Javier Amores, Javier Cañete, Rodrigo Garcia-Baquero, Maria Jose Ledo Cepero, Juan Solo Villalva, Blanca Madurga Patuel, Jose Luis Alvarez-Ossorio Fernandez, cadiz, Spain

V09-06 ENDOSCOPIC REMOVAL OF GIANT URETERAL POLYP

Oktay Demirkesen*, Cetin Demirdag, Cagatay Dogan, Bulent Alici, Istanbul, Turkey

V09-07 TURKISH ROBOT FOR COMMERCIALLY AVAILABLE FLEXIBLE URETERORENOSCOPES FOR THE RETROGRADE INTRARENAL SURGERY (RIRS)

Remzi Saglam*, Ankara, Turkey, Jens J. Rassweiler, Heilbronn, Germany, Ahmet Yaser Muslumanoglu, Istanbul, Turkey, Ahmet Sinan Kabakci, Ankara, Turkey

V09-08 MODIFIED TECHNIQUE OF RETROGRADE INTRA RENAL SURGERY

Nilkamal Joshi*, Al Ain, United Arab Emirates

V09-09 EXTRA-ANATOMIC STENTS: CHANGE IN REFRACTORY URETERIC OBSTRUCTION

Samuel Grimsley*, Kesapavilla Subramonian, Birmingham, United Kingdom

V09-10 THE TWO-WIRE TECHNIQUE: SHEATHLESS RETROGRADE INTRODUCTION OF FIBREOPTIC URETERORENOSCOPE IN INTRARENAL ENDOSCOPIC LASER LITHOTRIPSY

Basharat Hussain*, Wai Man Chow, Manchester, United Kingdom

V09-11 UPPER URINARY TRACT AMYLOIDOSIS: CASE PRESENTATION AND ENDOSCOPIC VIDEO

Ariel Schulman*, William Hilton, Antoun Toubaji, Hikmat Al-Ahmadie, Jonathan Coleman, New York, NY

V09-12 FLUOROLESS URETEROSCOPY

Min S Jun, Gene O Huang, Roger Li*, D Duane Baldwin, Loma Linda, CA

Thursday, October 24, 2013   Moderated Poster Session MP16   4:30 pm–6:15 pm

UROLITHIASIS II

Room Rhythms 1 @ Sheraton New Orleans

Faculty: Roger Sur and Richard Babayan

*Presenting author

MP16-01 ENDOCKSCOPE: USING MOBILE TECHNOLOGY TO CREATE GLOBAL POINT OF SERVICE ENDOSCOPY

Renai Yoon*, Samir Shreim, Atreya Dash, Ralph Clayman, William Sohn, Hak J. Lee, Irvine, CA

MP16-02 ENDOSCOPIC MANAGEMENT OF UROLITHIASIS IN THE HORSESHOE KIDNEY

Marcelino Rivera*, Amy Krambeck, Rochester, MN

MP16-03 SINGLE ENDOUROLOGY CENTRE EXPERIENCE IN PERCUTANEOUS CHEMOLYSIS OVER THE LAST TEN YEARS

Stefanos Kachrilas*, Andreas Bourdoumis, Faruquz Zaman, Christian Bach, Anuj Goyal, Athanasios Papatsoris, Junaid Masood, Noor Buchholz, London, United Kingdom

MP16-04 PREVALENCE OF 24-HOUR URINE COLLECTION AMONG HIGH-RISK STONE FORMERS

Jaclyn Milose*, Brent Hollenbeck, Samuel Kaufman, Gary Faerber, J. Stuart Wolf, Jeffrey Montgomery, Alon Weizer, John Hollingsworth, Ann Arbor, MI

MP16-05 MANIFOLD PURE URIC ACID BLADDER STONES: PRESENTATION AND ENDOSCOPIC MANAGEMENT

Shih-Chieh Jeff Chueh*, Fabio C. M. Torricelli, Shujane Shen, Manoj Monga, Cleveland, OH

MP16-06 IS THERE A DIFFERENCE IN 24-HOUR URINE COMPOSITION BETWEEN STONE PATIENTS WITH AND WITHOUT DIABETES MELLITUS?

Christopher Hartman*, Justin Friedlander, Daniel Moreira, Sammy Elsamra, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP16-07 EFFECTIVENESS OF FLEXIBLE URETEROSCOPIC STONE REMOVAL FOR TREATING URETERAL AND IPSILATERAL RENAL STONES: A SINGLE CENTER EXPERIENCE

Jae Dong Chung*, Seung Hyun Ahn, Jong Kyou Kwon, Tae-Hyoung Kim, Soon Chul Myung, Young Tae Moon, Kyung Do Kim, In Ho Chang, Seoul, Korea, Republic of

MP16-08 AN EVALUATION OF THE IMPACT OF CREATININE TO WEIGHT RATIO BY GENDER IN 24-HOUR URINE STUDIES FOR RENAL STONE PREVENTION

Justin M. Watson*, Shaun Wason, Michael D. Fabrizio, Norfolk, VA, Nicole L. Miller, Nashville, TN, Mark D. Sawyer, Norfolk, VA

MP16-09 INFECTION, SIRS AND SEPSIS IN PATIENTS WITH OBSTRUCTIVE PYELONEPHRITIS DUE TO URETERAL STONES

Jodi Antonelli*, Daniel Mollengarden, Jeffrey Shoss, Yair Lotan, Margaret Pearle, Dallas, TX

MP16-10 MULTIPLE SCLEROSIS AND KIDNEY STONE DISEASE

Shubha De*, Giovanni Marchini, Benjamin Larson, Manoj Monga, Cleveland, OH

MP16-11 BILATERAL TUBELESS AND JJ STENTLESS PCNL EXPERIENCE OF 37 CASES

Mohammed Bhuiyan*, MF Islam, ZH Bhuiyan, KMH Tawhid, NIU Ahmed, K Salahuddin, Dhaka, Bangladesh

MP16-12 NON-LINEAR LOGISTIC REGRESSION MODEL FOR OUTCOMES AFTER ENDOUROLOGIC PROCEDURES: A NOVEL PREDICTOR

Adam Kadlec*, Maywood, IL, Samuel Ohlander, James Hotaling, Chicago, IL, Jessica Hannick, Maywood, IL, Craig Niederberger, Chicago, IL, Thomas Turk, Maywood, IL

MP16-13 RANDALL'S PLAQUE AND INTRADUCTAL PLUGGING: ASSOCIATION WITH STONE EVENTS AND COMPOSITION

Mitra de Cogain*, Amy Krambeck, Eric Bergstralh, Xujian Li, John Lieske, Rochester, MN

MP16-14 DIABETES MELLITUS AND UROLITHIASIS: DOES RANDALL'S PLAQUE ACCOUNT FOR INCREASED STONE RISK?

Mitra de Cogain*, Amy Krambeck, Eric Bergstralh, Xujian Li, John Lieske, Rochester, MN

MP16-15 NEW DESIGNED TIP-FLEXIBLE SEMI-RIGID URETEROSCOPY IN THE MANAGEMENT OF RENAL STONES: INITIAL EXPERIENCE

Yinghao Sun*, Xiaofeng Gao, Shanghai,China, China, People's Republic of, Ling Li, Shanghai, China, People's Republic of, Yonghan Peng, Shanghai, China, China, People's Republic of

MP16-16 EVALUATION OF HEAVY METALS AND TRACE ELEMENTS CONTENTS IN URINARY CALCULI: MICROANALYTICAL STUDY

Mahmoud Elnagar*, Naimat Alsayegh, Alain, United Arab Emirates, Bedier Ali-El-Dein, Mansoura, Egypt, Saeed Alqahtani, Paris, France, Sanjeev Mehta, Ahmadabad, India, Nilkamal Joshi, Alain, United Arab Emirates, Emad Elsobky, Abu Dhabi, United Arab Emirates

MP16-17 EVALUATION OF MICRO CT ANALYSIS OF URINARY STONE COMPOSITION

James Williams*, Indianapolis, IN, Kalba Usman, Ruth Tor, Petach Tikva, Israel, James McAteer, Indianapolis, IN, David Lifshitz, Petach Tikva, Israel

MP16-18 SIMULTANEOUS DIGITAL FLEXIBLE URETERORENOSCOPY AND EXTRACORPORAL SHOCK WAVE LITHOTRIPSY: A NEW APPROACH FOR RENAL STONE TREATMENT?

Thomas Knoll*, Patrick Honeck, Sindelfingen, Germany, Ulf Balsmeyer, Dirk Fahlenkamp, Chemnitz, Germany, Gunnar Wendt-Nordahl, Sindelfingen, Germany

MP16-19 HIGHER HEMOGLOBIN A1C IS ASSOCIATED WITH A GREATER LIKELIHOOD OF URIC ACID STONE FORMATION: IS CONTROL OF DIABETES IMPORTANT FOR STONE PREVENTION?

Sara Best, Jonathan Shiau*, Rachel Bell, Kristina Penniston, Madison, WI

MP16-20 URETEROSCOPY VERSUS SHOCK WAVE LITHOTRIPSY – FACTORS INFLUENCING PATIENT TREATMENT PREFERENCES

Adam Shrewsberry*, Steven Gerhard, Tania Solomon, Dana Nickleach, Yuan Liu, John Pattaras, Kenneth Ogan, Atlanta, GA

MP16-21 HYPERLIPIDEMIA IS ASSOCIATED WITH AN INCREASED RISK OF NEPHROLITHIASIS

LCDR James H Masterson, Jason R Woo, David C Chang, CDR James O L'Esperance, San Diego, CA, Marshall L Stoller, San Francisco, CA, Roger L Sur*, San Diego, CA

MP16-22 GENDER INEQUALITIES IN URINARY METABOLIC EVALUATION OF STONE FORMERS: A 10 YEAR EXPERIENCE FROM A WESTERN INDIAN STONE BELT REGION

Jitendra Jagtap*, Raguram Ganesamoni, Jigish Vyas, Shashikant Mishra, Arvind Ganpule, Ravindra Sabnis, Mahesh Desai, Nadiad, India

MP16-23 MONTHLY VARIATIONS IN UROLITHIASIS PRESENTATIONS AND THEIR ASSOCIATION WITH METEOROLOGICAL FACTORS IN NEW YORK CITY

Benjamin Katz*, Mohit Sirohi, New York, NY, Daniel Moreira, New Hyde Park, NY, Caner Dinlenc, New York, NY

MP16-24 URINARY TRACT STONE DEVELOPMENT IN PATIENTS WITH MYELODYSPLASIA SUBJECTED TO AUGMENTATION CYSTOPLASTY

Courtney Shepard*, David Joseph, Dean Assimos, Betsy Hopson, Ralee Bishop, Birmingham, AL

MP16-25 USING 24-HOUR URINALYSIS TO PREDICT STONE TYPE

Justin Friedlander*, Daniel Moreira, Chris Hartman, Sammy Elsamra, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP16-26 THE PREDICTION FACTORS OF FLEXIBL URETERORENOSCOPY REQUIREMENT AFTER RIJID URETERORENOSCOPY IN RENAL PELVIS STONES

Evren Suer, Omer Gulpinar, Cihat Ozcan*, Cagatay Gogus, Seymur Kerimov, Siddik Mut Safak, Ankara, Turkey

Thursday, October 24, 2013   Moderated Poster Session MP17   4:30 pm–6:15 pm

FEMALE UROLOGY/ADRENAL/TESTIS

Room Rhythms 2 @ Sheraton New Orleans

Faculty: Gopal Badlani and Ramakrishna Venkatesh

*Presenting author

MP17-01 SINGLE PORT INTRAVESICAL LAPAROSCOPIC REPAIR OF VESICOVAGINAL FISTULA

Ahmed Moharram*, Giza, Egypt

MP17-02 BILATERAL LAPAROSCOPIC ADRENALECTOMY IN A PREGNANT WOMAN WITH CUSHING'S SYNDROME

Mohammad Aslzare*, Amirabbas Asadpour, Mohammad Alipour, Mohammadreza Darabi Mahboub, Morteza Taghavi, Alireza Ghoreifi, Mashhad, Iran

MP17-03 LAPAROSCOPIC VARICOCELECTOMY FOR CHRONIC SCROTAL PAIN. A SINGLE CENTRE EXPERIENCE

Stefanos Kachrilas*, Elenko Popov, Andreas Bourdoumis, Faruquz Zaman, Christian Bach, Anuj Goyal, Athanasios Papatsoris, Junaid Masood, Noor Buchholz, London, United Kingdom

MP17-04 EXTRAPERITONEAL LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR NONSEMINOMATOUS GERM CELL TUMORS

Changjun Yin*, Nanjing, China, People's Republic of

MP17-05 LAPAROSCOPIC PARTIAL VERSUS TOTAL ADRENALECTOMY FOR ADRENAL MASS

Young Gon Kim, Hyung Jin Kim, Young Beom Jeong*, Jeonju, Korea, Republic of

MP17-06 LAPARASCOPIC SACROPEXY USING A TITANIZED POLYPROPYLENE MESH FOR PELVIC ORGAN PROLAPSE: FUNCTIONAL AND ANATOMICAL OUTCOME AFTER 2.5 YEARS

Jan-Peter Jessen, Gunnar Wendt-Nordahl, Thomas Knoll, Patrick Honeck*, Sindelfingen, Germany

MP17-07 OUTCOMES OF ROBOT-ASSISTED URETERONEOCYSTOSTOMY IN THE MANAGEMENT OF GYNECOLOGICAL SURGERY ASSOCIATED URETERIC COMPLICATIONS

Amar Singh*, Sarah Hunt, Argil Wheelock, Norman Galen, Colin Goudelocke, Juan Class, Chattanooga, TN

MP17-08 COMPARISON OF POSTOPERATIVE PAIN AFTER TRANSOBTURATOR OR RETROPUBIC SUBURETHRAL SLING FOR FEMALE STRESS URINARY INCONTINENCE: A PROSPECTIVE RANDOMIZED STUDY

Jin Ho Choe*, Hui Dai Lee, Se Hwan Park, Dae Gi Jo, Hyo Serk Lee, Joong Shik Lee, Ju Tae Seo, Seoul, Korea, Republic of

MP17-09 A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY OF TAMSULOSIN AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR A SINGLE PROXIMAL URETERAL STONE

Yong Hyun Park*, Gyeonggi-do, Korea, Republic of, Jae Young Park, Ansan, Korea, Republic of, Hyunsoo Ahn, Hyeon Hoe Kim, Seoul, Korea, Republic of

MP17-10 ROBOTIC RETROPERITONEAL LYMPH NODE DISSECTION FOR CLINICAL STAGE I TESTIS CANCER: INITIAL SERIES AND FEASIBILITY STUDY

Gautam Jayram*, Mark Ball, Trinity Bivalacqua, Mohamad Allaf, Baltimore, MD

MP17-11 CORRELATION OF ULTRASOUND WITH SURGERY IN PATIENTS WITH UNILATERAL NON-PALPABLE TESTICLES: IMPACT OF WEIGHT AND CONTRALATERAL TESTICULAR SIZE

Wissem Hmida, Ghassen Tlili*, Faouzi Mallat, Sidiya Chavey, Nadia Mama, Mahdi Jaidane, Faouzi Mosbah, Sousse, Tunisia

MP17-12 COMPARATIVE ANALYSIS OF ROBOTIC VS. OPEN RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER STAGING

Sean Stroup*, San Diego, CA, Michael Liss, Kerrin Palazzi, La Jolla, CA, James Masterson, San Diego, CA, Ithaar Derweesh, La Jolla, CA, James L'Esperance, San Diego, CA

MP17-13 POST-CHEMOTHERAPY LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION IN LOW VOLUME RESIDUAL GERM CELL CANCER

Christian Schwentner*, Tilman Todenhöfer, Georgios Gakis, Stefan Aufderklamm, Tuebingen, Germany

MP17-14 ROBOTIC VERSUS LAPAROSCOPIC ADRENALECTOMY: A COMPARISON OF TECHNIQUES

Brett Parker*, Mohammad Malik, Jennifer Yates, Ravi Munver, Hackensack, NJ

MP17-15 COEXISTENCE OF LOWER EXTREMITY VARICES AND STRESS URINARY INCONTINCE IN WOMEN

Alper Otunctemur, Emin Ozbek*, Murat Dursun, Mustafa Erkoc, Eyyup Danis, Recep Bayraktarli, Tahsin Yasar, Istanbul, Turkey

MP17-16 MINIMALLY INVASIVE TREATMENT OF URETEROVAGINAL FISTULA: A REVIEW AND REPORT OF A NEW TECHNIQUE

Khalid Al Otaibi, Reem Al Damanhori*, Alkhobar, Eastern Province, Saudi Arabia

MP17-17 INTRAVESICAL MIGRATION OF IUCD (INTRAUTERINE DEVICE) WITH CALCULUS FORMATION

Yoheeswaran Nallaswami*, Sangeetha Karunanidhi, Erode, India

MP17-18 FERTILITY OF PATIENTS WITH A HISTORY OF BILATERAL CRYPTORCHIDISM TREATED

Wissem Hmida, Ghassen Tlili*, Faouzi Mallat, Sidiya Chavey, Nadia Mama, Mahdi Jaidane, Faouzi Mosbah, Sousse, Tunisia

MP17-19 ROBOT-ASSISTED LYMPH NODE DISSECTION IN TESTIS CANCER. EXPERIENCE IN 12 CONSECUTIVE CASES

Octavio Castillo, Ivar Vidal-Mora, Daniel Revello*, Matias Poblete, Andres Silva, Jorge Lopez-Vallejo, Santiago, Chile

MP17-20 DIAGNOSIS AND TREATMENT OF ELEVEN CASES OF ADRENOCORTICAL ONCOCYTIC ADENOMA:REPORT OF 11 CASES

Xiao Qing Wang, Yan Wang, Hai Feng Zhang, Hai Ming Wang, Chun Xi Wang*, Changchun, China, People's Republic of

MP17-21 IS THERE ANY INDICATION OF PERCUTANEOUS BIOPSY OF A LARGE ADRENAL MASS BEFORE CONSIDERING SURGERY?

Janica Chavda*, Aditi Kumar, Tamer El-Husseiny, Nuwan Premachandra, Birmingham, United Kingdom, Sashi Kommu, London, United Kingdom, Aniruddha Chakravarti, Birmingham, United Kingdom

MP17-22 INVESTIGATION AND MANAGEMENT OF INCIDENTAL ADRENAL MASSES

Jorge Clavijo-Eisele*, Mark Rogers, Shahzad Laghari, Lucy Nicholson, Grimsby, United Kingdom, Diego Abreu, Montevideo, Uruguay

MP17-23 CHANGING TRENDS IN ACUTE SCROTUM PRESENTATION: UK EXPERIENCE

Syed Ali Shahzad*, Ugo Otite, Birmingham, United Kingdom

MP17-24 THE UTILITY OF NOVEL REUSABLE DOPPLER PROBE INTEGRATED WITH GRASP FORCEPS

Junichi Inokuchi*, Takeshi Ohdaira, Keijiro Kiyoshima, Katsunori Tatsugami, Akira Yokomizo, Makoto Hashizume, Seiji Naito, Fukuoka, Japan

MP17-25 TRANSURETHRAL SEMINAL VESICULOSCOPY FOR INTRACTABLE SEMINAL VESICULITIS

Bianjiang Liu, Jie Li, Jiexiu Zhang, Pengchao Li, Zengjun Wang*, Nanjing, China, People's Republic of

Thursday, October 24, 2013   Moderated Poster Session MP18   4:30 pm–6:15 pm

ROBOTICS/LAPAROSCOPY: UPPER TRACT III

Room Rhythms 3 @ Sheraton New Orleans

Chair: Gunter Janetschek

Faculty: Mohammed Allaf and Jay Bishoff

*Presenting author

MP18-01 ROBOT-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR CLINICAL T1B RENAL MASSES

Yong Hyun Park*, Gyeonggi-do, Korea, Republic of, Hyunsoo Ahn, Seoul, Korea, Republic of, Jung Keun Lee, Byung Ki Lee, Jin-Woo Jeong, Chang Wook Jeong, Seok-Soo Byun, Gyeonggi-do, Korea, Republic of

MP18-02 ROBOTIC ASSISTED LAPAROSCOPIC PYELOPLASTY: LESSONS LEARNT AFTER 9 YEARS

Nicholas Faure Walker*, Oussama Elhage, Corinna Slawinski, Ben Challacombe, Prokar Dasgupta, London, United Kingdom

MP18-03 THE LEARNING CURVE FOR ROBOTIC PARTIAL NEPHRECTOMY IN A HIGH VOLUME ROBOTIC SURGERY CENTRE

Osayuki Nehikhare*, Ahalya Kadirvelarasan, Paul Sturch, Amit Patel, Matthew Brown, Nikita Joji, Gordan Kooiman, Tim O'Brien, Ben Challacombe, London, United Kingdom

MP18-04 COMPARISON OF SELECTIVE PARENCHYMAL CLAMPING TO HILAR CLAMPING DURING ROBOTIC-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY

Ryan Hsi*, Liam Macleod, John Gore, Jonathan Wright, Jonathan Harper, Seattle, WA

MP18-05 RETROPERITONEAL VERSUS TRANSPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY FOR POSTERIOR RENAL TUMORS: RESULTS OF MATCHED-PAIR COMPARISON FROM TWO MAJOR REFERRAL CENTERS

Marc Bjurlin*, New York, NY, Hamed Ahmadi, Los Angeles, CA, Tyler McClintock, James Wysock, New York, NY, Mihir Desai, Monish Aron, Inderber Gill, Los Angeles, CA, William Huang, Samir Taneja, Michael Stifelman, New York, NY

MP18-06 EVALUATION OF PERIOPERATIVE OUTCOMES IN ELDERLY PATIENTS AND COMPARISON WITH YOUNGER PATIENTS UNDERGOING ROBOTIC ASSISTED PARTIAL NEPHRECTOMY

Louis Krane*, Victor Romero, Ashok Hemal, Winston-Salem, NC

MP18-07 COMPARING MINIMALLY INVASIVE SURGICAL APROACHES TO RADICAL NEPHRECTOMY

Priayanka Arshanapalli, Tim Large*, Jason Sea, Clint Bahler, Thomas Gardner, Chandru Sundaram, Indianapolis, IN

MP18-08 OPEN AND ROBOTIC NEPHRON SPARING SURGERY FOR T1B OR GREATER RENAL CELL CARCINOMA: A SINGLE CENTER EXPERIENCE

Amar Singh*, Sarah Hunt, Argil Wheelock, Norman Galen, Colin Goudelocke, Juan Class, Chattanooga, TN

MP18-09 ROBOT-ASSISTED MANAGEMENT OF BENIGN DISTAL URETERAL STRICTURES IN REOPERATIVE FIELD: SINGLE INSTITUTION EXPERIENCE

Alonso Carrasco*, Matthew Gettman, George Chow, Matthew Tollefson, Rochester, MN

MP18-10 PERINEPHRIC FAT THICKNESS INCREASES OPERATIVE COMPLEXITY INDEPENDENT OF NEPHROMETRY SCORE DURING ROBOTIC PARTIAL NEPHRECTOMY

Liam C. Macleod*, Ryan S. Hsi, John L. Gore, Jonathan L. Wright, Jonathan D. Harper, Seattle, WA

MP18-11 ROBOTIC NEPHRECTOMY IS NOT COSTLIER THAN STANDARD LAPAROSCOPY WHEN ROBOT AVAILABLE

Daniel Gilbert*, Dublin, OH, Iahn Gonsenhauser, Columbus, OH, Ronney Abaza, Dublin, OH

MP18-12 THE IMPACT OF BODY MASS INDEX ON RENAL FUNCTIONAL OUTCOMES FOLLOWING MINIMALLY INVASIVE PARTIAL NEPHRECTOMY

Edris Negron*, Kyle Richards, Joshua Cohn, Zoe Steinberg, Scott Eggener, Arieh Shalhav, Chicago, IL

MP18-13 COST AND SAFETY ANALYSIS OF LAPAROSCOPIC CRYOABLATION AND ROBOTIC PARTIAL NEPHRECTOMY FOR MANAGEMENT OF RENAL MASSES

Qiang Li*, Zachary Klaassen, Bruce Shingleton, Rabii Madi, Augusta, GA

MP18-14 PREOPERATIVE, POSTOPERATIVE RENAL FUNCTION TEST USING TC 99 M-DTPA FOLLOWING LAPAROSCOPIC AND ROBOT-ASSISTED PARTIAL NEPHRECTOMY AT SHORT WARM ISCHEMIC

Kang Sup Kim*, Yong Sun Choi, Hyuk Jin Cho, Sung-Hoo Hong, Seoul, Korea, Republic of

MP18-15 IMPACT OF EARLY ARTERIAL UNCLAMPING DURING ROBOTIC PARTIAL NEPHRECTOMY

Christopher Reilly*, Elton Llukani, Blake Moore, Ziho Lee, David Lee, Jack Mydlo, Daniel Eun, Philadelphia, PA

MP18-16 OUTCOMES OF PARTIAL NEPHRECTOMY IN PATIENT WHO MEET PERCUTANEOUS ABLATION CRITERIA

Mark Ball*, Michael Gorin, Gautam Jayram, Mohamad Allaf, Baltimore, MD

MP18-17 ROBOT-ASSISTED VERSUS PURE LAPAROSCOPIC RADICAL NEPHRECTOMY: ARE ADDITIONAL COSTS OFFSET BY TECHNICAL GAINS?

Scott Tobis, Helen Levey*, Anees Fazili, Justin Houman, Deep Trivedi, Bryce Allio, Tamara John, Emelian Scosyrev, Jean Joseph, Hani Rashid, Guan Wu, Rochester, NY

MP18-18 THE “EUNORRHAPHY”: A MODIFIED SLIDING CLIP RENORRHAPHY USING A DOUBLE-ARMED BARBED SUTURE FOR ROBOTIC PARTIAL NEPHRECTOMY

Christopher Reilly*, Elton Llukani, Blake Moore, Ziho Lee, David Lee, Jack Mydlo, Daniel Eun, Philadelphia, PA

MP18-19 MINIMALLY INVASIVE PARTIAL NEPHRECTOMY VERSUS RENAL CRYOABLATION FOR SMALL RENAL MASSES

Samuel Juncal*, Michael Ordon, Achim Lusch, Zhamshid Okhunov, Orange, CA, Cassio Andreoni, São Paulo, Brazil, Jaime Landman, Orange, CA

MP18-20 ROBOTIC PARTIAL NEPHRECTOMY IN PT1B AND LARGER RENAL MASSES: SINGLE INSTITUTION ANALYSIS WITH 3 YEAR FOLLOW UP

Louis Krane*, Victor Romero, Ashok Hemal, Winston-Salem, NC

MP18-21 EQUIVOCAL OVERALL SURVIVAL IN ROBOTIC, LAPAROSCOPIC, AND OPEN NEPHROURETERECTOMY AT INTERMEDIATE FOLLOW UP

David Koslov*, Louis Spencer Krane, Winston Salem, NC, Theodore Manny, Ashok Hemal, Winston-Salem, NC

MP18-22 DEFINING THE LEARNING CURVE OF ROBOTIC PARTIAL NEPHRECTOMY: ANALYSIS OF ISCHEMIA S

Philip Dorsey*, Eric Shaw, Sree Mandava, Benjamin Lee, New Orleans, LA

MP18-23 A COMPARATIVE STUDY OF OPEN, LAPAROSCOPIC AND ROBOTIC PARTIAL NEPHRECTOMY IN OBESE PATIENTS

Clairese Webb*, Mohamed Kamel, Ehab Eltahawy, Mohammed Elfaramawi, Rodney Davis, Nabil Bissada, Little Rock, AR

MP18-24 DO WE NEED TO CLAMP THE RENAL HILUM LIBERALLY DURING THE INITIAL PHASES OF THE LEARNING CURVE FOR ROBOT-ASSISTED NEPHRON-SPARING SURGERY?

Tarik Esen, Omer Acar*, Ahmet Musaoglu, Metin Vural, Istanbul, Turkey

MP18-25 LAPAROSCOPIC NEPHROURETERECTOMY IS A SAFE AND ADHERENT MODALITY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA IRRESPECTIVE OF BODY MASS INDEX

Takahiro Hirayama*, Kazumasa Matsumoto, Morihiro Nishi, Kenichi Tabata, Daisuke Ishii, Tetsuo Fujita, Kazunari Yoshida, Masatugu Iwamura, Kanagawa, Japan

MP18-26 LAPAROSCOPIC PARTIAL NEPHRECTOMY WITH SEGMENTAL RENAL ARTERY CLAMPING

Changjun Yin*, Pengfei Shao, Chao Qin, Nanjing, China, People's Republic of

Thursday, October 24, 2013   Moderated Poster Session MP19   4:30 pm–6:15 pm

IMAGING, UROLITHIASIS & NEW TECHNIQUES

Room Grand Ballroom D @ Sheraton New Orleans

Chair: David Tolley

Faculty: Salvatore Micali and Gianpaolo Bianchi

*Presenting author

MP19-01 EMERGENCY SEMIRIGID URETROSCOPY FOR MANAGEMENT OF DIFFERENT URETERAL DISEASES

Mohamed Mohamed*, Mostafa Shamaa, Hassan A.elwahab, Gamal Elatrash, Ismailia, Egypt

MP19-02 RETROGRADE ENDOSCOPIC URETERAL STENT PLACEMENT IN TRANSPLANT KIDNEYS: TECHNIQUE AND OUTCOMES OF A CONTEMPORARY SERIES

Shailja Mehta*, Chris Wright, Khushabu Kasabwala, Jennifer Yates, Michael Shapiro, Nicole Ali, Ravi Munver, Hackensack, NJ

MP19-03 SPECTROSCOPIC HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) MONITORING IN KIDNEY

Mei Wang*, Kate Elfer, Nguyen Hoang, Damir Khismatullin, J. Quincy Brown, New Orleans, LA

MP19-04 FLUORESCENCE STAINING STRATEGIES FOR HISTOLOGICAL ASSESSMENT OF PROSTATE BIOPSY

Kate Elfer, New Orleans, LA, Andrew Moore*, Hillary Kimbrell, New Orelans, LA, J. Quincy Brown, New Orleans, LA

MP19-05 IN VIVO OPTICAL COHERENCE TOMOGRAPHY FOR THE EVALUATION OF UPPER URINARY TRACT UROTHELIAL CARCINOMA: INITIAL RESULTS FROM A PILOT STUDY

Mieke Bus*, Berrend Muller, Daniel de Bruin, Dirk Faber, Maria Laguna Pes, Ton van Leeuwen, Theo de Reijke, Jean de la Rosette, Amsterdam, Netherlands

MP19-06 ENDOSCOPIC MANAGEMENT OF URINE LEAKS AFTER PARTIAL NEPHRECTOMY WITH URETEROSCOPIC RETROGRADE FIBRIN SEALANT

Aaron D Weiss*, John G Pattaras, Atlanta, GA

MP19-07 THE CLINICAL UTILITY OF MRI IN CHARACTERIZING THE DYNAMIC EFFECTS OF 5-ALPHA REDUCTASE INHIBITORS ON PROSTATE ZONAL VOLUMES

Hong Truong*, Jennifer Logan, Baris Turkbey, M. Minhaj Siddiqui, Soroush Rais-Bahrami, Anthony Hoang, Chad Pusateri, Brian Shuch, Annerleim Walton-Diaz, Srinivas Vourganti, Jeffrey Nix, Lambros Stamatakis, Peter L. Choyke, Bradford J. Wood, Peter A. Pinto, Bethesda, MD

MP19-08 HIGH INCIDENCE OF DONOR GIFTED LITHIASIS FROM CADAVERIC GRAFTS SCREENED USING NON CONTRASTED COMPUTERIZED AXIAL TOMOGRAPHY INITIAL RESULTS FROM A TERTIARY CENTRE IN MEXICO CITY

Jorge David Magaña Rodriguez*, Christian Isaac Villeda, Carolina Culebro Garcia, Ricarlo Alonso Castillejos Molina, Bernardo Gabilondo Pliego, Jorge Vazquez Lamadrid, Carlos E Mendez Probst, Mexico, Mexico

MP19-09 REDUCTION OF RADIATION EXPOSURE TO ENDOUROLOGIC SURGEONS WITH THE URO DYNA-CT

Manuel Ritter*, Marie-Claire Rassweiler, Carolin Hörmann, Mannheim, Germany, Alexandre E. Pelzer, Ingolstadt, Germany, Axel Häcker, Maurice-Stephan Michel, Mannheim, Germany

MP19-10 PRELIMINARY INVESTIGATION OF MICROWAVE ABLATIONS AT 915 MHZ IN EX-VIVO AND IN-VIVO PORCINE KIDNEYS

Karli Pease*, Gideon Lorber, Raymond Leveillee, Nelson Salas, Miami, FL

MP19-11 REDUCED RADIATION EXPOSURE OF ENDOUROLOGICAL PATIENTS BY NEW PROTOCOLS IN THE URO DYNA-CT

Marie-Claire Rassweiler*, Mannheim, Germany, Rosemarie Banckwitz, Christoph Koehler, Bernd Mueller-Allisaat, Forchheim, Germany, Maurice-Stephan Michel, Axel Haecker, Manuel Ritter, Mannheim, Germany

MP19-12 EFFICACY OF A NOVEL TECHNIQUE FOR PERSISTENT AND RECURRENT HEMOSPERMIA BY TRANSURETHRAL SEMINAL VESICULOSCOPY IN A SINGLE-CENTER OF SOUTH CHINA: LONG-TERM FOLLOW-UP RESULTS

Heng-Jun Xiao*, De-Juan Wang, Jun Chen, Jun Pang, Yun Luo, Xiao-Peng Liu, Yan Zhang, Jin-Ming Di, Jian-Guang Qiu, Xiang-Fu Zhou, Xin Gao, Guangzhou, China, People's Republic of

MP19-13 CAN RENAL MASS FEATURES ON CT PREDICT POSITIVE MARGINS?

Brian Duty*, Nick Tadros, Michael Conlin, Portland, OR

MP19-14 INITIAL INVESTIGATION OF A 2450 MHZ MICROWAVE SYSTEM FOR ABLATION OF RENAL TISSUES

Karli Pease*, Arturo Castro, Raymond Leveillee, Nelson Salas, Miami, FL

MP19-15 EVIDENCE FOR REVERSE STAGE MIGRATION AFTER ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY

Aaron Bernie*, Ranjith Ramasamy, Adnan Ali, Ashutosh Tewari, New York, NY, Zachary Smith,

MP19-16 IMPACT OF URETERAL JET FLOW ON URINARY TRACT STONE FORMATION

Serdar Celik*, Canan Altay, Sakir Ongun, Gorkem Uz, Ozan Bozkurt, Omer Demir, Mustafa Secil, Guven Aslan, Izmir, Turkey

MP19-17 EVALUATION OF A DISPOSABLE CYSTOSCOPE IN CONJUNCTION WITH PHOTOSELECTIVE LASER VAPORIZATION OF THE PROSTATE (PVP)

Joseph V. DiTrolio, M.D.*, Roseland, NJ, Nina N. Harkhani, Newark, NJ, Rahuldev Bhalla, M.D., Millburn, NJ

MP19-18 STONE DETECTION FOR RENAL COLIC: COMPARATIVE RESULTS BETWEEN IVU AND NCCT

Saher Anwer*, Tim Bryant, Iain Wilson, Bhaskar Somani, Southampton, United Kingdom

MP19-19 A NOVEL TECHNIQUES OF RETROPERITONEAL LAPAROSCOPIC NEPHRON-SPARING SURGERY WITHOUT SUTURE (WITH VIDEO )

Lulin Ma*, Xiaojun Tian, Yi Huang, Beijing, China, People's Republic of

MP19-20 THE IMPACT OF MUSIC ON PAIN AND ANXIETY EXPERIENCED IN PATIENTS UNDERGOING FLEXIBLE CYSTOSCOPY: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

Luke Dixon*, Alberto Coscione, Mathias Winkler, London, United Kingdom

MP19-21 ARE PSA, FREE TO TOTAL PSA RATIO, & P2PSA LEVELS HELPFUL TO MONITOR PATHOLOGICAL GRADES OF PROSTATE CANCER PATIENTS ON ACTIVE SURVEILLANCE?

Waseem Akhter*, Sally Benton, Frank Chinegwundoh, London, United Kingdom

MP19-22 ULTROSOUND-GUIDED CRYOABLATION OF SMALL RENAL TUMORS

Jian Bo Lu, Xiao Qing Wang*, Changchun, China, People's Republic of

MP19-23 HOW TO DO PROSTATE BIOPSY IN PATIENTS WITH NO ANUS

Andy Huang*, Allen Chiu, Thomas Hsueh, Taipei CIty, Taiwan

MP19-24 OUTCOME OF SEMIRIGID URETROSCOPY FOR BILATERAL URETERAL DISEASES

Mohamed Bakr*, Hassan Abd Elwahab, Gamal Elatrash, Mostafa Shamaa, Ismailia, Egypt

MP19-25 LARGE OBSTRUCTED UPPER URETERIC CALCULIAIM=TO COMPARE THE EFFICACY BETWEEN LAPAROSCOPY & URS IN THE TREATMENT OF LARGE UPPER URETERIC CALCULI (>2.5 CM)

Prashant Pattnaik, Mumbai, India, Prashant Pattnaik, Prashant Pattnaik*, Mumbai, India

MP19-26 SINGLE-SESSION INTRACORPOREAL PNEUMATIC LITHOTRIPSY FOR NUMEROUS URETERIC CALCULI IN ONE URETER OF A COMPLETE PELVI-CALYCEAL AND URETERIC DUPLICATION: A CASE REPORT

Arif Hamid*, Srinagar, India

MP19-27 ENDOUROLOGY AND INFECTION CONTROL

Nilkamal Joshi*, Al Ain, United Arab Emirates

MP19-28 COMPLICATIONS IN UPPER URETEROSCOPY AND LITHOTRIPSY

Andrius Gaizauskas*, Sergejus Gaizauskas, Vilnius, Lithuania

Thursday, October 24, 2013   Moderated Poster Session MP20   4:30 pm–6:15 pm

ENDOUROLOGY & NEW TECHNOLOGIES II

Room Grand Chenier @ Sheraton New Orleans

Faculty: Matthew Raynor and Murali Ankem and John Dushinski

*Presenting author

MP20-01 UROLOGY AND INTERVENTIONAL RADIOLOGY: MOVING TOWARDS AN INTERGRATED CARE MODEL

Alberto Coscione*, Luke Dixon, Lisa Henderson, Rebecca Powell, Sachin Agrawal, Altaf Shamsuddin, London, United Kingdom

MP20-02 MAPPING OF THE USSQ SCORES TO EUROQOL VALUES TO PERFORM ECONOMIC AND UTILITY IMPACT OF URETERAL STENTS

Ana Carvalho, Prof. S. Salek, Hrishi Joshi*, Cardiff, United Kingdom

MP20-03 ANTEGRADE AND RETROGRADE ENDOPYELOTOMY AS TREATMENT FOR PRIMARY AND SECONDARY URETEROPELVIC OBSTRUCTION (PUJO)

Stefanos Kachrilas*, Andreas Bourdoumis, Faruquz Zaman, Christian Bach, Anuj Goyal, Athanasios Papatsoris, Noor Buchholz, Junaid Masood, London, United Kingdom

MP20-04 RESCUE FROM PCN DRAINAGE AFTER FAILURE OF INTERNAL URETERAL STENT PLACEMENT FOR EXTRINSIC URETERAL OBSTRUCTION WITH A WIRE-REINFORCED URETERAL STENT

Casey A. Dauw, M.D.*, Gary J. Faerber, M.D., John M. Hollingsworth III, M.D., M.S, William W. Roberts, M.D., Ann Arbor, MI, J. Stuart Wolf Jr., M.D., 48109, MI

MP20-05 CONSERVATIVE RESECTION AND BCG INSTILLATION FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA – PRELIMINARY DATA FROM A SINGLE INSTITUTE IN TAIWAN

Jentai Lin*, Chia-Cheng Yu, Tony Wu, Kaohsiung, Taiwan

MP20-06 LONG-TERM OUTCOMES OF RESONANCE METALLIC STENTS FOR MALIGNANT AND CHRONIC-BENIGN URETERAL OBSTRUCTION

Crystal Castaneda*, Yungkhan Tan, Edan Shapiro, Natasha Leigh, Mantu Gupta, New York, NY

MP20-07 BASELINE SERUM 25-HYDROXYVITAMIN D LEVELS IN MEN UNDERGOING RADICAL PROSTATECTOMY: IS THERE AN ASSOCIATION WITH ADVERSE PATHOLOGIC FEATURES?

Edan Shapiro*, William Berg, Ari Bergman, Kyle Scarberry, Trushar Patel, Ketan Badani, New York, NY

MP20-08 ANTERIOR URETHRAL VALVE- A STUDY OF 8 PATIENTS

Dipak Rajyaguru*, Mehsana, India, Jitendra Amlani, Rajkot, India, Ashwin Gami, Palanpur, India

MP20-09 EVOLUTION OF TECHNOLOGY: SHORT TERM OUTCOMES WITH INTEGRATED IMAGING ABLATHERM-HIFU

Rafael Sanchez-Salas*, Dominique Prapotnich, Paris, France, Fernando Secin, Buenos Aires, Argentina, Eric Barret, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP20-10 ENDOSCOPIC INGUINOFEMORAL LYMPH NODE DISSECTION FOR MALIGANCIES OF THE EXTERNAL GENITALIA

Christian Schwentner*, Tilman Todenhöfer, Stefan Aufderklamm, Georgios Gakis, Tuebingen, Germany

MP20-11 UPPER URINARY TRACT RECURRENCE FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER WITH ITS HISTOLOGY: AN ANALYSIS OF INCIDENCE AND RISK FACTORS

JungHoon Lee*, Jae Hyun Jung, Sung Han KIM, EunSik Lee, EunSik Lee, Seoul, Korea, Republic of

MP20-13 LONG-TERM ONCOLOGIC OUTCOME AND COMPLICATIONS OF LAPAROSCOPIC RADICAL NEPHRECTOMY IN 286 CONSECUTIVE PATIENTS IN AKITA-JAPAN: RELATIVELY HIGH RECURRENCE RATE IN CT1 TUMORS

Kazuyuki Numakura*, Hiroshi Tsuruta, Susumu Akihama, Mitsuru Saito, Takamitsu Inoue, Shintaro Narita, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi, Akita, Japan

MP20-14 5-YEAR EXPERIENCE OF METALLIC MESH STENT (UVENTA) IN MALIGNANT URETERAL OBSTRUCTION

Wonho Jung*, Seol Ho Choo, Seong Soo Jeon, Hyung Keun Park, Deok Hyun Han, Seoul, Korea, Republic of

MP20-15 AN OVERVIEW OF THE USE OF CHECKLISTS IN SURGICAL SPECIALITIES - A SYSTEMATIC REVIEW

Janki Patel*, Kamran Ahmed, London, United Kingdom, Khurshid Guru, Buffalo, NY, Howard Marsh, Kent, United Kingdom, Mohammed Shamim Khan, Prokar Dasgupta, London, United Kingdom

MP20-16 LONG-TERM RESULTS FOR SUBCUTANEOUS DETOUR® PROSTHESIS FOR URETERAL OBSTRUCTION: EXPERIENCES OF IMPLANTATION, AFTERCARE AND MANAGEMENT OF COMPLICATIONS

Andreas Janitzky, Markus Porsch, Uwe-Bernd Liehr, Martin Schostak*, Magdeburg, Germany

MP20-17 DOES SOCIOECONOMIC DEPRIVATION, BODY MASS INDEX AND SMOKING STATUS INFLUENCE GRADE, STAGE, MULTIFOCALITY AND RECURRENCES IN UPPER TRACT TRANSITIONAL CELL CARCINOMA?

Angela Gillan*, Paimaun Zakikhani, Bhavan Rai, Campbell Tait, Ghulam Nabi, Dundee, United Kingdom

MP20-18 TRENDS IN THE MANAGEMENT PATTERNS OF RENAL ANGIOMYOLIPOMAS: A CASE SERIES OF 392 PATIENTS

Idir Ouzaid*, Riccardo Autorino, Richard Fatica, Vishnuvardhan Ganesan, Robert Stein, Jihad Kaouk, Georges-Pascal Haber, Cleveland, OH

MP20-19 KIDNEY SIZE AND CANCER SPECIFIC SURVIVAL FOR PATIENTS UNDERGOING NEPHRECTOMY TO TREAT PT1 CLEAR CELL RENAL CELL CARCINOMA

Jacob Jorns*, David Thiel, Jacksonville, FL, Christine Lohse, Rochester, MN, Adrienne Williams, Michelle Arnold, Jacksonville, FL, John Cheville, Bradley Leibovich, Rochester, MN, Alexander Parker, Jacksonville, FL

MP20-20 RADIOFREQUENCY ABLATION OF RENAL TUMORS:4-YEAR FOLLOW-UP RESULTS IN 47 PATIENTS

Soo-dong Kim*, Seong Guk Yoon, Gyung Tak Sung, Busan, Korea, Republic of

MP20-21 ISOLATION AND BIOLOGICAL BEHAVIOR STUDY OF CD133 POSITIVE CELLS FROM BLADDER CANCER CELL LINE 5637

Shuaiqi Chen, Tao Yang, Yuchuan Hou*, Changchun, China, People's Republic of

MP20-22 A NOVEL PNEUMATIC ELECTROCAUTERY DEVICE

Herman Bagga*, Joe Miller, Thomas Chi, San Francisco, CA, Michael Blomeyer, Walnut Creek, CA, Marshall Stoller, Maxwell Meng, San Francisco, CA

MP20-23 THE IMPACT OF OUTPATIENT ENDOSCOPY ON UROLOGY SERVICES IN A TERTIARY HOSPITAL IN A LOW RESOURCE ENVIRONMENT

Augustine Takure, Sikiru Adebayo, Olayiwola Shittu, Linus Okeke, Oluwabunmi Olapade-Olaopa, Augustine Takure*, Ibadan, Nigeria

MP20-24 “CLOSED ACCESS” STERILE DRAINAGE: IT WORKS FOR PERITONEAL DIALYSIS—IT WILL WORK FOR THE URINARY BLADDER, ALSO

Chris Smith*, Don Griffith, Houston, TX

MP20-25 RETROPERITONEAL AND EXTRAPERITONEAL LAPAROSCOPIC UROLOGICAL SURGERY USING SPACEMAKERTM, DISSECTION BALLOON (COVIDIEN, USA): SINGLE SURGEON¡¯S EXPERIENCE OF THE FIRST 27 CASES

Cheol Kyu Oh*, Seok San Park, Sang Hyun Park, Jae Seung Chung, Seong Cheol Kim, Busan, Korea, Republic of

MP20-26 A DECADE OF NATIONAL AND INTERNATIONAL TRENDS IN BASIC SCIENCE UROLOGIC RESEARCH: 2002–2011

Christopher Miller, David Kurz, Philadelphia, PA, Saum Ghodoussipour, Los Angeles, CA, John Graham Jr., Brooklyn, NY, Phillip Mucksavage*, Philadelphia, PA

Thursday, October 24, 2013   Video Session V10   4:30 pm–6:00 pm

UROLITHIASIS

Room Armstrong @ Sheraton New Orleans

Chair: Fernando Kim

Faculty: Saint Siou Chen, Ryan C. Hedgepeth and Alex Martov

*Presenting author

V10-01 RETROGRADE RENAL ACCESS IN PATIENTS WITH URINARY DIVERSION

Aryeh Keehn*, David Hoenig, Bronx, NY

V10-02 MYTHS, DOUBTS AND FACTS ABOUT LASER LITHOTRIPSY

Peter Kronenberg*, Amadora, Portugal, Olivier Traxer, Paris, France

V10-03 PERCSAC: A NOVEL DEVICE TO PREVENT STONE FRAGMENT MIGRATION DURING PERCUTANEOUS LITHOTRIPSY

Jodi Antonelli*, Jeffrey Gahan, Justin Friedlander, Heather Beardsley, Margaret Pearle, Jeffrey Cadeddu, Dallas, TX

V10-04 COMBINED ROBOTIC CYSTOLITHOTOMY, URETEROLITHOTOMY, AND PYELOLITHOTOMY IN A MORBIDLY OBESE PATIENT

Mathew Oommen*, Ahmet Gudeloglu, Kevin Lee, Jamin Brahmbhatt, Sijo Parekattil, Winter Haven, FL

V10-05 TRANSPERITONEAL FLEXIBLE ENDOSCOPY FACILITATES STONE REMOVAL DURING MINIMALLY INVASIVE PYELOLITHOTOMY

James Borin*, Jeff McDaniel, Sarah Chan, Baltimore, MD

V10-06 IATROGENIC COLON INJURY DURING PERCUTANEOUS STONE EXTRACTION

Sammy Elsamra*, Nithin Theckumparampil, Justin Friedlander, Hector Motato, Arthur Smith, Zeph Okeke, New Hyde Park, NY

V10-07 RETROGRADE ENDOSCOPIC MANAGEMENT OF CALYCEAL DIVERTICULUM WITH CONCOMITANT RENAL CALCULI

Mathew Oommen, Kush Patel, Arthur Caire, Philip Dorsey*, Ben Woodson, Raju Thomas, New Orleans, LA

V10-08 ANTEROGRADE URETERORENOSCOPY – PERCUTANEOUS LITHOTRIPSY AND INTESTINAL DILATION OF URETEROSIGMOIDOSTOMY STENOSIS AND ASSOCIATED LITHIASIS

Sandro Gaspar*, José Dias, Tito Leitão, Ricardo Silva, Joao Lopes, Tomé Lopes, Lisboa, Portugal

V10-09 RETROGRADE PERCUTANEOUS EXTRAPELVIC LASER ENDOPYELOTOMY

Khalid Alotaibi*, khobar, Saudi Arabia

V10-10 TREATMENT OF PEDIATRIC RENAL MATRIX STONE WITH PERC NCIRCLE®IN MINIMALLY INVASIVE PERCUTANEOUS NEPHROLITHOTOMY

Hakan Kilicarslan*, Onur Kaygisiz, Hakan Vuruskan, Yakup Kordan, Sinan Celen, Burhan Coskun, Bursa, Turkey

V10-11 THE WORLD'S FIRST SUPINE ULTRA-MINI PERCUTANEOUS NEPHROLITHOLAPAXY (UMP)

Andreas Bourdoumis, Stefanos Kachrilas*, Junaid Masood, Noor Buchholz, London, United Kingdom

V10-12 HEMOSTATIC PLUG: NOVEL TECHNIQUE FOR CLOSURE OF PERCUTANEOUS NEPHROSTOMY TRACTS

Joel E Abbott*, Roger W Jump III, Detroit, MI, Arman Cicic, Des Moines, IA, Julio G Davalos, Baltimore, MD

Thursday, October 24, 2013   Video Session V11   4:30 pm–6:00 pm

LAPAROSCOPY/ROBOTICS: PROSTATE, BLADDER & LOWER TRACT III

Room Grand Ballroom E @ Sheraton New Orleans

Chair: Evangelos N. Liatsikos

Faculty: Robert Figenshau and S. Duke Herrell

*Presenting author

V11-01 ROBOT – ASSISTED RADICAL CYSTECTOMY FOR FEMALE PATIENTS. THE O.L.V. VATTIKUTI ROBOTIC SURGERY INSTITUTE TECHNIQUE

Achilles Ploumidis*, Melanie Gan, Geert De Naeyer, Peter Schatteman, Aalst, Belgium, Alessandro Volpe, Novara, Italy, Alexandre Mottrie, Aalst, Belgium

V11-02 ROBOT–ASSISTED SACROCOLPOPEXY FOR PELVIC ORGAN PROLAPSE (POP). THE O.L.V. TECHNIQUE

Anne-Françoise Spinoit*, Achilles Ploumidis, Melanie Gan, Geert De Naeyer, Peter Schatteman, Alexandre Mottrie, Aalst, Belgium, Alessandro Volpe, Novara, Italy

V11-03 ROBOTIC RADICAL CYSTECTOMY. TIPS AND TRICKS IN PELVIC LYMPHADENECTOMY AND NEUROVASCULAR BUNDLES PRESERVATION

Camilo Giedelman*, Bogota, Colombia, Francois Rozet, Rafael Sanchez-salas, Eric Barret, Marc Galiano, Luca Lunelli, Youness Ahallal, Paris, France, Petr Macek, Prague, Czech Republic, Laurent Mascle, Xavier Cathelineau, Paris, France

V11-04 EXPLORING THE MARCILLE TRIANGLE DURING ROBOT-ASSISTED PELVIC LYMPHADENECTOMY FOR BLADDER CANCER: REPLICATING THE OPEN SURGICAL TECHNIQUE

Ahmed M. Mansour*, Hassan Abol-Enein, Mansoura, Egypt, Murugesan Manoharan, Miami, FL

V11-05 ROBOTICALLY ASSISTED BILATERAL VASOVASOSTOMY, AFTER A SUCCESSFUL BILATERAL VASECTOMY

Theodoros Tokas*, Ali Serdar Gözen, Jens Rassweiler, Heilbronn, Germany

V11-06 ROBOT-ASSISTED LAPAROSCOPIC REPAIR OF RECTO-VESICAL FISTULA FOLLOWING OPEN RADICAL PROSTATECTOMY

Raguram Ganesamoni*, Shashikant Mishra, Arvind Ganpule, Jigish Vyas, Jitendra Jagtap, Amit Bhattu, Ravindra Sabnis, Mahesh Desai, Nadiad, India

V11-07 NERVE-SPARING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL CYSTECTOMY AND URINARY DIVERSION

Amit Bhattu*, Nadiad, Gujarat, India, Shashikant Mishra, Jitendra Jagtap, Raguram Ganesamoni, Jigish vyas, Arvind Ganpule, Ravindra Sabnis, Nadiad, India, Mihir Desai, Los Angeles, CA, Mahesh Desai, Nadiad, India

V11-08 ROBOTIC ASSISTED TOTALLY INTRACORPOREAL STAPLED ILEAL NEOBLADDER IN FEMALE

Giuseppe Simone*, Rocco Papalia, Mariaconsiglia Ferriero, Salvatore Guaglianone, Michele Gallucci, Rome, Italy

V11-09 ROBOT ASSISTED LAPAROSCOPIC URETERONEOCYSTOSTOMY FOR VESICOURETERAL REFLUX AFTER URETEROCELE INCISION FOR HUGE URETEROCELE WITH MULTIPLE STONES

Won Sik Jeong*, Won Sik Ham, Hong Sang Moon, Tchun Yong Lee, Sung Yul Park, Kyung Hyun Moon Seoul, Korea, Republic of

V11-10 ROBOTIC INTRACORPOREAL STUDER POUCH CONSTRUCTION

Erdal Alkan, Oguz Ozkanli, Merve Yilmaz, Derya Balbay*, Istanbul, Turkey

V11-11 RE-DO ROBOTIC-ASSISTED RADICAL PROSTATECTOMY AT 48 HOURS: SUCCESSFUL RE-RESECTION FOR POSITIVE MARGINS

Paul Sturch*, Declan Cahill, Prokar Dasgupta, Rikki Vendivil, Ashish Chandra, Ben Challacombe, London, United Kingdom

V11-12 TECHNICAL MODIFICATIONS TO ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY FOR PATIENTS WITH HIGH-RISK PROSTATE CANCER AS DEFINED BY NATIONAL COMPREHENSIVE CANCER NETWORK CRITERIA

Wassim Bazzi*, New York, NY, Jonathan Silberstein, New Orleans, LA, Vincent Laudone, New York, NY

Thursday, October 24, 2013   Video Session V12   4:30 pm–6:00 pm

ADRENAL, IMAGING & NEW TECHNIQUES

Room Nottoway @ Sheraton New Orleans

Chair: Marshall L. Stoller

Faculty: Michael Maddox and Steven J. Schichman

*Presenting author

V12-01 LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION (L-RPLND): CHALLENGING YET TECHNICALLY FEASIBLE WITHOUT CHANGE IN PATIENT POSITION

Arup Mandal*, Ravimohan Mavuduru, Shrawan Singh, Sudheer Devana, Chandigarh, India

V12-02 RETROPERITONEAL LAPAROSCOPIC ADRENALECTOMY

Roberto Sanseverino*, Giorgio Napodano, Oliver Intilla, Umberto Di Mauro, Carmine Cicalese, Tommaso Realfonso, Nocera Inferiore, Italy

V12-03 LAPAROSCOPIC REMOVAL OF A PARAGANGLIOMA SURROUNDED WITH THE INFERIOR VENA CAVA AND THE RENAL VEIN AND ARTERY AT THE RIGHT RENAL HILUM: A CASE REPORT

Mamoru Fukuda*, Masayoshi Kawakami, Nobuyuki Nakajima, Toshiro Terachi, Isehara City, Japan

V12-04 POST CHEMOTHERAPY BILATERAL ROBOTIC RETROPERITONEAL LYMPH NODE DISSECTION (PC-RRPLND) FOR TESTICULAR MIXED GERM CELL TUMOR (MGCT): THREE ARMS APPROACH

Mohamed Kamel*, Rodney Davis, C Mark Jackson, J Taylor Moore, Little Rock, AR

V12-05 AN INNOVATIVE INSIDE-OUT APPROACH TO SUPRAPUBIC CATHETER INSERTION IN THE OBESE PATIENT WITH A NEUROGENIC BLADDER: THE TRANSURETHRAL SUPRAPUBIC ENDO-CYSTOSTOMY DEVICE

Vassilis Siomos*, Thomas Pshak, Brian Flynn, Aurora, CO

V12-06 NOVEL LAPAROSCOPIC APPROACH TO PENILE PROSTHESIS RESERVOIR ABSCESS

Erin M. Burns*, Jonathan Picard, Rana C. Pullatt, Charleston, SC

V12-08 ENDOCKSCOPE: BRIDGING ENDOSCOPY WITH MOBILE TECHNOLOGY

Philip Bucur, B.S.*, Adam Spjute, B.A., Renai Yoon, B.S., Ashleigh Menhadji, B.S., Samir Shreim, Ph.D., Victor Huynh, B.S., Atreya Dash, M.D., Ralph Clayman, M.D., Hak Lee, M.D., William Sohn, M.D., Orange, CA

V12-09 THE FIRST ASSISTANT SPARING TECHNIQUE (F.A.S.T) OF ROBOTIC PARTIAL NEPHRECTOMY USING IMMUNOFLUORESCENCE AIDED SELECTIVE ARTERIAL CLAMPING

Ketan Badani, Ari Bergman*, Edan Shapiro, Trushar Patel, New York, NY

V12-10 FLEXIBLE CO2 LASER FOR ROBOTIC TARGETED MICROSURGICAL DENERVATION OF THE SPERMATIC CORD

Jamin Brahmbhatt, Ahmet Gudeloglu*, Sijo Parekattil, Winter Haven, FL

V12-11 DEVELOPMENT OF DEDICATED STONE DETECTION PROTOCOLS USING A RESEARCH-BASED ULTRASOUND IMAGER

Ryan Hsi*, Bryan Cunitz, Barbrina Dunmire, Marla Paun, Jonathan Harper, Michael Bailey, Mathew Sorensen, Seattle, WA

V12-12 ROBOTIC RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE 1 TESTICULAR CANCER USING THREE ROBOTIC ARMS

Mohamed Kamel*, Rodney Davis, C Mark Jackson, Samy M Heshmat, Little Rock, AR

Friday, October 25, 2013   Moderated Poster Session MP21   2:30 pm–4:15 pm

ROBOTICS/LAPAROSCOPY: UPPER TRACT IV

Room Rhythms 1 @ Sheraton New Orleans

Chair: Ali Kural

Faculty: Chang-Jun Yin and Kun-Yuan Chiu

*Presenting author

MP21-01 ROBOTIC VERSUS LAPAROSCOPIC ADRENALECTOMY: A META-ANALYSIS OF SURGICAL OUTCOMES

Riccardo Autorino*, Georges-Pascal Haber, Humberto Laydner, Dinesh Samarasekera, Ali Khalifeh, Idir Ouzaid, Luis Felipe Brandao, Cleveland, OH, Marco De Sio, Napoli, Italy, Francesco Porpiglia, Orbassano, Italy, Robert J. Stein, Jihad Kaouk, Cleveland, OH

MP21-02 MEDIUM TERM RESULTS OF MINI LAPAROSCOPIC PYELOPLASTY USING THE SMALL-INCISION ACCESS RETROPERITONEOSCOPIC TECHNIQUE IN ADULTS

Murad Al Nasser*, Ali Goezen, Theodore Tokas, Giovannalberto Pini, Marcel Hruza, Jens Rassweiler, Heilbronn, Germany

MP21-03 SURGICAL TEAM ASSESSMENT OF THE OF THE 3D VIDEO SYSTEM AS USED IN LAPAROSCOPIC PARTIAL NEPHRECTOMY

Bogdan Petrut*, Hogea Maximilian, Vlad Schi&#539;cu, Andrei Kozan, Tiberiu Calistru, Alb Alexandra, Vasile Buda, Cluj Napoca, Romania

MP21-04 RETROPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR PT1B AND ABOVE LESIONS

Eric Moskowitz*, Derek Prabharasuth, Andrew Fishman, Michael Grasso, Valhalla, NY

MP21-05 REVIEW OF COMPLICATIONS FOR OPEN VERSUS ROBOTIC PARTIAL NEPHRECTOMY

Rudolph Bowens*, J Sea, C Bahler, C Sundaram, Indianapolis, IN

MP21-06 DOES THE AMOUNT OF PERI-RENAL FAT AFFECT TOTAL OPERATIVE DURING ROBOTIC PARTIAL NEPHRECTOMY?

Piruz Motamedinia*, Trushar Patel, Yungkhan Tan, Vijay Goru, Edan Shapiro, Ari Bergman, Ketan Badani, New York, NY

MP21-07 OUTCOMES OF AN AGED AND COMPLEXITY MATCHED COMPARISON BETWEEN OPEN AND ROBOTIC-ASSISTED PARTIAL NEPHRECTOMY

Osayuki Nehikhare*, Ahalya Kadirvelarasan, Paul Sturch, Amit Patel, Matthew Brown, Gordan Kooiman, Tim O'Brien, Ben Challacombe, London, United Kingdom

MP21-08 SINGLE-CENTER EXPERIENCE OF RETROPERITONEOSCOPIC ADRENALECTOMY FOR ADRENAL TUMORS LARGER THAN 6 CM

Jianfei Ye*, Lulin Ma, Beijing, China, People's Republic of

MP21-10 RETROPERITONEAL LAPAROSCOPIC RADICAL NEPHROURETERECTOMY WITH 3 FORMS OF BLADDER CUFF CONTROL

Jianfei Ye*, Lulin Ma, Beijing, China, People's Republic of

MP21-11 NEW TECHNOLOGIES OF IDENTIFICATION OF RENAL ARTERY IN RETROPERITONEAL LAPAROSCOPIC RENAL SURGERY

Yichang Hao*, Lulin Ma, Beijing, China, People's Republic of

MP21-12 OUTCOMES OF LAPAROSCOPIC PARTIAL NEPHRECTOMY IN PATIENTS WITH CHRONIC RENAL DISEASE

Ahmed Alasker, Steve Williams*, Reza Ghavamian, Bronx, NY

MP21-13 SUPER SELECTIVE RENAL ARTERIAL CLAMPING WITHOUT INTRA-OPERATIVE IMAGINING IN ROBOT-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY USING PREOPERATIVE CT ANGIOGRAPHY AND INTRAOPERATIVE PERFUSION VISUALIZATION

Shadi Al Ekish, Michael Maddox*, Andrew Leone, Gyan Pareek, Dragan Golijanin, Providence, RI

MP21-14 LUMBOSCOPIC SURGERY FOR THE LITHIASIS OF LUMBAR URETER

Tania González, María Elena Suárez, Mayuri Machado, David Perdomo*, Havana, Cuba

MP21-15 ASSOCIATION OF R.E.N.A.L. SCORE, PADUA SCORE AND CENTRALITY INDEX SCORE WITH PERIOPERATIVE OUTCOMES AND POSTOPERATIVE RENAL FUNCTION

Katsunori Tatsugami*, Junichi Inokuchi, Takumi Adachi, Seiji Naito, Fukuoka, Japan

MP21-16 RETROPERITONEAL LAPAROSCOPIC NEPHRECTOMY FOR NONFUNCTIONING TUBERCULOUS KIDNEY: A SINGLE-CENTER EXPERIENCE WITHOUT LARGE VOLUME OF PATIENTS

Bi Hai*, Hou Xiao-fei, Ma Lu-lin, Beijing, China, People's Republic of

MP21-17 SELECTIVE RENAL PARENCHYMAL CLAMPING IN LAPAROSCOPIC PARTIAL NEPHRECTOMY

Noriaki Utsunomiya*, Yuka Kono, Daisaku Nishihara, Keiyu Matsumoto, Takashi Matsuoka, Toshifumi Yano, Hiroyuki Tsunemori, Takuya Okada, Takehiko Segawa, Koei Muguruma, Mutsushi Kawakita, Kobe, Japan

MP21-18 A MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES OF A SINGLE LAPAROSCOPIC SURGEON VERSUS A MULTISURGEON ROBOT-ASSISTED COHORT FOR PARTIAL NEPHRECTOMY

Ivar Vidal-Mora, Octavio Castillo, Daniel Revello*, Matias Poblete, Santiago, Chile

MP21-19 METACHRONOUS RENAL CRYOABLATION FOR BILATERAL RENAL MASSES

Zachary Klaassen*, Qiang Li, Rabii Madi, W. Bruce Shingleton, Augusta, GA

MP21-20 HYBRID COMBINATION OF LAPAROSCOPE AND VIDEO-ASSISTED THORACOSCOPIC SURGERY FOR RENAL CANCER WITH LEVEL IV INFERIOR VENA CAVAL THROMBUS

Changjun Yin*, Pengfei Shao, Chao Qin, Nanjing, China, People's Republic of

MP21-21 LEARNING CURVE ANALYSIS FOR TRANSUMBILICAL LAPAROENDOSCOPIC SINGLE-SITE SURGERY (LESS) ADRENALECTOMY

Kyungtae Ko*, Jeong Woo Lee, Woo Suk Choi, Yong Hyun Park, Hyeon Hoe Kim, Seoul, Korea, Republic of

MP21-22 RETROPERITONEOSCOPIC HAND-ASSISTED NEPHROURETERECTOMY USING A HOMEMADE DEVICE

Chien-Hui Ou*, Wen-Horng Yang, Tainan, Taiwan

MP21-23 SIMPLE, EASY AND EFFECTIVE TECHNIQUE FOR RENORRHAPHY DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY: EXTRACORPOREAL SLIDING KNOT SUTURE

Joon Woo Kim*, Yoon Hyoung Lee, Joon Beom Kwon, Daegu, Korea, Republic of, Kang Soo Sim, Andong, Korea, Republic of, Jae Soo Kim, Daegu, Korea, Republic of

MP21-24 RETROPERITONEAL LAPAROSCOPIC LIVING-DONOR NEPHRECTOMY AND RECIPIENT OUTCOME

Jhih Cheng Wang*, Yu-Feng Tian, Steven K. Huan, Ling-Hsien Lee, Tainan City, Taiwan, Allen W. Chiu, Taipei, Taiwan

MP21-25 ROBOTIC ASSISTED PARTIAL NEPHRECTOMY FOR SMALL RENAL TUMOR: ONE SURGEON′S INITIAL EXPERIENCE

Kazunori Namiki*, Yohei Sawada, Hidenori Okubo, Ryo Iseki, Takeshi Hashimoto, Naoya Satake, Yoshihiro Nakagami, Yutaka Horiguchi, Kunihiko Yoshioka, Masaaki Tachibana, Tokyo, Japan

MP21-26 THE EXPERIENCE OF RETROPERITONEAL LAPAROSCOPIC RENAL CAPSULECTOMY FOR PATIENTS WITH IDIOPATHIC RENAL SUBCAPSULAR FLUID COLLECTION

Dapeng Wu*, Guodong Zhu, Wenbin Song, Linlin Zhang, Zhishang Yang, Dalin He, Xi'an, China, People's Republic of

Friday, October 25, 2013   Moderated Poster Session MP22   2:30 pm–4:15 pm

PERCUTANEOUS NEPHROLITHTOMY II

Room Rhythms 2 @ Sheraton New Orleans

Chair: Manoj Monga

Faculty: Michael Wong and Norberto Bernardo

*Presenting author

MP22-01 DOES BODY MASS INDEX IMPACT THE OUTCOMES OF TUBELESS PERCUTANEOUS NEPHROLITHOTOMY?

Nicholas J Kuntz, Andreas Neisius, Durham, NC, Gastón M Astroza, Santiago, Chile, Matvey Tsivian, Richard H Shin*, Muhammad W Iqbal, Ramy Youssef, Michael N Ferrandino, Glenn M Preminger, Michael E Lipkin, Durham, NC

MP22-02 THE EFFECT OF OBESITY ON THE OUTCOMES OF THE PATIENTS UNDERGOING PERCUTANEOUS NEPHROLITHOTOMY

Alper Otunctemur, Emin Ozbek*, Huseyin Besiroðlu, Murat Dursun, Suleyman Sahin, Ismail Koklu, Mustafa Erkoc, Eyyup Danis, Muammer Bozkurt, Galip Dedekarginoglu, Istanbul, Turkey

MP22-03 OUR EXPERIENCES OF PERCUTANEOUS NEPHROLITHOTOMY FOR TEN YEARS

Alper Otunctemur, Emin Ozbek*, Huseyin Besiroðlu, Murat Dursun, Suleyman Sahin, Ismail Koklu, Mustafa Erkoc, Eyyup Danis, Muammer Bozkurt, Galip Dedekarginoglu, Istanbul, Turkey

MP22-04 TUBELESS PERCUTANEOUS NEPHROLITHOTOMY WITHOUT TRACT SEALANT: FEASIBILITY AND OUTCOMES

Gautam Jayram*, Jason Michaud, Brian Matlaga, Baltimore, MD

MP22-05 MICROPERC: MULJIBHAI PATEL UROLOGICAL HOSPITAL EXPERIENCE

Ravindra Sabnis*, Raguram Ganesamoni, Arvind Ganpule, Shashikant Mishra, Jigish Vyas, Jitendra Jagtap, Amit Bhattu, Mahesh Desai, Nadiad, India

MP22-06 PERCUTANEOUS STONE EXTRACTION FOR CALYCEAL DIVERTICULAR STONES: HOW DOES IT COMPARE?

Sammy Elsamra*, Hector Motato, Zhamshid Okhunov, Arvin George, Nikhil Waingankar, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP22-07 PERCUTANEOUS NEPHROLITHOTOMY IN THE EXTREMELY OBESE (BMI>40), IS IT STILL SAFE?

Benjamin Larson*, Shubha De, Fabio Torricelli, Manoj Monga, Mark Noble, Cleveland, OH

MP22-08 COMPLIANCE WITH GUIDELINES FOR ANTIBIOTICS AFTER PERCUTANEOUS NEPHROLITHOTOMY DOES NOT INCREASE INFECTIOUS COMPLICATIONS

Sameer Deshmukh*, Seth Bechis, Brian Eisner, Boston, MA

MP22-09 THE EFFECT OF PRONE-FLEXED POSITIONING (PFP) ON AIRWAY PRESSURES DURING PERCUTANEOUS NEPHROLITHOTOMY (PCNL)

Kirsten Foell*, Michael Ordon, Andrea G. Lantz, Kenneth T. Pace, R. John D'A. Honey, Toronto, Canada

MP22-10 INFECTIOUS OUTCOMES IN NEPHROSTOMY DRAINAGE PRIOR TO PERCUTANEOUS NEPHROLITHOTOMY COMPARED TO CONCURRENT ACCESS

Aaron Benson*, Trisha Juliano, Ryan Pickens, Nicole Miller, Nashville, TN

MP22-11 EFFECT OF ADJUVANT INTRACAVITARY THERAPY ON UPPER TRACT UROTHELIAL CARCINOMA

Amin Herati*, Sammy Elsamra, Hector Motato, Daniel Moreira, Arvin George, Manaf Alom, Arthur Smith, Zeph Okeke, New Hyde Park, NY

MP22-12 COMPARISON OF RETROGRADE INTRARENAL SURGERY VERSUS SINGLE-TRACT PERCUTANEOUS NEPHROLITHOTOMY FOR LOWER POLE STONES WITH A DIAMETER OF 10 TO 20 MM: A PROPENSITY SCORE-MATCHING STUDY

Sung Yong Cho, Jae Hyun Jung*, Min Soo Choo, Seoul, Korea, Republic of, Chang Wook Jeong, Seongnam, Korea, Republic of, Islah Munjih Ab Rashid, Kyung Tae Ko, Seung Bae Lee, Hwancheol Son, Hyeon Jeong, Hyeon Hoe Kim, Seung-june Oh, Seoul, Korea, Republic of

MP22-13 RANDOMIZED CONTROLLED TRIAL COMPARING TOTALLY TUBELESS, TUBELESS AND EARLY TUBE REMOVAL IN MINIPERC

Raguram Ganesamoni*, Ravindra Sabnis, Shashikant Mishra, Arvind Ganpule, Jigish Vyas, Jitendra Jagtap, Amit Bhattu, Mahesh Desai, Nadiad, India

MP22-14 STANDARDIZATION OF SURGICAL OUTCOMES REPORTING IN PERCUTANEOUS NEPHROLITHOTOMY

Dedan Opondo, Amsterdam, Netherlands, Stavros Gravas*, Larissa, Greece, Adrian Joyce, Leeds, United Kingdom, Margaret Pearle, Dallas, TX, Tadashi Matsuda, Osaka, Japan, Ying Hao Sun, Shanghai, China, People's Republic of, Dean Assimos, Birmingham, AL, John Denstedt, London, Canada, Jean de la Rosette, Amsterdam, Netherlands

MP22-15 A COMPARISON OF PERIOPERATIVE ANTIBIOTIC REGIMENS FOR PERCUTANEOUS NEPHROLITHOTOMY

Matthew Ferroni*, Pittsburgh, PA, Julie Riley, Albuquerque, NM, Timothy Averch, Stephen Jackman, Michael Ost, Pittsburgh, PA

MP22-16 SUPINE PERCUTANEOUS NEPHROLITHOTOMY (SPCNL): UPPER POLE ACCESS IS POSSIBLE WITHOUT INCREASED RISK OF COMPLICATIONS

Paras Singh*, Ramin Mandegaran, Gideon Ellis, Anthie Papadopoulou, Neil Davies, Antony Goode, Nick Woodward, Dominic Yu, Darrell Allen, Leye Ajayi, London, United Kingdom

MP22-17 EFFECT OF STONE COMPOSITION ON OPERATIVE AND SPEED OF STONE CLEARANCE DURING PERCUTANEOUS NEPHROLITHOTOMY

Johann Ingimarsson*, Lebanon, NH, Seth Bechis, Brian Eisner, Boston, MA, Vernon Pais Jr., Lebanon, NH

MP22-18 EXTERNAL VALIDATY OF TWO PREDICTOR SCORES FOR RENAL CALCULI STONE FREE RATE AFTER PERCUTANEOUS NEPHROLITHOTOMY IN A TERTIARY REFERRAL CENTER IN MEXICO

Christian Villeda Sandoval*, Carlos Mendez Probst, Mexico City, Mexico

MP22-19 PRONE POSITION OR COMPLETELY SUPINE POSITION IN PERCUTANEOUS NEPHROLITHOTOMY FOR STAGHORN STONES IN PATIENTS WITH SOLITARY KIDNEY

Chunping Li, Yanbo Wang, Fengming Jiang*, Changchun, China, People's Republic of

MP22-20 CLINICAL OUTCOMES OF 76 CASES OF PERCUTANEOUS NEPHROLITHOTOMY OVER A 10-YEAR PERIOD

Go Anan*, Yutaka Chiba, Ikuo Maehara, Sendai, Japan

MP22-21 HIGH-RISK PATIENTS FOR PERCUTANEOUS NEPHROLITHOTOMY: A SINGLE-CENTER EXPERIENCE

Yan Wang*, Yanbo Wang, Yuchuan Hou, Changchun, China, People's Republic of

MP22-22 MINIPERC: MPUH EXPERIENCE

Amit Bhattu*, Nadiad, Gujarat, India, Raguram Ganesamoni, Shashikant Mishra, Nadiad, India, Narendra Parekh, Nadiad, Gujarat, India, Jitendra Jagtap, Arvind Ganpule, Jigish vyas, Ravindra Sabnis, Mahesh Desai, Nadiad, India

MP22-23 OUTCOMES OF PERCUTANEOUS NEPHROLITHOTOMY: COMPARISON OF ELDERLY AND YOUNGER PATIENTS

Bannakij Lojanapiwat*, Thongchai Nakamon, Pruit Kittirattrakarn, Chiangmai, Thailand

MP22-24 A NOVEL 7 F MINI-NEPHROSCOPE THROUGH A 10 F SHEATH FOR A NOVEL TECHNIQUE OF SUPER-MINI-PERCUTANEOUS NEPHROLITHOTOMY (SMP): A PRELIMINARY REPORT

Guohua Zeng*, Zhijian Zhao, Wenqi Wu, Guanghzou, China, People's Republic of

MP22-25 RETROGRADE INTRARENAL SURGERY VERSUS PERCUTANEOUS NEPHROLITHOTOMY FOR THE MANAGEMENT OF LARGER THAN 3 CM STONES IN SOLITARY KIDNEYS: A MATCHED CASE COMPARATIVE STUDY

Guohua Zeng*, Zhijian Zhao, Wenqi Wu, Guanghzou, China, People's Republic of

Friday, October 25, 2013   Moderated Poster Session MP23   2:30 pm–4:15 pm

BPH/LUTS II

Room Rhythms 3 @ Sheraton New Orleans

Chair: Andreas Gross

Faculty: Neville Perera and Richard Vanlangendonck

*Presenting author

MP23-01 THE VERY LARGE PROSTATE: DO ABLATIVE TECHNIQUES HAVE A ROLE? EXPERIENCE WITH PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE USING THE 180 W LITHIUM TRIBORATE LASER

Helen Nicholson*, Henry Woo, Sydney, Australia

MP23-02 THULIUM VAPOENUCLEATION OF THE PROSTATE: FOUR-YEAR OUTCOME

Christopher Netsch, Alexander Engbert, Thorsten Bach, Sophie Knipper*, Andreas Gross, Hamburg, Germany

MP23-03 THULIUM LASER IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA ON ANTICOAGULANT AND ANTIPLATELET DRUGS

Stefano Mattioli*, Alessandro Picinotti, Andreina Burgio, Arezzo, Italy

MP23-04 PHOTOSELECTIVE VAPORIZATION VERSUS TRANSURETHRAL RESECTION FOR BENIGN PROSTATIC HYPERPLASIA: A PROSPECTIVE RANDOMIZED STUDY

Waleed Hasan*, Hussain Al Durazi, Noor Al-Nooh, Zainab Ebrahim, Manama, Bahrain

MP23-05 T1470 LASER FOR ENUCLEATION AND ABALATION OF PROSTATE AS OUTPATIENT SURGERY

Binod Sinha*, Edison, NJ

MP23-06 HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) AND PERIOPERATIVE DIAGNOSIS OF PROSTATE CANCER: PREDICTORS OF HIGH RISK DISEASE

Marcelino Rivera*, Igor Frank, Amy Krambeck, Rochester, MN

MP23-07 THE UNDERSTANDING OF THE ANTEROPOSTERIOR DISSECTION HOLEP CAN HELP TO BE AN INDEPENDENT SURGEON WITH SHORTER LEARNING CURVE

Masaki Shimbo*, Fumiyasu Endo, Kazuhito Matsushita, Yoko Kyono, Kazunori Hattori, Osamu Muraishi, Kosuke Hishiki, Tokyo, Japan

MP23-08 TREATMENT OF HIGH-RISK PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA BY 2-MICRON LASER VAPORESECTION

Fengming Jiang*, Yanbo Wang, Chunping Li, Changchun, China, People's Republic of

MP23-09 HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) IN PATIENTS WITH PRE-EXISTING DIAGNOSIS OF PROSTATE CANCER: AN OUTCOME ANALYSIS

Marcelino Rivera*, Igor Frank, Amy Krambeck, Rochester, MN

MP23-10 PEEZY AT EASE: OUR INITIAL 106 PATIENTS EXPERIENCE ON AN INNOVATIVE DEVICE FOR COLLECTION OF MID-STREAM URINE (MSU) SAMPLES

Wai Man Chow*, Basharat Hussain, Manchester, United Kingdom

MP23-11 CONTINUOUS VERSUS CONVENTIONAL BIPOLAR PLASMA VAPORIZATION OF THE PROSTATE AND STANDARD MONOPOLAR RESECTION – A RANDOMIZED COMPARISON OF A NEW TECHNOLOGICAL ADVANCEMENT

Bogdan Geavlete*, Florin Stanescu, Cristian Moldoveanu, Marian Jecu, Leon Adou, Petrisor Geavlete, Bucharest, Romania

MP23-12 THE SAFETY AND FEASIBILITY OF CONCOMITANT SURGERY DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP)

Amar Patel*, Rafael Nunez, M.D., Chinedu Mmeje, M.D., Mitchell Humphreys, M.D., Phoenix, AZ

MP23-13 TRANSURETHRAL HIGH ENERGY WATER VAPOR THERAPY FOR BPH; INITIAL CLINICAL RESULTS OF THE FIRST-IN-MAN AND REZUM 1 CLINICAL TRIALS USING THE REZUM SYSTEM

Christopher Dixon*, NY, NY, Edwin Rijo-Cedano, La Romana, Dominican Republic, Dalibor Pacik, Vitislav Vit, Gabriele Varga, Brno, Czech Republic, Lance Mynderse, Dennis Hanson, Rochester, MN, Thayne Larson, Scottsdale, AZ

MP23-14 HOLMIUM LASER ENUCLEATION OF THE ABLATED PROSTATE (HOLEAP): AN INNOVATIVE SURGICAL TECHNIQUE FOR BENIGN PROSTATIC HYPERPLASIA

Sanjay Razdan*, Alaa Hamada, Yubiry Morales, Miami, FL

MP23-15 LOW-POWERED HOLEP FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Peter Gilling*, Rana Reuther, Mark Fraundorfer, Tauranga, New Zealand

MP23-16 THE CLINICAL RESEARCH OFFICE OF THE ENDOUROLOGICAL SOCIETY (CROES) GREEN LIGHT LASER GLOBAL STUDY: BASELINE CHARACTERISTICS IN A MULTINATIONAL CONTEMPORARY REGISTRY OF 713 PATIENTS

Jean de la Rosette*, Amsterdam, Netherlands, Seiji Naito, Fukuoka, Japan, Hassan Razvi, London, Canada, Alexander Bachmann, Basel, Switzerland, Gerasimos Alivizatos, Athens, Greece, Gopal Badlani, Winston-Salem, NC, Carson Wong, Middleburg Heights, OH, Alexis Te, New York, NY, Carl-Jørgen Arum, Trondheim, Norway

MP23-17 A PROSPECTIVE-RANDOMIZED COMPARISON OF A 1.9 μM AND 2 μM THULIUM:YTTRIUM-ALUMINIUM-GARNET LASER DEVICE FOR THULIUM VAPOENUCLEATION OF THE PROSTATE: FIRST RESULTS

Andreas Gross*, Christian Tiburtius, Sophie Knipper, Christopher Netsch, Hamburg, Germany

MP23-18 IS THERE A POTENTIAL ROLE FOR HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN PATIENTS WITH PROSTATE CANCER, VERY LARGE PROSTATES, AND OBSTRUCTION?

Jessica E Paonessa*, Naeem Bhojani, James E Lingeman, Indianapolis, IN

MP23-19 COMPLICATIONS FOLLOWING PROSTATE BIOPSY: A RETROSPECTIVE SINGLE-INSTITUTIONAL STUDY

Sung Chul Kam*, Jae Hwi Choi, Seong Uk Jeh, Jeong Seok Hwa, Jae Seog Hyun, Jinju, Korea, Republic of

MP23-20 PREDICTING ACUTE URINARY RETENTION IN PATIENTS WITH ELEVATED POST VOID RESIDUALS

David Cahn, Curtis Ross*, Michelle Persun, Richard Harkaway, Philip Ginsberg, Philadelphia, PA

MP23-21 BIPOLAR PLASMA VAPORIZATION VERSUS STANDARD TUR IN CASES OF SECONDARY BLADDER NECK SCLEROSIS – A PROSPECTIVE, MEDIUM TERM, RANDOMIZED COMPARISON

Bogdan Geavlete, Cristian Moldoveanu, Florin Stanescu, Marian Jecu, Leon Adou, Petrisor Geavlete*, Bucharest, Romania

MP23-22 DIABETES AND BENIGN PROSTATE HYPERPLASIA: CLINICAL, BIOCHEMICAL AND RADIOLOGICAL EVALUATION

Alper Otunctemur, Emin Ozbek*, Huseyin Besiroðlu, Istanbul, Turkey, Emre Can Polat, Sanliurfa, Turkey, murat dursun, Mustafa Erkoc, Recep Bayraktarli, Mine Adas, Istanbul, Turkey

MP23-23 THE EVALUATION OF THE EFFECTS OF OBTURATOR NERVE BLOCKAGE IN ENDOSCOPIC RESECTION OF BLADDER TUMOR OPERATION IN PATIENTS WITH BLADDER SIDE WALL TUMOURS >3 CM

Mehmet Bilgehan Yüksel*, Manisa, Turkey, Ayhan Karaköse, Sacit Nuri Görgel, Izmir, Turkey, Necip Pirinççi, Van, Turkey, Yusuf Ziya Ateþçi, Izmir, Turkey, Bilal Gümüþ, Manisa, Turkey

MP23-24 NO EFFECT OF HOLMIUM LASER ENUCLEATION OF PROSTATE (HOLEP) ON SEXUAL FUNCTION IN BENIGN PROSTATIC HYPERPLASIA PATIENTS: A PROSPECTIVE SHORT-TERM STUDY USING MALE SEXUAL HEALTH QUESTIONNAIRE

Sung Han KIM*, Kyanggi, Korea, Republic of, Hahn-Ey LEE, Jae-Seung Paick, Seung-June OH, Seoul, Korea, Republic of

MP23-25 VISCERAL FAT AS A MARKER IN KIDNEY AND TUMOR PHYSIOLOGY

Aryeh Keehn*, Reza Ghavamian, Joseph Divito, Abhishek Srivastava, Joshua Stern, Bronx, NY

MP23-26 TOO FRAIL FOR SURGERY? PROSPECTIVE STUDY OF FRAILTY AS A PREDICTOR OF POST-OPERATIVE COMPLICATIONS IN MINIMALLY INVASIVE SURGERY

Louis Revenig*, Daniel Canter, Viraj Master, John Pattaras, Joshua Preiss, Maxwell Taylor, Kenneth Ogan, Atlanta, GA

Friday, October 25, 2013   Moderated Poster Session MP24   2:30 pm–4:15 pm

LESS/NOTES

Room Grand Ballroom D @ Sheraton New Orleans

Chair: Abhay Rane

Faculty: Davis Viprikasit and Faith Atug

*Presenting author

MP24-01 SUPRAPUBIC-ASSISTED LAPAROENDOSCOPIC SINGLE-SITE SURGERY IN UROLOGY WITH REPORT OF 324 CASES

Xiaofeng Zou*, Guoxi Zhang, Gengqing Wu, Yuanhu Yuan, Rihai Xiao, Yijun Xue, Xiaoning Wang, Dazhi Long, Yuting Wu, Min LIu, Folin Liu, Hui Xu, Ganzhou, China, People's Republic of

MP24-02 A COMPARISON AMONG SUPRAPUBIC-ASSISTED LAPAROENDOSCOPIC SINGLE-SITE, UMBILICAL LAPAROENDOSCOPIC SINGLE-SITE AND RETROPERITONEAL LAPAROSCOPIC URETEROLITHOTOMY

Xiaofeng Zou*, Guoxi Zhang, Xiaoning Wang, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Yijun Xue, Dazhi Long, Min Liu, Hui Xu, Gang Xu, Ganzhou, China, People's Republic of

MP24-03 SUPRAPUBIC-ASSISTED LAPAROENDOSCOPIC SINGLE-SITE SURGERY (SA-LESS) HEMINEPHRECTOMY FOR DUPLEX KIDNEYS IN CHILDREN WITH REPORT OF 6 CASES

Xiaofeng Zou*, Guoxi Zhang, Yuting Wu, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaoning Wang, Yijun Xue, Dazhi Long, Hui Xu, Yunfeng Liao, Gang Xu, Ganzhou, China, People's Republic of

MP24-04 DOUBLE-CROSSING TECHNIQUE FACILITATES EXPOSURE AND DISSECTION OF ADRENAL TUMORS AND/OR UPPER KIDNEYS DURING PURE LAPAROENDOSCOPIC SINGLE SITE SURGERY (LESS)

Shih-Chieh Chueh*, Cleveland, OH, Bashir Sankari, Abu Dhabi, United Arab Emirates, Anthony Avallone, Cleveland, OH

MP24-05 COMPARISON OF RETROPERITONEAL LAPAROENDOSCOPIC SINGLE-SITE (R-LESS) AND MULTIPORT RETROPERITONEAL LAPAROSCOPIC RADICAL NEPHRECTOMY

Michael Liss*, La Jolla, CA, Sean Stroup, San Diego, CA, Ryan Kopp, Jason Woo, Hak Lee, Ithaar Derweesh, La Jolla, CA

MP24-06 LESS RADICAL NEPHRECTOMY FOR RENAL CELL CANCER IN HIGH- RISK PATIENTS: RESULTS OF AN INITIAL PROSPECTIVE SINGLE-SURGEON STUDY AND ANALYSIS OF PERIOPERATIVE AND SHORT-TERM OUTCOMES

Francesco Greco*, Halle Saale, Germany, Christopher Springer, Vienna, Austria, Paolo Fornara, Paolo Fornara, Halle Saale, Germany

MP24-07 A STEP-BY-STEP STRATEGY TO INTRODUCE LAPAROENDOSCOPIC SINGLE-SITE (LESS) DONOR NEPHRECTOMY USING GELPOINT® WITHOUT ARTICULATING INSTRUMENTS

Takamitsu Inoue*, Shintaro Narita, Norihiko Tsuchiya, Kazuyuki Numakura, Mitsuru Saito, Shigeru Satoh, Tomonori Habuchi, Akita, Japan

MP24-08 PURE LAPAROENDOSCOPIC SINGLE-SITE RADICAL PROSTATECTOMY: TECHNIQUE AND INITIAL OUTCOMES

Gang Zhu*, Yan qun Zhang, Pengjie Wu, Shengjie Liu, Bin Jin, Ben Wan, Jianye Wang, Beijing, China, People's Republic of

MP24-09 TRANSVAGINAL NATURAL ORIFICE TRANSLUMENAL ENDOSCOPIC SURGERY (NOTES)-ASSISTED VERSUS CONVENTIONAL LAPAROSCOPIC NEPHRECTOMY: A COMPARISON OF PERIOPERATIVE OUTCOMES AND SHORT-TERM MEASURES OF CONVALESCENCE

Xiaofeng Zou*, Guoxi Zhang, Yijun Xue, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaoning Wang, Dazhi Long, Yuting Wu, Min Liu, Jun Yang, Zhong Xin, Ganzhou, China, People's Republic of

MP24-10 SUPRAPUBIC-ASSISTED LAPAROENDOSCOPIC SINGLE-SITE VERSUS CONVENTIONAL LAPAROSCOPIC NEPHRECTOMY

Guoxi Zhang, Xiaofeng Zou*, Xiaoning Wang, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Yijun Xue, Dazhi Long, Yuting Wu, Min Liu, Ruiquan Xu, Yuhua Zou, Ganzhou, China, People's Republic of

MP24-11 PURE TRANSURETHRAL NATURAL ORIFICE TRANSLUMENAL ENDOSCOPIC SURGERY (NOTES) FOR FENESTRATION AND DRAINAGE TREATMENT OF RENAL CYST: REPORT OF THREE CASES

Guoxi Zhang, Hui Xu, Xiaofeng Zou*, Min Liu, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaoning Wang, Yijun Xue, Dazhi Long, Bo Jiang, Ruiquan Xu, Ganzhou, China, People's Republic of

MP24-12 COMPARISON OF POSTOPERATIVE STRESS IN PATIENTS UNDERGOING TRANSVAGINAL NOTES-ASSITED LAPAROSCOPIC AND STANDARD LAPAROSCOPIC NEPHRECTOMY

Li Chen, Guoxi Zhang, Xiaofeng Zou*, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaoning Wang, Yijun Xue, Dazhi Long, Yuting Wu, Hui Xu, Ju Yang, Min Liu, Ganzhou, China, People's Republic of

MP24-13 LAPAROENDOSCOPIC SINGLE-SITE RADICAL NEPHRECTOMY BY SINGLE-CUP OR SINGLE-RING GLOVE TECHNIQUE

Zhang Shudong*, Ma Lulin, Qiu Min, Bi Hai, beijing, China, People's Republic of

MP24-14 SIMULTANEOUS LAPAROENDOSCOPIC SINGLE-SITE SURGERY FOR SURGICAL TREATMENT OF INTRA-ABDOMINAL PATHOLOGIES IN TWO DIFFERENT ORGANS

Kwang Taek Kim*, Incheon, Korea, Republic of, Yong Hyun Park, Seung-Yong Jeong, Seoul, Korea, Republic of, Sang Jin Yoon, Chang Hee Kim, Incheon, Korea, Republic of, Hyeon Hoe Kim, Seoul, Korea, Republic of

MP24-15 LAPAROENDOSCOPIC SINGLE-SITE SURGERY (LESS) FOR TREATMENT OF DIFFERENT UROLOGIC PATHOLOGIES IN PEDIATRICS: SINGLE-CENTER EXPERIENCE

Aly Abdel-Karim*, Ashraf Saad, Moussa Ahmed, Ahmed Abolfotof, Mostafa Elmissery, Haytham Badawy, Salah Elsalmy, Alexandria, Egypt

MP24-16 STEP-WISE ‘EXIT STRATEGIES’ DURING LAPAROENDOSCOPIC SINGLE SITE LIVE DONOR NEPHRECTOMY— EXPERIENCE SHARING

Shih-Chieh Chueh*, Cleveland, OH, Bashir Sankari, Abu Dhabi, United Arab Emirates, J Stephen Jones, Cleveland, OH

MP24-17 SUBJECTIVE SCAR APPEARANCE AND SEXUAL SATISFACTION IN TRANSVAGINAL NOTES ASSISTED LAPAROSCOPIC RADICAL CYSTECTOMY

Giovannalberto Pini*, Nasreldin Mohammed, Francesco Greco, Vincenzo Maria Altieri, Paolo Fornara, Halle, Germany

MP24-18 IS THERE INCONGRUENCE BETWEEN THE GOLD STANDARD APPROACH FOR CT1 RENAL MASSES - NEPHRON SPARING SURGERY - AND DIAGNOSIS RELATED GROUPS (DRG) REIMBURSEMENT? ANALYSIS OF INTRAOPERATIVE COSTS FOR LAPAROENDOSCOPIC SINGLE-SITE (LESS), LAPAROSCOPIC AND OPEN APP

Giovannalberto Pini*, Ascalone Luigi, Francesco Greco, Paolo Fornara, Halle, Germany

MP24-19 PERIOPERATIVE NURSING OF PATIENTS UNDERGOING PURE NATURAL ORIFICE TRANSLUMENAL ENDOSCOPIC SURGERY (NOTES) TRANSVAGINAL NEPHRECTOMY

Lanying Liu, Meiying Meng, Lili Li, Xiaoying Zeng, Fangzhen Xiao, Yulan Huang, Guoxi Zhang, Xiaofeng Zou*, Ganzhou, China, People's Republic of

MP24-20 CLINICAL EXPERIENCE OF LAPAROENDOSCOPIC SINGLE-SITE BIOPSY FOR DIAGNOSIS OF RETROPERITONEAL TUMOR OF UNKNOWN ORIGIN

Tetsuo Nozaki*, Akihiro Morii, Kenji Yasuda, Hideki Fuse, Toyama, Japan

MP24-21 PRELIMINARY EXPERIENCE WITH TRANSPERITONEAL LAPAROENDOSCOPIC SINGLE-SITE RADICAL NEPHRECTOMY USING A HOME-MADE SINGLE-PORT DEVICE IN CHINA

Bi Hai*, Ma Lu-lin, Hou Xiao-fei, Beijing, China, People's Republic of

MP24-22 PURE LAPAROENDOSCOPIC SINGLE-SITE RETROPERITONEOSCOPIC ADRENALECTOMY: TECHNIQUE AND EARLY OUTCOMES

Gang Zhu*, Shengjie Liu, Ya Qun Zhang, Pengjie Wu, Jianlong Wang, Hong Ma, Ben Wan, Jianye Wang, Beijing, China, People's Republic of

MP24-23 OPTIMAL INSTRUMENT LENGTH FOR TRANSUMBILICAL LAPARO-ENDOSCOPIC SINGLE SITE (LESS) SURGERY

Justin Houman*, Scott Tobis, Changyong Feng, Vikram Dogra, Guan Wu, Rochester, NY

MP24-24 LAPAROENDOSCOPIC SIMULTANEOUS DRAINAGE OF INTRAABDOMINAL ABSCESS AND PERITONEAL DIALYSIS CATHETER INSERTION

Thomas Y. Hsueh*, Yi-Shen Lin, Allen W. Chiu, Taipei, Taiwan

MP24-25 LONGTERM RESULTS AFTER TWELVE YEARS OF RETROPERITONEOSCOPIC PYELOPLASTY FOR THE TREATMENT OF URETEROPELVIC JUNCTION OBSTRUCTION

Svetozar Subotic, Armin Halla*, Antje Feicke, Georg Müller, Basel, Switzerland, Thomas Gasser, Liestal, Switzerland, Stephen Wyler, Alexander Bachmann, Basel, Switzerland

Friday, October 25, 2013   Moderated Poster Session MP25   2:30 pm–4:15 pm

PEDIATRICS

Room Grand Chenier @ Sheraton New Orleans

Chair: Michael Ost

Faculty: Brian VanderBrink and Lars Cisek

*Presenting author

MP25-01 UTILIZATION AND OUTCOMES OF PEDIATRIC PYELOPLASTY

Stacey Carter*, Lorna Kwon, Jim Hu, Los Angeles, CA

MP25-02 MINI PCNL IN PAEDIATRIC UROLITHIASIS

Jitendra Amlani*, Deepak Rajyaguru, Aswin Gami, Rajkot, India

MP25-03 NATURAL HISTORY OF HYDRONEPHROSIS AFTER ROBOTIC EXTRAVESICAL URETERAL REIMPLANTATION IN CHILDREN

Dennis Lee, Leo Dalag, Mukil Patil, Roger De Filippo, Andy Chang, Los Angeles, CA, Chester Koh*, Houston, TX

MP25-04 A LEVEL ONE TRAUMA CENTER REVIEW OF PEDIATRIC RENAL TRAUMA

Katherine Rotker*, Liza Aguiar, Kennon Miller, Pamela Ellsworth, Jeremy Aidlen, Anthony Caldamone, Providence, RI

MP25-05 EXPERIENCE WITH ENDOSCOPIC INJECTION OF NONANIMAL DEXTRANOMER/HYALURONIC ACID WITH SMALLER DIAMETER MICROSPHERES (80–120 MICRON)IN THE TREATMENT OF PRIMARY VUR AND A MULTIVARIATE ANALYSIS OF FACTORS FOR FAILURE

Yigit Akin*, Erzincan, Turkey, Erol Guntekin, Mehmet Baykara, Selcuk Yucel, Antalya, Turkey

MP25-06 OUR EXPERIENCE IN HOLMIUM LASER CYSTOLITHOTRIPSY IN CHILDREN

Waseem Aboul Ela*, Hani Morsi, Ahmed Shoman, Mohamed El Shiemy, Ahmed Shokry, Mohamed Eissa, Cairo, Egypt

MP25-07 HIDES TECHNIQUE TROCAR PLACEMENT FOR PEDIATRIC ROBOTIC PYELOPLASTY: COMPARISON TO CONVENTIONAL TROCAR PLACEMENT

Danesh Bansal, Nicholas G. Cost, Christopher M. Bean, W. Robert DeFoor, Jr., Pramod P. Reddy, Eugene A. Minevich, Brian A. VanderBrink, Paul H. Noh*, Cincinnati, OH

MP25-08 TREATMENT OF RENAL STONES WITH FLEXIBLE URETEROSCOPY IN PRE-SCHOOL AGE CHILDREN

Bülent Erkurt, Turhan Caskurlu, Gokhan Atis*, Cenk Gurbuz, Sabri Pelit, Ozgur Arikan, Bulent Altay, Istanbul, Turkey

MP25-09 CAVITATION-BASED FOCUSED ULTRASOUND FOR NONINVASIVE PUNCTURE OF URETEROCELES: IN VITRO RESULTS

Adam Maxwell*, Ryan Hsi, Michael Bailey, Seattle, WA, Pasquale Casale, New York, NY, Thomas Lendvay, Seattle, WA

MP25-10 SMALL INCOMPLETE POSTERIOR URETHRAL VALVES

Amlesh Seth*, Rajan Gupta, Ashish Saini, Prabhjot Singh, PN Dogra, New Delhi, India

MP25-11 TRANSURETHRAL NEOURETERAL ORIFICE CREATION: A NEW TECHNIQUE FOR MANAGEMENT OF UPPER POLE HYDROURETERONEPHROSIS IN INFANTS: INITIAL EXPERIENCE

Hubert Swana*, Orlando, FL, Tariq Hakky, Tampa, FL, Mark Rich, Orlando, FL

MP25-12 MANAGEMENT OF DISLODGED URETERAL STENT THROUGH A NEFROSCOPIC APPROACH IN A INFANT CHILD – TWO CASE REPORT AND REVIEW OF THE LITERATURE

Marino Cabrera*, Camilo Orjuela, Yair Cadena, Adolfo Serrano, Bogota, Colombia

MP25-13 LAPAROSCOPIC MODIFIED BYPASS PYELOPLASTY: INITIAL EXPERIENCES

Nobuhiro Haga*, Yuichi Sato, Tomoyuki Koguchi, Junya Hata, Tomomichi Yabe, Hidenori Akaihata, Norio Takahashi, Tomohiko Yanagida, Yoshiyuki Kojima, Fukushima, Japan

MP25-14 INFANT ROBOTIC PYELOPLASTY: INITIAL EXPERIENCE AND COMPARISON WITH AN OPEN COHORT

Danesh Bansal, Nicholas G. Cost, Christopher M. Bean, Edward Riachy, Brian A. VanderBrink, Shumyle Alam, W. Robert DeFoor, Jr., Pramod P. Reddy, Eugene A. Minevich, Curtis A. Sheldon, Paul H. Noh*, Cincinnati, OH

MP25-15 INFANT ROBOTIC ASSISTED LAPAROSCOPIC PYELOPLASTY: COMPARISON WITH NON-INFANT COHORT

Danesh Bansal, Nicholas G. Cost, Christopher M. Bean, Brian A. VanderBrink, W. Robert DeFoor, Jr., Pramod P. Reddy, Shumyle Alam, Eugene A. Minevich, Paul H. Noh*, Cincinnati, OH

MP25-16 LEARNING CURVES FOR PEDIATRIC ROBOTIC ASSISTED LAPAROSCOPIC PYELOPLASTY: A SINGLE PEDIATRIC INSTITUTION EXPERIENCE

Danesh Bansal, Nicholas G. Cost, Christopher M. Bean, W. Robert DeFoor, Jr., Pramod P. Reddy, Paul H. Noh*, Cincinnati, OH

MP25-17 EFFECTS OF ACETYLSALICYLIC ACID ON SYMPTOMS RELATED TO THE SYNDROME NUTCRACKER

Sidiya Chavey*, Sousse, Tunisia, Wissem Hmida, Faouzi Mallat, Sana Mosbahi, Mehdi Jaidane, Faouzi Mosbah, Sahloul, Tunisia

MP25-18 COMPARISON OF CHILDREN VERSUS ADULTS UNDERGOING MINI-PERCUTANEOUS NEPHROLITHOTOMY: LARGE-SCALE ANALYSIS OF A SINGLE INSTITUTION

Guohua Zeng*, Zhijian Zhao, Wenqi Wu, Guanghzou, China, People's Republic of

MP25-19 EFFECTIVENESS OF PENILE BLOCK WITH BUPIVACAINE DURING CIRCUMCISION IN CHILDREN: A COMPARATIVE STUDY

Faouzi Mallat*, Wissem Hmida, Nawel Bjaoui, Faouzi Mosbah, Sahloul, Tunisia

MP25-20 HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) BEFORE HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOR THE PROSTATE CANCER TREATMENT: OUR EXPERIENCE

Antonio Salvaggio*, Angelo Cafarelli, Donato Dente, Abano Terme (Padua), Italy, Emanuele Cappa, Chieti, Italy, Angelo Porreca, Abano Terme (Padua), Italy

MP25-21 SIMPLE TECHNIQUE FOR NON-INVASIVE REMOVAL OF URETERAL STENT IN RENAL TRANSPLANT RECIPIENTS; COMPARISON WITH CONVENTIONAL CYSTOSCOPIC REMOVAL

Taek Sang Kim*, Jung Hyun Oh, Hyun Yul Rhew, Busan, Korea, Republic of

MP25-22 SURGEONS’ PREFERENCES AND PRACTICE PATTERNS REGARDING INTRA-OPERATIVE FROZEN SECTION DURING PARTIAL NEPHRECTOMY

Abhinav Sidana*, James F Donovan, Krishnanath Gaitonde, Cincinnati, OH

MP25-23 ALL OUT: THE INGLORIOUS END OF “BUCKYBALLS”

Lawrence Wyner*, Huntington, WV

MP25-24 INNER PREPUTIAL INLAY GRAFT URETHROPLASTY IN HYPOSPADIAS REPAIR: WORTH DOING?

Mamdouh Ahmed*, Abdulnaser Al Said, Kuwait, Kuwait

MP25-25 NEW THERAPEUTIC APPROACH TO TREAT SLOWLY RISING PROSTATIC SPECIFIC ANTIGEN FOLLOWING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY

Alaa Hamada*, Sanjay Razdan, Jolly Varki, Yubiry Morales, Miami, FL

Friday, October 25, 2013   Video Session V13   2:30 pm–4:30 pm

LESS/NOTES

Room Armstrong @ Sheraton New Orleans

Faculty: Matthew J. Maurice and Steven Lucas

*Presenting author

V13-01 TRANSVAGINAL NATURAL ORIFICE TRANSLUMENAL ENDOSCOPIC SURGERY (NOTES)-ASSISTED LAPAROSCOPIC NEPHRECTOMY

Xiaofeng Zou*, Guoxi Zhang, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaoning Wang, Yijun Xue, Dazhi Long, Yuting Wu, Folin Liu, Hui Xu, Ganzhou, China, People's Republic of

V13-02 SUPRAPUBIC-ASSISTED LAPAROENDOSCOPIC SINGLE-SITE SURGERY (SA-LESS) FOR NEPHROURETERECTOMY

Xiaofeng Zou*, Guoxi Zhang, Yunfeng Liao, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaoning Wang, Yijun Xue, Dazhi Long, Min Liu, Hui Xu, Gang Xu, Ganzhou, China, People's Republic of

V13-03 PURE TRANSVAGINAL NATURAL ORIFICE TRANSLUMENAL ENDOSCOPIC SURGERY (NOTES) FOR NEPHRECTOMY:REPORT OF 15 CASES

Xiaofeng Zou*, Guoxi Zhang, Rihai Xiao, Yuanhu Yuan, Yijun Xue, Gengqing Wu, Xiaoning Wang, Dazhi Long, Yuting Wu, Folin Liu, Hui Xu, Min Liu, Ganzhou, China, People's Republic of

V13-04 COST-EFFECTIVE GLOVE-URETERIC CATHETER SINGLE PORT FOR LAPARO-ENDOSCOPIC SINGLE SITE NEPHRECTOMY

Raguram Ganesamoni*, Shashikant Mishra, Arvind Ganpule, Jigish Vyas, Jitendra Jagtap, Amit Bhattu, Ravindra Sabnis, Mahesh Desai, Nadiad, India

V13-05 LESS TRANSVESICAL DIVERTICULECTOMY

Lokesh Sinha, Rajendra Godbole, Dombivli, India, Prashanth Rao, Pradeep Rao*, Mumbai, India

V13-06 BILATERAL SPERMATIC CORD DISSECTION E LIGATION BY LAPAROENDOSCOPIC SINGLE SITE SURGERY: OUR TECHNIQUE “STEP BY STEP”

Salvatore MIcali*, Eugenio Martorana, Alessio Zordani, Marco Rosa, Modena, Italy, Ahmed Ghaith, Tanta, Egypt, Francesco Fidanza, Giampaolo Bianchi, Modena, Italy

V13-07 RETROPERITONEAL LAPAROENDOSCOPIC SINGLE-SITE SURGERY: OUR TECHNIQUE IN RENAL CYST DECORTICATION

Salvatore MIcali*, Eugenio Martorana, Alessio Zordani, Riccardo Galli, Modena, Italy, Ahmed Ghaith, Tanta, Egypt, Maria Chiara Sighinolfi, Giampaolo Bianchi, Modena, Italy

V13-08 LAPAROENDOSCOPIC SINGLE-SITE (LESS) DONOR NEPHRECTOMY USING GELPOINT® WITHOUT ARTICULATING INSTRUMENTS

Takamitsu Inoue*, Shintaro Narita, Mitsuru Saito, Norihiko Tsuchiya, Shigeru Satoh, Tomonori Habuchi, Akita, Japan

V13-09 A NEW INTERNAL RETRACTOR SYSTEM USEFUL FOR LAPARO-ENDOSCOPIC SINGLE-SITE LIVING DONOR NEPHRECTOMY

Kazunori Iwasaki*, Toshitaka Shin, Mutsushi Yamasaki, Yasuhiro Sumino, Takeo Nomura, Fuminori Sato, Hiromitsu Mimata, Oita, Japan

V13-10 INNOVATIVE ARTICULATING INSTRUMENTS FOR LAPAROENDOSCOPIC SINGLE-SITE SURGERY: PRECLINICAL EVALUATION OF THE PROTOTYPE

Chang Wook Jeong*, Seoul, Korea, Republic of, Jin-Woo Jung, Byung Ki Lee, Sangchul Lee, Seongnam, Korea, Republic of, Seung Bae Lee, Seoul, Korea, Republic of, Sang Eun Lee, Seongnam, Korea, Republic of

V13-11 PERCUTANEOUS ACCESS UNDER DIRECT ENDOSCOPIC VISUALIZATION: A MODIFIED APPROACH FOR PERCUTANEOUS NEPHROLITHOTOMY

Shubha De, Robert Brown*, Giovanni Marchini, Carl Sarkissian, Manoj Monga, Cleveland, OH

V13-12 ROBOTIC INGUINAL LYMPHADENECTOMY FOR PENILE CANCER

René Sotelo*, Oswaldo Carmona, Robert De Andrade, Golena Fernández, Marino Cabrera, Oscar Martin, Juan Arriaga, Caracas, Venezuela, David Canes, Burlington, MA

Friday, October 25, 2013   Video Session V14   2:30 pm–4:30 pm

LAPAROSCOPY: UPPER TRACT II

Room Grand Ballroom E @ Sheraton New Orleans

Chair: Alejandro Rodriguez

Faculty: Ashley Bowen and Alex Lin

*Presenting author

V14-01 LAPAROSCOPIC PARTIAL NEPHRECTOMY WITH “KIDNEY INVERSION”

Roberto Sanseverino*, Oliver Intilla, Umberto Di Mauro, Giovanni Molisso, Carmine Cicalese, Giorgio Napodano, Nocera Inferiore, Italy

V14-02 ZERO ISCHEMIA LAPAROSCOPIC PARTIAL NEPHRECTOMY

Roberto Sanseverino*, Oliver Intilla, Umberto Di Mauro, Giovanni Molisso, Carmine Cicalese, Giuseppe Lubrano, Giorgio Napodano, Nocera Inferiore, Italy

V14-03 ALTERNATIVE TECHNIQUES TO PERFORM SUPERSELECTIVE MICRODISSECTION DURING UNCLAMPED LAPAROSCOPIC PARTIAL NEPHRECTOMY

Giuseppe Simone*, Rocco Papalia, Mariaconsiglia Ferriero, Salvatore Guaglianone, Michele Gallucci, Rome, Italy

V14-05 LAPAROSCOPIC URETEROVESICOSTOMY IS A SAFE AND EFFECTIVE PROCEDURE USING INTRAVESICAL OR EXTRAVESICAL APPROACH IN PATIENTS WITH MEGAURETER DUE TO URETEROVESICAL JUNCTION OBSTRUCTION

Dai Kouguchi*, Morihiro Nishi, Kazumasa Matsumoto, Takahiro Hirayama, Teppei Oyama, Tetsuo Fujita, Kazunari Yoshida, Masatsugu Iwamura, Sagamihara, Japan

V14-06 J-TUBE TECHNIQUE FOR DOUBLE-J STENT INSERTION DURING LAPAROSCOPIC UPPER URINARY TRACT SURGERY

Byung Ki Lee*, Seongnam, Korea, Republic of, Chang Wook Jeong, Seoul, Korea, Republic of, Jin-Woo Jung, Jung Keun Lee, Yong Hyun Park, Seok-Soo Byun, Sang Eun Lee, Seongnam, Korea, Republic of

V14-07 RETROPERITONEAL ADRENALECTOMY USING LIGASURE

Redouane Rabii*, Mohamed El Mrini, Youssef Elkattani, Rachid Aboutaieb, Fathi Meziane, Casablanca, Morocco

V14-08 LAPAROSCOPIC PYELOPLASTY WITH INTRACORPOREAL FLEXIBLE URETEROSCOPY FOR MANAGEMENT OF PELVIURETERIC JUNCTION OBSTRUCTION AND MULTIPLE CALICEAL CALCULI: PRELIMINARY EXPREIENCE

Krishanu Das*, Muscat, Oman

V14-09 SINGLE SESSION LAPAROSCOPIC PARTIAL NEPHRECTOMY AND CONTRALATERAL TOTAL NEPHRECTOMY: A FEASIBLE PROCEDURE THROUGH THE SAME PORTS

Isaac Braga*, João Cabral, Nuno Louro, Avelino Fraga, José Soares, Luís Osório, Porto, Portugal

V14-10 LAPAROSCOPIC PARTIAL NEPHRECTOMY: INITIAL EXPERIENCE AND TECHNIQUE ILLUSTRATION

Diogo Gil Sousa*, Filipe Coutinho, Avelino Fraga, José Soares, Luís Osório, Porto, Portugal

Friday, October 25, 2013   Video Session V15   2:30 pm–4:30 pm

ROBOTICS: UPPER TRACT II

Room Nottoway @ Sheraton New Orleans

Chair: Richard E. Link

Faculty: Andres Hernandez Porras and Shuo Wang

*Presenting author

V15-01 OFF-CLAMP RIGHT ROBOTIC PARTIAL NEPHRECTOMY USING INTUITIVE ENDOWRIST® ONE™ VESSEL SEALER

Derek Prabharasuth, Valhalla, NY, Farshid Hajimirzaee*, Gregory Lovallo, Mutahar Ahmed, Hackensack, NJ

V15-02 ROBOTIC-ASSISTED LAPAROSCOPIC DISTAL URETERAL REIMPLANTATION TECHNIQUES

Tracy Marien*, New York, NY, Darko Kropfl, Michael Musch, Lukas Hohenhorst, Essen, Germany, Matthew Bilbily, Suzannah Sorin, New York, NY, Gaurav Rao, Buffalo, NY, Ojas Shah, Michael Stifelman, New York, NY

V15-03 A NOVEL USE OF RUMMEL TOURNIQUET FOR RENAL ARTERY OCCLUSION DURING ROBOTIC PARTIAL NEPHRECTOMY

Gordon Fifer*, Matthew Raynor, Eric Wallen, Michael Woods, Matthew Nielsen, Chapel Hill, NC

V15-04 ROBOTIC MICROSURGICAL MANAGEMENT OF LARGE RENAL ARTERY ANEURYSM

Kush Patel*, Mathew Oommen, Janet Colli, Philip Dorsey, Arthur Caire, Christopher Keel, Albert Sam, Anil Paramesh, Raju Thomas, New Orleans, LA

V15-05 ROBOTIC-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY: RESECTION OF MULTIPLE RENAL MASSES AND DEMONSTRATION OF THE SEQUENTIAL PRE-PLACED SUTURETECHNIQUE

Dinesh Samarasekera*, Emad Rizkala, Riccardo Autorino, Jihad Kaouk, Cleveland, OH

V15-06 ROBOTIC-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR A COMPLEX CYSTIC TUMOR: TIPS, TRICKS, AND TROUBLESHOOTING

Dinesh Samarasekera*, Riccardo Autorino, Ali Khalifeh, Jihad Kaouk, Cleveland, OH

V15-07 ROBOTIC-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR A COMPLETELY ENDOPHYTIC HILAR RENAL MASS

Dinesh Samarasekera*, Humberto Laydner, Ali Khalifeh, Luis Felipe Brandao, Riccardo Autorino, Jihad Kaouk, Cleveland, OH

V15-08 OFF-CLAMP ROBOTIC-ASSISTED LAPAROSCOPIC RETROPERITONEAL PARTIAL NEPHRECTOMY

Michael Johnson*, Jonathan Mobley, R. Sherburne Figenshau, Saint Louis, MO

V15-09 ROBOTIC-ASSISTED LAPAROSCOPIC CALICEAL DIVERTICULECTOMY

Richard Link*, Dominic Lee, Houston, TX

V15-10 ROBOT-ASSISTED ADRENAL METASTASECTOMY IN LARGER-SIZED TUMORS, REPORT OF TWO CASES

René Sotelo*, Oswaldo Carmona, Robert De Andrade, Marino Cabrera, Golena Fernández, Eric Saenz, Caracas, Venezuela, David Canes, Burlington, MA

V15-11 FEMALE ORGAN-SPARING ROBOTIC CYSTECTOMY: A STEP-BY-STEP ANATOMIC APPROACH

Alvin Goh*, Houston, TX, Andre Abreu, Los Angeles, CA, Miguel Mercado, Houston, TX, Rene Sotelo, Golena Fernandez, Caracas, Venezuela, Monish Aron, Inderbir Gill, Mihir Desai, Los Angeles, CA

V15-12 ROBOT-ASSISTED INTRACORPOREAL ILEAL NEOBLADDER: SIMPLIFIED STEP-BY-STEP TECHNIQUE AND SURGICAL OUTCOMES

Idir Ouzaid*, Riccardo Autorino, Emad Rizkala, Dinesh Samarasekera, Vishnuvardhan Ganesan, Robert Stein, Jihad Kaouk, Georges-Pascal Haber, Cleveland, OH

Friday, October 25, 2013   Moderated Poster Session MP26   4:30 pm–6:15 pm

ROBOTICS/LAPAROSCOPY: UPPER TRACT V

Room Rhythms 1 @ Sheraton New Orleans

Chair: Pilar Laguna

Faculty: Peter Remington and Tomonori Habuchi

*Presenting author

MP26-01 TRANSPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY FOR POSTERIOR RENAL MASSES

Mark Ball*, Michael Gorin, Phillip Pierorazio, Gautam Jayram, Mohamad Allaf, Baltimore, MD

MP26-02 LONG-TERM FOLLOW-UP RESULTS OF LAPAROSCOPIC PYELOPLASTY

Ill Young Seo*, Tae Hoon Oh, Jea Whan Lee, Iksan/Jeonbuk, Korea, Republic of

MP26-03 ROBOTIC PARTIAL NEPHRECTOMY: WHERE DO WE STAND IN TERMS OF ONCOLOGIC OUTCOMES?

Brandy Hood*, Spencer Krane, Theodore Manny, Ashok Hemal, Winston-Salem, NC

MP26-04 LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HILAR TUMORS: ONCOLOGIC AND RENAL FUNCTIONAL OUTCOMES

Arvin George*, Amin Herati, Soroush Rais-Bahrami, Nikhil Waingankar, Zhamshid Okhunov, Louis Kavoussi, Lee Richstone, New Hyde Park, NY

MP26-05 OFF-CLAMP LAPAROSCOPIC PARTIAL NEPHRECTOMY: LONG TERM RENAL FUNCTIONAL OUTCOMES

Arvin George*, Paras Shah, Soroush Rais-Bahrami, Zhamshid Okhunov, Sammy El-Samra, Louis Kavoussi, New Hyde Park, NY

MP26-06 ROBOTIC VS. PURE LAPAROSCOPIC PARTIAL NEPHRECTOMY: COMPARISON OF OUTCOMES AND EVALUATION OF LEARNING CURVE

Steve K Williams*, Jared Winoker, Abhishek Srivastava, Reza Ghavamian, Bronx, NY

MP26-07 FACTORS PREDICTIVE OF SYMPTOMATIC PRESENTATION IN RENAL CELL CARCINOMA

Joseph Song*, Youssef Tanagho, Saint Louis, MO, Sam Bhayani, St Louis, MO, Robert Figenshau, Saint Louis, MO

MP26-08 MULTI-CENTER, LONGITUDINAL OUTCOMES OF ROBOTIC PARTIAL NEPHRECTOMY FOR MODERATE TO HIGHLY COMPLEX RENAL MASSES: COMPARATIVE OUTCOMES BASED ON R.E.N.A.L NEHPROMETRY SCORE

James Bienvenu*, Brent Hardin, Eric Heidel, Frederick Klein, Knoxville, TN, David Thiel, Jacksonville, FL, Wesley White, Knoxville, TN

MP26-09 POSTERIOR ABDOMINAL AND LATERAL ABDOMINAL WALL FAT IS CORRELATED WITH OPERATIVE IN ROBOTIC ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMIES

Andrew Leone*, William Loverme, Providence, RI, Sammy Elsamra, New Hyde Park, NY, Michael Maddox, Shadi Al-Ekish, Damian Dupuy, Gyan Pareek, Dragan Golijanin, Providence, RI

MP26-10 COMPARISON OF PERIOPERATIVE OUTCOMES OF RETROPERITONEAL AND TRANSPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY

Greg Gin*, Alexandra Maschino, Massimiliano Spaliviero, Melanie Bernstein, Jonathan Coleman, New York, NY

MP26-11 LAPAROSCOPIC NEPHRECTOMY: SAFETY AND EFFICACY IN PATIENTS ON ANTICOAGULANT THERAPY

Takaharu Ichikawa*, Kurashiki, Japan, Yasuhiro Nishiyama, Susumu Yamane, Shunji Hayata, Tottori, Japan, Tomoko Sako, Youichi Shiotsuka, Yasuo Yamamoto, Noritaka Ishito, Hitoshi Takamoto, Kurashiki, Japan

MP26-12 UTILIZATION OF THE ROBOTIC SURGICAL PLATFORM FOR RADICAL NEPHRECTOMY: A NATIONAL COMPARISON OF TRENDS FOR OPEN, LAPAROSCOPIC, AND ROBOTIC APPROACHES

Aaron Weinberg*, Christopher Deibert, Bronx, NY, Tim Wen, Mitchell Benson, Ketan Badani, New York, NY

MP26-13 MID-TERM OUTCOMES OF LAPAROSCOPIC RADICAL NEPHRECTOMY IN PATIENTS WITH LOCALIZED RENAL TUMOR

Luca Lunelli*, Eric Barret, Rafael Sanchez-Salas, Youness Ahallal, Laurent Mascle, Petr Macek, Camilo Giedelman, Dominique Prapotnich, Francois Rozet, Marc Galiano, Annick Mombet, Nathalie Cathala, Xavier Cathelineau, Paris, France

MP26-14 MULTI-INSTITUTIONAL ANALYSIS OF RENAL FUNCTION FOLLOWING CRYOABLATION OF SMALL RENAL MASSES IN SOLITARY KIDNEYS

Fahd Khan*, Wasim Mahmalji, Sanjeev Madaan, Ian K. Dickinson, Kent, United Kingdom, Frank X. Keeley, Bristol, United Kingdom, Brunolf Lagerveld, Amsterdam, Netherlands, Seshadri Sriprasad, Kent, United Kingdom

MP26-15 LAPAROSCOPIC NEPHRECTOMY FOR XANTHOGRANULOMATOUS PYELONEPHRITIS

Oscar Fugita*, Sao Paulo, Brazil, Paulo Kawano, Hamilto Yamamoto, Joao Amaro, Rodrigo Guerra, Botucatu, Brazil, Marcos Nogueira, Sao Paulo, Brazil, Horacio Consolmagno, São Paulo, Brazil, Americo Sakai, Sao Paulo, Brazil

MP26-16 ASSESSING THE USEFULNESS OF DIAMETER-AXIAL-POLAR NEPHROMETRY SCORE FOR PREDICTION OF OPERATIVE PARAMETERS IN ROBOTIC PARTIAL NEPHRECTOMY

Young Eun Yoon, Kwang Suk Lee*, Kyung Hwa Choi, Sang Woon Kim, Ji Yong Ha, Won Sik Ham, Koon Ho Rha, Young Deuk Choi, Woong Kyu Han, Seoul, Korea, Republic of

MP26-17 RETROPERITONEAL LAPAROSCOPIC APPROACH IN UROLGY DEPARTEMENT OF IBN ROCHD HOSPITAL UNIVERSITY: A REPORT OF 133 CASES

Redouane Rabii*, Mohamed El Mrini, Youssef Elkattani, Rachid Aboutaieb, Fathi Meziane, casablanca, Morocco

MP26-18 LAPAROENDOSCOPIC SINGLE SITE PYELOPLASTY AND NEPHROLITHOTOMY PERFORMED SIMULTANEOUSLY

Yasuyuki Naitoh*, Akihiro Kawauchi, Fumiya Hongo, Jintetsu Soh, Kazumi Kamoi, Tsuneharu Miki, Kyoto, Japan

MP26-19 INDUCTION OF COLD ISCHEMIA IN PATIENTS WITH SOLITARY KIDNEY USING RETROGRADE INTRARENAL COOLING: UPDATE AND 3-YEAR FUNCTIONAL OUTCOMES

Philip Dorsey*, New Orleans, LA, Janet Colli, Memphis, TN, Benjamin R Lee, New Orleans, LA

MP26-20 LAPAROSCOPIC DISMEMBERED PYELOPLASTY

Boris Komyakov, Bakhman Guliev*, Ruslan Aliev, Saint-Petersburg, Russian Federation

MP26-21 RETROPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY: 10 YEAR SURGICAL EXPERIENCE AND OUTCOMES

Derek Prabharasuth*, Eric Moskowitz, Andrew Fishman, Michael Grasso, Valhalla, NY

MP26-22 LAPAROSCOPIC NEPHROURETEREKTOMY IN A PATIENT WITH UNUSUAL STONE LOCALISATION

Bilal Firat Alp, Ankara, Turkey, Zafer Demirer, Eskisehir, Turkey, Seref Basal*, Ali Guragac, Ankara, Turkey, Ercan Malkoc, Corlu, Turkey, Hasan Cem Irkilata, Ibrahim Yidirim, Ankara, Turkey

MP26-23 INITIAL OPERATIVE EXPERIENCE WITH ROBOTIC URETERAL RECONSTRUCTION DISTAL TO THE URETEROPELVIC JUNCTION

Gordon Fifer*, Matthew Raynor, Michael Woods, Eric Wallen, Raj Pruthi, Chapel Hill, NC

MP26-24 ROBOTIC PARTIAL NEPHRECTOMY: THE IMPACT OF WARM ISCHEMIA

Mohamad Salkini*, AbdulRaouf Lamoshi, Morgantown, WV

MP26-25 A SINGLE SURGEON, SINGLE CENTRE, 5 YEARS EXPERIENCE IN RETROPERITONEOSCOPY- AN INDIAN SCENARIO

Venugopal Ganapathy, Haris C H*, Thiruvananthapuram, India, Sudin S R, Kollam, India, Navin C Angus, Ginson V George, Sandeep Krishnan, Thiruvananthapuram, India, Suchindra P Unni, Kochi, India, Jibu K Pillai, Thiruvananthapuram, India, Jithunath M R, Thrissur, India

Friday, October 25, 2013   Moderated Poster Session MP27   4:30 pm–6:15 pm

ROBOTICS/LAPAROSCOPY: UPPER TRACT VI

Room Rhythms 2 @ Sheraton New Orleans

Faculty: Rene Sotelo and Hiromitsu Mimata

*Presenting author

MP27-01 LAPAROSCOPIC RADICAL NEPHRECTOMY FOR CLINICAL T1B AND T2A RENAL MASSES. DOES THE APPROACH MAKE A DIFFERENCE? COMPARISON OF LAPARO-ENDOSCOPIC SINGLE-SITE AND MULTIPORT LAPAROSCOPIC SURGERY

Omer Raheem, Michael Liss, La Jolla, CA, Reza Mehrazin, Memphis, TN, Jason Woo, Sean Stroup, Ithaar Derweesh*, La Jolla, CA

MP27-02 THE PRESENCE OF GLOMERULOSCLEROSIS IS NOT ASSOCIATED WITH WORSENED DECLINE IN RENAL FUNCTION FOLLOWING ROBOTIC ASSISTED PARTIAL NEPHRECTOMY

Michael Johnson*, Jonathan Mobley, Joel Vetter, R. Sherburne Figenshau, Sam Bhayani, Saint Louis, MO

MP27-03 HAND-ASSISTED LAPAROSCOPIC LIVING DONOR NEPHRECTOMY (HALDN): A 10-YEAR SINGLE-CENTER EXPERIENCE IN ORIENTAL POPULATION

Yoshihide Higuchi*, Akihiro Kanematsu, Kimihiro Shimatani, Takeshi Hanasaki, Toeki Yo, Yukako Nakanishi, Yoshikazu Togo, Shuken Go, Toru Suzuki, Michio Nojima, Shingo Yamamoto, Nishinomiya, Japan

MP27-04 R.E.N.A.L. NEPHROMETRY SCORE DOES NOT PREDICT SURGICAL COMPLEXITY

Nikhil Waingankar*, Arvin George, Mostafa Sadek, Louis Kavoussi, New Hyde Park, NY

MP27-05 THE INCREASED POSTOPERATIVE RENAL FUNCTION LOSS AFTER LAPAROSCOPIC PARTIAL NEPHRECTOMY WITH GREATER WARM ISCHEMIA TENDS TO BE RECOVERED IN MID TERM FOLLOW-UP

Selcuk Erdem*, Abubekir Boyuk, Tzevat Tefik, Feyyaz Ural, Halim Issever, Ismet Nane, Oner Sanli, Istanbul, Turkey

MP27-06 PORT-SITE METASTASIS AFTER SURGERY FOR RENAL CELL CARCINOMA: A HARBINGER OF FUTURE METASTASIS

Joseph Song*, Eric Kim, Jonathan Mobley, Goutham Vemana, Youssef Tanagho, Joel Vetter, Sam Bhayani, Robert Figenshau, St Louis, MO

MP27-07 ROBOT-ASSISTED URETERECTOMY AND URETERAL REIMPLANT FOR MANAGEMENT OF DISTAL URETERAL MALIGNANCIES: SINGLE INSTITUTION EXPERIENCE WITH LONG FOLLOW-UP

Alonso Carrasco*, Matthew Gettman, George Chow, Matthew Tollefson, Rochester, MN

MP27-08 COMPARATIVE ANALYSIS OF VASCULAR BULLDOG CLAMPS USED IN ROBOTIC PARTIAL NEPHRECTOMY

Brian Le, Richard Matulewicz, Samuel Eaton*, Kent Perry, Robert Nadler, Chicago, IL

MP27-09 STATIN THERAPY MAY BE ASSOCIATED WITH INCREASED RISK OF LONG TERM RENAL DYSFUNCTION FOLLOWING HILAR CLAMPING IN ROBOTIC PARTIAL NEPHRECTOMY

Louis Krane*, Victor Romero, Ashok Hemal, Winston-Salem, NC

MP27-10 ROBOT-ASSISTED CYSTECTOMY WITH SIMULTANEOUS NEPHROURETERECTOMY: CASE SERIES FROM A SINGLE INSTITUTION

Helen Levey*, Justin Houman, Anees Fazili, Hani Rashid, Guan Wu, Rochester, NY

MP27-11 OUTCOMES IN PARTIAL NEPHRECTOMY AT UNIVERSITY HOSPITAL COVENTRY AND WARWICKSHIRE, UK

Claire Webster*, Coventry, United Kingdom, Salil Umranikar, Solihull, United Kingdom, Husam Ibrahim, Anthony Blacker, Michael Wills, Coventry, United Kingdom

MP27-12 RETROPERITONEAL LAPAROSCOPIC LIVING DONOR NEPHRECTOMY: REPORT OF 151 CASES

Hongxian Zhang*, Xian Zhang, Lei Zhao, Lulin Ma, Beijing, China, People's Republic of

MP27-13 PRONE VERSUS SUPINE LASIX RENAL SCAN TO ASSESS SURGICAL SUCCESS FOLLOWING LAPAROSCOPIC AND ROBOTIC ASSISTED PYELOPLASTY

Andrea G. Lantz*, Michael Ordon, Kenneth T. Pace, R. John Honey, Toronto, Canada

MP27-14 PURE RETROPERITONEAL LAPAROSCOPIC COMPLETE NEPHROURETERECTOMY AND BLADDER CUFF RESECTION FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA

Fang Zhenqiang*, Ye Gang, He Fan, Shen Chongxing, Wang Xiangwei, Yi Shanhong, Jia Weisheng, Chongqing, China, People's Republic of

MP27-15 COMPARATIVE ASSESSMENT OF PERIOPERATIVE OUTCOMES FOR TRANSPERITONEAL LAPAROSCOPIC RADICAL NEPHRECTOMIES PERFORMED ON VERY LARGE TUMOURS (>10 CM). DOES SIZE MATTER ?

Simon Ouellet*, Michel Carmel, Arold Martel, Robert Sabbagh, Sherbrooke, Canada

MP27-16 CAN THE R.E.N.A.L. NEPHROMETRY SCORE BE OPTIMIZED FOR PATIENTS UNDERGOING CRYOABLATION?

Peter Clark*, S. Duke Herrell, Nashville, TN, Jaime Landman, Irvine, CA, Stephen Savage, Charleston, SC, Stephen Strup, Lexington, KY, Chad LaGrange, Omaha, NE, David Schulsinger, Stony Brook, NY

MP27-17 THE EFFECT OF THE SURGICAL ROBOT ON THE HOSPITAL-LEVEL UTILIZATION OF PARTIAL NEPHRECTOMY

Ganesh Sivarajan*, Glen Taksler, Dawn Walter, Marc Bjurlin, New York, NY, Cary Gross, New Haven, CT, R Ernest Sosa, Danil Makarov, New York, NY

MP27-18 ROBOTIC ASSISTED RETROPERTONEOSCOPIC PARTIAL NEPHRECTOMY FOR SMALL RENAL MASS: EXPERIENCE OF CHI MEI MEDICAL CENTER

Chien-Liang Liu*, Steven K Huan, Tainan, Taiwan, Allen W Chiu, Taipei, Taiwan

MP27-19 RENAL PARENCHYMAL NON-SUTURING TECHNIQUE USING TACHOSIL TISSUE SEALING SHEET IN LAPAROSCOPIC PARTIAL NEPHRECTOMY

Hidehumi Kinoshita, Motohiko Sugi*, Tadashi Matsuda, Hirakata, Japan

MP27-20 ROBOTIC PARTIAL NEPHRECTOMY FOR COMPLETELY ENDOPHYTIC RENAL MASSES: A SINGLE INSTITUTION EXPERIENCE

Riccardo Autorino*, Ali Khalifeh, Humberto Laydner, Dinesh Samarasekera, Idir Ouzaid, Luis Felipe Brandao, Robert J. Stein, Georges-Pascal Haber, Jihad Kaouk, Cleveland, OH

MP27-21 RENAL CRYOABLATION VERSUS ROBOT-ASSISTED PARTIAL NEPHRECTOMY: SINGLE-CENTER EXPERIENCE

Youssef Tanagho, Eric Kim*, Sam Bhayani, Robert Figenshau, St. Louis, MO

MP27-22 DOWNWARD NEPHROPEXY IS A USEFUL ADJUNCTIVE MANEUVER DURING ROBOT-ASSISTED URETEROURETEROSTOMY

Ziho Lee*, Daniel Parker, Elton Llukani, Christopher Reilly, Daniel Eun, Philadelphia, PA

MP27-24 MINIMALLY INVASIVE HEMINEPHRECTOMY: A SPECIFIC DEFINITION

Joseph Klink*, Ali Khalifeh, Dinesh Samarasekera, Kamol Panumatrassamee, Jihad Kaouk, Cleveland, OH

MP27-25 ANALYSIS OF OPERATIVE METHODS AND CENTER-SPECIFIC PROPORTION IN MAJOR UROLOGICAL ONCOLOGY SURGERIES IN KOREA, BASED ON THE 2010 ANNUAL REPORT OF KOREAN UROLOGICAL ASSOCIATION

Sunghyun paick*, Sangrak Bae, Hyoungkeun Park, Yongsoo Lho, Hyeonggon Kim, Seoul, Korea, Republic of

Friday, October 25, 2013   Moderated Poster Session MP28   4:30 pm–6:15 pm

URETEROSCOPY II

Room Rhythms 3 @ Sheraton New Orleans

Chair: Manoj Monga

Faculty: Lorenzo Defidio and Ugur Boylu

*Presenting author

MP28-01 URETEROSCOPY FOR BENIGN ESSENTIAL HEMATURIA: A SYSTEMATIC REVIEW

Nicholas Tadros*, Michael Conlin, Portland, OR

MP28-02 HIGH DEFINITION FLEXIBLE CYSTOSCOPY: IS IT WORTH THE COST?

Nicholas J Kuntz, Andreas Neisius, W. Neal Simmons, Muhammad W Iqbal, Richard H Shin*, Ramy Youssef, Michael N Ferrandino, Glenn M Preminger, Michael E Lipkin, Durham, NC

MP28-03 BALLOON DILATION OF THE URETER: A CONTEMPORARY REVIEW OF OUTCOMES AND COMPLICATIONS

Nicholas Kuntz, Andreas Neisius, Matvey Tsivian, Momin Ghaffar, Richard Shin*, Muhammad W Iqbal, Ramy Youssef, Durham, NC, Nishant Patel, Roger Sur, San Diego, CA, Michael Ferrandino, Glenn Preminger, Michael Lipkin, Durham, NC

MP28-04 A NOVEL STONE MANAGEMENT DEVICE DURING ENDOLITHOTRIPSY FOR URETERAL STONES: FIRST MULTI-INSTITUTIONAL EXPERIENCE

Nicola Macchione, Milan, Italy, Francesco Sanguedolce*, London , United Kingdom, Stephan Hruby, Salzburg, Austria, Fabrizio Longo, Milan, Italy, Stefanos Kachrilas, Junaid Masood, Noor Buchholz, London, United Kingdom, Emanuele Montanari, Milan, Italy

MP28-05 URETEROSCOPY AND LASER LITHOTRIPSY OF LARGE RENAL STONE BURDEN >2.0 CM

Jessica M. Yih*, Cleveland Heights, OH, Robert M. Kohut, Edward E. Cherullo, Cleveland, OH

MP28-06 A CRITICAL COMPARISON OF THE PERFORMANCES AND LIMITATIONS OF THREE OF THE LATEST MODELS OF FLEXIBLE URETEROSCOPES

Razvan Multescu*, Bogdan Geavlete, Petrisor Geavlete, Bucharest, Romania

MP28-07 COMPARATIVE STUDY OF THE TREATMENT OF RENAL STONES WITH FLEXIBLE URETERORENOSCOPY IN OBESE, MORBIDLY OBESE AND NORMAL WEIGHT PATIENTS

Steeve Doizi*, Sixtina Gil Diez De Medina, Olivier Traxer, Paris, France

MP28-08 EXTENDED OPERATIVE FOR URETEROSCOPIC STONE REMOVAL: DOES IT IMPACT MORBIDITY?

Patrick Mufarrij*, Washintong, DC, Jessica Lange, L. Spencer Krane, Kyle Wood, Winston-Salem, NC, Dean Assimos, Birmingham, AL

MP28-09 HOW ACCURATE IS ENDOSCOPIC INTRA-OPERATIVE ASSESSMENT OF KIDNEY STONE SIZE?

Nishant Patel*, San Diego, CA, Ben Chew, Vancouver, Canada, Bodo Knudsen, Columbus, OH, Michael Lipkin, Durham, NC, Roger Sur, San Diego, CA

MP28-10 INITIAL CLINICAL EXPERIENCE WITH A BALL TIPPED HOLMIUM:YAG OPTICAL FIBER FOR FLEXIBLE URETEROSCOPY

Bodo Knudsen*, Columbus, OH, Shubha De, Cleveland, OH, Manog Monga, Celveland, OH

MP28-11 BEST STENT LENGTH PREDICTED BY SIMPLE CT MEASUREMENT, RATHER THAN PATIENT HEIGHT

Kirsten Foell*, Andrea G. Lantz, Michael Ordon, Jason Y. Lee, Kenneth T. Pace, R. John D'A. Honey, Toronto, Canada

MP28-12 USE OF PERCSYS ACCORDION^TM TO AVOID URETERAL STONE FRAGMENT MIGRATION DURING LASER ENDOLITHOTRIPSY: INITIAL RESULTS OF AN OPEN RANDOMIZED CONTROLLED TRIAL

Christian Villeda Sandoval*, Daniel Olvera Posada, Mario Ramirez Bonilla, Francisco Rodriguez Covarrubias, Carlos Mendez Probst, Mexico City, Mexico

MP28-13 RECURRENT SYMPTOMS FOLLOWING SURGICAL MANAGEMENT OF URETEROPELVIC JUNCTION OBSTRUCTION WITH A NORMAL ENDOSCOPIC EVALUATION: ASSESSMENT AND OUTCOMES

Dominic Lee*, Richard E. Link, Houston, TX

MP28-14 IS PROLONGED OPERATION A PREDICTOR FOR THE OCCURRENCE OF COMPLICATIONS?

Sophie Knipper*, Christian Tiburtius, Christopher Netsch, Andreas Gross, Hamburg, Germany

MP28-15 THE CLINICAL RESEARCH OFFICE OF THE ENDOUROLOGICAL SOCIETY URETEROSCOPY GLOBAL STUDY: INDICATIONS, COMPLICATIONS, AND OUTCOMES IN 11885 PATIENTS

Jean de la Rosette*, Amsterdam, Netherlands, John Denstedt, London, Canada, Petrisor Geavlete, Bucharest, Romania, Francis Keeley, Bristol, United Kingdom, Tadashi Matsuda, Osaka, Japan, Margaret Pearle, Dallas, TX, Glenn Preminger, Durham, NC, Olivier Traxer, Paris, France

MP28-16 A NEW STONE OCCLUSION DEVICE (INNOVEX) PARALLEL TO NTRAP IN URETEROSCOPIC HO:YAG LITHOTRIPSY FOR UPPER URETERAL CALCULI

Zhong Wu*, Chen-chen Feng, Peng Gao, Lu jia Wang, Qiang Ding, Shanghai, China, People's Republic of

MP28-17 COMPLETELY STANDARDIZED FLEXIBLE URETERORENOSCOPY FOR TREATING RENAL CALCULI: A SINGLE-CENTER EXPERIENCE

Nikolaos Karpathakis, Konstantinos Fasoulakis, Ioannis Georgopoulos, Ioannis Bolonakis, Fragiskos Sofras, Charalampos Mamoulakis*, Heraklion, Greece

MP28-18 URETERIC STENT INSERTION AND DOCUMENTATION OF REMOVAL; IS IT CONTRIBUTING TO ‘FORGOTTEN’ STENTS

Carolyn Thomas*, Zubair Al-Qassim, Zeb Khan, Kettering, United Kingdom

MP28-19 USE OF A 1.3 F NITINOL STONE RETRIEVAL BASKET FACILITATES EXTRACTION OF RENAL AND URETERAL CALCULI TO RENDER PATIENTS STONE FREE

Mohammad Malik*, Chris Wright, Jennifer Yates, Ravi Munver, Hackensack, NJ

MP28-20 ASSESSING DIFFICULTY OF URETEROSCOPIC STONE EXTRACTION USING PREOPERATIVE CT IMAGING

Saman Moazami*, Mira Herman, Abhishek Srivastava, David Hoenig, Joshua Stern, Bronx, NY

MP28-21 NEW URETERAL ACCESS SHEATHS: A DOUBLE-STANDARD

Shubha De, Fabio Torricelli, Carl Sarkissian*, Manoj Monga, Cleveland, OH

MP28-22 MODULAR FLEXIBLE URETEROSCOPY AND HOLMIUM LASER LITHOTRIPSY FOR TREATMENT OF UPPER URINARY TRACT CALCULI: A SINGLE-SURGEON EXPERIENCE OF 382 CASES

Cheng Yue*, Yan Zejun, Xie Guohai, Yuan Hesheng, Ningbo, China, People's Republic of

MP28-23 RISK FACTORS FOR URETERIC STRICTURES FOLLOWING SEMI-RIGID URETEROSCOPIC LASERTRIPSY: RESULTS FROM MULTICENTRE STUDY

Syed Ali Shahzad*, Phil Polson, Birmingham, United Kingdom, Fahad Khan, Howard Marsh, Sri Sriprasad, Kent, United Kingdom, Raghu Devarajan, Birmingham, United Kingdom

MP28-24 RETROGRADE INTRARENAL SURGERY (RIRS) IN THE TREATMENT OF RENAL STONES IN SOLITARY KIDNEY

Guido Giusti*, Rozzano (MI), Italy, Silvia Proietti, Rozzano, Italy, Roberto Peschechera, Davide Giraudo, Gianluigi Taverna, Pierpaolo Graziotti, Rozzano (MI), Italy

MP28-25 URETEROSCOPIC TREAMENT OF LARGE, COMPLEX, NON-INFECTIOUS STONE BURDENS GREATER THAN 2.0 CM

Andrew I. Fishman*, Jacob Cohen, Michael Grasso, Valhalla, NY

MP28-26 PREVENTING FLEXIBLE URETERORENOSCOPE DAMAGE: HOW WE DID IT

Hiro Ishii*, Tamsin Drake, Bhaskar Somani, Southampton, United Kingdom

Friday, October 25, 2013   Moderated Poster Session MP29   4:30 pm–6:15 pm

PERCUTANEOUS NEPHROLITHOTOMY & URETEROSCOPY

Room Grand Ballroom D @ Sheraton New Orleans

Faculty: Ranan DasGupta and Evangelos Liatsikos

*Presenting author

MP29-01 COMPARISON OF USING SPLITTED SIDE AND CONVENTIONAL AMPLATZ SHEATH IN PATIENTS UNDERGOING PERCOTANEOUS NEPHROLITHOTOMY

Nasim Irani*, Daryush Irani, Shiraz, Iran

MP29-02 STAGHORN CALCULI: COMPOSITION, BACTERIOLOGY AND MANAGEMENT: AT MONKLANDS HOSPITAL, WEST OF SCOTLAND, UK

Edward Mains*, Imran Ahmad, Sarath Nalagatla, Airdrie, United Kingdom

MP29-03 SUPINE PCNL: AN EFFECTIVE AND SAFE APPROACH FOR RENAL STONES MANAGEMENT – AN EARLY EXPERIENCE

Tarek El-Leithy*, Hany Nour, Mohandessin City, Egypt

MP29-04 PERCUTANEOUS NEPHROLITHOTOMY:CRITICAL ANALYSIS OF UNFAVORABLE RESULTS

Abdulqadir Alobaidy*, doha, Qatar, Abdulla Al-Naimi, Doha,, Qatar, Khalid Assadiq, Haidar Alkhafaji, Abdulla Al-Ansari, doha, Qatar, Ahmed Shokeir, Almansoura, Egypt

MP29-05 PCNL RENAL TRACT ACCESS BY UROLOGISTS- OUR EXPERIENCE

Alexandra Zachou*, Calvin Nathaniel, Maneesh Ghei, Barry H. Maraj, London, United Kingdom

MP29-06 PERCUTANEOUS NEPHROLITHOTOMY (PCNL) IN AN ELDERLY POPULATION. IS IT SAFE?

Ross Vint*, Sarath Nalagatla, Airdrie, United Kingdom

MP29-07 STANDARD-TRACT COMBINED WITH MINI-TRACT IN PERCUTANEOUS NEPHROLITHOTOMY FOR RENAL STAGHORN CALCULI

Yanbo Wang*, Ning Xu, Min Liu, Chunxi Wang, Changchun, China, People's Republic of

MP29-08 RENAL ACCESS BY SONOGRAPHER VERSUS UROLOGIST DURING PERCUTANEOUS NEPHROLITHOTOMY

Yanbo Wang*, Zhihua Lu, Jinghai Hu, Haifeng Zhang, Chunxi Wang, Changchun, China, People's Republic of

MP29-09 PERCUTANEOUS NEPHROLITHOTRIPSY (PCNL) IN CHILDREN

Mohammad Reza Darabi Mahboub*, Mashhad , Iran, Mohammad Aslzare, Alireza Ghoreifi, Mashhad, Iran

MP29-10 MASSIVE HEMORRHAGE AFTER PERCUTANEOUS NEPHROLITHOTOMY: HOW TO SAVE THE KIDNEY WHEN ANGIOEMBOLIZATION HAS FAILED OR IS UNAVAILABLE?

Alireza Aminsharifi*, Shiraz, Iran

MP29-11 COMPARISON BETWEEN SUPINE AND PRONE PCNL IN THE THERAPY OF STAGHORN STONES

Viorel Bucuras*, Razvan Bardan, Adrian Muresan, Alin Cumpanas, Cristina Balarie, Ciprian Secasan, Timisoara, Romania

MP29-12 EVALUATION OF SAFETY AND EFFICACY PERCUTANEOUS NEPHROLITHOTRIPSY IN TREATMENT OF ANTERIOR DIVERTICULAR RENAL STONES

Daryush Irani, Nasim Irani*, Reza Haghpanah, Shiraz, Iran

MP29-13 RESULTS AND COMPLICATIONS OF SUPINE POSITION FOR PERCUTANEOUS NEPHROLITHOTOMY (PCNL)

Sadrollah Mehrabi Sisakht*, Yasuj, Iran

MP29-14 THE EVALUATION OF SAFETY AND EFFICACY OF MULTIPLE TRACKS PERCUTANEOUS NEPHROLITHOTOMY UNDER SPINAL ANESTHESIA

Seyed Habibollah Mousavi-Bahar*, abdolmajid iloon kashkouli, Babak Borzouei, hamadan, Iran

MP29-15 COMPLICATIONS OF PERCUTANEOUS NEPHROLITHOTOMY: A SINGLE SURGEON'S EXPERIENCE

Nathaly Francois*, Springfield, IL

MP29-16 COMPARATIVE STUDY OF RESULTS AND COMPLICATIONS OF PERCUTANEOUS NEPHROLITHOTOMY (PNL) WITH NEPHROSTOMY AND WITHOUT NEPHROSTOMY (TUBELES)

Mohmed eTafy*, miami, FL, gamal hasan, Ayut, Egypt, Hazem Deef, Asyut, Egypt, magdy badr, Ayut, Egypt, Sayeda Ali, Mamdouh Fareed, Sayed Mousa, cairo, Egypt, Emad Ali, Gamal Morsi, Ayut, Egypt

MP29-17 THE HISTORY OF PERCUTANEOUS NEPHRO-LITHOTOMY

Katherine Hall*, Priyadarshi Kumar, Moeketsi Mokete, Preston, United Kingdom

MP29-18 EXPERIENCE OF MINI-PERCUTANEOUS NEPHROLITHOTOMY FOR PROXIMAL URETERAL STONES OF PATIENTS WITH REPEATED EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FAILURE

Jingjing Guan*, Yanbo Wang, Xuesong Li, Yangyang Li, Zhengyi Lv, Xiaoming Yang, Qianqian Zhao, Changchun, China, People's Republic of

MP29-19 LOCKED DEFLECTION DURING FLEXIBLE URETEROSCOPY: AN UNDERREPORTED COMPLICATION

Scott Hubosky*, Nir Kleinmann, Demetrius Bagley, Philadelphia, PA

MP29-20 PREOPERATIVE STENTING ENABLE US TO REMOVE RENAL STONES WITH FLEXIBLE URETERORENOSCOPE AT FIRST ATTEMPT

Shohei Ishida*, Toru Kimura, Takashi Kato, Yuta Sano, Fumitoshi Sakamoto, Tomonori Komatsu, Yoshikazu Tsuji, Tsuneo Kinukawa, NAGOYA, Japan

MP29-21 THE WALLSTENT®: 23 YEARS OF EXPERIENCE IN THE TREATMENT OF BENIGN URETEROENTERIC ANASTOMOTIC STRICTURES AFTER BRICKER DEVIATION

Thijs Campschroer*, Tycho Lock, Utrecht, Netherlands

MP29-22 TUL-ASSISTED PCNL (TAP): IMPACT OF URETEROSCOPY IN THE MODIFIED SUPINE POSITION FOR MANAGEMENT OF UPPER URINARY TRACT STONE DISEASE

Kae Ante-Sugihara*, Noritaka Ishito, Yumiko Yamashita, Tomoko Sako, Shohei Yokoyama, Yoichi Shiotsuka, Takaharu Ichikawa, Yasuo Yamamoto, Hitoshi Takamoto, Kurashiki, Japan

MP29-23 COMPARISON OF OPTICAL RESOLUTION AMONG 2 DIGITAL AND STANDARD FIBEROPTIC URETERORENOSCOPES USING AN IN VITRO MODEL

Kikuo Nutahara*, Mitaka, Japan, Junichi Matsuzaki, Yokohama, Japan, Soichi Mugiya, Hamamatsu, Japan, Akito Yamaguchi, Hukuoka, Japan

MP29-24 APPLICATION OF FLEXIBLE URETEROSCOPY IN UPPER URINARY DISEASES

Yan Zejun*, Cheng Yue, Xie Guohai, Ningbo, China, People's Republic of

MP29-25 OUR THREE CENTRE TREATMENT OUTCOME OF RETROGRADE INTRARENAL SURGERY FOR RENAL STONES AND PREDICTIVE FACTORS OF STONE FREE

Ashvinkumar Gami*, Palanpur, India, Dipak Rajyaguru, Mahesana, India, Jitendra Amlani, Rajkot, India

MP29-26 ACUCISE® ENDOURETEROTOMY: A FORGOTTEN TREATMENT OPTION IN URETERAL STRICTURES

Thijs Campschroer*, Tycho Lock, Utrecht, Netherlands

Friday, October 25, 2013   Moderated Poster Session MP30   4:30 pm–6:15 pm

UROLITHIASIS III

Room Grand Chenier @ Sheraton New Orleans

Chair: Viorel Bucaras

Faculty: Mohamad Alomar and Mordechai Duvdevani

*Presenting author

MP30-01 EXTRACORPOREAL LITHOTRIPSY USING IN LINE AND ON LINE FLUOROSCOPY WITH THE INTEGRA LITHOTRIPTER

Dr. Ruben Munoz Montastruc*, Dr. Ricard Recasens Guijuan, Dr. C. Berbegal Colas, Dr. D. Garcia Belmonte, Dra. Merce Pascual Queralt, Lleida, Spain

MP30-02 UNDERUTILIZATION OF 24-HOUR URINE TESTING IN KIDNEY STONE PATIENTS

E. Will Kirby, David C. Johnson, James E. Ferguson, D. Kim Chantala, Davis P. Viprakasit*, Chapel Hill, NC

MP30-03 MANAGEMENT OF STRUVITE STONES USING COMBINED ENDOUROLOGICAL AND MEDICAL TREATMENT: PREDICTORS OF UNFAVORABLE CLINICAL OUTCOME

Muhammad Iqbal, Ramy Youssef*, Andreas Neisius, Nicholas Kuntz, Richard Shin, Jonathan Hanna, Michael Ferrandino, Glenn Preminger, Michael Lipkin, Durham, NC

MP30-04 CLINICO-METABOLIC CHARACTERISTICS OF OLDER PATIENTS WITH URINARY STONE DISEASE

Won Tae Kim*, Sang-Cheol Lee, Cheongju, Korea, Republic of, Hoon Jang, Daejeon, Korea, Republic of, Yong-June Kim, Seok-Joong Yun, Wun-Jae Kim, Cheongju, Korea, Republic of

MP30-05 PREDICTION OF URIC ACID STONE COMPOSITION BY HOUNSFIELD UNITS: TECHNIQUE AND STONE SIZE IMPACTS PREDICTIVE VALUES

Sangtae Park*, Glencoe, IL

MP30-06 SURVEY OF PRACTICE PATTERNS FOR THE TREATMENT OF UPPER URINARY TRACT STONES IN NEW ENGLAND

Vik Uberoi*, David Wang, Boston, MA

MP30-07 EFFECT OF POMEGRANATE SUPPLEMENTATION ON SERUM AND URINE MARKERS OF INFLAMMATION, OXIDATIVE STRESS AND 24 HOUR URINE IN PATIENTS WITH RECURRENT NEPHROLITHIASIS

Jonathan Henning*, Lincoln, NE, Mark Newton, Miriam Zimmerman, Chad Tracy, Iowa City, IA

MP30-08 A GLOBAL UROLITHIASIS MANAGEMENT SURVEY BY THE CLINICAL RESEARCH OFFICE OF THE ENDOUROLOGICAL SOCIETY (CROES): DO UROLOGISTS FOLLOW THE “GOLDEN RULE”?

Gregory Roberts*, Darren Beiko, Kingston, Canada, Dedan Opondo, Jean de la Rosette, Amsterdam, Netherlands, Hassan Razvi, London, Canada

MP30-09 COMPARISON OF STONE COMPOSITION AND URINARY RISK FACTORS BETWEEN ELDERLY AND YOUNGER COHORT WITH NEPHROLITHIASIS

Yaniv Shilo*, Pittsburgh, PA, Ilia Beberashvili, Zerifin, Israel, Julie M. Riley, Jocelyn Kim, Stephen V. Jackman, Timothy D. Averch, Pittsburgh, PA

MP30-10 STONEDIAGNOSTIC IN THE URO DYNA-CT COMPARED TO STANDARD NON-CONTRAST CT

Marie-Claire Rassweiler*, Stefan Haneder, Joachim Brade, Benjamin Meister, Maurice-Stephan Michel, Axel Haecker, Manuel Ritter, Mannheim, Germany

MP30-11 CORELATION BETWEEN GUY'S STONE CLASSIFICATION AND PERCUTANEOUS LITHOTRIPSY OUTCOMES

Norberto Bernardo*, Horacio Sangunetti, Buenos Aires, Argentina, Maximiliano Lopez Silva, Javier Garcia Villalba, bu, Argentina, Osvaldo Mazza, Buenos Aires, Argentina

MP30-12 THE CONCORDANCE OF ULTRASOUND AND CT SCAN IMAGES FOR KIDNEY STONE DISEASE

Dan Greene*, Shubha De, Carl Sarkissian, Manoj Monga, Cleveland, OH

MP30-13 UPPER URINARY TRACT STONES PRESENTING TO THE EMERGENCY DEPARTMENT IN THE UNITED STATES: TRENDS IN HOSPITALIZATION AND CHARGES

Khurshid Ghani*, Detroit, MI, Florian Roghman, Montreal, Canada, Jesse Sammon, Detroit, MI, Vincent Trudeau, Montreal, Canada, Ramesh Kumar, Shyam Sukumar, James Peabody, Mani Menon, Detroit, MI, Quoc-Dien Trinh, Montreal, Canada

MP30-14 RADIATION EXPOSURE OF THE PATIENT SUBMITTED TO URETEROSCOPY FOR URETERAL CALCULI

Filippo Nigro, Paolo Ferrarese, Ciro Ammendola, Enrico Scremin, Giuseppe Benedetto, Emiliano Bratti, Andrea Tasca*, Vicenza, Italy

MP30-15 GIANT URETERIC AND STAGHORN CALCULI IN YOUNG-ADULTS

Wissem Hmida*, Sousse, Tunisia, Faouzi Mallat, Mouna Ben Othmen, Ghassen Tlili, Mehdi Jaidane, Faouzi Mosbah, Sahloul, Tunisia

MP30-16 RESULTS OF TRANSURETHRAL URETEROLITHOTRIPSY (TUL) AND CLINICAL CHARACTERISTICS OF ACUTE PYELONEPHRITIS FOLLWING TUL

Yasunobu Hashimoto*, Kita-Aoyama, Minato-ku, Tokyo, Japan, Takafumi Yagisaway, Yukiko Kouchi, Kawada-cho, Shinjyuku-ku, Tokyo, Japan, Yoshiko Maeda, Kita-Aoyama, Minato-ku, Tokyo, Japan, Tomokazu Shimizu, Kazunari Tanabe, Kawada-cho, Shinyuku-ku, Tokyo, Japan

MP30-17 IS URINARY LITHIASIS RELATED TO CORONARY ATHEROESCLEROSIS?

Hector Sandoval Barba*, Christian Villeda Sandoval, Ricardo Castillejos Molina, Monica Chapa Ibarguengoitia, Carlos Mendez Probst, Mexico City, Mexico

MP30-18 DIFFERENT ANALGESIC METHODS FOR SHOCKWAVE LITHOTRIPSY

Farkhod Abdurakhmonov*, Samarkand, Uzbekistan

MP30-19 OUTCOMES AND SAFETY OF RETROGRADE INTRA-RENAL SURGERY(RIRS) FOR RENAL STONES :–OUR EXPERIENCE

Vikas Agarwal*, Atul Goswami, Delhi, India

MP30-20 CLINICAL EVALUATION OF DIGITAL FLEXIBLE URETEROSCOPY WITH HOLMIUM LASER LITHOTRIPSY FOR COMPLICATED RENAL CALICULI

Cheng Yue, Yan Zejun*, Xie Guohai, Ningbo, China, People's Republic of

MP30-21 DIABETES IN ASIAN AND CAUCASIAN PATIENTS WITH NEPHROLITHIASIS

Raghuram Devarajan*, Solihull, United Kingdom

MP30-22 THE CORRELATIONS BETWEEN THE HOUNSFIELD UNIT (HU) ON NON-CONTRAST COMPUTERIZED TOMOGRAPHY SCANS AND THE METABOLIC TEST RESULTS OF URINARY STONE PATIENTS

Hoon Jang*, Daejeon, Korea, Republic of, Ho wun Kang, Dong Wook Kim, Won Tae Kim, Seok Joong Yoon, Sang Cheol Lee, Cheongju, Korea, Republic of

MP30-23 IS IT POSSIBLE TO REDUCE THE COST OF FLEXIBLE URETEROSCOPIC LITHOTRIPSY

Cenk Gurbuz*, Gokhan Atýþ, Ozgur Arikan, Ozgur Efilioglu, Onur Danacýoglu, Turhan Caskurlu, Istanbul, Turkey

MP30-24 PREVENTING RETROGRADE STONE DISPLACEMENT DURING PNEUMATIC LITHOTRIPSY FOR URETERAL CALCULI USING LIDOCAINE JELLY

Mohammad Reza Darabi Mahboub*, Mashhad , Iran, Rahim Taghavi, Mohammad Aslzare, Behtash Pedramrad, Mashhad, Iran

MP30-25 THE EFFECT OF STONE LOCALIZATION ON SUCCESS RATES OF RETROGRADE INTRARENAL SURGERY

Hakan Kilicarslan*, Burhan Coskun, Yakup Kordan, Hakan Vuruskan, Onur Kaygisiz, Omur Gunseren, Bursa, Turkey

MP30-26 SHORT TERM RESULTS OF URETEROSCOPIC LASER LITHOTRIPSY AT AKDENIZ UNIVERSITY

Mehmet Baykara*, Antalya, Turkey, Yigit Akin, Erzincan, Turkey, Selcuk Yucel, Arif Kol, Ilker Fatih Sahiner, Antalya, Turkey

Friday, October 25, 2013   Video Session V16   4:30 pm–6:00 pm

LAPAROSCOPY: UPPER TRACT III

Room Armstrong @ Sheraton New Orleans

Chair: Yew-Lam Chong

Faculty: Benjamin W. Woodson and Ramakrishna Venkatesh

*Presenting author

V16-01 LAPAROSCOPIC REPAIR OF IATROGENIC A RENAL VEIN INJURY DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY

Bogdan Petrut*, Hogea Maximilian, Vlad Schitcu, Andrei Kozan, Tiberiu Calistru, Alb Alexandra, Vasile Buda, Cluj Napoca, Romania

V16-02 VARIOUS TECHNIQUES OF STENT PLACEMENT DURING LAPAROSCOPIC URETERAL RECONSTRUCTIVE SURGERY

Seok Kwan Hong*, Yee Mun Lee, Yew Lam Chong, Keng Siang Png, Singapore, Singapore

V16-03 LAPAROSCOPIC RADICAL NEPHRECTOMY WITH LEFT RENAL VEIN THROMBECTOMY

Worapat Attawettayanon, sompol permpongkosol*, Bangkok, Thailand

V16-04 LAPAROSCOPIC URETEROLITHOTOMY WITH FIBRIN SEALANT IN THE TREATMENT OF LARGE IMPACTED PROXIMAL URETERAL STONE

Ugur Boylu*, Cem Basatac, Ahmet Tahra, Fikret Fatih Onol, Eyup Gumus, Istanbul, Turkey

V16-05 OPEN SURGICAL ANASTOMOSIS WITH MUSCLE SPLITTING TECHNIQUE DURING LAPAROSCOPIC PYELOPLASTY IN ADULTS

Seref Basal*, Bilal Firat Alp, Ankara, Turkey, Zafer Demirer, Eskisehir, Turkey, Ali Guragac, Ankara, Turkey, Ercan Malkoc, Corlu, Turkey, Emin Aydur, Ibrahim Yidirim, Ankara, Turkey

V16-06 LAPAROSCOPIC PYELOLITHOTOMY USING A FLEXIBLE URETEROSCOPE ANTEGRADLLY

Yakup Kordan, Gokhun Ozmerdiven, Burhan Coskun, Onur Kaygisiz, Hakan Vuruskan, Hakan Kilicarslan*, Ismet Yavascaoglu, Bursa, Turkey

V16-07 NYU TECHNIQUE FOR ROBOTIC-ASSISTED BOARI FLAP

Arielle Miller*, Tracey Marien, Suzzane Sorin, Marc Bjurlin, Michael Stifelman, New York, NY

V16-08 LAPAROSCOPIC PYELOLITHOTOMY IN AN ECTOPIC PELVIC KIDNEY

Christopher Keel*, Arthur Caire, Benjamin Woodson, Benjamin Lee, New Orleans, LA

V16-09 RIGHT LAPAROSCOPIC RADICAL NEPHRECTOMY: STEP-BY-STEP

René Sotelo*, Oswaldo Carmona, Robert De Andrade, Frederic Birkhauser, Caracas, Venezuela, Flavio Santinelli, Buenos Aires, Argentina, Arvind Gampule, Nadiad, India, Martin Piana, Santa Fe, Argentina, Roberto Garza, Golena Fernandez, Juan Castro, Cesar Ignacio, Roberto Cisneros, Caracas, Venezuela, David Canes, Burlington, MA, Ralph Clayman, Irvine, CA

V16-10 LEFT LAPAROSCOPIC RADICAL NEPHRECTOMY: STEP-BY-STEP

René Sotelo*, Oswaldo Carmona, Robert De Andrade, Caracas, Venezuela, Flavio Santinelli, Buenos Aires, Argentina, David Subira, Madrid, Spain, Cesar Ignacio, Golena Fernandez, Roberto Garza, Juan Castro, Frederic Birkhauser, Roberto Cisneros, Caracas, Venezuela, Ralph Clayman, Irvine, CA

V16-11 ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY IN KIDNEY TRANSPLANT RECIPIENT

Mohammed Zaher, Downer's Grove, IL, Samuel Ohlander*, Neha Malhotra, Wendy Padilla, Christopher Yang, Leslie Deane, Chicago, IL

V16-12 EARLY RETURN OF CONTINENCE IN PATIENTS UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY USING MODIFIED MAXIMAL URETHRAL LENGTH PRESERVATION TECHNIQUE

Sanjay Razdan*, Alaa Hamada, Miami, FL, Shirin Razdan, Doral, FL, Mohamed Etafy, Miami, FL

Friday, October 25, 2013   Video Session V17   4:30 pm–6:00 pm

ROBOTICS: UPPER TRACT IV

Room Grand Ballroom E @ Sheraton New Orleans

Chair: Peter Wiklund

Faculty: Justin Friedlander and Sero Andonian

*Presenting author

V17-01 IMMEDIATE ROBOTIC ASSISTED DISTAL URETEROURETEROSTOMY WITH OMENTAL INTERPOSITION GRAFT AFTER IATROGENIC INJURY

Blake W Moore*, Ziho Lee, Adam Reese, Jack H Mydlo, Daniel D Eun, Philadelphia, PA

V17-02 ZERO ISCHEMIA, SELECTIVE ISCHEMIA, AND TOTAL ISCHEMIA FOR THREE MASSES IN A SOLITARY KIDNEY: THE VERSATILITY OF ROBOTIC PARTIAL NEPHRECTOMY

Richard Knight*, Michael White, San Antonio, TX

V17-03 ROBOTIC ANATROPHIC NEPHROLITHOTOMY: INITIAL CASE

Sherita King*, Zachary Klaassen, Ray King, Rabii Madi, Augusta, GA

V17-04 ROBOTIC ANATROPHIC NEPHROLITHOTOMY WITH RENAL HYPOTHERMIA FOR TREATING STAGHORN CALCULI

Khurshid Ghani*, Craig Rogers, Akshay Sood, Ramesh Kumar, Michael Ehlert, Wooju Jeong, Detroit, MI, Arvind Ganpule, Nadiad, India, Mahendra Bhandari, Detroit, MI, Mahesh Desai, Nadiad, India, Mani Menon, Detroit, MI

V17-05 ROBOTIC-ASSISTED RADICAL NEPHRECTOMY WITH INFERIOR VENA CAVA TUMOR THROMBECTOMY

Mark Ball*, Gautam Jayram, Mohamad Allaf, Baltimore, MD

V17-06 ROBOTIC ASSISTED PARTIAL NEPHRECTOMY IN A PELVIC KIDNEY

Aryeh Keehn*, Reza Ghavamian, Bronx, NY

V17-07 COMPLEX PARTIAL NEPHRECTOMY FOLLOWING TUMOR DOWNSIZING WITH NEOADJUVANT THERAPY

Luis Felipe Brandao*, Humberto Laydner, Riccardo Autorino, Ali Khalifeh, Dinesh Samarasekera, Emad Rizkala, Oliver Ko, Georges-Pascal Haber, Jihad Kaouk, Robert Stein, Cleveland, OH

V17-08 ROBOTIC CALYCEAL DIVERTICULECTOMY AND NEPHROLITHOTOMY

Christopher Keel*, Kush Patel, Benjamin Woodson, Benjamin Lee, New Orleans, LA

V17-09 ROBOTIC RADICAL NEPHRECTOMY AND INFRA-HEPATIC INFERIOR VENA CAVA THROMBECTOMY

Andre Berger*, Andre Luis de Castro Abreu, Dennis J. Lee, Sheaumei Tsai, Scott Leslie, Mihir M. Desai, Monish Aron, Inderbir S. Gill, Los Angeles, CA

V17-10 COMPLETELY INTRACORPOREAL ROBOTIC RENAL AUTOTRANSPLANTATION

Daniel Gilbert*, Jordan Angel, Ronney Abaza, Dublin, OH

V17-11 ILEAL CONDUIT REVISION AND URETERAL STENOSIS REPAIR: ROBOT ASSISTED LAPAROSCOPIC TECHNIQUE

Idir Ouzaid*, Edward Diaz, Riccardo Autorino, Dinesh Samarasekera, Vishnuvardhan Ganesan, Robert Stein, Jihad Kaouk, Georges-Pascal Haber, Cleveland, OH

V17-12 ROBOTIC ANATROPHIC INCISION FOR NEPHRON SPARING SURGERY FOR COMPLETE INTRARENAL TUMOR IN THE RENAL SINUS

René Sotelo*, Oswaldo Carmona, Robert De Andrade, Carmen Rodriguez, Golena Fernandez, Rafael Clavijo, Roberto Garza, Caracas, Venezuela

Friday, October 25, 2013   Video Session V18   4:30 pm–6:00 pm

PEDIATRICS & OBSTRUCTION

Room Nottoway @ Sheraton New Orleans

Chair: Michael C. Ost

Faculty: Blake Palmer and Bulent Onal

*Presenting author

V18-01 ROBOTIC-ASSISTED LAPAROSCOPIC LEFT RETROPERITONEAL LYMPH NODE DISSECTION

Jacob Jorns*, Michael Erhard, Jacksonville, FL

V18-02 ENTIRELY MINIMALLY-INVASIVE MANAGEMENT OF AN INFECTED URACHAL CYST IN THE PEDIATRIC PATIENT

Christopher Jaeger*, Candace Granberg, Rochester, MN

V18-03 ROBOTIC- ASSISTED, LAPAROSCOPIC EXCISION OF BILATERAL HUTCH DIVERTICULI WITH BILATERAL EXTRAVESICAL URETERAL REIMPLANTATION

Carlos Villanueva*, Michael Belsante, Patricio Gargollo, Dallas, TX

V18-04 PEDIATRIC ROBOTIC PYELOPLASTY IN HORSESHOE KIDNEY

Candace Granberg, Rochester, MN, Daniel DaJusta, Louisville, KY, Patricio C. Gargollo*, Dallas, TX

V18-05 LAPAROSCOPIC EXCISION OF A LARGE PROSTATIC UTRICLE IN A SYMPTOMATIC 1 YEAR-OLD

Mark Currin*, Todd Purves, Andrew Stec, Charleston, SC

V18-06 MINILAPAROENDOSCOPIC SINGLE-SITE (MILESS) DISMEMBERED PYELOPLASTY: TECHNIQUE AND SURGICAL OUTCOMES

Francesco Greco*, Giovannalberto Pini, Paolo Fornara, Halle, Germany

V18-07 ROBOTIC SINGLE SITE PYELOPLASTY USING CROSSED ARTICULATING INSTRUMENTS AND 5 MM FLARED CANNULAS

Maurilio Garcia-Gill, Jeffrey Gahan*, Jeffrey Caddedu, Dallas, TX

V18-08 LAPAROENDOSCOPIC SINGLE SITE (LESS) SURGERY FOR URACHAL REMNANT IN ADULTHOOD

Kyohei Kuorse*, Takamatsu, Japan

V18-09 LAPAROSCOPIC URETEROLYSIS IN RETROPERITONEAL FIBROSIS

Burhan Coskun, Onur Kaygisiz, Berna Aytac, Hakan Kilicarslan, Yakup Kordan, Hakan Vuruskan*, Bursa, Turkey

V18-10 ROBOT ASSISTED RADICAL PROSTATECTOMY IN A PATIENT WITH EPISPADIAS

Samuel Eaton*, Robert Nadler, Kent Perry, Chicago, IL

V18-11 ROBOTIC URETERAL REIMPLANTATION UTILIZING A BOARI FLAP

John Gannon*, Jeffery Redshaw, Salt Lake City, UT, Jeff Piacitelli, Jay Bishoff, Murray, UT

V18-12 ROBOTIC ASSISTED EXCISION OF A GIANT SEMINAL VESICLE CYST AND ATRETIC URETER

Ramgopal Satyanarayana*, Devendar Katkoori, Ezekiel Young, Murugesan Manoharan, Miami, FL

MP1A BASIC RESEARCH: UPPER TRACT PHYSIOLOGY

MP1A-01 EVALUATION OF POTENTIAL PHARMACEUTICAL AGENTS FOR A DRUG ELUTING URETERIC STENT USING EX-VIVO INVESTIGATION INTO THE UROTHELIAL PERMEABILITY

Nicholas Williams, Chris Allender, Jenna Bowen, Marc Gumbleton, Cardiff, United Kingdom, Tim Harrah, Jamie Li, Boston, MA, Hrishi Joshi*, Cardiff, United Kingdom

INTRODUCTION AND OBJECTIVES: Oral administartion of agents such as anticholinergics, NSAIDs and alpha blockers are used to address side effects of uretric stents. The symptoms, do not respond adequately to oral therapy and future management may involve incoporation of suitable drug/s into the stent itself. Such a stent would allow continuous exposure of high concentrations of drug locally. Selection of a suitable drug must take into account the permeability of drug across the urothelium. We report the findings of an ex-vivo study investigating the trans-urothelial transport of oxybutinin, ketorolac and tamsulosin, potential candidates from different groups.

METHODS: Porcine bladder was mounted in Franz-type diffusion cells and drug applied to the urothelium. At pre-defined time points, tissue samples were excised and drug extracted from tissue prior to HPLC analysis. Transurothelial permeability coefficients (Kp) were calculated.

RESULTS: Using a robust ex-vivo porcine bladder model, the permeability of oxybutinin, ketorolac and tamsulosin has been determined. All drugs permeated the urothelium, however, they demonstrated different rates of transport. Kp values were calculated a 3.1×10–06, 2.54×10–06 and 8.4×10–07 cm s-1 for oxybutinin, ketorolac and tamsulosin respectively.

CONCLUSIONS: These studies reveal crucial information about the urothelium's permeability to oxybutinin, ketorolac and tamsulosin. Calculated Kp values suggest oxybutinin and ketorolac to be better candidates for incorporation into a drug eluting stent. Our ex-vivo model and investigations into the urolthelial permeability of drugs can provide valuable information when selcting a suitable candidate for incorporation into a drug eluting stent.

Source of Funding: Cardiff university and Boston Scientific corporation

MP1A-02 UNDERSTANDING STENT-INDUCED URETERAL APERISTALSIS

Claudia Janssen*, Wolfgang Jaeger, Dennis Solomon, Ladan Fazli, Ralph Buttyan, Ben H. Chew, Chun Y. Seow, Dirk Lange, Vancouver, Canada

INTRODUCTION AND OBJECTIVES: Indwelling double J (DJ) stents are known to interfere with coordinated ureteral peristalsis. The exact mechanisms for this are not well understood. During development, the Sonic Hedgehog signaling pathway (Shh) regulates the development of pacemaker cells throughout the urinary tract required for coordinated ureteral peristalsis. Defects in Shh signaling result in hydronephrosis and hydroureter due to a loss of ureteral peristalsis. In addition, these processes are activated during healing and the regeneration of epithelial layers in adults. Since stent movement in the bladder, ureter, and kidney results in urothelial irritation and inflammation, we hypothesize that stent-induced disruption of ureteral peristalsis may be the result of changes in Shh signaling in the ureteral tissue.

METHODS: To investigate effects of ureteral stenting the expression of Shh and its Gli effectors was analyzed via immunohistochemistry in upper ureteral segments of unilaterally stented Yorkshire pigs at 48 hrs, 1, 2, 4, 7 and 10 wks post stent-insertion (n=4/time point) and compared to the contralateral non-stented sides. Four un-stented animals served as controls. Furthermore, ureteral peristalsis was assessed macroscopically in vivo at 48 h (group 1) or 7 days (group 2) post stent placement. In addition, at each time point ureters were harvested bilaterally in each animal and the effects of stenting on smooth muscle (SM) contractility were assessed ex vivo using tissue baths.

RESULTS: The expression of the transcriptional activator Gli 1 was significantly decreased in ureteral SM 1 wk post stent insertion, which coincided with maximal inflammation. Interestingly, this decrease was paralleled by an increase in Gli 1 expression in the SM of the contralateral non-stented ureters. Following stent removal at 7 wks and decreased inflammation, Gli 1 expression increased back towards normal levels.

Aside from the effects on the Shh pathway, ureteral dilation due to stenting completely abolished peristalsis in vivo and significantly decreased ureteral SM contractility ex vivo compared to un-stented controls. No spontaneous or stimulated peristalsis was observed within 30 minutes following stent removal.

CONCLUSIONS: DJ stents induce significant ureteral dilation (as early as 48 hrs post-insertion) resulting in SM overexpansion, reduced contractility and overall aperistalsis. Furthermore, chronic ureteral inflammation 1 wk post stent insertion results in the loss of Gli 1 expression in the ureteral SM, potentially delaying healing and recovery of peristalsis.

Source of Funding: Canadian Urological Association-Astellas Research Grant, Urologic Care Foundation, Endourological Society, Friend's of Joe

MP1A-03 ACOUSTIC BUBBLE REMOVAL TO ENHANCE THE EFFICACY OF SHOCK WAVE LITHOTRIPSY: AN IN-VITRO STUDY

Alexander P. Duryea*, William W. Roberts, Charles A. Cain, Hedieh A. Tamaddoni, Timothy L. Hall, Ann Arbor, MI

INTRODUCTION AND OBJECTIVES: Rate dependent efficacy has been extensively documented in shock wave lithotripsy (SWL) stone comminution, with shock waves (SWs) delivered at low rate producing more efficient fragmentation in comparison to those delivered at high rates. Cavitation is postulated to be the primary source underlying this rate phenomenon. Residual bubble nuclei that persist along the axis of SW propagation can drastically attenuate the waveform's negative phase, reducing the energy that is ultimately delivered to the stone and compromising comminution. The effect is more pronounced at high shock rates as bubbles have less time to passively dissolve between successive SWs. Here, we explore a strategy for the active removal of these residual bubbles using low-intensity acoustic pulses designed to stimulate their coalescence.

OPEN IN VIEWER

METHODS: Cystine-mimicking model stones were held within a vinyl finger cot for treatment. SWL was delivered using an electrohydraulic research system designed to simulate the acoustic output of the Dornier HM3. Bubble removal pulses were generated using a separate unfocused piezoelectric transducer driven at 370 kHz. A 100 ms burst at an amplitude of 500 kPa was used to sonicate remnant bubbles following a SW. Stones were treated at 30, 60, or 120 SW/min with or without bubble removal. Five stones were treated with each respective scheme, and the number of SWs required to achieve complete comminution (all debris <2 mm) was recorded.

RESULTS: Consistent with previous studies the number of SWs required to achieve complete stone comminution in conventional SWL was observed to decrease with decreasing shock rate (P<0.0001), indicating that the 'per-shock' efficiency is higher when a lower rate is used. The introduction of bubble removal pulses resulted in a significant reduction in the number of SWs required to achieve complete comminution at both 120 and 60 SW/min (P≤0.003), while no difference was detected at the lower rate of 30 SW/min (P=0.88).

CONCLUSIONS: Active removal of residual bubble nuclei following a SW can dramatically improve the in-vitro comminution efficacy of SWL at higher rates (120 and 60 SW/min). Maintaining this efficiency at high shock rate has the potential to allow for faster and more complete SWL therapy.

Source of Funding: Research reported in this abstract was supported by The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R01DK091267. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

MP1A-04 COMPARATIVE IN-VITRO STUDY OF THE EFFECTIVENESS OF NANOSECOND ELECTRICAL PULSE AND LASER LITHOTRIPTERS

Alexey Martov*, Moscow, Russian Federation, Valery Diamant, Katsrin, Israel, Artem Borisik, Andrey Andronov, Moscow, Russian Federation, Vladimir Chernenko, Tomsk, Russian Federation

INTRODUCTION AND OBJECTIVES: The use of various endourological techniques and lithotripters is increasing for the treatment of nephrolithiasis and ureterolithiasis. A novel lithotripsy method has been developed that differs in its principle of application from other methods in that it employs high voltage electrical pulses with nanosecond front and duration.

The purpose of this study is to evaluate the effectiveness of nanosecond electropulse lithotripsy (NEPL) in comparison with established Ho: Yag laser lithotripsy (LL).

METHODS: Four sizes of BegoStone phantoms of various densities were fabricated. The stones were placed on a grid with 2×2 mm cells immersed in the water. NEPL and LL devices were operated at comparable settings using varying probe/fiber sizes in order to achieve fragments less than 2 mm. The LL device was also tested at higher power settings in order to identify a mode where its efficiency can be comparable with NEPL. The number of pulses, cumulative energy and operation time were recorded. Cumulative energy was chosen as the criterion for comparing the effectiveness of the devices. A statistical analysis of the results was conducted.

RESULTS: Stone clearance was achieved in 100% for both lithotripters at all settings and probe/fiber sizes. The results demonstrated that NEPL in all cases requires less cumulative energy to destroy stones than LL and that the difference between them reaches nearly one order of magnitude. The specific volumetric energy needed for stone fragmentation was also evaluated. The results obtained indicate that different correlations exist between the lithotripters in the specific volumetric energy required to destroy the phantoms relative to probe diameter and stone density.

CONCLUSIONS: The NEPL device is more effective than the LL device because, in all cases, it needs significantly less energy for stone disintegration. The two compared lithotripters differ according to the mechanisms at work, which explains the different results that were obtained. The results for NEPL confirmed the correlation between pulse energy used for fragmentation and the properties of stones, to wit: the device always required less energy for the destruction of soft stones than hard stones while LL often required the same or even higher energy on soft stones than on hard stones.

At the same time, no correlation among factors of specific volumetric energy, stone density and fiber diameter was observed for LL. In the case of NEPL, these parameters were clearly correlated.

Source of Funding: None

MP1A-05 DETECTING MICRO-STONES IN URINE WITH QUANTITATIVE RAMAN SPECTROSCOPY AFTER ESWL

Yichun Chiu*, Po-An Chen, Huihua Chiang, Thomas Hsueh, Shing-Hwa Lu, Allen Chiu, Taipei, Taiwan

INTRODUCTION AND OBJECTIVES: With the improvement of the stone management, less stone fragments could be collected after treatment especially extracoporeal shock wave lithotripys (ESWL). But stone analysis still highly involved the further metabolic study and stone management policy. We tried to develop the quantitative micro-raman spectroscopy (MRS) to detect the minute/micro stone in the urine after the ESWL.

METHODS: This study used calibration curves of known mixtures of synthetically prepared calcium oxalate monohydrate (COM), hydroxyapatite (HAP), calcium oxalate dehydrate (COD), dicalcium phosphate dehydrate (DCPD), and uric acid. A variety of samples of binary and ternary mixtures including COM/HAP, COM/COD, COD/HAP, COM/uric acid, COD/uric acid, HAP/uric acid, HAP/DCPD, and COM/COD/HAP were prepared in various concentration ratios for use as the basis of the quantitative analysis. Intensities of the characteristic bands at 961 cm-1 (IHAP), 986 cm-1 (IDCPD), 1402 cm-1 (IUric acid), 1462 cm-1 (ICOM and COD), and 1477 cm-1 (ICOD and COM) were used for the calculation. We also derived a set of quantitative analysis equations for the ternary composition COD/COM/HAP group by combining two binary equations from the groups COM/COD and the HAP/COM. Urine from 30 patients after ESWL were collected as one shot (within 1 hour) and 24 hours urine. Then we compared the result to the stone analysis from the subsequent expelled stones by FTIR.

RESULTS: This study extracted and measured 30 post-ESWL urine samples, including 12 single composition samples, 15 binary composition samples, and 3 ternary composition samples. Results with MRS disclosed 15 binary compositions and the intensity Raman spectra was used for quantitative analysis. There are six COM/COD samples, five HAP/COM samples, two HAP/DCPD samples, one HAP/COD samples and one Uric acid/COM samples. The figure revealed the raman spectra of the patiens with 3 compositions (HAP/COM/COD) and percent composition could also be calculated by quantitative MRS-based method. The MRS based method detected more precise composition than the stone analysis by FTIR and also could do the quantitative analysis in minute/micro stones in urine. And the result showed the same between one shot urine and 24 hours urine.

CONCLUSIONS: This research successfully applied the quantitative MRS-based analysis technique from bench to bedside to measure the minute/micro stone components in urine after ESWL.

Source of Funding: none

MP1A-06 URINE AQUAPORIN-1 AND PERILIPIN-2: CAN THESE MARKERS ASSIST IN THE EVALUATION OF SMALL RENAL MASSES?

Jonathan Mobley*, Jeremiah Morrissey, Sam Bhayani, Joseph Song, Joel Vetter, Evan Kharasch, Robert Figenshau, St. Louis, MO

INTRODUCTION AND OBJECTIVES: The use of abdominal imaging has resulted in the increased detection of small renal masses (SRMs). As the size of a renal mass decreases, the probability of a benign pathology increases. Currently, renal mass biopsy is one of the few techniques used to distinguish renal cell carcinoma (RCC) from benign lesions prior to surgical intervention. We retrospectively evaluate the ability of pre-operative urine Aquaporin-1 (AQP1) and Perilipin-2 (PLIN2) to distinguish between benign and malignant pathology in SRMs.

METHODS: Fifty-seven patients with renal masses less than 4 cm in size underwent preoperative urine AQP1 and PLIN2 prior to tumor excision. Urine concentrations of AQP1 and PLIN2 were measured using Western blot procedures normalized to the urinary creatinine excretion. We retrospectively reviewed the urine concentrations for various tumor pathologies.

RESULTS: The final pathology of the resected SRMs included 34 clear cell RCCs, 8 papillary RCCs, 2 chromophobe RCCs, 7 oncocytomas, and 6 angiomyolipomas (AML). The median AQP1 for clear cell RCC was 26.5, for papillary RCC was 53.0, for chromophobe RCC was 3.5, for oncocytoma was 2.0, and for AML was 3.5 relative absorbance units/mg creatinine. The median PLIN2 for clear cell RCC was 23.0, for papillary RCC was 53.5, for chromophobe RCC was 6.5, for oncocytoma was 3.0, and for AML was 10.5 relative absorbance units/mg creatinine (Figure 1). The median urine AQP1 and PLIN2 was significantly elevated in clear cell and papillary RCC when compared to chromophobe RCC, oncocytoma, and AML.

CONCLUSIONS: In this small retrospective study, urine AQP1 and PLIN2 were significantly elevated in SRMs with clear cell and papillary RCC. These urine markers have the potential to distinguish benign lesions from clear cell and papillary RCC at the cost of false negative results for patients with chromophobe RCC. Use of these urinary markers may provide a noninvasive means to characterize SRMs without the need for a biopsy, and may reduce unnecessary excision of benign SRMs.

Source of Funding: Funding for the study comes from two grants: R01CA141521 and the Barnes Jewish Hospital Foundation.

OPEN IN VIEWER

MP1A-07 INTRA AND EXTRA-RENAL AUTONOMIC NERVOUS SYSTEM REDEFINED

Achim Lusch*, Emon Heidari, Ryan Leary, Zhamshid Okhunov, Jamie Wikenheiser, Jaime Landman, Orange, CA

INTRODUCTION AND OBJECTIVES: The role of the autonomic nervous supply to the kidneys is known to be involved in the development of several diseases, including hypertension. The neural distribution at the segmental vessels and intra-renal vasculature has not been well characterized. Herein, we evaluated the autonomic nerve distribution from the great vessels to the renal cortex in a cadaveric model.

METHODS: We performed a detailed anatomic nerve dissection from the inferior mesenteric artery to the renal operculum in two human cadaveric torsos. Autonomic nerve fibers were verified by dissecting the greater splanchnic, sympathetic trunk and ganglia. We then systematically cross-sectioned the kidneys in twelve 1 mm slices across a total 3.6 cm, and stained the slices for histopathologic analysis of neural tissue in relation to segmental arteries and other anatomic landmarks. An advanced reconstructive software (SolidWorks; Waltham, MA, USA) was used to create a three dimensional computer image of the nerves in relation to arteries, veins, and the collecting system.

RESULTS: On the main renal arteries and segmental arteries autonomic nerve fibers are located almost exclusively anteriorly with only rare fibers wrapping posteriorly. No nerve fibers ran with veins. Once within the parenchyma, histopathology revealed that the intra-renal nerves continue to track with the arteries but were more circumferentially distributed around the arteries. As slides proceeded from medial to lateral, the distance from the nerves to the artery wall diminished. Specifically, the nerve to the lumen intima distance of the arteries decreased from 0.91 mm to 0.36 mm from the medial to lateral slides. While the nerve tissue did not run with the collecting system, the proximity of the collecting system put most nerves within a few millimeters. The mean distance of the nerves to the renal collecting system components was 7 mm [range 0.69–21.4 mm].

CONCLUSIONS: The autonomic nerves supplying the kidney maintain their distribution almost exclusively along the anterior surface of arteries as they pass from the aorta to the segmental arteries. Once inside the renal parenchyma, the nerves are circumferentially distributed around the renal arteries and are in close proximity to the renal collecting system.

Source of Funding: None

MP1A-08 SECRETED FACTORS FROM PERITUMOR ADIPOSE TISSUES OF CLEAR CELL RENAL CELL CARCINOMA INCREASED THE MOTILITY OF HUMAN ccRCC CELL LINE CAKI-2 VIA ENHANCEMENT OF WNT SIGNALING

Achim Lusch*, Christopher Blair, Molly Baker, Zhamshid Okhunov, Victor Huynh, Xiaolin Zi, Jaime Landman, Orange, CA

INTRODUCTION AND OBJECTIVES: Perinephric adipose tissue (PAT) is metabolically active and manifests endocrine function. We evaluated the interaction between PAT and clear cell renal cell cancer (ccRRC) cells.

METHODS: PAT was collected from 49 patients (27 clear cell, 7 chromphobe, 1 papillary, 3 uncharacterized RCCs, and 11 benign pathology). PAT was harvested from patients undergoing renal surgery and cultured for 24 hours to generate conditioned media (CM). The effect of PAT CM on the proliferation and migration of ccRCC cell line Caki-2 was measured by MTT assay and Boyden chamber cell migration assay, respectively. In addition, Wnt/&#61538;-Catenin activity in PAT CM was examined as induced levels of &#61538;-Catenin. The proliferative and migratory responses are expressed as a stimulation index (SI) calculated by dividing the mean number of proliferative or migratory cells of PAT CM-stimulated wells by those of non-stimulated wells. Wnt response is similarly expressed as a ratio of mean Wnt activity of PAT CM-stimulated cells divided by that of non-stimulated cells.

RESULTS: PAT CMs from pT3 ccRCC patients resulted in a significant increase of CaKi-2 cell migration (mean SI and standard deviation, 1.80±0.52, P<0.05) compared to those at pT1 ccRCC (1.36±0.71, P>0.05) and pT2 (1.60±1.22, P>0.05), respectively. Conversely, the mean proliferative SIs of PAT CMs from ccRCC patients decreased as clinical stage advanced (pT1 versus pT3, 1.28±0.37 vs. 0.83±0.08). PAT CMs from patients with benign pathology has no significant effect on proliferation and migration. PAT CMs from chromophobe RCC also significantly increased the migration of Caki-2 (migratory SI, 1.96±1.01) with no effect on proliferation (SI, 1.02±0.50). High Fuhrman Grade is associated with increased migration by PAT CMs. Increased tumor sizes were inversely associated with proliferative SIs (correlation coefficient, −0.45). The increased migration of Caki-2 cells is associated with enhanced Wnt activity in PAT CMs.

CONCLUSIONS: We demonstrate a novel interaction between PAT and RCC which may facilitate understanding of cancer cell migration and metastasis in RCC patients. Further analysis is in progress.

Source of Funding: None

MP1A-09 CAN REMOTE ISCHEMIC PRECONDITIONING CONFER PROTECTION AGAINST REPERFUSION INJURY FOLLOWING WARM ISCHEMIA IN A PORCINE SOLITARY-KIDNEY MODEL?

Jeffrey Gahan*, Jodi Antonelli, Bedir Selahattin, Yunbo Ma, Steve Faddegon, Payal Kapur, Jeffrey Cadeddu, Dallas, TX

INTRODUCTION AND OBJECTIVES: Ischemic preconditioning (IPC) has been proposed as a method to confer protective effects for renal tissue subjected to warm ischemia; however, the benefit of IPC remains controversial. Studies in small animal models have yielded promising results, whereas studies in large animal have demonstrated conflicting results and have focused on local IPC (L-IPC). Our study sought to demonstrate for the first time the effects of remote IPC (R-IPC) on renal function in a large animal (porcine) solitary-kidney model.

METHODS: Twelve pigs were assigned evenly to two groups: each underwent a right nephrectomy followed by a week of recovery. Group 1 underwent left renal hilar dissection followed by hilar clamping for 90 minutes. Group 2 underwent right and left iliac artery dissection and clamping for 10 minutes each (R-IPC), followed by a reperfusion period of 30 min and then left hilar clamping for 90 minutes. Serum creatinine was drawn for both groups prior to the second surgery (pre-op), then at 24 hours, 3 days and 7 days after. Kidneys were harvested for histologic analysis at 24 hours or 7 days. A pathologist, blinded to study design, quantified ischemic and inflammatory damage on a 1–5 scale for the two groups.

RESULTS: Paired serum creatinine values were analyzed between time points. For group 1, paired differences existed at 24 hours (p=0.044) but not at 3 days or 7 days. For group 2, paired differences existed at 24 hours (p=0.043) but not at 3 days or at 7 days. Mean serum creatinine was similar for both groups at pre-op (p>0.05). Mean change in serum creatinine from pre-op values was compared between Groups 1 and 2 at each time point and found not to be significantly different. Histologic analysis revealed rare evidence of ATN at 24 hours in the R-IPC group. At 7 days, neither group showed ATN and both showed 1–2+ evidence of lymphocytic infiltrates and lymphnode aggregates.

CONCLUSIONS: Remote ischemic pre-conditioning in a solitary-kidney porcine model does not confer renal protection after warm ischemia either on serum or histological analysis. The porcine kidney seems resilient to even prolonged warm ischemia times with only minor inflammatory damage or ATN detected at any point. Though a longer period of R-IPC may have an impact, this would likely become clinically impractical.

Source of Funding: None

MP1A-10 URINARY CYSTATIN C AND NGAL AS EARLY BIOMARKERS FOR ASSESSMENT OF RENAL ISCHEMIA- REPERFUSION INJURY: A SERUM MARKER TO REPLACE CREATININE?

Ben Woodson*, Liang Wang, Sree Mandava, Benjamin Lee, New Orleans, LA

INTRODUCTION AND OBJECTIVES: Cystatin C is a nonglycosylated 13 kDa basic protein that is a member of the cystatin superfamily of cysteine protease inhibitors and is produced by all nucleated cells. Cystatin C is filtered by the glomerulus, then undergoes essentially complete tubular reabsorption and catabolism. Clinically, it may be measured in the urine or the serum when attempting to make determinations of acute kidney injury. Our objective was to assess use of cystatin C and NGAL as biomarkers for renal injury after renal hilar clamping using a rodent animal model. We also evaluated the use of Allopurinol as a renoprotective agent applying the same model.

METHODS: In 58 Sprague-Dawley rats, urinary cystatin C (n=26) and NGAL (n=32) was measured as a biomarker for renal ischemia injury. Half of the rats were pretreated with allopurinol, and the other cohort was used as control. The right renal hilum and ureter were ligated in all animals, thereby creating a solitary kidney model. After a 30 minute stabilization period, the left hilar vessels were then clamped for time periods of 15, 30, and 60 minutes. Urinary levels of cystatin C and NGAL were then measured at the following time points: preclamp (after the 30 minute stabilization period) and post clamp (30, 45, and 60 minute time periods after unclamping had occurred).

RESULTS: With a 15 minute clamp time, Cystatin C values increased 11.7 fold compared to controls. With a 30 minute clamp time, the ratio of Cystatin C increased 14.5, and appeared to peak at this length of warm ischemia. At a prolonged 60 minute clamp time, the Cystatin C levels dropped to a 10.5 ratio. The 30 minute period of ischemia consistently demonstrated the greatest increase compared to controls.

Findings with NGAL also demonstrated a peak level of damage at 30 minutes, with a 4.13 fold increase over controls. Allopurinol did appear to serve a renoprotective function in those animals undergoing 30 minute clamp times.

CONCLUSIONS: Cystatin C and NGAL both appear to be useful biomarkers of renal injury after surgically induced ischemia, with reproducible maximal levels of damage at 30 minutes. However, studies with larger numbers are still needed. Also, allopurinol does exhibit renoprotective effects against renal ischemia and reperfusion.

Source of Funding: Departmental

MP1A-11 MULTIPHOTON MICROSCOPIC CHARACTERIZATION OF RENAL CELL CARCINOMA

Sara Best*, E. Jason Abel, Matthew Houlihan, Kevin Eliceiri, Madison, WI

INTRODUCTION AND OBJECTIVES: Optical biomarkers assessed via multiphoton microscopy (MPM) and Second Harmonic Generation Microscopy (SHG) have been linked to prognosis and outcomes in ovarian and breast cancer. These optical approaches can assay both H&E stained and non-stained samples to look at both labeled elements and intrinsic signals such as autofluorescence and SHG from collagen. We sought to characterize renal cell carcinoma (RCC) with MPM to assess for any changes in these intrinsic signals that correlated with pathologic assessment.

METHODS: An unstained tissue microarray was constructed using 0.6 mm cores of renal tissue specimens. Samples from 100 patients were analyzed with MPM, including RCCs grades 1–4 and benign tissue. A multiphoton workstation equipped with a Ti: Sapphire laser set to an excitation wavelength of 890 nm was used to analyze each specimen. This technique generated both second harmonic generation (SHG) and autofluorescence images that are separable by optical filters. The images were then compared.

RESULTS: Unstained renal tissue, both benign and malignant, generates excellent intrinsic signals, both SHG and autofluorescent, that were detected with MPM. Initial efforts to characterize differences among Fuhrman grades of RCC identified detectable differences in collagen patterning (Figure 1). These differences are also apparent on the small samples used in the microarray, which are similar to those that might be obtained from a renal tumor biopsy.

CONCLUSIONS: Multiphoton microscopy provides a flexible platform with which to analyze renal tumors and may provide additional information to characterize both whole specimens and biopsy cores. Further studies will aim to quantify renal cancer optical biomarkers such as collagen alignment and associate them with patient outcomes.

Source of Funding: none

OPEN IN VIEWER

MP1A-12 ADDITION OF SODIUM BICARBONATE TO IRRIGATION SOLUTION MAY ASSIST IN DISSOLUTION OF URIC ACID FRAGMENTS DURING URETEROSCOPY

Jessica E Paonessa*, Naeem Bhojani, James C Williams, Jr., James E Lingeman, Indianapolis, IN

INTRODUCTION AND OBJECTIVES: We hypothesized that addition of sodium bicarbonate (bicarb) to normal saline (NS) irrigation during ureteroscopy, in patients with uric acid (UA) nephrolithiasis, may assist in dissolving small stone fragments produced during laser lithotripsy. In vitro testing was performed to determine if dissolution of UA fragments could be accomplished in one hour or less.

METHODS: 100% UA renal calculi were fragmented, filtered and separated by size. Group 1 stones were <0.5 mm. Group 2 stones were 0.5–1 mm. Similar amounts of stone material (0.0121¨C0.0183 g) were agitated in 200 ml of solution. Four solutions were tested (NS, NS+1 ampule bicarb/liter, NS+2, NS+3). Both groups were filtered to remove solutions after fixed periods (¡Ü1 hr). Filtered specimens were dried and weighed. Stone dissolution rates were calculated as percent removed per hour.

RESULTS: For group 1, the NS+1 solution was not significantly different from any other solution. However, mean percent removed in NS (40.14%) was significantly lower than in NS+2 (80.65%) and NS+3 (85.56%)(p<0.02). For group 2, mean percent removed in NS (4.5%) was significantly lower than all NS+bicarb solutions (NS+1=16.6%, NS+2=21.45%, NS+3=23.34%) (p<0.05 for each).

CONCLUSIONS: Addition of bicarb to saline more than doubles the dissolution rate of UA fragments, and fragments <0.5 mm can be completely dissolved in ¡Ü1 hr. Addition of bicarb to NS may assist in dissolution of UA fragments during ureteroscopy, which may shorten operative times and reduce residual stone material in the kidney post-procedure.

Source of Funding: None

MP1A-13 DIETARY HYDROXYPROLINE INDUCED CALCIUM OXALATE LITHIASIS AND ASSOCIATED RENAL INJURY IN THE PORCINE MODEL

Sri Sivalingam*, Stephen Nakada, Priyanka Sehgal, Tom Crenshaw, Kristina Penniston, Madison, WI

INTRODUCTION AND OBJECTIVES: We previously reported hyperoxaluria and calcium oxalate calculi in adult pigs (sows) fed hydroxyproline (HP). The purpose of this study was to grossly and histopathologically characterize intra-renal effects in this model.

METHODS: In the swine facility at our campus, we maintained 21 gestating sows, of which 15 received daily treatment (10% HP mixed with dry feed) and 6 received no treatment (controls). Nine were sacrificed at 21 d (3 control, 6 HP). All kidneys were extracted and examined grossly and for radiographic evidence of stones (GE CT scanner, 80 kV, 400 MA, 1 sec rotation, 0.625 mm slices). Papillary and cortical samples were processed for histologic analysis.

RESULTS: Kidneys from treated sows showed significant calculi distributed within renal papilla on CT, appeared mottled in the renal cortex and papillary areas, and had less distinct cortico-medullary borders. Tiny crystals and mucinous debris lined the papillary tips, calyces, and pelvis in kidneys from 4 of 6 treated sows, and multiple stones were noted at the papillary tips. H&E revealed crystals in collecting tubules and papillary tips in treated kidneys and none in controls (Fig 1). Yasue staining confirmed crystals in proximal peri-glomerular tubules of treated but not control animals. Tubular dilation, and inflammatory/fibrotic changes were identified in kidneys from treated animals (fig 2); none of these changes were evident in control kidneys.

CONCLUSIONS: We report renal damage as a result of dietary-induced hyperoxaluria in adult sows. Specifically, we found crystalluria in proximal peri-glomerular tubules and collecting ducts, with tubular damage at all segments.

Source of Funding: none

OPEN IN VIEWER

FIG. 1.

papillary tips at 21 days, 4X magnification. H&E stain: (A) no crystals in CD kidney, and (B) crystals in TD kidney (arrows); Yasue stain: (C) no crystals in CD kidney & (D) crystals in TD kidney (arrows)

OPEN IN VIEWER

FIG. 2.

Cortical section, 21 days, H&E 20x. (A) normal glomerulus in control kidney; (B) peri-glomerular inflammation and fibrotic changes (white arrow), with crystal in proximal tubule (black arrow), (C) tubules surrounded by multinucleated giant cells (arrows), (D) 10X magnification, radiating regions in renal cortex with widening of interstitium with extracellar matrix (arrows) interpreted as fibrotic changes.

MP1A-14 THE RECOVERY OF URETERAL PERISTALSIS AFTER TRANSIENT OBSTRUCTION IN A NOVEL MURINE MODEL

Claudia Janssen*, Wolfgang Jaeger, Igor Moskalev, Ben H. Chew, Dirk Lange, Vancouver, Canada

INTRODUCTION AND OBJECTIVES: Ureteral obstruction in stone disease is the most common cause for disrupted ureteral peristalsis. While the impact of unilateral ureteral obstruction (UUO) on renal function has been addressed, information regarding how UUO affects ureteral function is limited.

Furthermore, erythropoeitin (EPO), an endogenous hormone of the kidney, has been suggested to play protective roles against injury and damage in various organs. As such it may also be protective against the negative effects induced by UUO.

This study introduces a novel murine model of transient UUO that allows for the investigation of how the duration of UUO impacts the recovery of peristalsis, as well as whether EPO has protective effects on ureteral patency and function following UUO.

METHODS: Abdominal laparotomy and UUO was performed in CD-1 mice for 24 h (group 1; n=6), 48 h (group 2; n=6) and 72 h (group 3; n=6) using a non-traumatic micro clamp. To test the protective effects of EPO as has been reported in the literature, n=5 animals at each time point were given 200 IU EPO intra peritoneally on four consecutive days prior to obstruction. Ureteral peristalsis was tracked bilaterally via video microscopy prior- and post-removal of the obstruction. The degree of hydronephrosis was assessed daily using ultrasound imaging.

RESULTS: The model's technical success rate was 94%. The natural variation in bilateral peristaltic activity in each animal prior to UUO was not significant (15%, P=0.19) to affect overall results. Hydronephrosis and aperistalsis were observed in all animals 24 h post-UUO. Following resolution of hydronephrosis, ureteral peristalsis was restored at 2 d (group 1), 6 d (group 2) and 8 d (group 3) post-obstruction removal. Despite the return of peristalsis, the activity in the previously obstructed ureters was significantly decreased in all groups. Overall, the period to resolution of hydronephrosis and recovery of ureteral peristalsis following UUO in all groups was significantly shorter in the EPO treated animals compared to un-treated groups.

CONCLUSIONS: Transient UUO significantly disrupts ureteral peristalsis, with the duration of obstruction being the major determining factor for the length to full recovery. EPO, when administered prior to UUO has protective effects on the ureters and significantly shortens the recovery period. The next steps will involve testing the protective functions of EPO when administered during and following UUO to determine whether this type of intervention could be used therapeutically.

Source of Funding: None

MP1A-15 RAMAN SPECTROSCOPIC COMPOSITION ANALYSIS OF URINARY CALCULI

Matthias Eder*, Elena Foditsch, Reinhold Zimmermann, Maurizio Musso, Guenther Redhammer, Paolo Sereni, Salzburg, Austria

INTRODUCTION AND OBJECTIVES: With accurate knowledge of urinary calculi composition followed by appropriate metaphylaxis, the recurrence rate can be reduced from 50 to 15 %. Therefore, various guidelines routinely recommend calculi composition analysis by infrared spectroscopic or X-ray diffraction analysis after sample pulverization. Only few studies dealt with non-destructive analysis of calculi by means of Raman spectroscopy, a technique complementary to infrared spectroscopy. Aim of this study is to evaluate the accordance accuracy of Raman spectroscopic methods with standard methods for urinary calculi composition analysis.

METHODS: Raman spectra of urinary calculi of 30 patient (stone size 2 mm–3 cm, removed from ureter and bladder in one case) were recorded using a Bruker FT-Raman spectrometer. Laser excitation at 1064 nm ensured low fluorescence disturbance for Raman spectra. A BioRad Raman database and own reference spectra were used to identify calculi composition. Raman spectroscopy requires no specific sample preparation, delivering spectral information from within the laser spot (0.1 mm diameter); infrared spectroscopy, on the other side, usually requires sample pre-treatment by pulverization, averaging information from the whole sample.

RESULTS: The results obtained by Raman spectroscopic composition analysis of the 30 cases were compared with those independently obtained by infrared spectroscopy, and in 5 cases with those additionally obtained by x-ray diffraction. Overall excellent accordance was obtained: neat calcium oxalate in 20 cases=66%, neat uric acid in 2 cases=6% and neat hydroxylapatite in 1 case=3%. 6 of the remaining 7 cases dealt with mixtures of two or three components, some secondary calculi components not being detected by Raman spectroscopy. The 5 x-ray diffraction results are in very good accordance with the Raman results, 4 of them with corresponding infrared results, a disagreement being found for a third component of a mixture.

CONCLUSIONS: Raman spectroscopy proves to be a reliable method to identify compositions of urinary calculi. In contrast to established calculi analysis by infrared spectroscopy or x-ray diffraction, Raman spectroscopy doesn't require specific sample preparation, but implies the risk of missing secondary components, if averaging over the whole sample is not performed. Future studies on whole calculi and their powders by Raman spectroscopic mixture analysis might provide information on the heterogeneities within given samples, and improve the metaphylaxis of urolithiasis.

Source of Funding: None

MP1A-16 KIDNEY STONE PREVENTION: CAN OBESE PATIENTS FOLLOW A DIET?

Fabio Torricelli*, Shubha De, Ina Tien, Manoj Monga, Cleveland, OH

INTRODUCTION AND OBJECTIVES: Obese patients have an increased risk of kidney stones, and several studies have identified specific urinary derangements on 24 hour collections. The objective of this study was to whether life-style and dietary changes are effective in obese patients for stone prevention.

METHODS: After IRB approval a retrospective analysis was carried out. All stone patients with a BMI >30, who performed a 24 hour urine collection before and after dietary counseling for stone disease (between Jan’03 to Mar’13) were included. Demographic data, medications, and 24 hour urine components suggesting dietary compliance (sodium, calcium, oxalate, uric acid and citrate) were assessed. Initial 24-hour urine results were compared to follow up results using Mann-Whitney U tests, with an alpha value<0.05 (SAS 9, Cary NC).

RESULTS: Eighty-seven obese stone patients (BMI 36.6 kg/m²) were identified and 66.7% were male. The mean time duration of follow-up with repeat 24-hour collections was 9.3 months. Obese stone patients significantly increased their urinary volume (1410 to 1746 mL, p=0.001) and citrate (159 to 704 mg/24 hrs p<0.001), while decreasing their sodium (279 to 240 mg/24 hrs p=0.007), oxalate (81 to 58 mg/24 hrs, p=0.01) and uric acid levels (958 to 732 mg/24 hrs, p=0.001).

CONCLUSIONS: Obese patients can follow a diet. Dietary recommendations can be an effective strategy in counseling obese patients in regards to their stone disease.

Source of Funding: none.

OPEN IN VIEWER

FIG. 1.

Changes in 24h urine collections before (blue) and after (red) dietary counseling

Dean Assimos*, Ross Holmes, John Knight, Birmingham, AL

INTRODUCTION AND OBJECTIVES: The metabolism that results in the formation of oxalate, an important component of most kidney stones, has not yet been resolved. Glyoxylate is the main precursor of oxalate. Hydroxyproline (Hyp) is a major source of glyoxylate as its breakdown produces an equimolar amount of glyoxylate which may be converted to glycolate, glycine or oxalate. This study was designed to examine the metabolism of Hyp using a primed, intravenous infusion of (13C515N)-Hyp.

METHODS: Five normal subjects were infused with 750 nmoles of (13C515N)-Hyp/kg/hr for 6 hrs in the fasted state after a priming dose equivalent to the amount to be infused in 2 hrs. Blood samples were obtained every 30 min and urine samples every hour. (13C515N)-Hyp was measured in plasma by GC/MS, 13C-glycolate in plasma by IC/MS, and 13C2-oxalate and 13C2-glycolate in urine by IC/MS.

RESULTS: Enrichment of plasma with (13C515N)-Hyp was constant from 4–6 hrs when it reached 19.0±4.3%. Urinary oxalate was enriched by 2.4±1.2% and glycolate by 11.9±1.6%, indicating that the mean contribution of Hyp metabolism to total urinary oxalate excretion was 13.0±5.5% and to urinary glycolate excretion was 63.4±3.7%. There was an 18.5±6.8% increase in the enrichment of urinary glycolate compared to the enrichment in plasma glycolate, suggesting that renal metabolism of Hyp contributed directly to the urinary glycolate pool. The total body flux of Hyp was calculated to be 3.93±0.08 μmoles/kg/hr or 840 mg/day for a 70 kg individual.

CONCLUSIONS: These results suggest that Hyp metabolism is a major source of urinary glycolate and a minor source of urinary oxalate in normal subjects. As much as half of the urinary oxalate may have been obtained from the diet, Hyp metabolism may contribute at least 25% to the urinary oxalate derived from endogenous synthesis. The inability of subjects with Primary Hyperoxaluria to efficiently metabolize glyoxylate produced from Hyp breakdown may be a major source of endogenous oxalate production in this disease. Assuming that collagen is 14% Hyp and all of the body flux of Hyp is derived from the breakdown of endogenous collagen, total body flux of collagen is approximately twice that previously estimated.

Source of Funding: This research was supported by NIH grants R01DK83527 and U54DK83908

MP1A-18 STONE DEPICTION WITH THE URO DYNA-CT: STONES OF DIFFERENT COMPOSITIONS

Benjamin Meister*, Marie-Claire Rassweiler, Maurice-Stephan Michel, Manuel Ritter, Mannheim, Germany

INTRODUCTION AND OBJECTIVES: With the Uro Dyna-CT (Siemens Healthcare, Erlangen, Germany) you can perform interventional 3D- and cross-sectional imaging in the endourological operation. Radiopaque stone visibility with the Uro Dyna-CT depends on contrast agent dilution1. Furthermore accuracy of stone measurement is essential for clinical decision making. The aim of our ex vivo study is to investigate the visibility and the accuracy of size measurement of renal stones of different compositions in specific contrast agent dilutions.

METHODS: We used 5 renal stones of different compositions: A (3,4 mm): 60% calcium-monohydrate+40% calcium-dihydrate, B (5,9 mm): 60% carbonate-apatite+40% magnesium-ammonium-phosphate, C (4,6 mm): 10% carbonate-apatite+20% calcium-monohydrate+70% calcium-dihydrate, D (5,4 mm): 40% calcium-monohydrate+60% calcium-dihydrate, E (5 mm): uric acid. We first measured the maximum diameter of each stone with a caliper. Afterwards the stones were put into small plastic jars filled with contrast agent dilutions ranged from 10% to 100%. They were scanned in the Uro Dyna-CT with two specific stone protocols (“Urology stone”,“Urology stone low dose”). The images were evaluated regarding stone visibility and the largest diameters of the stones were measured at the workstation. The size of the stone measured with the caliper was compared to the size measured with the Uro Dyna-CT in the different contrast agent dilutions (CAD).

RESULTS: Stone visibility and accuracy of size measurement showed the best results with a CAD of 20% for stone A-D with both stone protocols, whereas stone A and D showed the best visibility at 10% and 40% with the Urology stone low dose and Urology stone protocol respectively. For stone E 30%–50% showed to be the best CAD. There is almost no difference between the two stone protocols regarding accuracy in size measurement of the different stones. (Table: Results).

CONCLUSIONS: In our ex vivo setting a contrast agent dilution of 20%-30% allows imaging and highly accurate measurement of different radiopaque and radiolucent stones independent. This seems to be the ideal contrast agent dilution for interventional 3D- and cross-sectional imaging with the Uro Dyna-CT.

Source of Funding: none

OPEN IN VIEWER

¹Ritter M, Weiss C, Rassweiler M-C. et al. Optimizing imaging quality in endourology with the Uro Dyna-CT: contrast agent dilution matters. World J Urol 2012; [Epub ahead of print]

MP1A-19 IN VITRO STONE DISINTEGRATION OF STANDARDIZED BON(N) STONES TO COMPARE THE DIODE LASER 1.318 NM WITH THE HOLMIUM LASER 2.100 NM AND ESTABLISHING AN EX VIVO ANIMAL MODEL FOR IN SITU DIODE LASER EVALUATION

Reinhold Zimmermann*, Markus Wallner, Salzburg, Austria, Roswitha Siener, Bonn, Germany, Gunter Janetschek, Esra Foditsch, Salzburg, Austria

INTRODUCTION AND OBJECTIVES: The holmium laser (HL) is the gold standard for stone disintegration (SD). The diode laser (DL) with a wavelength of 1318 nm exhibits excellent cutting and coagulating properties for laparoscopic partial nephrectomy (lapPNE) and prostate enucleation. The DL was not yet evaluated for SD. The artificial BON(N) stones are an excellent tool to evaluate stone therapies. We compared for the first time the DL to the HL in an in vitro trial using BON(N) stones and investigated the DL in an ex vivo urinary tract model.

METHODS: BON(N) stones are standardized (mass, volume, diameter, density) uniform artificial stones (Whewellit, guanite, cystine), made of natural crystals. Cystine (n=11), whewellit (n=6) and guanite (n=7) stones were investigated using HL (wavelength 2.100 nm) and DL (wave length 1.318 nm). Stones were placed in a customized basket in a 37°C 0.9% NaCl solution. Laser pulse energy was obtained by a PVDF hydrophone. Laser-on time, fragment size and temperature changes were measured. In an ex vivo porcine model we treated natural stones by ureteroscopy (URS) and continuous wave DL with continuous temperature monitoring.

RESULTS: Average positive/negative peak pressure was 14.6 bar (+/−5.4 bar)/−1.8 bar (+/−1.5 bar) (DL) and 17.6 bar (+/−4.3 bar)/−1.9 bar (+/−0.8 bar) (HL). HL waves were more uniform. Disintegration time for cystine was 105 sec (85–138 sec, DL) and 128 sec (102–155 sec, HL), for Whewellit 500 sec (195–780 sec, DL), 464 sec (439–489 sec, HL) and for guanite 165 sec (43–220 sec, DL only). Final fragment size of <1 mm was achieved for cystine in 94.3%/92% (DL/HL), for whewellit in 68.4%/52.8% (DL/HL) and for guanite in 85% (DL only). Temperature increased approx. 0.8°C/min during laser-on time (DL only) in vitro. The ex vivo model proved feasibility for DL URS, stone disintegration time was 10–60 seconds, intraureteral temperature increased during disintegration period for up to 10°Celsius.

CONCLUSIONS: The DL exhibited in vitro stone disintegration power. BON(N) stones represent basically a feasible and reproducible model to investigate stone laser devices. Disintegration rate and laser-on time of the DL were similar compared to the HL. Temperature increased moderately using the DL. In the ex vivo model simulating URS with stone disintegration, the temperature rise was significant. This is the crucial limitation of the DL for stone treatment. An in vivo animal study will be conducted to evaluate stone disintegration and temperature for defining the DL role finally.

Source of Funding: none

MP1A-20 THE TENSION TEST AND IN VITRO DEGRADATION OF POLY (LACTIC ACID - GLYCOLIC ACID)/POLYCAPROLACTONE BIODEGRADABLE NANO-STRUCTURE URETERAL STENT FABRICATED BY ELECTROSPINNING

Xiao Qing Wang, Hong Li Shan, Zhi Hua Lu, Yu Chuan Hou, Chun Xi Wang*, Changchun, China, People's Republic of

INTRODUCTION AND OBJECTIVES: To investigate the mechanical property and In vitro Degradation of a polycaprolactone (PCL)/poly (lactic acid - glycolic acid)(PLGA) degradable ureteral stent.

METHODS: The PCL/PLGA ureteral stent was fabricated by electrospinning. The structure and properties of the stents were investigated by the mechanical property testing, scanning electron microscopy (SEM), degradability test in vitro.

RESULTS: The inner diameter of the tubular scaffold in our study was 1.0 mm and the outer diameter was 2.5 mm. The SEM results show that the scaffold has the nano-structure. The diameters of the fibers of different ratio of PCL/PLGA stents have no differences. The tension test showed that the mechanical property was enhanced with the increase in the proportion of the PCL. The degradation curves of different ratio of PCL/PLGA stent were close to a straight line. The 5% PCL/PLGA stent could collapse within 28 d, and the 15% PCL/PLGA and 25% PCL/PLGA could collapse within 42 d and 56 d, respectively.

CONCLUSIONS: The PCL/PLGA biodegradable ureteral stent has a good mechanical property and the degradation time can fully satisfied the demand of a ureteral stent.

Source of Funding: Supported by the National Natural Science Foundation of China (no. 50973043).

MP1A-21 HOW TO DETECT ACUTE POST-OPERATIVE KIDNEY INJURY AFTER CLAMPLESS LAPAROSCOPIC PARTIAL NEPHRECTOMY? A PILOT STUDY

Francesco Porpiglia*, Daniele Amparore, Riccardo Bertolo, Fabrizio Mele, Diletta Garrou, Giovanni Cattaneo, Matteo Manfredi, Cristian Fiori, Orbassano (Torino), Italy

INTRODUCTION AND OBJECTIVES: NGAL (Neutrophil gelatinase-associated lipocain), is a 25 KDa protein overexpressed in case of renal injury. NGAL measured in both plasma and urine is being discussing as a precocious biomarker of acute kidney injury (AKI). A few studies in Literature analysed the role of NGAL in the evaluation of renal injury in postpartial setting. The aim of this study was the evaluation of role of urinary-NGAL as marker to detect and quantify renal damage in patient who underwent clampless-Laparoscopic Partial Nephrectomy (c-LPN).

METHODS: Twenty-four consecutive patients who underwent c-LPN between March and July 2012 were involved in this prospective study. Demographic, peri-operative and pathological data were collected. Concerning functional data, NGAL urinary values were dosed on urine samples collected preoperatively, at 24 hours, 5 days and 3 months after surgery by ELISA in all patients. Serum Creatinine (SCr) and GFR (MDRD formula) were determined at the same time points. Data were analyzed with Friedman ANOVA and Kendall's Concordance test (p<0.05 considered significant).

RESULTS: Mean age and BMI were 65.6 years and 25.54, respectively. Hypertension was recorded in 16 patients (66.6%); mean Charlson's index, CT-scan size and PADUA score were 3.25, 4.51 cm and 8.08, respectively. Mean operative time and estimated blood losses were 115.2 min and 341.6 ml. Mean complications' rate and hospital stay were 8.3% (2/24) and 5.4 days, respectively. Mean thickness of healthy parenchyma excised was 0.7 mm. No positive surgical margins were recorded. Average SCr and GFR values were almost stable at every time point; average NGAL values were 21.3+21.7 ng/ml, 37.0+37.8 ng/ml, 56.5+42.7 ng/ml, 23.7+37.1 ng/ml, both tested respectively before surgery, 24 hours, 5 days and 3 months after surgery (p=0.042). No differences were found when specifically testing NGAL baseline versus 3rd month value (p=0.).

CONCLUSIONS: Notwithstanding the small sample size, we observed a progressive and proportional increase of urinary NGAL values from baseline until the fifth post-operative day; a return to basal values was recorded at 3rd month. Conversely, SCr and GFR values remained stable in all measurements. Our data suggest that NGAL could be a useful molecular marker to detect early onset renal damage, regardless of ischaemia. In our case study it showed able to detect even minimal damages and it was used to evaluate the trend acute kidney damage following c-LPN. Further studies are required.

Source of Funding: none

MP1A-22 BIOMECHANICAL PROPERTIES OF THE URETER: PRELIMINARY RESULTS

Yaniv Shilo*, Joseph E. Pichamuthu, Timothy D. Averch, Stephen V. Jackman, David A. Vorp, Pittsburgh, PA

INTRODUCTION AND OBJECTIVES: Ureteral injuries such as perforation and avulsion are directly related to mechanical damage of the ureter. Understanding the biomechanical properties of this tissue may assist in engineering efficient devices for urological applications, a better comprehension of pathological events in the ureter and prevention of iatrogenic injuries. While few studies looking on the mechanical properties of the animal ureter were reported, specific data on the tensile strength and elastic properties of the human ureter is unavailable. The purpose of this work was to study the biomechanical properties of the human ureter.

METHODS: After obtaining IRB approval, we harvested 6 human proximal ureters (4 male and 2 female) from patients who had nephrectomy for either renal cell carcinoma or nonfunctioning kidney from August, 2012 to February, 2013. The ureters were immediately placed in saline at 4°C and tested within 48 hrs. The ureter was then cut into multiple circumferentially- and longitudinally-oriented tissue specimens for tensile testing. Initial dimensions of each tissue specimen were measured and then mounted and stretched to failure after ten cycles of preconditioning in a uniaxial tensile testing machine. The corresponding force and displacement was recorded and stress-strain curve was plotted. Finally, stress at failure was noted as the tensile strength of the sample. Circumferential tensile strength was also compared in the proximal and distal regions of the specimens.

RESULTS: The age of the patients studied was 66.5±10.8 (mean±SEM) years and BMI was 24.5±1.8. The tensile strength of the ureter in circumferential and longitudinal orientations were found to be 538±50 MPa and 1059±197 MPa, respectively (p<0.03). The circumferential strength in the proximal portion of the ureter was 501±41 MPa in comparison to 575±94 MPa in the distal portion (p=0.15).

CONCLUSIONS: The circumferential tensile strength of the ureter was found to be significantly lower than the longitudinal. Additionally, the circumferential tensile strength of proximal segments of the ureter is lower than its distal segments, likely indicating the proximal portion of ureter is more prone to be damaged than the distal portion.

Source of Funding: none

MP1A-23 SPECTROSCOPIC TISSUE ANALYSIS OF RENAL ISCHEMIA AND RECOVERY DURING SEGMENTAL RENAL ARTERY VS MAIN RENAL ARTERY CLAMPING

Philip Dorsey*, Quincy Brown, New Orleans, LA, Janet Colli, Memphis, TN, Kate Elfer, Theodore Saitz, Ross McCaslin, Benjamin Lee, New Orleans, LA

INTRODUCTION AND OBJECTIVES: Spectroscopic tissue analysis has been used to monitor changes in tissue vascular hemoglobin oxygen saturation during periods of tissue ischemia. Our goals were to utilize spectroscopic tissue analysis to quantify renal ischemia during hilar clamping and to compare tissue vascular hemoglobin oxygen saturation levels while clamping the main renal artery versus clamping segmental renal arteries using a laparoscopic porcine model.

METHODS: Institutional Animal Care and Use Committee approval was obtained. Spectroscopic renal ischemia was measured before, during and after laparoscopic hilar clamping of 8 Yorkshire swine renal units. Spectroscopic renal measurements (n=257) were obtained at baseline (prior to selective renal hilar clamping), every 30 seconds during warm ischemia (5 min trials) and for 10 minutes after unclamping. Times to 10% of max hemoglobin saturation after clamping were recorded as ischemic times, while times to 90% of max hemoglobin saturation after unclamping were recorded as reperfusion times. Trials clamping the main renal artery were compared to clamping a segmental renal artery.

RESULTS: When the main renal artery was clamped, the drop in tissue ischemia occurred faster than compared to segmental artery clamping (22.3 vs 45.5 sec). In addition, during segmental artery clamping, tissue spectrometry levels remained higher when the probe was placed in regions not perfused by the clamped segmental artery. Upon reperfusion, mean renal spectrometry saturation levels returned to baseline slower when the main renal artery was clamped compared to when only a segmental renal artery was clamped (53.8 vs 45.5 sec).

CONCLUSIONS: Tissue spectrometry demonstrated a reproducible measurement of the drop in tissue oxygen saturation during periods of renal ischemia in a porcine model. Spectrometric tissue analysis during main renal arterial clamping demonstrated more significant drops in tissue oxygen saturation and slower recovery of tissue ischemia when compared to clamping a segmental renal artery alone. Further studies correlating tissue spectrometry to renal function recovery following hilar clamping are underway.

Source of Funding: None

MP1A-24 NOVEL BIOMARKERS TO MEASURE CHANGES IN KIDNEY FUNCTION IN THE ADULT HUMAN

Sree Harsha Mandava*, Benjamin Woodson, Liang Wang, Benjamin Lee, New Orleans, LA

INTRODUCTION AND OBJECTIVES: Acute kidney injury (AKI) can occur spontaneously or iatrogenically, and rates of AKI continue to rise over the last two decades despite improvements in clinical care and development of preventive strategies. Serum creatinine (sCr) is the current gold standard for measuring changes in kidney function and identifying AKI. Detection of AKI by sCr, however, is delayed. Biomarkers may represent an earlier assessment of changes in kidney function.

METHODS: A systematic review of the current literature was performed, looking at urinary biomarkers and evaluate their ability to measure change in kidney function. Specifically, neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-beta-D-glucosaminidase (NAG), Interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1), liver fatty-acid-binding protein (L-FABP), and cystatin-C were examined due to the ability to readily test human urine/serum with their respective kits.

RESULTS: Analysis of these biomarkers reveals that they individually have unique strengths and weaknesses that can provide different types of information about patients. Several urinary biomarkers, have shown an ability to predict AKI days before an elevation in sCr, and a few even seem to predict AKI-related morbidity and mortality better than sCr alone. Urinary excretion of NGAL increased gradually from baseline levels of 9.6±2.8 to a maximal value of 271.9±34.3 ng/min (P<0.05), 4 h after the induction of the renal injury. A similar trend in urinary excretion of KIM-1 was seen with a gradual increase in urinary KIM-1 from baseline levels of 2.71±0.67 to maximal levels of 182.6±77.08 ng/min (P<0.05), 3 h after renal insult.

CONCLUSIONS: Currently, NGAL is the urine biomarker with the most promise as an individual marker. However, combining multiple markers to form a 'biomarker panel' along with sCr is an improvement over current clinical risk prediction models alone, and may be able to provide more individualized detail about the type and location of renal injury.

Source of Funding: none

MP1A-25 INCIDENCE OF HYBRID TUMORS FOUND IN EXCISED RENAL MASSES: A MULTI-INSTITUTIONAL ANALYSIS

David Fumo*, Toledo, OH, Pengbo Jiang, Hackensack, NJ, Khaled Shahrour, Toledo, OH, Ravi Munver, Hackensack, NJ, Samay Jain, Toledo, OH

INTRODUCTION AND OBJECTIVES: The use of renal biopsy has gained popularity in recent times as an adjunct in the work up of renal masses, particularly small renal masses (<4 cm) suspicious for renal cell carcinoma (RCC). Our present study attempts to quantify the prevalence of tumors that contain more than one histology as a means of determining the potential accuracy of renal biopsy.

METHODS: In this IRB-approved, multi-institutional study, a retrospective review of renal masses excised between the years of 1999–2012 was performed. Patients and masses were included in the study if information pertaining to demographics and pathologic stage, mass size, and histology were present, respectively. Tumors were considered to be hybrid tumors if more than one distinct histology was reported in the final pathology. Granular cell RCC was considered a variant of clear cell RCC and, therefore, these masses were considered non-hybrid tumors. Statistical analyses were completed with paired T-tests and Chi Squared analysis, where appropriate. All analyses were completed using Microsoft Excel.

RESULTS: A total of 203 tumors were included in the analysis. Table 1 summarizes the patient demographics and results of the study. Of the entire cohort, 21 tumors (10%) displayed more than one distinct histology. The differences in mass size and age of patients between the two sub-groups were not statistically significant. There was a greater proportion of pT1a lesions in the hybrid tumor group compared to the single histology group (p=0.03).

The breakdown of each hybrid tumor with its described histology is listed in table 1. A majority of the hybrid tumors were pT1a and were a combination of clear cell and papillary cell RCC. Thirteen of the hybrid tumors were smaller than 4 cm in size and three of these showed a combination of a malignant and benign histology.

CONCLUSIONS: A majority (62%) of the hybrid tumors reviewed in this analysis were pT1a. Approximately 30% of these tumors contained a benign component mixed with a malignant component. This finding should be taken into consideration when interpreting a benign renal biopsy for a small renal mass. A larger analysis with more masses needs to be completed to validate the above findings.

Source of Funding: none

OPEN IN VIEWER

MP1B BASIC RESEARCH: UROLITHIASIS

MP1B-04 CHANGING TRENDS IN AMERICAN DIET AND THE RISING PREVALENCE OF KIDNEY STONES

Fabio Torricelli*, Shubha De, XIaobo Liu, Manoj Monga, Cleveland, OH

INTRODUCTION AND OBJECTIVES: It has been postulated that changing dietary habits may play a role in the prevalence of nephrolithiasis. The United States Department of Agriculture (USDA) annually accounts for all food available for human consumption (adjusting for export, spoilage, waste, etc). Our objective was to evaluate changing trends in the American diet from 1974–2010 and to identify whether caloric intake and the consumption of lithogenic foods has been rising.

METHODS: Prevalence values from NHANES survey data, were compared to USDA data on food distribution during the same period (1974–2010). Three data points for prevalence spanning 38 years were used from the literature to create two linear models, interpolating the yearly increase in stone prevalence. Changes in lithogenic foods were then correlated with increasing stone prevalence.

Spearman correlations were performed (p<0.05), using SAS 9.2.

RESULTS: Increased total daily calories (Rho 0.96, CI 0.86–1.00, p<0.001), fat grams (Rho 0.79, CI 0.55–1.00, p<0.001), protein ounces (Rho 0.85, CI 0.67–1.00, p<0.001), and fruit/vegetable (Rho 0.73, CI 0.49–0.97, p<0.001) correlated strongly with the annual increase in stone prevalence. Specific foods also showed strong correlations with stone prevalence, including dark green vegetables, flour/cereal products, fish/shellfish, corn products (including high fructose corn syrup) and added sugars. Citrus juice was negatively correlated to stone disease (Rho −0.18, CI −0.52–0.17, p=0.31) though not significant.

CONCLUSIONS: Several lithogenic components correlate temporally with the simultaneous increase in stones. Whether these correlations are incidental or causal is difficult to determine. The American diet has clearly changed over the last four decades and further investigation is required to better evaluate how this may impact the national prevalence of nephrolithiasis.

Source of Funding: none

OPEN IN VIEWER

MP1B-07 DEVELOPMENT OF A NOVEL ACCESS SHEATH THAT ALLOWS SIMULTANEOUS SHEATH PLACEMENT AND SAFETY WIRE ACCESS

Yung tan*, Doh Cha, Edan Shapiro, Ciara Marley, Mantu Gupta, New York, NY

INTRODUCTION AND OBJECTIVES: Ureteral access sheaths (UAS) have been shown to facilitate repeated access to the ureter and intrarenal collecting system, reduce intrarenal pressures, decrease operative times, and improve visibility. It remains a general dictum to have a safety guidewire when using access sheaths. In order to harness the advantages of both UAS and safety guidewire access, we are helping with the development of a novel prototype with Cook Medical (Bloomington, IN) that establishes safety wire access and sheath placement simultaneously.

METHODS: Three possible Flexor Parallel Ureteral Access Sheath (FPUAS) (Cook Medical, Bloomington, IN) prototypes; a narrow slit, a wide slit and a spiral slit, were evaluated with 3 types of 0.035” access wires; a standard guidewire, a super-stiff guidewire, and a glidewire, in a porcine kidney/ureter/bladder model (Sierra Medical Sciences Inc, Whittier, CA). Both FPUAS and control sheath were engaged and advanced to target in a co-axial manner, the force required to advance was quantified using a digital pressure sensor (Percsys, Palo Alto, CA). Ability of the prototype to stay on the access wire, ease of deployment and ureteroscopy of collecting system were assessed.

RESULTS: Altogether 20 trials were performed. It was found that only the narrow slit with a super stiff wire was 100% successful in all attempts at insertion of the flexor parallel access sheath. There were no cases of wire slippage when this configuration was used. The spiral prototype was the most challenging as it would catch the wire and drag it along in the ureter leading to failure of sheath advancement. The wide slit had the lowest advancement force (0.71 lbs) but any advantage was negated by failed insertions as the access sheath slipped off the wire in 100% of the trials. Advancement forces for the narrow slit prototype were found to be about 5 times higher than with a standard access sheath but not clinically significant (2.59 lbs vs 0.51 lbs). Flexible ureteroscopy in all cases did not reveal any significant trauma to the porcine ureters.

CONCLUSIONS: The narrow slit prototype was the most successful prototype. FPUAS facilitates safe simultaneous placement of ureteral access sheath and a safety wire. Further evaluations will have to be carried out to determine its effectiveness in humans.

Source of Funding: none

OPEN IN VIEWER

MP1B-08 DISSOLUTION KINETICS OF URIC ACID STONES IN RELATION TO URIC ACID SOLUTION CONCENTRATION. AN IN VITRO STUDY

Itay Sagy*, Bezalel Sivan, Petach Tikva, Israel, Ruth Frid, Ytzhak Mastai, Ramat-Gan, Israel, Pinchas M. Livne, David Lifshitz, Petach Tikva, Israel

INTRODUCTION AND OBJECTIVES: Dissolution by oral medications is the treatment of choice for non-obstructing renal uric acid (UA) stones. The major goal is urine alkalization, preferably to pH 6.5–7.0. Data on the effect of lowering the urine uric acid concentration on the chemolitholysis rate of uric acid stones are sparse. According to current practice, allopurinol is indicated for hyperuricosuria and its impact in the common uric acid stones former, who have a normal-range urine uric acid concentration, is unknown. The aim of this in vitro study was to evaluate the dissolution kinetics of pure uric acid stones in several alkaline solutions (pH 6.8) with various concentrations of uric acid.

METHODS: Whole and fragmented stones were obtained during percutaneous nephrolithotomy – PCNL and examined for crystalline structure by X-ray diffraction. Time-Resolved UV-Visible spectroscopy (wavelength 290 nm) was used to measure the dissolution kinetics of the uric acid stones, which are proportional to the rate of change in uric acid concentration in the solution. Solutions containing zero, normal-physiologic, and high concentrations of uric acid were tested (0, 50, 80, and 130 mg/dl).

RESULTS: Figure 1 shows that as the concentration of uric acid decreases, the dissolution rate of the uric acid stones increases. This effect was more significant for the lower range of concentrations. The most dramatic change was observed at uric acid concentrations of 0 to 50 mg/dL, which were associated with a tripling of the dissolution rate.

CONCLUSIONS: Lowering the urine uric acid concentration, even within the normal range (31–91 mg/dL), greatly enhances uric acid stone dissolution in vitro. This finding may suggest a benefit for allopurinol also in patients with normal uric acid levels. Further clinical trials are needed to confirm these findings.

Source of Funding: none

OPEN IN VIEWER

MP1B-09 EFFECT OF HYDROPHILIC EXTRACT OF ALHAGI MAURORUM ON ETHYLENE GLYCOL-INDUCED RENAL STONE IN MALE WISTAR RATS

Sadrollah Mehrabi*, Yasuj, Iran, Farhad Mehrabi, Shiraz, Iran

INTRODUCTION AND OBJECTIVES: Alhagi maurorum is one of the herbal medicine that routinely use for passage of urinary stones. Aim of this study is defining the effect of hydrophilic extract of Alhagi maurorum on ethylene glycol-induced renal stone in male wistar rats.

METHODS: In this experimental study 40 male Wistar rat randomly allocated in four groups and studied during 30 days. Two groups of healthy and prophylactic control received usual water and 1% ethylene glycol in water respectively during study. Prophylactic groups of low dose and high dose extract in addition to 1% ethylene glycol in water daily gavaged with 500 mg/kg and 1000 mg/kg extract respectively. All rats was hold in metabolic cages in days 0,15 and 30 and 24 hours urine sample was taken. After 30th day rats anesthetized with ether and after taking serum sample from them for measurement of calcium, uric acid and creatinine they killed and their kidneys removed and send for pathology and were examined for presence and volume of calcium oxalate crystals.

RESULTS: There was no significant difference between complexes of oxalate calcium crystals between studied groups. also comparison of urinary oxalate in 30th day was showed that urinary oxalate concentration in preventive and negative control groups were significantly more than positive control group (p</05). urinary oxalate concentration in preventive groups were less than negative control that was significant (p<05).measurement of biochemical factors in 30th day was showed significant rising of serum creatinine in negative control group in comparison to positive control (p<05), but there was no significant difference between preventives groups with positive control.

CONCLUSIONS: Hydrophilic extract of Alhagi maurorum with regard to reduction in urinary oxalate concentration may be effective in prevention of urinary calcium oxalate stones in rat as a suitable model for human stones, although it has no significant effect in rate of calcium oxalate crystal formation.

Source of Funding: Medicinal Plant Research Center, Yasuj University of Medical Sciences

OPEN IN VIEWER

Histologic view of Calcium oxalate crystal in rat renal tubules:H × E stain Zoom 10 × 40

MP1B-14 IS LYMPHOCYTOPENIA A NEW MARKER FOR PYONEPHROTIC OBSTRUCTED KIDNEYS (POK) SECONDARY TO URINARY STONE DISEASE?

Ahmed Ali*, Liam Farrell, Bhaskar Somani, Southampton, United Kingdom

INTRODUCTION AND OBJECTIVES: Leucocyte abnormalities are seen in severe urinary infections. Lymphocytopenia has been used as a marker for infections and trauma. We wanted to see if it has significance in Pyonephrotic obstructed kidneys (POK) secondary to urinary stone disease.

METHODS: Between Aug 2009-Aug 2012, patients with POK requiring percutaneous nephrostomy (PCN) were reviewed. Clinical presentation, radiological findings, microbiological culture, renal function and final treatment outcome were recorded. Leukocyte, neutrophil, lymphocyte counts and CRP were extracted from the daily complete blood count (CBC). Lymphocytopenia was defined as lymphocyte count <1.5.

RESULTS: Thirty-nine patients with a mean age of 55 years (range:22–92) had PCN for POK. Lymphocytopenia was seen in 25/39 (64%) patients with a mean lymphocyte count of 1.3 (range: 0.1–3.8). Following PCN, it improved in majority of cases (87%) with severe lymphocytopenia (count <1) associated with a significant rise in CRP in all cases. Lymphocytopenia was also associated with positive urine/blood culture in nearly two-third of patients. The mean leucocyte count, neutrophil count and CRP were 14.3 (1.8–34.6), 11.6 (1.4–31.6) and 205 (4–483) respectively. Renal dysfunction was seen in 15 patients (60%) with lymphocytopenia and 6 patients (42%) with normal lymphocyte count. The mean stone size was 14 mm (4–50 mm) with half stones in the PUJ (n=13) or upper ureter (n=7).

CONCLUSIONS: Lymphocytopenia seems to be associated with the severity of infection and could be a surrogate marker for initial diagnosis and monitoring response to treatment in patients with pyonephrotic obstructed kidneys.

Source of Funding: Nil

Table. Inflammatory markers and stone details (Pre and Post Nephrostomy (N)

OPEN IN VIEWER

MP1B-17 EXTERNAL VALIDATION OF AN INDIVIDUALIZED WEIGHT-BASED GOAL URINE VOLUME (WGUV) MODEL INTENDED TO IMPROVE EXPECTED CALIUM URINE CONCENTRATIONS

Jack Lambert*, Norfolk, VA, Nicole Miller, Nashville, TN, Justin Watson, Michael Fabrizio, Mark Sawyer, Norfolk, VA

INTRODUCTION AND OBJECTIVES: Current recommendations for urine volumes for stone prevention do not account for body size differences. A weight based goal urine volume (WGUV) model has been proposed as an alternative to a 2 L goal: WGUV=[0.466+0.0678*weight (kg)]/2.5 mM. This volume is intended to achieve a mean calcium concentration of 100 mg/L (2.5 mM) regardless of body weight. However, it remains to be externally validated in an adult patient population. The intent of this study was to assess the validity of the model in a larger external cohort.

METHODS: A retrospective database of 24-hour urine collections (Litholink) at our institution (EVMS) from 1/2006–8/2012 was established. Only the first urine volume for each patient was included. Excluded were patients with Cr/kg ratio outside the gender appropriate reference range and cystinurics. For each patient was then calculated actual calcium concentration and expected calcium concentrations using a goal volume of 2 L or WGUV. Actual and expected concentrations were compared.

RESULTS: Of 2956 stone forming patients, 1444 patients met study inclusion (M=831; F=613). Median age was 51 (18–91). Median weight was 83.9 kg (40.8–188.7 kg) with a median BMI of 28.0 (15.0–56.4). Mean actual urinary [Ca] was 142.9 (±77.7) mg/L, which would be expected to improve to 114.6 (±62.0) mg/L with a 2 L goal and to 92.8 (±46.4) mg/L with WGUV (Figure). Thus, the expected mean calcium concentration was 7.2% lower than the intended goal calcium concentration for WGUV in our cohort. Expected urinary [Ca] was also significantly lower using the WGUV as compared to a 2 L goal (p<0.0001). Median measured 24-hour urine volume was 1.66 L (0.356–5.05 L) whereas median WGUV was 2.46 L (1.29–5.30).

CONCLUSIONS: Evaluation of the WGUV model in a larger external data set demonstrates a slightly larger expected improvement in mean calcium concentration for WGUV relative to a 2 L goal urine volume than in the original cohort. This study appears to support the validity of the original model as well as the concept of adjusting goal urine volume for weight.

Source of Funding: none

OPEN IN VIEWER

MP1B-23 RADIATION EXPOSURE IS 2.6 FOLD HIGHER AT ENDOSCOPIC LITHOTRIPSY VERSUS SWL

Yoram I. Siegel, Shmuel Roizman*, sigalit Haruz-Waschitz, Zerifin, Israel, Avi Ben-Shlomo, yavne, Israel, David Yudelevich, Amir Cooper, Yaniv Shilo, Amnon Zisman, Zerifin, Israel

INTRODUCTION AND OBJECTIVES: All common stone therapies are performed under fluoroscopy guidance. On one hand there is a trend towards radiation-less endoscopic lithotripsy and on the other a call to increase SWL effectiveness by increase the frequency of focus repositioning during the procedure. The purpose of this study is to asses and compares the extent of radiation exposure of patients during endoscopic lithotripsy and SWL.

METHODS: Measurements of dose-area product (DAP) were performed in 47 (44%) patient who underwent endoscopic lithotripsy and 59 (56%) who underwent SWL. For SWL an exterior DAP-meter was assembled to the C-arm whereas for endoscopic lithotripsy the C-arm includes a built in DAP meter. A baseline Coefficient factor was determined for devices coordination. Demographic and clinical data were collected including age, sex, body mass index (BMI) as well as size and location of stone.

RESULTS: (see table)

CONCLUSIONS: The crude average radiation exposure is significantly higher during one session of endoscopic lithotripsy compared with SWL. Further effectiveness studies are warranted taking into consideration additional factors such as success rate and frequency of redo and ancillary procedures. More accurate information on the risk of radiation exposure may gain access to clinical decision making for these particular procedures.

Source of Funding: none

OPEN IN VIEWER

MP1B-25 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR RENAL CALCULI: A REVIEW OF 4041 CONSECUTIVE CASES DONE OVER 20 YEARS

Jitendra Jagtap*, Raguram Ganesamoni, Jigish Vyas, Shashikant Mishra, Arvind Ganpule, Ravindra Sabnis, Mahesh Desai, Nadiad, India

INTRODUCTION AND OBJECTIVES: Extracorporeal shock-wave lithotripsy (ESWL) remains a commonly utilized treatment modality for renal calculi. We reviewed the data of 4041 consecutive patients undergoing ESWL for renal calculi at our centre.

METHODS: We retrospectively reviewed clinical data for patients who had undergone ESWL for treatment of renal calculi from 1989 to 2012 at our tertiary referral centre in Western India. We analysed patient age, gender, stone size, location, comorbidities, postoperative complications, additional interventions and anatomical parameters of these patients.

RESULTS: The average age was 39.40±14.32 years. The Male: Female ratio was 2.64:1. Average Stone size was 1.34±0.55 cm with the left:right side ratio being 0.96:1.00. The average Hounsfield unit on CT scan was 1159.65±315.90 HU. 11.71% patients had comorbidities. The average number of shocks received were 2537 and the mean fluoroscopy time in our study was 240.86±146.10 sec. A total of 136 patients (3.36%) had complications ranging from fever to perinephric hematoma. 165 patients (4.0%) required an auxillary procedure. The overall success rate was 88.0 %.

CONCLUSIONS: Our long-term review of ESWL for renal calculi demonstrates that it is a safe, feasible treatment with good success rates in appropriately selected patients.

Source of Funding: none

Stone Clearance by Size

OPEN IN VIEWER OPEN IN VIEWER

Number of ESWL Sittings

OPEN IN VIEWER

MP2A BASIC RESEARCH: LOWER TRACT PHYSIOLOGY

MP2A-06 URINE CONCENTRATIONS OF AQUAPORIN-1 AND PERILIPIN-2 NORMALIZE IN PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING EXCISION OF TUMORS

Jonathan Mobley*, Jeremiah Morrissey, Sam Bhayani, Joseph Song, Joel Vetter, Evan Kharasch, Robert Figenshau, St. Louis, MO

INTRODUCTION AND OBJECTIVES: The purpose of this investigation is to evaluate the screening properties of Aquaporin-1 (AQP1) and Perilipin-2 (PLIN2) in patients with clear cell and papillary renal cell carcinoma (RCC).

METHODS: Western blot procedures determined the pre-operative urine AQP1 and PLIN2 levels of 61 patients undergoing either a partial or a radical nephrectomy for clear cell or papillary RCC. Concentrations of these markers were compared with 43 controls of equivalent age, sex, weight, smoking history, and estimated glomerular filtration rate. Post-operative urine concentration of both markers were obtained from RCC patients following tumor excision and compared to pre-operative samples and controls.

RESULTS: The median urine AQP1 for RCC and controls was 53 and 1.5 absorbance units/mg creatinine (p<0.001). The median urine PLIN2 for RCC and controls was 59 and 6 absorbance units/mg creatinine (p<0.001). The sensitivity and specificity for AQP1 was both 100%, and for PLIN2 was 92% and 100%. Figure 1 shows the trends in AQP1 and PLIN2 following either partial or radical nephrectomy. Post-operative AQP1 and PLIN2 levels in the RCC group was similar to the pre-operative concentrations in the controls.

CONCLUSIONS: Urine AQP1 and PLIN2 displayed both excellent sensitivity and specificity to distinguish RCC patients from controls in this retrospective, cohort study. The normalization of marker concentrations following tumor excision further supports the concept that RCC causes elevations in urine AQP1 and PLIN2.

Source of Funding: Funding is from two grants R01CA141521 and the Barnes Jewish Hospital Foundation.

OPEN IN VIEWER

FIG. 1.

Pre- and post-nephrectomy urine levels of AQP1 and PLIN2 in 47 patients with clear cell or papillary renal cell carcinoma.

MP2A-09 IMPACT OF RHO-KINASE INHIBITOR HYDROXYFUSIDIL IN PROTAMINE SULPHATE INDUCED CYSTITIS IN RATS

Yigit Akin*, Aliseydi Bozkurt, Erzincan, Turkey, Huseyin Serkan Erol, Mesut Halici, Fikret Celebi, Kubra Asena Kapakin Terim, Erzurum, Turkey, Hakan Gulmez, Ankara, Turkey, Mutlu Ates, Afyonkarahisar, Turkey, Taha Abdulkadir Coban, Baris Nuhoglu, Erzincan, Turkey

INTRODUCTION AND OBJECTIVES: Interstitial cystitis (IC) is defined as unpleasant sensations, such as pain, pressure and discomfort, perceived in relation to the bladder and lower urinary tract, with symptoms lasting for six weeks or longer in the absence of infection or any other confirmed causes. The aim of this study was to investigate the prevention of detrusor overactivity and also bladder tissue damage with hydroxyfasudil in protamine sulfate (PS) induced cystitis rat model in vivo and in vitro.

METHODS: Animals were divided into four groups. IC model was created by administrating PS intravesical for three days. At the end of the third day, Rhokinase (ROCK) inhibitor hydroxyfasudil or a corresponding volume of saline was administrated intraperitoneally. There were eight animals in each group. Group 1: PS and hydroxyfasudil were administrated. Group 2: PS and saline were administrated. Group 3: hydroxyfasudil was administrated intraperitoneal. Group 4 was the control group, PS and hydroxyfasudil were not administered. Invivo micturition behaviors were recorded. Invitro contractions of bladder tissue strips were measured in tissue-bath by administering acetylcholine (Ach) and potassium chloride (KCl). Concentration response curves were obtained. Biochemical analyses were performed for oxidative stress and pathological evaluations were investigated.

RESULTS: The mean weight of animal experiments was 280.2 g (±30,1). There was significantly higher frequency of micturition, lower volume and total urine output after PS administration in groups 1 and 2. Invitro contraction responses of bladder strips to KCl and Ach were statistically higher in Group 2 than other groups. Additionally, lower contraction response to KCl that was statistically significant was obtained in Group 3. Moreover, pathological and biochemical analyses supported our findings (figüre).

CONCLUSIONS: Hydroxyfasudil decreased invitro responses to contractions of bladder smooth muscle strips. Moreover, significant reduction of inflammation by affecting the anti-oxidant defence systems was provided with hydroxyfasudil which can be a potential new therapeutic option for OAB and inflammation in IC.

Source of Funding: None

OPEN IN VIEWER

MP2A-10 THE RECLASSIFICATION OF PREOPERATIVE HIGH RISK PROSTATE CANCER PATIENTS AFTER ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY

Vladimir Mouraviev*, Matt Kardjian, Po Lam, Angelo Rosalio, Elan Salzhauer, Harvey Sauer, Syracuse, NY, Matvey Tsivian, Durham, NC, Christopher Pieczonka, Jeffrey Sekula, Ilija Aleksic, David Albala, Syracuse, NY

INTRODUCTION AND OBJECTIVES: The most commonly used definition criteria for prostate cancer risk-stratification (D'Amico and Epstein) do not necessarily reflect the complexity and biological behavior of this disease. They include tissue diagnosis data (biopsy results) along with clinical (clinical stage) and biochemical parameters (PSA level). The aim of this study was to compare histologic high risk features preoperatively with final pathology results.

METHODS: 30 (5.5%) patients from 550 consecutive RALP cases performed from 2009 to 2011 had a high-risk features based on D'Amico-Epstein definition based mostly on biopsy histology data (Gleason Score ≥8, pT3 or positive lymphatic nodes). These pathological results were compared with final pathological results after RALP.

RESULTS: Of 30 patients who had high Gleason grade on biopsy (≥8), 15 (50%) were reclassified to lower risk based on final pathology (Gleason<8, organ-confined disease and negative lymph nodes). Patients with lower biopsy Gleason score were more likely to be down-staged (67% for Gleason 8, 17% in Gleason 9 and 0 in Gleason 10, p<0.05) (Table 1). Similarly, lower preoperative PSA levels and fewer positive cores were associated with increased likelihood of reclassification (p<0.05) (Table 1).

CONCLUSIONS: 50% of men with preoperatively high-risk prostate cancer were reclassified to a lower risk category upon final pathological results. Histopathologic features alone may guide clinicians away from definitive treatment such RALP. In the future, we believe more comprehensive pre-procedurual staging including advanced imaging as well as molecular and genetic testing to better correlate risk of recurrence.

Source of Funding: none

OPEN IN VIEWER